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Summary 
 New insights have revealed the complex and heterogeneous nature of reward-related behaviours: not 
only are different aspects of reward (e.g. reward 'liking' and 'wanting') subserved by dissociable neural 
mechanisms, but they are differentially expressed across major psychiatric disorders.  The aim of this thesis was 
to investigate discreet reward-related processes, pertaining to the hedonic and cognitive processing of rewards, 
in relation to schizophrenia and depression preclinical models.  The Methylazoxymethanol acetate (MAM) 
neurodevelopmental model of schizophrenia and the Wistar Kyoto (WKY) inbred depression model were chosen 
based on their good face and construct validities to the clinical conditions.  Microstructural analysis of licking in 
simple drinking and contrast situations were used to investigate the constructs of consummatory and anticipatory 
anhedonia in these models.  Whilst MAM-treated rats showed no behaviours indicative of consummatory or 
anticipatory anhedonia, WKY rats showed generally lower consummatory and palatability responses to sweet 
solutions and failed to suppress their palatability responses to a contrasted solution (when a preferred solution 
was expected).  Therefore, WKY rats demonstrated behaviours analogous to deficits in both consummatory and 
anticipatory aspects of hedonic processing.  To investigate cognitive processing of rewards, outcome devaluation 
and differential outcome paradigms were adopted, but no impairments on either task were found for the MAM 
model.  In contrast, WKY rats were insensitive to post-conditioning changes in reward value and did not benefit 
from stimulus-correlated outcomes during the acquisition of a conditional discrimination task.  Therefore, WKY 
rats do not appear to use the nature and /or value of rewards to guide their behaviours in the same manner as 
controls.  In short, MAM-treated animals did not display the hedonic deficits or impaired instrumental behaviours 
expected for a comprehensive schizophrenia model.  In contrast, the WKY inbred rat strain appears to be 
suitable in investigating manifestations of clinical depression in respect to reward-processing deficits. 
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Chapter One 
1. General Introduction 
1.1 Hedonia and Reward Processing 
 The term 'hedonia' comes from the ancient Greek word for pleasure ('hedone'), which in turn 
is derived from the sweet taste of honey ('hedus') (Berridge & Kringelbach, 2015; Rømer Thomsen, 
Whybrow & Kringelbach, 2015). From an evolutionary perspective, the ability to experience pleasure 
is essential (Rømer Thomsen et al., 2015).  Described by some as 'evolutions boldest trick' (p.230), it 
ensures that individuals engage in fundamental behaviours, such as food intake and procreation, that 
are necessary for the survival of the individual and of the species (Kringelbach & Berridge, 2009).  
Yet, despite its adaptive function, a significant proportion of the general population lack the ability to 
experience pleasure as a symptom of psychiatric and neurological disorders (Rømer Thomsen et al., 
2015).   
 The term Anhedonia (or anhedonie) was coined by Ribot, a French psychologist, in 1896, 
stating that "there are, undoubtedly, clinical cases characterised by the isolated lack of pleasure, that 
render these patients absolutely unable to find gratification from any sexual activity, food, relation or 
affection" (Ribot, 1896, as cited in Pelizza, Pupo & Ferrari, 2012).  Ribot's original definition of 
anhedonia, as an 'inability to experience pleasure', has remained largely unaltered over the last 
century (Rømer Thomsen et al., 2015).  However, there is now a growing understanding of the 
complexities of hedonia and how they relate to the processing of rewards (e.g. Der-Avakian &Markou, 
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2012).  As will be discussed in detail below, considerations of reward-related deficits in the clinical 
context of psychiatric disorders suggests that anhedonia it is not simply a unitary construct related to 
the isolated loss of subjective experiences of pleasure, as Ribot's definition would imply.   
 While the term anhedonia does not directly reflect the multifaceted nature of reward-related 
deficits, it has been retained as a general descriptor of maladjusted reward processing – including 
problems relating to motivation and learning as well as the hedonic experience.  The empirical work 
reported in this thesis will focus on the assessment of behavioural responses and learning related to 
rewarding stimuli in selected rat-based models of human psychiatric disorders – in particular 
schizophrenia and depression.  This focus on rodent models in the context of hedonic experience 
raises the question of whether the subjective states of non-humans are amenable to scientific study.  
At the risk of dismissing a venerable tradition of philosophical discourse (see for example Nagle’s 
(1974) classic work “What is it like to be a bat”), I will merely note that I will concentrate on objectively 
observable responses.  The fact that that these behavioural measures are lawfully related to the 
stimulus environment that the rodents are studied in means that these measures provide information 
about the factors controlling the animals’ behaviour (for a more detailed analysis of this issue, see 
Dwyer, 2012). 
1.2 Neurobiological Underpinnings of Hedonia and Reward Processing 
 Before considering the clinical background to my empirical work, I will first outline some of the 
neurobiological underpinnings of reward processing and hedonic reactions.  Affective neuroscience 
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has begun to tease apart the underlying brain circuits that serve different aspects of rewarded 
behaviour.  Here I will focus on just two aspects of reward to highlight that different reward-related 
processes have, at least partially, dissociable neural circuitry.  Despite the growing understanding of 
the complexities of hedonia, a full understanding of the underlying neurobiology is still lacking.  Much 
of the current research has focused on modified orofacial behaviours in rats (see section 1.5.1 for a 
detailed description of this taste reactivity procedure) in response to neurochemical or neurobiological 
manipulations.  This approach has led to the identification of localised regions in the rodent brain that, 
in consequence to certain stimulations, causally amplify the number of 'liking' reactions that are 
elicited by palatable tastes.  Such discrete subregions of the brain, or hedonic 'hotspots', have been 
shown to exist in limbic-related structures - such as the nucleus accumbens (NAc), ventral pallidum 
(VP) and in the parabrachial nucleus of the brain stem (Berridge & Kringelbach, 2015).   
a. Hedonic hotspots in the rodent brain 
 While orofacial reactions are elicited by sensorimotor circuitry in the brainstem (e.g. Grill & 
Norgren, 1978a), such hedonic 'liking' responses are not mere brainstem reflexes (as reviewed by 
Berridge & Kingelbach, 2015).  Critically, hedonic responses to a given taste are modified by forebrain 
structures, thus allowing appropriate modulation by an animal's physiological state (hunger vs. 
satiation) and prior associative learning (learnt preferences vs. aversions).  In particular, enhanced 
orofacial 'liking' responses are seen after direct stimulation of the NAc hotspot, positioned rostrally in 
the medial shell, by microinjections of opioid receptor agonists (mu, delta and kappa opioids) (Castro 
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& Berridge, 2014a; Peciña & Berridge, 2005; Smith, Berridge & Aldridge, 2011) and 
endocannabinoids (such as anandamide, an endogenous ligand for cannabinoid CB1 receptors) 
(Mahler, Smith & Berridge, 2007).  Microinjections in all other sites of the NAc fail to have any effect, 
whereas stimulation of more caudal areas of the medial shell (in a so-called hedonic 'coldspot') 
actually suppresses the palatability responses that would normally be elicited by sweet tastes (Castro 
& Berridge, 2014a).  Similarly, microinjections of mu opioids (Smith & Berridge, 2005) or orexin-A (Ho 
& Berridge, 2013) into a caudal hotspot of the VP result in enhanced hedonic impact of palatable 
solutions (see also Castro & Berridge, 2013, for an optogenetic confirmation of the location of this 
effect).  Again, stimulation outside this localised region of the VP fails to enhance hedonic reactions 
(Ho & Berridge, 2013; Smith & Berridge, 2005), while stimulation of the rostral coldspot of the VP can 
even suppress hedonic responses (Smith & Berridge, 2005).  Interestingly, both excitotoxin lesions 
and temporary inhibition of the VP hotspot not only disrupt hedonic 'liking' reactions to sweet tastes 
but replace them with aversive 'disgust' reactions (Cromwell & Berridge, 1993; Ho & Berridge, 2014).  
Indeed, it has now been shown that the negative 'disgust' reactions to food thought to be brought 
about by lesions of the lateral hypothalamus were actually due to these lesions incorporating the 
caudal aspects of the VP (as reviewed by Berridge & Kringelbach, 2015). 
 With regards to the brainstem, there is evidence suggesting a hotspot region in the pontine 
parabrachial nucleus (PBN), where GABA (γ-aminobutyric acid)-benzodiazepine mechanisms 
influence hedonic processing (Söderpalm & Berridge, 2000).  As reviewed by Castro and Berridge 
(2014b), systemic injections of the benzodiazepine drug, chlordiazepoxide, which enhances hedonic 
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'liking' in normal rats, has been shown to enhance 'liking' reactions in decerebrate rats.  Microinjection 
of the benzodiazepine, diazepam, into the fourth ventricle of the brain-stem in 'intact' rats has also 
been shown to enhance 'liking' reactions to sucrose.  Finally, microinjections of midazolam, another 
benzodiazepine, into the lateral PBN of normal rats enhances the 'liking' reactions elicited when 
consuming sweet sucrose solutions. 
 In terms of the circuitry underlying hedonic processing, neural projections exist between NAc, 
VP and PBN structures but not directly between the specific hotspots located within these structures 
(reviewed by Castro & Berridge, 2014b).  Regardless, it has been shown that NAc and VP at least 
share a reciprocal functional connection.  c-Fos (an indirect marker of neuronal activity) expression 
studies have shown that stimulation of one of the two hotspots can lead to mutual recruitment of the 
other (Smith & Berridge, 2007) and blocking one hotspot (e.g. using an opioid receptor antagonist 
such as naloxone) whilst simultaneously stimulating the other (i.e. with a mu opioid agonist) does not 
lead to the enhanced 'liking' reactions that would otherwise be expected (see Castro & Berridge, 
2014b, for a review). 
b. Tentative hedonic hotspots 
 In addition to the three subcortical limbic structures, there is emerging evidence to suggest 
further hedonic hotspots in the limbic areas of the prefrontal cortex, including the orbital frontal cortex 
(OFC) and insula (see Berridge & Kringelbach, 2015).  Similar to NAc and VP hotspots, it has been 
suggested that stimulating opioid or orexin systems in specific subregions of each structure, amplifies 
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the number of 'liking' reactions elicited by sweet solutions (as reviewed by Berridge & Kringelbach, 
2015).  This needs to be confirmed but would be consistent with human functional magnetic imaging 
(fMRI) studies which suggest that the OFC (at a mid-anterior site) codes for the subjective liking of 
pleasant stimuli on the basis of correlations with changes in subjective hedonic ratings produced by 
satiety manipulations (Kringelbach, O'Doherty, Rolls & Andrews, 2003).  Whilst this study does hinge 
upon subjective ratings of pleasure rather than direct and objective behavioural responses, it does 
support a role for the OFC in tracking hedonic changes in a similar fashion to the NAc, VP and PBN, 
especially when combined with the preliminary analysis performed in rodents. 
 The striatum (including the NAc hotspot) also recieves input from the amygdala, a structure 
divided into multiple subnuclei including the central (CeA) and basolateral amygdala (BLA) (as 
reviewed by Cardinal, Parkinson, Hall & Everitt, 2002).  Whilst this subcortical structure has long been 
implicated in emotional processes (Klüver & Bucy, 1939; Weiskrantz, 1956), primarily the processing 
of fear-related stimuli (e.g. Adolphs, Tranel, Damasio & Damasio, 1995; LeDoux, 1995), its role in 
reward processing is less clear.  Amygdala neurons respond to biologically salient rewards, including 
the anticipation (O'Doherty, Deichmann, Critchley & Dolan, 2002) and receipt (O’Doherty, Rolls, 
Francis, Bowtell & McGlone, 2001; Scott, Karadi, Oomura et al., 1993, but see O'Doherty et al., 2002) 
of pleasant tastes.  Amygdala lesions (i.e. of the BLA) cause animals to become insensitive to the 
devaluation of a reward (e.g. Balleine, Killcross & Dickinson, 2003; Hatfield, Han, Conley, Gallagher & 
Holland, 1996) and impair pavlovian and instrumental forms of appepitive conditioning (with 
dissociable effects seen between the BLA and CeA) (See Baxter & Murray, 2002, for a review).  
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However, studies have shown that opioid stimulations (i.e. by the microinjection of the mu opioid 
agonist DAMGO), which enhance hedonic 'liking' in hotspot regions, do not increase the 'liking' or 
palatabality of rewards when administered to the BLA or CeA (Mahler & Berridge, 2012).  One 
influential analysis is that the role of the amygdala in reward processing is to underpin the association 
between neutral environmental cues (Conditioned Stimuli or CSs) and the motivationally significant 
events they predict (Unconditioned Stimuli or USs).  More precisely, it is thought that the BLA 
supports learning about the specific sensory properties of the US, while the CeA supports learning 
about the general affective valence of the US (e.g. Balleine & Killcross, 2006; Killcross, 2000).   
c. Reward liking vs. reward wanting 
 Whilst 'liking' is fundamental to reward, another component is reward 'wanting' or the 
motivation towards a reward.  Reward 'wanting' and 'liking' where once thought to be intrinsically 
linked - you want what you like and vice versa.  However, it is now known that this is not necessarily 
the case.  For example, early in drug abuse, 'liking' and 'wanting' are closely correlated, but increased 
'wanting' in the absence of increased 'liking' characterises drug addiction (Robinson, Robinson & 
Berridge, 2013).  It has also been shown that motivational aspects of the reward are served by 
dissociated neuroanatomical structures and different neurochemical mechanisms.  For example, while 
stimulations of the amygdala do not enhance 'liking' (see above), they can increase the incentive 
salience or motivation to obtain rewards (e.g. DAMGO stimulation of the CeA enhances food 
consumption) (Mahler & Berridge, 2009). 
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 Returning to the NAc hedonic hotspot, microinjection of mu and delta opioids not only amplify 
'liking' reactions towards a reward, but also increase eating behaviour and food intake of that reward 
(Castro & Berridge, 2014a; Peciña & Berridge, 2005).  In contrast, microinjections of other regions 
outside the hotspots of the structure, which have no effects on 'liking', still amplify core 'wanting' 
reactions when stimulated by mu opioids (e.g. Castro & Berridge, 2014a).  Moreover, mu opioid 
stimulation of the hedonic coldspot can enhance 'wanting' for a reward, even though it actively 
suppresses 'liking' (Castro & Berridge, 2014a).  This goes at least some way towards demonstrating 
the differences in brain circuitries underlying these two components of reward, even when focusing on 
the same brain structures and neurochemical mechanisms (for a comprehensive review of the 
neurobiology of liking and wanting see Castro & Berridge, 2014b).  Intriguingly, co-recruitment of the 
NAc-VP circuits appears to be necessary for enhancing 'liking' (see above), whereas the 
simultaneous co-operation of the dual hotspots does not appear necessary for appetitive 'wanting'.  
While enhanced 'liking' by microinjecting DAMGO into the NAc hotspot was blocked by simultaneous 
infusion of naxolone into the VP hotspot, 'wanting' stimulation produced by DAMGO in the NAc 
hotspot was preserved.  This dissociation demonstrates that enhanced 'wanting' can occur 
independently of enhanced 'liking' even from the same anatomical location (as reviewed by Richard, 
Castro, DiFeliceantonio, Robinson & Berridge, 2013). 
 Whilst the neuroanatomical location helps dictate whether or not 'wanting' reactions will be 
enhanced, the neurochemicals by which those structures are stimulated is also critical.  As well as 
opioid stimulation increasing wanting when injected into the NAc hotspot, dopamine agonists and α-
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amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPA-R) antagonists have been 
shown to enhance wanting to a similar degree (Faure, Richard & Berridge, 2010; Smith et al., 2011). 
 Focusing on the role of dopamine, it must be conceded that this neurotransmitter was once 
referred to as the pleasure substrate: dopamine junctions represent a "synaptic way station"... where 
"sensory inputs are translated into the hedonic messages we experience as pleasure, euphoria, or 
'yumminess'" (p. 94, Wise, 1980). However, more recent evidence suggests that dopamine is 
relatively uninvolved in the hedonic impact of rewards, instead being critical for incentive salience or 
motivation (i.e. core 'wanting') (Berridge & Robinson, 1998).  Indeed, studies have shown that 6-
hydroxydopamine (6-OHDA) lesions of the nigrostriatal and mesolimbic circuits (which greatly reduce 
dopamine levels in these systems) do not impact on a rodents' palatability responses to sucrose 
(Berridge & Robinson, 1998; Berridge, Venier & Robinson, 1989).  Similarly, patients suffering from 
Parkinson's disease, who suffer from greatly depleted dopamine levels, give similar hedonic ratings to 
sweet tastes compared to healthy control subjects (Sienkiewicz-Jarosz, Scinska, Swiecicki et al., 
2013).  Mutant mice, which over-express striatal dopamine D2 receptors (D2R-OE), show similar 
hedonic reactions to appetitive stimuli compared to controls (Ward, Simpson, Richards, Deo, Taylor, 
Glendinning, Kandel & Balsam, 2012).  Futhermore, human studies have shown that an increase in 
dopamine as a result of L-DOPA administration does not increase a person's subjective hedonic 
ratings to pleasant stimuli (Liggins, Pihl, Benkelfat & Leyton, 2012).  In terms of the incentive salience 
of rewards, however, dopamine appears to have a critical role.  It has been shown that D2R-OE mice 
are less willing to work for a preferred reward in an effort related choice paradigm, instead opting to 
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consume a freely available but less preferred reward (Ward et al., 2012).  Similar results (i.e. 
decreased lever pressing but increased chow intake) have also been observed for dopamine receptor 
antagonists as well as for NAc dopamine depletion (Cousins & Salamone, 1994; Salamone, Correa, 
Farrar & Mingote, 2007; Salamone, Steinpreis, McCullough, Smith, Grebel & Mahan, 1991).  In 
contrast, increases in dopamine have been demonstrated to enhance the incentive motivation 
towards rewards.  Hyperdopaminergic mutant mice (induced by knocking down dopamine transporter 
levels to 10%) have been shown to run more 'eagerly' down a runway towards a goal box containing a 
food reward, suggestive of increased incentive salience for that reward.  These mice displayed 
increased positive orofacial responses to increasing concentrations of sweet tastes, but  fewer total 
positive orofacial reactions to the highest (1.0 M) concentration of sucrose compared to their wild-type 
controls (Peciña, Cagniard, Berridge, Aldridge & Zhuang, 2003).  Such results are reminiscent of 
other studies, which showed that microinjection of amphetamine into the NAc also increased cue-
triggered wanting for a reward (as shown by a study using a Pavlovian-to-instrumental transfer 
paradigm) even though 'liking' of that reward was slightly decreased (Wyvell & Berridge, 2000).  This 
reiterates the independence between 'wanting' and 'liking' systems and highlights that, whilst 
dopamine does not have a central role in hedonic liking of a reward, it can induce some changes in 
'liking' behaviour, although sometimes in the opposite direction to original proposals.   
 By highlighting the differences between 'wanting' and 'liking' systems it becomes clear that 
different aspects of reward processing - hedonic or otherwise - are partially dissociated at 
behavioural, neuroanatomical and neurochemical levels.  As a result, the focus of this thesis is on 
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parsing out different aspects of reward processing and hedonics in relation to models of psychiatric 
disorders.  How hedonic processing, specifically, and reward processing, more generally, can be 
further sub-divided will be the focus of upcoming sections. 
1.3 Psychiatric Disorders and Anhedonia 
 Anhedonia has been observed in numerous neurological and psychiatric disorders, including 
mood disorders (e.g. Schrader, 1997), eating disorders (e.g. Davis & Woodside, 2002), psychosis 
(e.g. Blanchard & Cohen, 2006) and Parkinson's disease (as shown by a questionnaire assessment 
method, Isella, Iurlaro, Piolti et al., 2003), to name but a few.  Most critically for my current concerns, 
anhedonia has long been considered as a core symptom of schizophrenia and depression (e.g. 
Rømer Thomsen et al., 2015).  As has been seen in section 1.1 and section 1.2, reward-processing is 
multifaceted in nature and does not rely on a singular biological circuit.  Unfortunately, however, 
anhedonia has often been used as a blanket term inappropriately incorporating reward-processing 
deficits beyond pure hedonic capacity (e.g. Der-Avakian & Markou, 2012; Treadway & Zald, 2013).  It 
is only relatively recently that such nuances in reward-related processes have been considered in 
relation to disease. 
 The emphasis on anhedonia in the schizophrenia and depression literature, as opposed to 
other aspects of reward, primarily reflects a historical precedence (Treadway & Zald, 2013).  Patient 
populations have frequently complained about anhedonia, and diminished enjoyment has been 
captured through self-report and interview-based assessments (Treadway & Zald, 2013; Watson & 
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Naragon-Gainey, 2009).  Furthermore, patients with schizophrenia and depression display decreased 
goal-directed behaviour (e.g. Barch, Pagliaccio & Luking, 2015, Gard, Kring, Germans Gard, Horan 
&Green, 2007; Sherdell, Waugh & Gotlib, 2012), which at an intuitive level has been assumed to 
reflect decreases in hedonic capacity (Treadway & Zald, 2013).  However, with increases in our 
understanding of reward processing, together with affective neuroscience starting to tease apart 
reward-related processing at the level of the brain (e.g. Berridge & Kringelbach, 2008), efforts have 
been made to quantify enjoyment in isolation from other aspects of reward (e.g. Cohen & Minor, 2010; 
Dowd & Barch, 2010; Kring & Moran, 2008).  As has been seen above, decreases in the motivation or 
'wanting' of a reward does not necessarily mean an accompanying decrease in 'liking' for that reward.  
Whilst depression may include a reduced ability to experience pleasure together with a reduced ability 
to pursue pleasurable activities, the picture may be more complicated in schizophrenia (see Rømer 
Thomsen et al., 2015).  As will be discussed in section 1.3.2, there is increasing evidence to suggest 
that hedonic capacity is unaltered in schizophrenia with patients experiencing as much pleasure from 
potentially enjoyable stimuli, events and daily experiences as healthy controls.  If reduced motivation 
does not reflect reduced pleasure in this patient population then we need to understand the 
mechanisms that translate reward into reward-related behaviour and how these might be impaired.  
My empirical work will concentrate initially on distinguishing between consummatory and anticipatory 
aspects of hedonic reactions, in relation to schizophrenia and depression, and examine how these 
relate to the cognitive processing of rewarding events. 
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1.3.1 Overview of Schizophrenia 
 Schizophrenia (schizo = split, phrenia = mind) is a highly debilitating neuropsychiatric disorder 
that affects approximately 1% of the global population (Mueser & McGurk, 2004).  As a highly 
heterogeneous disorder, its clinical presentation is complex, including a range of behavioural traits 
that are by no means specific to the condition (NICE, 2009).  Due to this complexity, efforts have been 
made to group the symptoms into natural categories or domains, with the latest iteration grouping 
them into positive, cognitive and negative symptom clusters (Andreasen, 1995).  Positive symptoms 
refer to behaviours that are additional to normal human experience (i.e. 'gain of function').  They 
consist of hallucinations (often auditory), delusions (usually paranoid in nature) and aggressive or 
stereotyped behaviours.  These symptoms are amenable to the effects of currently available 
antipsychotic treatments (e.g. Pratt, Winchester, Dawson & Morris, 2012).  Cognitive symptoms 
include inattention, problems with executive control (such as rule learning and selection) and deficits 
in both working and long-term memory.  Negative symptoms refer to the lack of behaviours relative to 
normal human experience (i.e. 'loss of function'), and encompass blunted affect, anhedonia, avolition, 
poverty of speech and deficits in general social functioning.  These aspects of the disorder often 
present as prodromal symptoms before cognitive and positive symptoms arise, and can often persist 
after positive symptoms have subsided (Arango & Carpenter, 2011).  Unlike positive symptoms, both 
negative and cognitive aspects of the disorder are inadequately addressed by currently available 
medications (e.g. Pratt et al., 2012).  Moreover, they have been suggested to contribute more to poor 
functional outcome and quality of life in schizophrenia patients than do positive symptoms 
14 
(Rabinowitz, Levine, Garibaldi et al., 2012).  In light of this, the treatment of non-psychotic aspects of 
schizophrenia represents a vital unmet clinical need. 
 The aetiology and pathophysiology of schizophrenia is largely unknown.  It usually has a post-
pubertal onset, with emergence typically between 16 and 30 years old (Mueser & McGurk, 2004).  It 
affects males more than females, with the male to female ratio (median) in the order of 1.4:1 
(McGrath, Saha, Welham et al., 2004).  Moreover, males tend to have a more chronic form of the 
disorder (with a greater presentation of negative symptoms) and an earlier age of onset compared to 
females (Jablensky, 2000; Lewine, 1981).  At the broadest level, schizophrenia is thought to result 
from the complex interplay of environmental factors and biological pre-disposing factors (e.g. van OS 
& Kapur; van OS, Kenis & Rutten, 2010).  At the biological level, genetics, development and 
neurobiology have been identified as important contributory factors in the risk of developing 
schizophrenia (e.g. Mueser & McGurk, 2004).  At the environmental level, early environment, 
psychosocial factors and the use of recreational drugs also appear to cause or exacerbate symptoms 
(van OS et al., 2010; Mueser & McGurk, 2004).  Interestingly, both migration and living in urban areas 
increases the risk of schizophrenia (McGrath et al., 2004; McGrath, Saha, Chant & Welham, 2008).  
There is also increasing evidence to suggest that early insults to the brain can impact on 
developmental factors with a subsequent increase in the associated risk of schizophrenia in adulthood 
due to multiple effects on brain circuitries (Mueser & McGurk, 2004). 
 The most frequently confirmed neurobiological finding in schizophrenia, as shown by post-
mortem studies, is the enlargement of the lateral and third ventricles of the brain (Brown, Colter, 
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Corsellis et al., 1986; Pakkenberg, 1987).  Differences in the total volume of the frontal lobes, 
hippocampus, amygdala, temporal lobes and thalamus have also been identified (Bogerts, Meertz & 
Schönfeldt-Bausch, 1985; Brown et al., 1986; Lawrie & Abukmeil, 1998; Pakkenberg, 1992; Wright, 
Rabe-Kesketh, Woodruff, David, Murray & Bullmore, 2000).  As confirmed by meta-analyses, these 
changes in the volume of brain structures are accompanied by a reduced total brain volume (Wright, 
et al., 2000), and reduced total brain weight (of approximately 2%: Harrison, Freemantle & Geddes, 
2003).  Further evidence of neuropathology comes from increased cell packing density in the dorso-
lateral prefrontal cortex (Daviss & Lewis, 1995; Selemon, Rajkowska & Goldman-Rakic, 1995; 1998).  
What is more, many of these neuropathological findings, such as brain volume reductions and 
increased ventricle size, have been indentified in never treated patients and in unaffected 'at-risk' 
relatives (Fannon, Chitnis, Doku et al., 2000; McDonald, Grech, Toulopoulou et al., 2002, as cited in 
Mueser & McGurk, 2004).  This suggests that such pathologies are not secondary to chronicity of the 
disorder or to prolonged antipsychotic treatment (Mueser & McGurk, 2004). 
a. Dopamine hypothesis 
 From the discovery that psychostimulant drugs (such as amphetamine) increase neuronal 
dopamine levels and result in a psychotic state closely resembling schizophrenia, the dopamine 
hypothesis of the disease was established (as reviewed by Howes, McCutcheon & Stone, 2015).  
This hypothesis is greatly supported by the fact that all existing therapeutic drugs block dopamine (D2) 
receptors at least to some degree (as reviewed by Talbot & Laurelle, 2002).  Furthermore, 
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neuroimaging studies have revealed augmented dopamine synthesis and release, together with 
higher resting-state concentrations of dopamine in the synapse, during acute psychosis (Howes et al., 
2015; van Os & Kapur, 2009).  With mesolimbic dopamine involved in assigning motivational salience 
to events (both internal and external), Kapur (2003) has proposed that aberrant dopamine 
transmission in the schizophrenic brain causes patients to attribute abnormally high salience to 
internal representations - essentially generating hallucinations.  In turn, the delusions often associated 
with schizophrenia may be formed as the patient attempts to 'make-sense' of these abnormal 
experiences (as reviewed by Pratt et al., 2012). 
 Whilst there is support for dopamine dysfunction underlying the positive symptoms of 
schizophrenia, hyperactive dopamine in the brain cannot account for negative or cognitive symptoms.  
The revised dopamine hypothesis proposes a hyperdopaminergic tone (resulting in hyperactivation of 
D2 receptors) in mesolimbic circuits (including dopamine dysfunction in the amygdala and overactive 
dopamine systems in the hippocampus), but hypodopaminergic tone in mesocortical circuits (Brisch, 
Saniotis, Wolf et al., 2014).  Indeed, there is a well-established link between frontal dysfunction and 
the cognitive impairments exhibited by schizophrenia patients (Barch & Caeser, 2012).  That said, 
there is currently no direct (i.e. in-vivo imaging) evidence for negative and cognitive symptoms 
attributable to low cortical dopamine (Howes et al., 2015). 
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b. Glutamate hypothesis 
 A subset of patients (approximately one-third) does not respond to dopaminergic 
antipsychotic drugs, suggesting that the pathophysiological basis for their symptoms does not involve 
a dysregulated dopamine system (Howes & Kapur, 2014).  This has lead researchers to investigate 
other pathways. 
 The glutamate hypothesis of schizophrenia primarily centres on the observation that non-
competitive NMDA (N-methyl-D-aspartate) receptor antagonists (such as phencyclidine, PCP) induce 
a psychotic state indistinguishable from schizophrenia in healthy human subjects (as reviewed by 
Howes et al., 2015).  Importantly, the administration of NMDA receptor antagonists produces 
symptoms corresponding to the positive, negative and cognitive symptom domains. It has also been 
shown that these drugs exacerbate symptoms of people already diagnosed with schizophrenia.  At 
the neuronal level, it is thought that NMDA receptor antagonism reduces the activity of GABA-ergic 
interneurons.  This in turn is thought to disinhibit pyramidal cell firing leading to increased glutamate 
release in regions including the prefrontal cortex (as reviewed by Pratt et al., 2012). 
 Further support for the glutamate hypothesis comes from in-vivo imaging studies.  Pilowsky 
and colleagues (2006) in a neuroreceptor occupancy study revealed that patients have reduced 
NMDA receptor activity in the left hippocampus - but this study has not yet been replicated (Pilowsky, 
Bressan, Stone et al., 2006).  Proton magnetic resonance imaging studies have also revealed that 
unmedicated patients with first episode psychosis have increased glutamine (a marker of glutamate 
neurotransmission) in the anterior cingulate cortex (although chronic patients tend to have normal or 
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reduced levels) and increased glutamate in the NAc.  Moreover, such studies have suggested that 
increased glutamate levels may predict poor treatment response to dopaminergic antipsychotics.  Be 
that as it may, a major limitation of the glutamatergic hypothesis is the fact that there are currently no 
glutamatergic agents on the market, with clinical trials producing inconsistent results (as reviewed by 
Howes et al., 2015). 
 It should be recognised at this stage that dopamine and glutamate hypotheses of 
schizophrenia are not mutually exclusive.  Indeed, there is some suggestion that dopamine 
dysfunction is secondary to altered glutamate neurotransmission in patients (see Howes et al., 2015).  
Indeed, as will be highlighted when I discuss preclinical models of schizophrenia (see section 1.4.1), 
NMDA receptor antagonists such as PCP can alter the dopamine system of the brain and increase 
sensitivity to subsequent amphetamine challenge (indicating a sensitised dopamine system).  
Furthermore, in the methylazoxymethanol acetate model of schizophrenia, it has been shown that 
abnormal hippocampal glutamatergic drive could be the cause of altered dopamine neuronal firing in 
the midbrain of these animals (Grace, 2012). 
c. Neurodevelopmental hypothesis 
 The neurodevelopmental hypothesis of schizophrenia posits that exposure of genetically 
predisposed individuals to early life adverse events leads to an altered course of neuronal 
development, consequently creating a vulnerability to schizophrenia in later life (Lewis & Levitt, 2002). 
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 As mentioned previously, schizophrenic individuals suffering from first-episode psychosis, 
together with their first degree relatives, exhibit morphological abnormalities in the brain - including 
ventricular enlargement and brain volume reductions (McDonald et al., 2002; Fannon et al., 2000 - as 
cited by Mueser & McGurk, 2004).  These observations suggest that altered brain morphology is not a 
pathological consequence of schizophrenia, but constitutes a risk factor for the disease (Mueser & 
McGurk, 2004).  Patients with schizophrenia also have a higher prevalence of physical abnormalities, 
particularly in the craniofacial area, indicative of a developmental disruption in utero, whilst an 
increased prevalence of cavum septum pellucidum in the brain (a fluid filled space formed from the 
incomplete closure of the septal leaflets during the first 6 months of life) is consistent with abnormal 
development during prenatal or early postnatal periods (as reviewed by Brown, 2011).  Also 
consistent with a prenatal developmental disruption, is the lack of gliosis in the schizophrenic brain - a 
reaction commonly found in adult-onset brain injuries and neurodegenerative disorders such as 
Alzheimer's disease (Weinberger, 1995).  Furthermore, post-mortem analyses of the schizophrenic 
brain have revealed an inward displacement of cortical neurons which can only be explained in terms 
of altered early brain development (see Weinberger, 1995, for a review). 
 Prenatal and perinatal insults including infections, malnutrition, neurotoxin exposure and 
maternal stress have been shown to increase the risk of developing schizophrenia (see Brown, 2011).  
In ecologic and birth cohort studies prenatal exposure to rubella (Brown, Cohen, Harkavy-Friedman et 
al., 2001), maternal respiratory infection (Brown, Schaefer, Wyatt et al., 2000), Herpes simplex virus 
type 2 (Buka, Cannon, Torrey & Yolken, 2008) and bacterial infection (Sørensen, Mortensen, Reinish 
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& Mednick, 2009) have each been shown to increase the risk of developing schizophrenia and/or 
schizophrenia spectrum disorders.  Influenza during the first half or pregnancy (Brown, Begg, 
Gravenstein et al., 2004) as well as increased maternal levels of antibodies against Toxoplasma 
gondii (an intracellular parasite) have also been associated with an increased risk of schizophrenia in 
offspring (Brown, Schaefer, Quesenberry, Liu, Babulas & Susser, 2005; Mortensen, Nøgaard-
Pedersen, Waltoft et al., 2006).  Further support has come from preclinical studies which have shown 
that viral infections during the perinatal period lead to both neuropathological abnormalities and a 
behavioural phenotype of relevance to schizophrenia (e.g. Piontkewitz, Assaf & Weiner, 2009; 
Romero, Ali, Molina-Holgado, Castellano, Guaza & Borrell, 2007).  What remains unclear is whether 
the infection per se increases the risk of schizophrenia or whether it is due to the maternal immune 
response elicited by the infection.  Indeed, this latter hypothesis is consistent with the fact that the 
identity of the pathogen appears to be largely irrelevant.  Furthermore, cytokines which are implicated 
in the differentiation, morphology and survival of developing neural cells, alongside their role in the 
inflammatory response (see Brown, 2011, for a review), are elevated in the mothers of schizophrenia 
patients (Brown, Hooton, Schaefer et al., 2004; Buka, Tsuang, Torrey, Klebanoff, Bernstein & Yolken, 
2001). 
 Urban, as opposed to rural, births constitutes another risk factor for developing schizophrenia, 
perhaps due to higher levels of pollutants or the higher population densities increasing the risk and 
spread of infection (McGrath & Scott, 2006).  The seasonal patterns of infection may also explain why 
people born in winter and early spring are more likely to develop the disorder (see Brown, 2011).  
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Alternatively the high percentage of schizophrenia patients born in winter could be due to a reduction 
in maternal vitamin D levels at this time of year (McGrath, 1999).  Whilst the precise mechanisms are 
not completely understood, preclinical studies have implicated vitamin D in neurogenesis and foetal 
development (see Brown, 2011).   
 Prenatal malnutrition also constitutes an important risk factor.  A study investigating the Dutch 
Winter Famine, which occurred during 1944-1945, has revealed that severe famine during conception 
or pregnancy was associated with an increased susceptibility to schizophrenia in offspring (Susser, 
Neugebauer, Hoek, et al., 1996).  This finding has since been replicated by two ecologic studies 
investigating famine (between 1956 and 1961) across two different regions of China (St Clair, XU, 
Wang et al., 2005; Xu, Sun, Liu et al., 2009).  Further support for the association between prenatal 
famine and increased risk of developing schizophrenia has come from preclinical investigations.  
Pregnant dam mice placed on a protein deficient diet led to morphological and behavioural alterations 
in the offspring which are of relevance to schizophrenia (See Brown, 2011). 
 Finally obstetric complications have been shown to increase the risk of schizophrenia (see. 
Cannon, Jones & Murray, 2002, for a meta-analysis).  These include complications of pregnancy (e.g. 
preeclampsia, bleeding, diabetes and rhesus incompatibility), decreased birth weight, and delivery 
complications (e.g. emergency caesarean section and asphyxia) (Cannon et al., 2002).  Hypoxia is 
linked to many of these obstetric complications but it is unclear whether or not this constitutes a 
common pathogenic mechanism by which this diverse array of obstetric complications have their 
effect (see Brown. 2011 for a review).   
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 The reason why prenatal and early postnatal brain alterations lead to the delayed onset of 
psychosis in adolescence and early adulthood remains unclear.  One possibility is that the synaptic 
pruning that naturally occurs during adolescence causes a threshold level of neuronal loss to be 
reached, beyond which psychosis occurs.  The neuronal loss which occurs with hypoxic birthing 
complications may further increase the risk of this threshold being reached (see Mueser & McGurk, 
2004, for a review). 
1.3.2 Anhedonia in Schizophrenia 
 Anhedonia has been described as one of the core symptoms of schizophrenia since the 
beginning of the 20th century with classic descriptions from both Kraeplin (1919) and Bleuler (1911). 
Theorists Rado (1956, as cited in Pelizza & Ferrari, 2009) and Meehl (1962) also assigned anhedonia 
a prominent role in their aetiological models of schizophrenia, suggesting that it constitutes one of four 
cardinal symptoms.  Meehl (1962) described anhedonia as a "marked, widespread, and refractory 
defect in pleasure capacity" and "one of the most consistent and dramatic behavioural signs of the 
disease" (p.829).  Rado (see Pelizza & Ferrari, 2009) and Meehl (1962) both considered anhedonia to 
constitute a genetic vulnerability factor, predisposing individuals to the onset of schizophrenia (see 
also Horan, et al., 2006; Wolf, 2006).  Historical perspectives regarding the importance of anhedonia 
have been supported by empirical research with the development of clinical assessment scales and 
self-report questionnaires.  For example, the Chapman Anhedonia Scales (Chapman, Chapman & 
Raulin, 1976), self-report questionnaires which distinguish between physical (e.g. eating) and social 
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(e.g. friendships) forms of anhedonia, have revealed that schizophrenia patients report less pleasure 
from both physical and social sources (e.g. Berebaum & Oltmanns, 1992; Blanchard, Horan & Brown, 
2001; Blanchard, Mueser & Bellack, 1998; Cohen, Dinzeo, Nienow , Smith, Singer & Docherty, 2005).  
Similar results have also been found with other self-report methods, such as elevated anhedonia 
scores on the Snaith-Hamilton Pleasure scale (SHAPS: Snaith, Hamilton, Morley, Humayan, 
Hargreaves & Trigwell, 1995), which was originally developed to assess anhedonia in depression 
(Fortunati, Ossola, Camerlengo et al., 2015; Silver & Shlomo, 2002). Self-reported trait anhedonia has 
been shown to correlate with poor pre-morbid and current community functioning and a reduced 
quality of life amongst patients (e.g. Horan et al., 2006a; Ritsner, Arbtman & Lisker, 2011).  In terms 
of interview-based assessments, the most frequently utilised is the Scale for the Assessment of 
Negative Symptoms (SANS) which includes an anhedonia-asociality subscale.  As reviewed by Horan 
and colleagues (2006a), the anhedonia-asociality subscale reveals at least mild anhedonia in the 
majority of schizophrenia patients, even during the early stages of illness.  High anhedonia-asociality 
scores have also been related to worse pre-morbid adjustment, social incompetency and poor long-
term outcome (Horan et al., 2006a).  
 Findings of reduced pleasure in schizophrenia, however, have not been consistently 
replicated, and questions have been raised regarding the construct validity of early methods (see 
Foussias, Siddiqui, Fervaha, Agid & Remington 2015; Strauss & Gold, 2012).  Laboratory-based 
evaluations of hedonic capacity, which are not as noisy or biased as self-report measures, have 
revealed that schizophrenia patients have an intact capacity to experience pleasant emotions to a 
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diverse range of emotional stimuli (e.g. Cohen & Minor, 2010; Kring & Moran, 2008; Llerena, et al., 
2012).  In their seminal work, Berenbaum and Oltmanns (1992) presented schizophrenia patients and 
healthy controls with emotion-eliciting stimuli which comprised short video clips and different tasting 
drinks.  Whilst schizophrenia patients displayed affective flattening, their subjective experiences did 
not differ from those of the control group.  These results have been replicated for other types of stimuli 
including food (Horan, Green, Kring & Nuechterlein, 2006), briefly presented pictures (Schlenker, 
Cohen & Hopmann, 1995; Volz, Hamm & Kirsch, 2003) and simulated social interactions (Aghevli, 
Blanchard, Horan, 2003).  Furthermore, Kring and Colleagues have found normal experience of 
pleasure (to film clips) in unmedicated patients, suggesting that normal subjective ratings in laboratory 
settings are not secondary to drug status (Kring, Kerr & Neale, 1993; Kring & Neale, 1996).   
 Normal hedonic experiences among schizophrenia patients have been shown in daily life with 
the use of the experience sampling method, a time-sampling self-assessment technique.  Gard and 
colleagues (2007) assessed patients seven times a day (pseudorandomly assigned) across seven 
consecutive days.  Prompted by a pager, patients and controls were required to record what they 
were doing at the time and rate the enjoyment they were experiencing on a 7-point Likert scale.  
Compared to healthy control subjects, people suffering from schizophrenia reported similar levels of 
pleasure in the activities they were engaged in. 
Consistent with these objective findings of intact hedonic capacity in schizophrenia, the use of 
signal detection tasks has revealed normal response biases in patients (Heerey, Bell-Warren & Gold, 
2008; Pizzagalli, Jahn & O’Shea, 2005).  Furthermore, patients with schizophrenia demonstrate some 
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intact aspects of memory enhancement for positive stimuli (Hall, Harris, McKirdy, Johnstone & Lawrie, 
2007; Horan et al., 2006b, but see Herbener, Rosen, Khine & Sweeney, 2007) and a similar 
diminished startle response to pleasant stimuli as healthy controls (Curtis, Lebow, Lake, Katsanis & 
Iacono, 1999; Volz, Hamm, Kirsch & Rey, 2003), both consistent with normal hedonic processing 
(Barch & Dowd, 2010). 
 At the level of the brain, the results appear to be more mixed.  As reviewed by Kring and 
Barch (2014), intact striatal responses to the receipt of monetary rewards are often seen in 
schizophrenia patients, yet some studies have revealed abnormal cortical responses (e.g. reduced 
reward-related responses in the medial prefrontal cortex (mPFC)).  Furthermore, in terms of primary 
rewards, there is some evidence for reduced activation of the OFC, insula and striatum (Kring & 
Barch, 2014) - areas that are consistent with Berridge's so-called hedonic hotspots in the rodent brain.  
The picture is further obscured by reports that patients suffering from schizophrenia show muted 
neural responses, despite normative self-reports of pleasure (Waltz, Schweitzer, Gold et al., 2009). 
The finding that people with schizophrenia score highly on interview-based assessments of 
anhedonia and self-report lower levels of positive emotions compared to healthy controls, yet display 
similar amounts of pleasant emotion in response to emotion-eliciting stimuli, has been referred to as 
the 'emotion paradox' (Strauss & Gold, 2012; Buck & Lysaker, 2014).  Efforts to clarify the precise 
nature of hedonic experience in schizophrenia, and understand this discrepancy in the literature, have 
drawn attention to the importance of distinguishing between the temporally distinct components of 
hedonic processing (Buck & Lysaker, 2014).  Klein (1984) was the first to distinguish between 
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consummatory pleasure, which reflects the in-the-moment pleasure experienced while engaged in an 
enjoyable activity, and anticipatory pleasure, which reflects the pleasure anticipated from future 
activities.  Kring (1999) posited that schizophrenia patients may not experience less pleasure when 
presented with positive stimuli (consistent with laboratory-based measures), but may be less able to 
anticipate that events or rewards in the future will elicit pleasure.  This is perhaps consistent with self-
report measures of anhedonia, which can also reflect retrospective and prospective processing 
alongside hedonic capacity (e.g. Strauss & Gold, 2012). 
Gard and colleagues (2007) were among the first to measure consummatory and anticipatory 
anhedonia in a schizophrenia sample.  Using the temporal experience of pleasure scale (Gard, 
Germans Gard, Kring & John, 2006), a newer self-report instrument specifically designed to evaluate 
these distinct aspects of pleasure; they showed deficits in anticipatory but not consummatory pleasure 
among individuals with schizophrenia.  Further, use of an experience sampling method, asking 
individuals to record how much pleasure they expected from future events throughout the day, also 
revealed the same pattern of results.  That is, patients differed from controls in the pleasure they 
anticipated they would get from future activities, particularly in relation to goal-directed activities (such 
as work and school) as opposed to non-goal directed activities (such as watching TV; Gard et al., 
2007).  Whilst similar results have recently been found in the literature (Chan, Wang, Huang et al., 
2010; Fortunati et al., 2015; Wang, Huang, Yang, Lui, Cheung & Chan, 2015), it should be noted that 
inconsistencies also exist.  Strauss and colleagues (Strauss, Wilbur, Warren, August & Gold, 2011) 
found differences between schizophrenia patients and controls only on the consummatory, and not on 
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the anticipatory, anhedonia measures.  That said, other laboratory-based paradigms might also speak 
towards an anticipatory hedonic deficit in schizophrenia patients.  Delay discounting paradigms 
measure whether an individual will wait for a better future reward, or opt for a currently available 
reward of lesser value.  This has revealed that patients with schizophrenia more readily discount 
future rewards, choosing the smaller immediate reward, compared to healthy control subjects, 
perhaps reflective of anticipatory anhedonia (Heerey, Robinson, McMahon & Gold, 2007). 
 Reward anticipation is a construct closely related to motivation or reward 'wanting'.  As such, 
both subcomponents of reward are thought to be subserved by overlapping midbrain dopaminergic 
neurons together with their ventral and dorsal striatum targets (Barbano & Cador, 2006; Kring & 
Barch, 2014).  Anticipatory hedonic processing involves not only an affective component (pleasure 
expected from future events) but also a prediction component (the ability to predict future events).  In 
the fMRI literature, the most commonly used approach to assessing reward prediction has been 
through the Monetary Incentive Delay (MID) task.  This instrumental task involves the presentation of 
cues indicating potential monetary gain or loss (vs. no consequence) and has been shown to recruit 
the dorsal and ventral striatum (including the NAc) in healthy adults (Knutson, Adams, Fong & 
Hommer, 2001; Knutson, Westdorp, Kaiser & Hommer, 2000).  In schizophrenia patients, studies 
using the MID task have shown reduced ventral striatal activation to reward-predicting cues compared 
to healthy control subjects.  These reduced striatal responses have been demonstrated in 
unmedicated patients (Juckel, Schlagenhauf, Koslowski et al., 2006b) and in patients taking typical 
antipsychotics (Juckel, Schlagenhauf, Koslowski et al., 2006a).  In contrast, no striatal differences 
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between patients and controls have been observed when patients are being treated with atypical 
antipsychotics (Juckel, Schlagenhauf, Koslowski et al., 2006a) or are in a prodromal state (Juckel, 
Friedel, Koslowski et al., 2012).  Dowd and Barch (2012) demonstrated similar reductions in striatal 
responses to reward-related cues in patients with high levels of self-reported anhedonia.  
Interestingly, this was using a passive Pavlovian paradigm, aimed at eliminating confounds 
associated with the instrumental MID task, such as the execution of motor responses.  Grimm, 
Vollstadt-Klein, Krebs, Zink and Smolka (2012) have also reported similar reductions in striatal 
activation to appetitive food cues.  Importantly, in medicated and unmedicated schizophrenia patients, 
negative symptom severity has been shown to correlate with the reductions in ventral striatal activity 
to anticipated monetary reward (Juckel, Schlagenhauf, Koslowski et al., 2006a, 2006b).   
 The relationship between anhedonia and schizophrenia is clearly very complicated.  Overall, it 
appears that schizophrenia patients display deficits in their anticipatory hedonic capacity, while their 
in-the-moment (consummatory) pleasure is relatively intact.  However, many inconsistencies exist in 
the empirical literature.  For example, while normal hedonic responses have been observed for many 
emotion-eliciting stimuli (including pictures, films, sounds and drinks), schizophrenia patients display 
impaired hedonic responses to odours (Kamath, Moberg, Kohler, Gur & Turetsky, 2011).  Also, in 
contrast to the results of Gard et al. (2007) employing the experience sampling method, a similar 
study showed group differences between schizophrenia patients and controls, with patients reporting 
less intense positive emotions from their daily experiences (Myin-Germeys, Delespaul & deVries, 
2000). 
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1.3.3 Reward Related Deficits, Beyond Anhedonia, in Schizophrenia 
 In an attempt to understand the so-called 'emotion paradox', other researchers have 
considered how cognitive deficits might produce an apparent anhedonic profile in schizophrenia.  That 
is, schizophrenia patients may be unable to appropriately encode the value associated with rewards 
and/or integrate this representation with knowledge regarding the causal consequences of specific 
actions.  At the anecdotal level, inflexible behaviour is often noted in schizophrenia, with patients 
unable to adjust their ongoing actions to take into account prior rewards, future goals or current 
emotional states (Barch & Dowd, 2010).  A lost relationship between value representations and action 
selection is consistent with the reduced goal-directed behaviour characteristic of schizophrenia, 
despite normative hedonic processing, as well as the dysfunctional decision making commonly 
observed among patients (see Griffiths, Morris & Balleine, 2014 for a review).  What is more, impaired 
representations of value may also explain the discrepancy between self-report measures of 
anhedonia, yet normal hedonic responses to evocative stimuli.  As discussed by Gold and colleagues 
(2008), questionnaires such as the Chapmans Anhedonia Scales require participants to generate and 
maintain representations of the experiences in question, upon which their judgements regarding 
affective value must be based (Gold, Waltz, Prentice, Morris & Heerey, 2008).  A patient who is 
unable to draw upon value representations may therefore respond in an anhedonia-consistent 
manner to the true/false question - 'The sound of rustling leaves has never much pleased me' (p. 923) 
- despite feeling normative pleasure during in-the-moment experiences of 'rustling leaves' (see 
Winterstein, Silvia, Kwapil et al., 2011, for a list of some of the items on this scale). 
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 A number of studies have reported evidence of impaired value representations and action 
selection in schizophrenia.  Heerey and Gold (2007) used an evoked and representational responding 
task and demonstrated that, whilst patients rated hedonic experience to emotional stimuli to a similar 
extent to healthy controls, they were unable to transmit this rating into the effort they were 
subsequently willing to exert to gain access to the same stimuli in the future.  That is, when 
representations of the stimulus had to be relied upon, schizophrenia patients were unable to couple 
their in-the-moment pleasure ratings with their behavioural responses. 
 This inability to maintain value representations may also account for the greater delay 
discounting seen in schizophrenia, where patients opt for a smaller reward available immediately as 
opposed to a larger reward available after a delay.  As suggested in section 1.3.2, anticipatory 
anhedonia may account for this deficit.  However, an equally plausible explanation is that patients are 
unable to maintain value representations, preventing them from forming or updating associations 
between actions and their outcomes.  Indeed, patients more readily discount future rewards across 
longer-term delays compared to shorter delays (Ahn, Rass & Fridberg, 2011; Heerey, Robinson & 
McMahon, 2007), perhaps reflecting a degradation of internal value representations across time 
(Heerey, Matveeva & Gold, 2011). 
 A recent study by Morris, Quail, Griffiths, Green and Balleine (2015) directly investigated 
whether schizophrenic individuals can integrate causal knowledge of actions and their outcomes with 
changes in outcome value to flexibly control choice behaviour.  In line with outcome devaluation tasks 
developed in rodents (to be explained in section1.6.1), subjects were trained to perform two actions 
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(left and right key presses) to cause the liberation of two different snack foods (e.g. chocolate cookies 
or barbecue flavoured crackers) from a 'virtual' vending machine.  One of these two snack foods (i.e. 
food A) was then devalued by pairing it with disgust, achieved through a 4 min video in which the 
snack food was depicted as infested with cockroaches.  If an individual is able to flexibly encode 
reward value and understands the causal consequences of their actions (e.g. left key press leads to 
snack food A), then they will be less willing to perform actions that lead to the devalued outcome (i.e. 
they will refrain from pressing the left key).  This was found to be the case for healthy control 
individuals; after pairing one of the snack foods with disgust, healthy subjects reduced the 
performance of the action associated with the devalued food relative to the alternative action.  
Furthermore, this was in the absence of the food rewards being delivered and so was in the absence 
of new learning.  In contrast, schizophrenia patients continued to perform the devalued action just as 
much as the action associated with the valued reward.  With the outcome devaluation procedure itself 
being just as effective in schizophrenia patients as controls (i.e. both groups had reduced subjective 
ratings to devalued compared to valued foods), this pattern of responding suggests that patients 
cannot integrate action-outcome learning with changes in outcome value.   
 The use of outcome devaluation in rodents (and its subsequent use in humans) has 
uncovered the neural circuits of the brain necessary for promoting flexible goal directed actions.  
Regions of particular importance include the medial prefrontal cortex (prelimbic cortex in rats) and the 
dorsal striatum (including the anterior caudate, homologous to dorsomedial striatum in rats) (see 
Griffiths et al., 2005 and Balleine & O'Doherty, 2010, for a review).  Interestingly, the study by Morris 
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et al. (2015) provided evidence of regional activity differences in the caudate of schizophrenia 
patients, compared to controls, during the choice phase of the task.  What is more, this reduced 
activity, primarily within the head of the caudate, correlated with the severity of negative symptoms in 
these patients.  This finding is consistent with research in schizophrenia indicating neuropathology in 
the 'associative striatum' of the brain (de la Fuente-Sandoval, León-Ortiz, Favila, Stephano, Mamo, 
Ramirez-Bermúdez & Graff-Guerrero, 2011; Howes, Montgomery, Asselin et al., 2009; Kegeles, Abi-
Dargham, Frankleet al., 2010), together with evidence for a disconnection between the caudate and 
its cortical afferents (Fornito, Harrison, Goodby et al., 2013; Quan, Lee, Kubicki et al., 2013; Quidé, 
Morris, Shepherd, Rowland & Green, 2013).  Taken together, this evidence led Morris and colleagues 
(2015) to propose that the impaired goal-directed behaviour they observed is due to a functional 
disconnection in the cortico-striatal loops of the schizophrenic brain. 
 In summary, there is clear evidence that aspects of reward processing in schizophrenia - 
including flexible goal-directed behaviour - are impaired beyond the narrow conception of anhedonia.  
Moreover, the neurobiological underpinnings of goal-directed behaviour appear to overlap with at 
least some of the neurobiological impairments associated with schizophrenia. 
1.3.4 Overview of Depression 
 Depression is a highly debilitating disorder with symptoms that manifest at the psychological, 
behavioural and physiological levels.  With higher prevalence than other psychiatric disorders, it has 
been reported that approximately 16% of people will develop depression at some point over their 
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lifetime (Kessler, Berglund, Demler et al., 2003).  Moreover, depression is predicted to become the 
second leading cause of disability worldwide by 2030 (second to ischemic heart disease) (Mathers & 
Loncar, 2006). 
According to the diagnostic criteria for Major Depressive Disorder, a diagnosis of depression 
is contingent on the presence of at least five of the following symptoms: a low or depressed mood, 
anhedonia, weight disturbances, disturbed sleep, psychomotor abnormalities (i.e. agitation or 
retardation), fatigue or loss of energy, excessive guilt, difficulty concentrating and suicidal ideation 
(American Psychiatric Association, 2013).  Highlighting the heterogeneity of the disorder, two people 
could both receive a depression diagnosis but only share a single overlapping symptom (Treadway & 
Zald, 2011).  That said, at least one of the symptoms presented must be either low mood or 
anhedonia (American Psychiatric Association, 2013). 
The aetiology and pathophysiology of depression is not completely understood.  It is a 
recurrent condition, where the likelihood of developing a subsequent depressive episode is positively 
correlated with the number of previous episodes (Burcusa & Iacono, 2007; Lewinsohn, Zeiss, & 
Duncan, 1989; Solomon, Keller, Leon et al., 2000).  Approximately 60% of patients that have 
experienced a single depressive episode will succumb to a second, whereas 90% of patients who 
have experienced three depressive episodes will succumb to a fourth (Winans & Bettinger, 2004). 
Prevalence is much higher among post-pubertal women than men, with a female:male risk ratio of 
approximately 2:1 (Kessler, 2003).  This gender bias reflects a higher risk of first onset among 
women, as gender differences do not impact on the persistence of symptoms or the recurrence of 
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further depressive episodes (Kessler, 2003 – but see Lewinsohn et al., 1989).  Whilst adult onset is 
most prevalent (the average age of onset is in the mid-20s), approximately two percent of children 
and five percent of adolescents also suffer from depression (Iyer & Khan, 2012; Winans & Bettinger, 
2004).
Several hypotheses have been proposed to explain the onset and persistence of depressive 
symptoms.  The monoamine hypothesis, which has dominated the literature since its introduction 
around fifty years ago, states that depressive symptoms are driven by an absolute or relative 
deficiency of monoamines in the brain (as reviewed by Willner, Scheel-Krüger & Belzung, 2013).  This 
hypothesis has received support from cerebral spinal fluid (CSF), neuroendocrine and post-mortem 
analyses which have revealed abnormalities in monoamine precursor/metabolite concentrations and 
receptor/transporter binding site densities that are consistent with monoamine deficiency in the 
disease (see Saveanu & Nemeroff, 2012 for a review – see also Belmaker & Agam, 2008).  For 
example, low levels of noradrenaline (NA) and serotonin (5-HT) metabolites have been found in the 
CSF of depressed patients, while increased density of 5-HT2 and β-adrenergic receptors has been 
revealed in post-mortem brain tissue, perhaps reflecting a compensatory mechanism to low synaptic 
5-HT and NA concentrations (see Saveanu & Nemeroff, 2012; Belmaker & Agam, 2008).  Whilst 
dopamine has been primarily implicated in the pathophysiology of schizophrenia, there is also 
evidence to support its role in depression.  As reviewed by Pizzagalli (2014), one of the first 
suggestions of a hypodopaminergic tone in depression came from studies revealing lower levels of 
homovanillic acid (HVA), a major metabolite of dopamine, in the CSF of depressed patients compared 
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to healthy controls.  Positron emission tomography (PET) studies have also revealed increased 
postsynaptic striatal dopamine (D2/D3) receptor concentrations in depression, possibly reflecting lower 
dopamine availability in the synapse.  Furthermore, post-mortem studies have revealed decreased 
dopamine transporter (DAT) binding sites in striatal regions (caudate, putamen and NAc) of 
depressed individuals, again suggestive of blunted DA transmission.
The Role of Stress in Depression 
Whilst the monoamine hypothesis is supported by the clinical efficacy of currently available 
antidepressants, which act to increase monoamine levels, the latency of clinical onset for these drugs 
(taking several weeks before the full therapeutic effect is achieved), suggest that a cascade of 
molecular and neural changes occur in the presence of antidepressant therapies.  This, together with 
the fact that up to 30-40% of patients respond poorly to current treatments, has led some researchers 
to search for alternative, although not mutually exclusive, hypotheses (as reviewed by Willner et al., 
2013).   
The diathesis-stress hypothesis proposes that an interaction between pre-morbid vulnerability 
factors (including genetic and neurobiological factors) and stress (external or internal) leads to the 
development of depressive symptoms (see Willner et al., 2013, for a review).   
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a. Diathesis. 
A variety of factors may contribute to a person's vulnerability (or diathesis) to develop 
depression.  For example, it is thought that approximately 30-40% of depression is inherited, as 
shown by concordance studies of monozygotic and dizygotic twins (Saveanu & Nemeroff, 2012; 
Sullivan, Neale & Kendler, 2000).  As reviewed by Willner and colleagues (2013) some early life 
factors also predispose a person to depression, particularly poor parental relationships and childhood 
abuse.  Adverse events in early life, such as criticism, rejection or having a parent with depression, 
may lead to the development of a negative ‘cognitive schema’ - causing an individual to have negative 
world views and heighted attention towards negative information (Beck, 1967 - as cited by Willner et 
al., 2013).  Emotional instability, resulting from poor parental care or loss of a parent, may also 
mitigate social support in later life.  Finally, Willner et al. (2013) recognise that personality factors such 
as neuroticism, which result from genetic-environmental interactions, also increase the likelihood of 
developing depression.  Not only do these individuals possess a negative-information processing bias 
(akin to depression), they also act in dysfunctional ways that might increase their exposure to 
stressful events.  As mentioned earlier, female gender is also a predisposing factor, as is the 
experience of previous depressive episodes. The presence of minor depression also increases risk, 
with a longitudinal study demonstrating that over 22% of people sampled with minor depression later 
suffered from a unipolar disorder (Akiskal, Bitar, Puzantian, Rosenthal & Walker, 1978). 
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b. Stress. 
Stress has been strongly implicated in the pathogenesis of depression (e.g. Tennant, 2002; 
Hammen, 2005).  Whilst the stress could be internal (such as a traumatic head injury or hormonal 
challenge), external stresses are more common precipitants of depression (see Willner et al., 2013).  
In community samples, stressful life events (e.g. health-related disability and bereavement) have 
been demonstrated to precede the onset of approximately 80% of depressive episodes (as reviewed 
in Auerbach, Admon & Pizzagalli, 2014).  The accumulation of chronic mild stressors, such as loss of 
employment, family discord and poverty, has also been implicated in depression onset (see Willner et 
al., 2013).  Moreover, chronic stressors have been strongly linked to poor prognosis, stronger 
depressive symptoms, and treatment resistance (see Pizzagalli, 2014, for a review). 
One of the major physiological responses to stress is the activation of the hypothalamic-
pituitary-adrenal (HPA) axis.  Briefly, activation of the hypothalamus in response to stress leads to the 
release of corticotrophin releasing hormone (CRH), which stimulates the pituitary glands to release 
adrenocorticotrophic hormone (ACTH).  This is turn stimulates the adrenal cortex to release 
glucocorticoids (cortisol in humans, corticosterone in rats) into the blood.  In a negative feedback loop, 
cortisol receptors on the hypothalamus respond by decreasing the production of CRH, thus 
maintaining a homeostatic state (Smith & Vale, 2006). 
In a sub-group of depressed patients, several indicators suggest altered activity of the HPA 
axis.  For example, patients display an altered response to the dexamethasone/CRH challenge (i.e. 
fail to show the normal suppression of cortisol levels that would suggest a regulated system) (Carroll, 
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Cassidy, Naftolowitz et al., 2007; Ising, Kunzel, Binder et al., 2005; Saveanu & Nemeroff, 2012); have 
higher basal levels of CRH (Nemeroff, Widerlov, Bisette et al., 1984); and hypersecrete cortisol 
(Sachar, Hellman, Fukushima et al., 1970).  Whilst activity of the HPA axis is an adaptive response to 
stress, its prolonged activation can have detrimental consequences including neurotoxic effects 
(Willner et al., 2013).  Reports have shown that depressed patients display the expected neuronal 
alterations of a hyperactive HPA system (Booij, Wang, Lévesque, Tremblay & Szyf, 2013), 
demonstrating decreased sensitivity of glucocorticoid receptors (as reviewed by Booij et al., 2013), 
smaller hippocampal volume (MacQueen, Campbell, McEwen et al., 2003) and a reduced ability to 
down-regulate the activity of the HPA axis (Maletic et al., 2003; as cited by Booij et al., 2013).  Brain-
derived neurotrophic factor (BDNF), a neuropeptide involved in neurogenesis that is sensitive to 
stress (Angelucci, Brenè & Mathè, 2005; Kozlovsky, Matar, Kaplan, Kotler, Zohar & Cohen, 2007), is 
also reduced in the hippocampus of depressed suicide victims (Karege, Vaudan, Schwald, Proud & 
La Harpe, 2005), as shown by post-mortem brain tissue.  Patients suffering from depression also 
have elevated levels of pro-inflammatory cytokines (including Interleukin-1, Interleukin-6 and Tumour 
Necrosis Factor-alpha), with the severity of depressive symptoms correlating with the magnitude of 
cytokine elevation (as reviewed by Saveanu & Nemeroff, 2012).  Consistent with high circulating 
levels of cortisol, this relationship is particularly interesting given the role of proinflammatory cytokines 
in modulating the CRH and HPA axis, as well as their role in neurotransmitter metabolism (e.g. 5-HT) 
(as reviewed by Saveanu & Nemeroff, 2012).  Furthermore, neuroimaging studies have shown that 
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depressed patients exhibit higher activity levels of monoamine-oxidase-A (MAO-A), again consistent 
with high stress/cortisol levels (Willner et al., 2013). 
 Whilst stress has been strongly implicated in the development of depression, it should be 
noted that it does not necessarily predispose an individual to a depressive episode.  That is, whilst 
one person may develop depression from being exposed to a stressor, another person exposed to the 
same stressor will not.  The diathesis-stress model proposes that individuals with a strong depressive 
diathesis will succumb to minor or trivial stressors, whereas an individual with a weak depression 
diathesis requires more intense stressors to precipitate depressive symptoms (see Willner et al., 
2013).  As mentioned earlier, previous experience of depression increases the diathesis for future 
episodes.  Interestingly, evidence suggests that as the occurrence of depressive episodes increases, 
the importance of stress decreases (Kendler, Thornton & Gardner, 2000).  Thought to be due to a 
sensitsation or ‘kindling’ effect (see Pizzagalli, 2014), the more a person succumbs to depressive 
episodes, the more likely these episodes will be independent of large stressors. 
 In summary, many depressed patients experience a range of abnormalities at both the 
neurochemical and structural level that resemble those observed following hyperactivity of the HPA 
axis in response to prolonged stress exposure. 
1.3.5 Anhedonia in Depression 
 Whereas Rado and Meehl (section 1.3.2) were critical in highlighting the role of anhedonia in 
schizophrenia, its importance in relation to depression was highlighted by Klein: stating that "a sharp, 
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unreactive pervasive impairment of the capacity to experience pleasure, or to respond affectively, to 
the anticipation of pleasure" (p. 449) is a central component of endogenomorphic (i.e. 'classic' or 
'melancholic') depression (Klein, 1974 - as cited by Der-Avakian & Markou, 2012). Now defined by the 
DSM-V as a decrease in interest or pleasure in most activities, it constitutes one of the two main 
symptoms required for depression diagnosis, the second being a generally low or depressed mood 
(American Psychiatric Association, 2013).  As diagnosis depends on only one of these two main 
symptoms being present (alongside at least four additional symptoms – see above), it is interesting to 
note that an individual may be diagnosed with depression without them experiencing a depressed 
mood, if anhedonia is present (Dichter, 2010).  The importance of anhedonia in this disorder is further 
highlighted by studies revealing that low hedonic capacity predicts poor outcome for depressed 
patients (see Pizzagalli, 2014). 
 Similarly to schizophrenia, assessments of anhedonia in depression have relied heavily on 
self-report instruments.  Whilst some of these were originally developed with schizophrenia in mind 
(e.g. the Chapman Anhedonia Scales), others have been developed specifically for hedonic deficits in 
depression (e.g. SHAPS).  Use of the Chapman Social and Physical Anhedonia Scales (Berlin,Givry-
Steiner, Lecrubier, Puech, 1998; Loas, Salinas, Guelfi & Samuel-Lajenunesse, 1992), SHAPS 
(Franken, Rassin & Muris, 2007; Liu, Chan, Wang, Huang, Cheung, Gong & Gollan, 2011) and the 
Fawcett-Clark Pleasure Scale (Berlin et al., 1998), another self-report instrument, has indicated that 
depressed individuals exhibit higher levels of anhedonia compared to healthy controls.   
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 The presence of anhedonia measured through self-report instruments has generally been 
supported by laboratory-based assessments.  In contrast to schizophrenia, patients with depression 
have been shown to rate emotion-eliciting stimuli as being less positive and less arousing compared 
to healthy controls.  Such reduced pleasure ratings have been observed for a range of stimuli 
including pictures (Dunn, Dalgleish, Lawrence, Cusack & Ogilvie, 2004; Sloan, Strauss, Quirk & 
Sajatovic, 1997), film-clips (Rottenberg, Gross & Gotlib, 2005; Rottenberg, Kasch, Gross & Gotlib, 
2002), emotional words (Liu, Wang, Zhao, Ning & Chan, 2012) and flavoured drinks (Berenbaum & 
Oltmanns, 1992), although inconsistencies do exist in the literature (Amsterdam, Settle, Doty, 
Abelman & Winokur, 1987; Berlin et al.,1998; Clepce, Gossler, Reich, Kornhuber & Thuerauf, 2010; 
Dichter, Smoski, Kampov-Polevoy, Gallop & Garbutt, 2010; Gehricke & Shapiro, 2000).  Impaired 
hedonic capacity has also been examined through a range of other laboratory methods.  For example, 
depressed patients fail to exhibit the typical attenuation of their startle response during the 
presentation of positive stimuli (Allen, Trinder & Brennan, 1999; Dichter, Tomarken, Shelton & Sutton, 
2004; Kaviani, Gray, Checkley, Raven, Wilson & Kumari, 2004).  Furthermore, Henriques and 
colleagues (1994) demonstrated that people suffering from depression do not display a response bias 
towards rewarding stimuli (Henriques, Glowacki & Davidson, 1994), a result that has since been 
replicated (Pizzagalli, Iosifescu, Hallet, Ratner & Fava, 2008; Pizzagalli, Jahn & O'shea, 2005).  
Overall, the literature supports reduced hedonic capacity in depression.   
 There are many overlaps between the neurobiological changes associated with depression 
and the brain regions linked to hedonic function.  For example, structural MRI studies have revealed a 
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reduced grey matter volume in the striatum (see Koolschijn, van Haren, Lensvelt-Mulders, Hulshoff 
Pol & Kahn, 2009 for a review), including the NAc (Wacker, Dillon & Pizzagalli, 2009), of depressed 
individuals.  Moreover, diminished responses of the ventral striatum to the receipt of rewards have 
been reported in both currently depressed (Epstein, Pan & Kocsis et al., 2006; Pizzagali, Holmes, 
Dillon et al., 2009; Wacker, et al., 2009) and previously depressed (McCabe, Cowen & Harmer, 2009) 
individuals compared to healthy controls, with a negative correlation revealed between activity levels 
and anhedonia severity (Epstein et al., 2006; Wacker et al., 2009).  As reviewed by Rømer-Thomsen 
et al. (2015), alterations in ventral mPFC activity (including activity in the OFC, an area putatively 
involved in hedonic responses - see section 1.2) have been shown in depressed subjects in response 
to positive stimuli, while smaller OFC volume has also been reported in the literature (as reviewed by 
Treadway & Zald, 2011).  Furthermore, there is some evidence suggesting that opioid deficiency 
features in depression.  As reviewed by Treadway and Zald (2011), this suggestion first emerged 
when two convergent studies demonstrated a temporary alleviation of depressive symptoms after the 
injection of a non-selective opioid receptor agonist (β-endorphin), which occurs endogenously in the 
brain.  However, since these early studies, results in the literature have been largely equivocal (see 
Hegadoren, O'Donnell, Lanius, Couplland & Lacaze-Mamonteil, 2009, for a meta-analysis of β-
endorphin levels in depressed patients).  That said, there is emergent interest in the role of kappa 
opioids antagonists1 as a treatment of depression (as reviewed by Barch, Pagliaccio & Luking, 2015), 
1 Whilst this might appear to be inconsistent with the role of opioid systems in hedonic processing, it likely reflects kappa 
stimulation outwith the small rostral hedonic ‘hotspot’ of the NAc shell.  Indeed, while kappa effects induce positive liking 
reactions inside the hotspot, stimulation of the entire caudal half of the shell produces negative effects as shown by the 
induction of conditioned place avoidance (Castro & Berridge, 2014a).  Systemic activation of the kappa opioid receptor has also 
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but further work directly addressing the relationships between opioid systems and anhedonic 
symptoms in depression are needed. 
 As highlighted earlier, Klein's original definition of anhedonia as it relates to depression 
included a temporal distinction between consummatory and anticipatory anhedonia.  Whilst the 
importance of this distinction has been clearly demonstrated for schizophrenia patients, studies 
examining reward anticipation in individuals with depression have produced inconsistent results. 
Abnormalities in the anticipation or prediction of rewards in depression is intuitively plausible 
given that depressed individuals self-report lower levels of pleasure, and exhibit abnormal behavioural 
and neural responses to positive stimuli.  Preliminary work by Sherdell, Waugh and Gotlib (2012) has 
provided some support for this hypothesis, demonstrating that people suffering from depression self-
report reduced levels of anticipatory pleasure.  However, this study investigated the construct of 
anticipatory hedonics with one item from the Hamilton Rating Scale of Depression (HAM-D; Hamilton, 
1967).  The questions included in this item (e.g. "Have you felt interested in doing...") better reflect 
motivational capacity of the individual rather than pure anticipatory hedonics.  In terms of rating 
scales, however, promise has come from a Chinese sample demonstrating that clinically depressed 
subjects report higher anticipatory anhedonia on TEPS (Liu et al., 2011).  Whilst the scale used 
differed from the original designed by Gard and colleagues (2006) (with four factors instead of two), 
high correlation has been demonstrated across the two versions (Chan, Shi, Lai, Wang, Wang & 
Kring, 2011).  Additionally, work by McFarland and Kein (2009) found that depressed patients 
been observed to decrease social play and increase the stimulation threshold of intracranial self-stimulation in rodents (see 
Lalanne et al., 2014).
44 
reported significantly less pleasure when anticipating monetary rewards compared to healthy 
individuals, and marginally less pleasure compared to remitted individuals, again consistent with an 
inability to predict pleasure from future events. 
 There are some examples of abnormal neurobiological responses in depressed individuals 
during reward anticipation tasks (e.g. reduced activation in striatal regions; Smoksi, Felder, Bizzell, 
Green, Ernst, Lynch & Dichter, 2009; Forbes, Hariri, Martin, Silk, Moyles, Fisher, Brown, Ryan, 
Birmaher, Axelson & Dahl, 2009), but also reports of the absence of such differences (Knutson, 
Bhanji, Cooney, Atlas & Gotlib, 2008; Pizzagalli, Holmes, Dillon et al., 2009). Given the paucity of 
work, and potential confounds due to differences in the precise anticipation tasks used, further work 
using more focused and common methods, such as the TEPS scale, is needed before the 
neurobiology of anticipatory reward processing in depression is understood. 
1.3.6 Reward Related Deficits, Beyond Anhedonia, in Depression 
In addition to the disorders of mood that are central to depression, it has long been 
recognised that depression also involves cognitive and motivational disturbances as well.  Indeed, 
early theoretical analyses of depression placed these cognitive/motivational aspects at the centre of 
their accounts.  For example, both learned helplessness/attributional theory (see Abramson, Seligman 
& Teasdale, 1978; Alloy, Abramson, Peterson & Seligman, 1984) and Beck’s cognitive theory (Beck, 
1967; 2008), place a large emphasis on cognitive inflexibility.  More recently, it has been suggested 
(Griffiths et al., 2014) that these cognitive disturbances may be centred on reward processing, with 
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the result that depressed patients might also fail to flexibly control their actions based on the 
consequences those actions engender, instead relying on antecedent stimuli to form stimulus-
response associations or habits (to be explained in section 1.6.1).  This idea is consistent with 
impaired decision-making abilities in depressed patients (DSM-V; WHO, 1992), together with the high 
comorbidity seen between depression, impulse control disorder and substance abuse (other habit-
based disorders) (Winans & Bettinger, 2004).
 Although goal-directed behaviour has not been explicitly investigated in a depressed sample, 
and thus there has been no direct test of the idea that impairments of goal-directed action are central 
to depression, the examination of neurobiological factors does provide at least some suggestive 
evidence.  For example, Friedel and colleagues (2009) reported that depressive symptom severity is 
negatively correlated with connectivity between the medial OFC and the BLA (Friedel, Schlagenhauf, 
Sterzer et al., 2009).  Critically, in both rats (Zeeb & Winstanley, 2013) and monkeys (Baxter, Parker, 
Lindner, Izquierdo & Murray, 2000), contralateral lesions of the OFC-BLA connections have been 
shown to prevent subjects from flexibly controlling their behaviour based on reward value.  Moreover, 
investigation of the formation of goal-directed actions in a healthy population have found that goal-
directed behaviour correlates significantly with the activity of the OFC (Valentin, Dickinson & 
O'Doherty, 2007), while abnormal recruitment of the mOFC has been seen when depressed patients 
perform behavioural tasks (involving planning and behavioural choice) that recruit the frontal system 
(see Griffiths et al., 2014, for a full review).   
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Whilst the literature regarding instrumental control in depression per se is extremely 
underdeveloped, there is converging evidence for the idea that impaired reward processing might 
contribute to depression from the examination of the effects of stress.  As discussed in section 1.3.4, 
stress is an important risk factor for the development of depression.  With this in mind, studies directly 
investigating the balance between goal-directed and habitual systems in response to stress may 
provide us with insights into whether similar abnormalities might also exist in depressed patients.  
In a seminal study by Schwabe and Wolf (2009), participants were exposed to an acute stress 
protocol, which combined physical and psychosocial stressors, before being trained to perform 
different instrumental responses for the delivery of distinct food rewards.  After training, participants 
were invited to consume one of the two rewards to satiety (essentially devaluing this reward relative to 
the alternative reward).  When subsequently given the choice between the two instrumental 
responses in the absence of any reward delivery, stressed individuals responded in a way consistent 
with habitual control of behaviour.  That is, unlike non-stressed control subjects, stressed individuals 
were insensitive to the current motivational value of the outcome.  Furthermore, this insensitivity was 
paralleled by a reduction in the participant’s causal knowledge of action-outcome contingencies, also 
consistent with habitual as opposed to cognitive instrumental control.   
A similar effect has since been reported in rodents after a chronic mild stress procedure.  
Results showed that rats chronically stressed across a 21-day period were unable to adjust their 
behaviour to match changes in outcome value or action-outcome contingency (Dias-Ferreira, Sousa, 
Melo et al., 2009).  Thus, stress applied acutely or chronically appears to bias instrumental control 
47 
away from goal-directed systems.  Furthermore, studies in humans (Schwabe & Wolf, 2010) and 
rodents (Braun & Hauber, 2013) have demonstrated that the application of an acute stressor after
instrumental training of the task also renders performance insensitive to changes in outcome value.  
Whilst this does not speak to the effects of stress in the acquisition of goal-directed behaviours (which 
may or may not be intact), it does show that stress can affect the expression of goal-directed actions 
independent of learning effects.  Moreover, in the human study (Schwabe & Wolf, 2010) it was shown 
that cortisol levels and the participant’s behavioural insensitivity to the outcomes value were 
significantly correlated.  Whilst this is not necessarily causative in nature, the fact that elevations in 
cortisol are also seen in depression (see section 1.3.4) highlights the possibility that impaired goal-
directed behaviour and an imbalance towards habitual control could be an important feature in this 
disorder.  In addition, the fact that stress in rodents impacts on corticostriatal circuits implicated in 
both goal-directed behaviours (Dias-Ferreira et al., 2009) and in depression (Griffiths et al., 2014 –
see the start of this section), is also suggestive of potentially impaired goal-directed behaviour in 
depressed individuals.
In summary, the large overlap between stress responses and depression in terms of 
endocrine and neurotransmitter systems reinforces the idea that goal-directed behaviours might be 
impaired in depressed individuals.  Like the medial prefrontal cortex in rats, the ventromedial 
prefrontal cortex (vmPFC, including the OFC) in humans has been implicated in the formation of goal-
directed actions (see section 1.6.1 for full discussion).  The abnormal recruitment/activity of this area 
in depression (whilst a contentious issue) might also suggest a dependence on habit (see Griffiths et 
48 
al., 2014).  Structural abnormalities have also been reported for the frontal cortical regions (e.g. 
Rajkowka, Miguel-Hidalgo, Wei et al., 1999) (as well as for the caudate nucleus of the striatum (see 
Griffiths et al., 2014) - another structure implicated in goal-directed behaviour, see section 1.6.1) of 
depressed individuals.  Together with the observation that patients perform poorly on tasks that 
depend on frontal systems (e.g. Braw, Aviram, Bloch & Levkovitz, 2011; Moritz, Birkner, Kloss et al., 
2002), this evidence, strongly suggests impairment of prefrontal-cortex dependent goal-directed 
behaviours in depressed patients.
1.4 Animal Models of Psychiatric Disorders 
 Animal models are instrumental in better understanding the mechanisms underlying the 
symptoms of disease and for the development of novel treatments.  This, first and foremost, is 
because they provide us with a unique opportunity to test hypotheses which are not amenable to 
human investigation.  In many cases, it is animal models that have allowed us to determine what 
changes occur in the schizophrenic or depressed brain.  For example, understanding changes in 
neurotransmitter levels in humans has had to rely, in large part, on post-mortem analysis (potentially 
confounded by comorbid disorders and treatment effects) as well as imaging studies that indirectly 
measure the brains activity levels.  Animal models on the other hand allow specific hypotheses 
regarding the disorder to be tested at the basic science level.  They can also side-step the numerous 
problems associated with human studies such as heterogeneity in symptom course and outcome and 
the patients' drug medication status. 
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 As well as being able to appropriately measure the discreet constructs of reward processing 
(and other symptom-like behaviours) (to be discussed in sections 1.5 and 1.6), it is essential that 
animal models of disease possess good translational value.  Models of disorders must be rigorously 
evaluated for their ability to satisfy requirements of 'face', 'construct' and 'predictive' validities (see 
Jones, Watson & Fone, 2011).  For a model to have good 'face' validity, there must be a large overlap 
between the behavioural phenotype exhibited by the model and the profile of clinical symptoms in the 
disorder.  Challenges to face validity arise due to the uniquely human characteristics of schizophrenia 
and depression.  After all, measuring hallucinations, or a generally low mood, that require the 
individual to self-report their experiences, are impossible in non-verbal animals.  However, several 
symptoms can be replicated in rodents and, most importantly for the current thesis, this includes 
reward-related behavioural deficits.   
 Construct validity requires the model to replicate the theoretical biological rationale and 
underlying pathophysiology of the disease.  Since the aetiology and pathophysiology of schizophrenia 
and depression are not clearly established, most animal models have been developed to exhibit some 
aspect of the neurobiological features that have been detected in schizophrenia (e.g. neurotransmitter 
deficits, enlarged ventricles and reduced hippocampal volume) and depression (e.g. neurotransmitter 
deficits, dysregulation of the HPA axis and hypercortisolaemia).   
 For a model to have predictive validity, the depression- or schizophrenia-like symptoms must 
be attenuated by clinically effective therapeutic treatments, whilst not being effected by drugs known 
to be ineffective in the clinic.  Typically, in drug discovery research, assessing novel compounds 
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against current gold-standards provides this level of validation.  However, in the case of 
schizophrenia, gold standard drugs have not yet been developed to target the negative and cognitive 
symptoms, whereas in depression, all current drugs have the same underlying mechanism on 
monoamine systems - which makes it hard to identify any drugs with a novel mechanism. 
1.4.1 Animal Models of Schizophrenia 
 Schizophrenia is a disorder in which similar pathology can arise from multiple different 
aetiologies.  As a result, a range of pharmacological (i.e. amphetamine, PCP, ketamine and MK-801), 
genetic (i.e. mutant DISC-1, knockout of neuregulin-1 and mutant dysbindin), and 
neurodevelopmental models (i.e. MAM, neonatal ventral hippocampal lesion, post-weaning social 
isolation and maternal infection) have been introduced to represent schizophrenia in animals (see 
Jones et al., 2011). 
a. Pharmacological models 
 Pharmacological models have focused in large part on the dopaminergic hypothesis of 
schizophrenia due to the majority of current antipsychotics having dopamine D2 receptor antagonist 
activity.  Repeated administration of drugs that increase dopamine levels, such as amphetamine, 
increase spontaneous locomotor activity as well as activity to subsequent psychostimulant challenge 
after withdrawal (Miyamoto & Nitta, 2014).  Depending on the dosing regimen, amphetamine has also 
been shown to produce persistent deficits in the prepulse inhibition (PPI) of acoustic startle responses 
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(Jones et al., 2011), a deficit identified in schizophrenia patients (Braff, Geyer & Swerdlow, 2001), 
thought to involve impaired pre-attention processing (Young, Powell, Risbrough, Marston & Geyer, 
2009).  The face validity of such models, however, is limited by the fact that they do not incorporate 
the negative symptoms associated with the disease (Sams-Dodd, 1995, 1998).   
 Glutamate (i.e. NMDA receptor hypofunction) has also been implicated in the pathophysiology 
of schizophrenia and has led to glutamate-based pharmacological models.  Chronic PCP 
administration (a NMDA receptor antagonist) has been shown to be particularly relevant in modelling 
the disease (see Neill, Barnes, Cook et al., 2010).  Not only does subchronic PCP induce a range of 
neurobiological processes akin to schizophrenia (i.e. mesolimbic DA hyperfunction and mesocortical 
DA hypofunction) (Jentsch, Taylor & Roth, 1998; Jentsch, Tran, Le, Youngren & Roth, 1997; Jentsch 
& Roth, 1999), it also induces behaviours reminiscent of the positive, negative (Neil, Harte, Haddad, 
Lydall & Dwyer, 2014; Sams-Dodd, 1995; 1998) and cognitive symptom clusters (Neill et al., 2010).  
That said, sub-chronic PCP does not induce behaviours analogous to consummatory (Lydall, Gilmour 
& Dwyer, 2010) or anticipatory anhedonia (Wright, Dwyer & Gilmour, 2013), nor does it induce 
impairments in reward valuation (own observation) or motivational competencies (Lydall, 2011).  
Moreover, this model has resulted in false-positives with respect to currently available antipsychotics, 
questioning its predictive validity (see Jones et al., 2011). 
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b. Genetic models 
 Genetic models of schizophrenia rely on the high heritability of the disorder and as such have 
good construct validity (McGuffin, Tandon & Corsico, 2003).  Example models include DISC-1, 
neuregulin-1 and dysbindin where susceptible genes that may predispose an individual to develop 
schizophrenia have been manipulated.  Whilst these models show promise, schizophrenia is 
considered to be both poylgenic in nature and involve a complex interplay between genetic and 
environmental factors.  With this in mind, the relevance of a single genetic alteration is hard to 
determine (see Miyamoto & Nitta, 2014, for a review), although these models may well support the 
examination of converging 'downstream' effects of the different genetic manipulations investigated 
(e.g. relating to neural signalling). 
c. Neurodevelopmental models 
 As discussed earlier, the risk of developing schizophrenia is greatly enhanced if the neonate 
has been exposed to adverse environmental conditions during the critical gestational or perinatal 
periods of development (Jones et al., 2011).  A wide range of perturbations have been considered of 
relevance, including maternal stress and malnutrition, infections and complications such as hypoxia 
during birth (Jones et al., 2011).  Animal models that utilise perinatal and postnatal insults have been 
shown to induce behavioural phenotypes of relevance to schizophrenia (Meyer & Feldon, 2010).  For 
example, post-weaning social isolation produces spontaneous locomotor hyperactivity, 
hyperdopaminergic tone of the mesolimbic system and causes a consistent decrease in PPI (Jones et 
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al., 2011), whereas maternal malnutrition has similar effects on PPI and increases amphetamine 
induced hyperlocomotion (e.g. Palmer, Printz, Butler et al., 2004).  Neonatal excitotoxic lesions of the 
ventral hippocampus have also been a popular modelling approach, producing a phenotype emerging 
during adolescence (see Miyamoto & Nitta, 2014).  Behavioural characteristics of relevance to 
schizophrenia include: increased sensitivity to amphetamine (Beninger, Tuerke, Forsyth et al., 2009), 
PCP and MK-801; deficits in PPI; impaired latent inhibition; working-memory problems and decreased 
sociability (a symptom independent of sexual maturity, as reviewed by Lipska & Weinberger, 2000).  
However, the predictive validity of this model has been questioned and lesioned rats also show 
increased sucrose preference (potentially questioning the face validity of the model - see Miyamoto & 
Nitta, 2014, for a review). 
 Another popular approach is to disrupt neurogenesis using immune activation (via 
polyriboinosinic-polyribocytidilic acid - PolyI:C) or Methylazoxymethanol acetate.  As 
Methylazoxymethanol acetate is the chosen animal model for this thesis, it will be reviewed in some 
detail. 
 Methylazoxymethanol acetate (MAM) is a naturally occurring substance derived from the 
seeds of cycad plants which, when administered to a pregnant dam rat, disrupts embryonic brain 
development (Matsumoto & Higa, 1966).  As an antimitotic and antiproliferative agent, MAM acts by 
methylating DNA, specifically targeting developing neuronal cells, without affecting glial cells or 
peripheral organs (Cattabeni & Di Luca, 1997). 
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 In common with neurodevelopmental models in general, the timing of MAM administration is 
of upmost importance as neuronal development follows a rigid timetable (see Bayer & Altman, 2004).  
With MAM preventing cell mitosis for a short time after injection (Balduini, Elsner, Lombardelli, Peruzzi 
& Cattabeni, 1991; Cattabeni & Di Luca, 1997), it allows for very targeted brain disruption.  
Administration of MAM on gestational day fifteen (GD15), when cortical neurogenesis of the 
developing rat pup is at its peak, produces a disruption which is too widespread to be applicable to 
schizophrenia (see Jones et al., 2011).  For example, at this time, MAM produces gross changes in 
total cortical mass and brain weight  (Moore, Jentsch, Ghajarnia, Geyer & Grace, 2006), which are far 
removed from the subtle changes in cortical and temporal lobe morphology seen in patients (Shenton, 
Dickey, Frumin & McCarley, 2001).  However, administration of MAM on GD17 is considered to be 
optimal: Neuronal proliferation is reduced, but not entirely blocked, in most cortical regions by this 
time point (Jones et al., 2011).  As a result, MAM treatment at GD17 causes subtle effects across 
cortical areas, the hippocampus and the limbic system - all of which are relevant to schizophrenia 
pathophysiology (Liddle et al., 2006; Lodge & Grace, 2009; Moore et al., 2006).  
 Structurally, GD17 MAM has been shown to increase ventricle size (including lateral and third 
ventricles) (Jones et al., 2011, but see Matricon, Bellon, Friedling et al., 2010), reduce hippocampal 
volume and cause reductions in the thickness of the cortex and mediodorsal thalamus (see Table 1; 
Chin, Curzon, Schwartz et al., 2011; Flagstad, Mork, Glenthoj, van Beek, Michael-Titus & Didriksen, 
2004; Le Pen, Gourevitch, Hazane, Hoareau, Jay & Krebs, 2006; Matricon et al., 2010; Moore et al., 
2006).  Neuronal packing density is increased in the mPFC (Moore et al., 2006), while disorganisation 
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of pyramidal neurons features in the hippocampus (Le Pen et al., 2006; Moore et al., 2006), as does a 
decrease in hippocampal parvalbumin (PV) containing GABA-ergic interneurons (Lodge, Behrens & 
Grace, 2009; Penschuck, Flagstad, Didriksen, Leist & Michael-Titus, 2006).  Decreases in total brain 
weight have also been seen after GD17 MAM treatment (of approximately 11%) which is also 
somewhat consistent with schizophrenia (Flagstad et al., 2004). 
Table 1 Morphological and neurochemical deficits induced by the administration of MAM on GD17.  Due to timing of the 
intraperitoneal injection, disruptions are restricted to the paralimbic and temporal cortices reflecting the histopathology 
observed in schizophrenia patients. 
1) Honea, Crow, Passingham & Mackay (2005), 2) Nelson, Saykin, Flashman & Riordan (1998), 3) Shenton et al. (2001), 4)
Wright, Rabe-Hesketh, Woodruff, David, Murray & Bullmore (2000), 5) Flagstad et al. (2004), 6) Le Pen et al. (2006), 7)
Matricon et al. (2010), 8) Moore et al. (2006), 9) Harrison (1999) as cited by Lodge & Grace (2009), 10) Kovelman & 
Scheibel (1984), 11) Lewis, Hashimoto & Volk (2005), 12) Lodge, Brehens & Grace (2009), 13) Penschuck et al. (2006), 14)
Thune & Pakkenberg (2000), 15) Selemon, Mrzljak,  Kleinman, Herman & Goldman-Rakic (2003), 16) Selemon, Rajkowska &
Goldman-Rakic (1995), 17) Laruelle, Abi-Dargham, van Dyck et al. (1996), 18) Abi-Dargham, Rodenhiser, Printz et al. (2000). 
Human Schizophrenia Refs MAM-Exposed Rat
(GD17)
Refs
↓ Tissue volume/thickness in prefrontal 
cortical and temporal lobe regions
1,2,3,4 ↓Cortical area/thickness
 mPFC
 Hippocampus
 Parahippocampal cortices
5,6,7,8
No change in neocortical neuron 
number
9 No change in neocortical neuron number 8
Hippocampal pyramidal neurons are 
disorganised
 Variation in neuronal 
orientation
10 Heterotopias, disorganisation and 
sporadic density of hippocampal 
pyramidal neurons
5,6,8
↓ PV-positive GABA-ergic interneurons 
in cortical and limbic areas
11 ↓ PFC/ hippocampal PV-positive GABA-
ergic interneurons
12, 13
↓ Size and/or cell number in 
anterior/medial dorsal thalamus
4, 9,14 ↓size of medial dorsal thalamus 8
↑ Neuron packing density in the dorsal 
cortex and occipital cortex
15,16 ↑ Neuron packing density in mPFC and 
occipital cortex
8
Hyper-active sub-cortical DA system 17, 18 Increased DA release (i.e. from Nac) in 
response to amphetamine challenge
5
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 At the neurochemical level, MAM administration at GD17 produces abnormalities in 
dopaminergic function of relevance to schizophrenia.  Primarily, elevated dopamine release has been 
reported in the NAc (but not the frontal cortex) of these animals after acute amphetamine challenge –
analogous to the mesolimbic hyperdopaminergic tone seen in schizophrenia (Flagstad et al., 2004; 
Jones et al., 2011; Moore et al., 2006).  This is consistent with an increased rate of spontaneous firing 
of dopamine neurons in the ventral tegmental area (VTA) of these offspring, an area of the brain from 
which dopamine neurons project to the striatum (as reviewed by Miamoto & Nitta, 2014).  With both 
elevated amphetamine-induced locomotion (see below) and spontaneous increases in VTA neurons 
being reversed by inactivation of the ventral hippocampus (Lodge & Grace, 2007), it suggests that 
hippocampal dysfunction may underlie this hyperdopaminergic tone.  Indeed, Lodge and Grace 
(2008) posit that hyperactivity of the ventral subiculum of the hippocampus, which itself may be 
caused by the loss of inhibitory (parvalbumin-containing) GABA-ergic interneurons (Penschuck et al., 
2006), is causative of the hyperactivity displayed by dopamine neurons in the VTA (as reviewed by 
Jones et al., 2011). 
 Behaviourally, MAM treatment at GD17 increases spontaneous and PCP-induced orofacial 
dyskinesias which are thought to reflect fronto-cortical lesions in these animals (Moore et al., 2006).  
Correlating with increased dopamine release from the NAc, GD17 MAM rats display enhanced 
hyperlocomotion in response to amphetamine (Flagstad et al., 2004; Le Pen et al., 2006; Lodge & 
Grace, 2007; Moore et al., 2006).  Enhanced hyperactivity to the NMDA receptor antagonist MK-801 
is also a robust finding of this model (Le Pen et al., 2006).  Further increasing the model’s validity, 
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these altered locomotor responses to psychostimulant drugs (together with basal differences in 
locomotion) are only found in rats once they have reached puberty (Hazane, Krebs, Jay and Le Pen, 
2009; Le Pen et al., 2006; Moore et al., 2006).  This time course is seen with other behavioural 
deficits, such as impaired PPI, and is analogous to the post-pubertal onset profile seen in 
schizophrenia patients (Hazane et al., 2009; Le Pen et al., 2006).  Furthermore, PPI deficits are only 
observed after GD17 treatment, not GD15 treatment, reinforcing the importance of selecting this 
treatment window (Moore et al., 2006). 
 In terms of modelling the non-psychotic symptoms of schizophrenia, MAM treated rats show a 
range of cognitive deficits such as hippocampal-dependent spatial working memory impairments 
(Flagstad, Glenthoj & Didriksen, 2005; Gourevitch, Rocher, Le, Krebs & Jay, 2004; Moore et al., 
2006).  MAM treated rats have also been shown to require significantly more trials to reach criterion 
during both the reversal and extradimensional shift phases of the bowl-digging attentional set shifting 
task (Featherstone, Rizos, Nobrega, Kapur & Fletcher, 2007; Gastambide, Cotel, Gilmour, O’Niell, 
Robbins & Trickleback, 2012; Moore et al., 2006) - the rodent equivalent of the wisconsin card sorting 
task where schizophrenia patients show an impairment (Tyson, Laws, Roberts & Mortimer, 2004; 
Jazbec, Pantelis, Robbins, Weickert & Weinberger, 2007).  With regards to the negative symptoms, 
no attempts have been made to assess hedonic ability or reward encoding in this model.  However, 
promise is given by pre-pubertal reduced social interaction (as mentioned negative symptoms are 
often prodromol) exercised by MAM treated rats, reminiscent of asociality in schizophrenia (Flagstad 
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et al., 2004).  The lack of characterisation of reward processing is a neglect that this thesis will 
address. 
 It should be noted that whilst MAM administration at GD17 shows both good face and 
construct validities, its predictive validity is relatively unknown.  To date, studies have investigated the 
ability of current (Le Pen, Jay & Krebs, 2011) and novel (Gill, Lodge, Cook, Aras & Grace, 2011) 
antipsychotics to attenuate the locomotor enhancing effects of MK-801 and amphetamine.  Clearly, 
further investigation is required to determine whether or not GD17 MAM administration can be 
considered as a comprehensive rodent model of schizophrenia, with predictive validity for negative 
and cognitive symptoms. 
1.4.2 Animal Models of Depression
 A wide variety of approaches have been taken in attempting to model depression in rodents.  
These include approaches based on genetic manipulations (e.g. glucocorticoid receptor antisense 
transgenic mice, CRH receptor subtype knock-outs - see Willner & Mitchell, 2002), lesions (e.g. 
olfactory bulbectomy - e.g. Slattery, Markou & Cryan, 2007) and pharmacological manipulations (e.g. 
reserpine - see O'Niel & Moore, 2003) and psychostimulant withdrawal (e.g. Barr & Markou, 2005).   
While all such approaches have potential advantages – e.g. potentially capturing aspects of the 
precise genetic basis for the heritability of depression – they all have potential problems with both face 
and construct validity – e.g. relatively few examples of human depression are reported to stem directly 
from abuse of stimulants and this approach produces only short-lived effects.  Therefore, I will focus 
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on stress-based models and inbred rat strains – which reflect one of the commonly cited causal 
factors and produce the long-lasting symptomatology of the disorder.  Particular attention will be given 
to the Wistar Kyoto inbred rat strain, as this model was the focus of the experimental efforts reported 
in this thesis. 
a. Animal models based on stress exposure 
 Social stresses such as losing social status or rank are considered to be important risk factors 
in depression (Brown, 1993, as cited in Czéh, Fuchs, Wiborg & Simon, 2015).  As a result this has led 
to the development of paradigms based on social stressors in rodents such as the resident-intruder 
paradigm (see Czéh for a review, 2015).  This model utilises conflict between members of the same 
species by introducing a novel male 'intruder' rat into the home cage of another 'resident' male.  This 
paradigm has been shown to induce a pessimistic response bias to ambiguous tones after 3 weeks of 
daily social defeat (Papciak, Popik, Fuchs & Rygula, 2013) as well as a reduction in sucrose 
preference after 5 weeks of social defeat (Rygula, Abumaria, Flügge et al., 2005).  Moreover, it has 
been shown that the reward related deficits are attenuated by the chronic administration of an 
antidepressant, suggesting that the model holds predictive validity (Rygula, Abumaria, Flügge et al., 
2006). 
 Feelings of helplessness are a common symptom of depression with patients displaying 
deficient behavioural control of an aversive stimulus if they have previously experienced aversive 
stimuli which are uncontrollable (Pryce, Azzinnari, Spinelli, Seifritz, Tegethoff & Meinlschmidt, 2011).  
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The learned helplessness paradigm was one of the first attempts to replicate depressive like 
behaviours in rodents (Czéh et al., 2015).  Involving the exposure of animals to uncontrollable foot-
shocks, it induces helpless behaviour in subsequent escape trials as well as additional behaviours of 
relevance to depression (as reviewed by Wiborg, 2013).  For example, helpless mice have been 
shown to reduce responding for rewarding brain stimulation (in intracranial self-stimulation, or ICSS, 
e.g. Zacharko, Bowers, Kokkinidis & Anisman, 1983) while helpless rats fail to suppress 
corticosterone after a dexamethasone challenge (Greenberg, Edwards & Hen, 1989), suggesting 
hyperactivity of the HPA axis.  Whilst this model holds promise, paradigm differences across the 
literature as well as strain effects question the generalisability of the results (see Willner & Mitchell, 
2002).  The spontaneous recovery of the animals also means that this model is less amenable to drug 
discovery efforts (as reviewed by Wiborg, 2013). What is more, the 'shock duration order effect' 
suggests that the rats are not really 'helpless' so much as directly conditioned to be unresponsive 
(Balleine & Job, 1991; Prabhakar & Job, 1996). 
 Chronic mild stress (CMS) is one of the most validated preclinical models of depression.  It 
involves exposing the animals to sequential chronic mild stressors (i.e. social isolation, pair-housing, 
dampening bedding, disruption of the light-dark cycle, and food and water deprivation) in an 
unpredictable manner for at least two weeks (as reviewed by Czéh et al., 2015).  This induces a long-
lasting behavioural phenotype in susceptible rodents as well as a range of neurochemical, 
neuroendocrinological and neuroimmune abnormalities reminiscent of those observed in depressed 
patients (see Czéh et al., 2015, and Willner, 1997, for reviews).  For example, rats susceptible to 
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stress have lower consumption of sucrose in both single bottle consumption tests and two-bottle 
preference (sucrose vs. water) tests (reviewed by Willner, 1997).  Also in line with reward-related 
deficits in depression, they demonstrate impaired food-induced place-preference conditioning (Papp, 
Willner & Muscat, 1991) and an increased stimulation threshold in the ICSS paradigm (Moreau, 
Jenck, Martin, Mortas & Haefely, 1992).  Stress-susceptible rats also show hypercortisolaemia and a 
dysregulation of the HPA axis (although these have been shown to recover after eight weeks of 
chronic stress exposure, see Wiborg for a review, 2013), while all rats subjected to the CMS 
procedure have working memory impairments (Henningsen, Andreasen, Bouzinova et al., 2009), a 
pessimistic response bias (Harding, Paul & Mendl, 2004) and altered sleep architecture (i.e. REM 
sleep occurs earlier in the cycle - Cheeta, Ruigt, van Proosdij & Willner, 1997; Grønli, Murison, 
Bjorvatn, Sørensen, Portas & Ursin, 2004). 
 Originally, the chronic stress paradigm was developed by Katz and colleagues and utilised 
harsher physical stressors (i.e. electric shock, shaker stress and cold swim) (Katz & Hersh, 1981).  
The modified paradigm used today (developed by Willner, e.g. Willner, Towell, Sampson, 
Sophokleous & Muscat, 1987) has been argued to better reflect the inducing factors of depression in 
humans (see Wiborg, 2013, for a review).  The unpredictable nature of the stressors used is also of 
importance, as it prevents the animals from habituating over time.  As a result, deficits in reward-
related behaviours have been shown to persist as long as stressors are repeatedly applied.  After 
cessation of stress, the animals recover after a period of four to five weeks allowing the possibility of 
subsequent stress-induced behaviours in the future.  This gives the chronic mild stress model a 
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unique ability to replicate the repetition of episodes seen in depression (as reviewed by Czéh et al., 
2015).  The use of outbred rat strains in this model means that some animals are highly susceptible to 
stress whereas others show stress resilience (as is also the case for other stress-based paradigms 
including social defeat and learned helplessness, see Czéh et al., 2015 and Wiborg, 2013 for 
reviews).  Furthermore, of the susceptible animals, only half respond to chronic antidepressants 
(Christensen, Bisgaard & Wiborg, 2011).  Both these latter features of the model make it highly 
consistent with features of the general (i.e. heterogeneity in stress susceptibility) and depressed 
populations (i.e. therapeutic treatment refraction).  Unfortunately, however, the CMS procedure is 
labour-intensive, and has not produced consistent results in some laboratories (as reviewed by 
Willner, 1997).  Furthermore, not all the reward-related deficits thought to feature in depression are 
found after CMS exposure.  For example, stressed rats do not differ in their lever press responses for 
sucrose under a progressive ratio schedule of reinforcement (Barr & Phillips, 1998).   
b. Animal models based on selective breeding 
Rats displaying helpless behaviour after exposure to inescapable shocks have been 
selectively bred to produce the congenital learned helplessness rat strain (cLH).  Conversely, their 
controls (cNLH) were developed from inbreeding rats which showed stress resilience on the learned 
helplessness paradigm.  In terms of reward-related behaviours, cLH and cNLH rats are identical prior 
to precipitating stressors.  After either social isolation (Sanchis-Segura, Spanagel, Henn & Vollmayr, 
2005) or foot-shock stress (Enkel, Spanagel, Vollmayr & Schneider, 2010), however, cLH rats 
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consume significantly less sweet solution compared to their controls.  Furthermore, stress challenge 
has been shown to induce a significantly reduced pleasure-attenuated startle response for sweet 
solutions in cLH rats (Enkel et al., 2010).  As such, the cLH rat strain perhaps provides a model of 
predisposition to depression.  Consistently, neuroimaging studies have revealed that metabolism is 
significantly lower in various cortical regions of the cLH rat (i.e. dorsal frontal, medial orbital and 
anterior cingulated cortex), but significantly higher in the subgenual cingulate cortex - similar to 
changes which have been previously demonstrated in depression (as reviewed by Willner & Mitchell, 
2002).  That said, unlike the rats from which this strain was developed, cLH rats do not show adrenal 
responsiveness to stress (King, Abend & Edwards, 2001).  Indeed, some authors, based on 
hyporesponsiveness of the HPA axis, together with the cognitive impairments and stress-induced 
analgesia displayed by the strain, have posited that cLH rats better reflect post-traumatic stress 
disorder (King et al., 2001). 
Similarly to the cLH rat, the Roman Low Avoidance (RLA) rat strain was selectively bred for 
impaired performance in the shuttle box paradigm, whereas their controls (RHA) were developed for 
good performance on this task.  Compared to the RHA strain, RLA inbred rats exhibit behaviours in 
the open field test and elevated plus maze which are consistent with high emotionality/anxiety or an 
inability to cope with stress (as reviewed by Willner & Mitchell, 2002).  Consistently, when RLA rats 
were given daily access to a 22% sucrose solution they exhibited a larger suppression in their 
consummatory behaviour after a downward shift to a less valued 4% sucrose solution, as compared 
to their control strain.  This may reflect an increased level of disappointment or frustration in this rat 
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strain, or a greater susceptibility to the stress-inducing effects of reward loss (Gómez, Escarabajal, de 
la Torre, Tobeña, Fernández-Teruel & Torres, 2009).  Inconsistent with depression, RLA and RHA 
rats show similar behaviour in response to social defeat (as reviewed by Willner & Mitchell, 2002).  
Moreover, RLA rats are (potentially) unimpaired in their ability to predict future rewards, and adjust 
their behaviour in light of this prediction (as shown by the development of a between-subjects 
anticipatory contrast effect in consumption), suggesting that anticipatory hedonics are normal in this 
rat strain (Gómez et al., 2009). 
 The Flinders sensitive line (FSL) is another inbred rat strain where rats were selected based 
on their sensitivity to the hypothermic effects of cholinergic agonists, thus mimicking the increased 
cholinergic sensitivity reported in depression (reviewed by Willner & Mitchell, 2002).  Alongside 
cholinergic hypersensitivity, FSL rats display altered serotonergic and dopaminergic systems 
compared to their controls (the Flinders Resistant Line, FRL) (Willner & Mitchell, 2002), as well as 
decreased BDNF in the hippocampus (but not in the frontal cortex) (see Neumann, Wegener & 
Homberg et al., 2011 for a review) and smaller hippocampal volume (Chen, Madsen, Wegwnwe & 
Nyengaard, 2010).  Phenotypically, the FSL strain exhibits behaviours which resemble symptoms of 
depression.  For example, FSL rats exhibit weight disturbances (Overstreet, 1993), sleep 
disturbances (i.e. decreased latency to the onset of REM sleep and increased REM sleep episodes) 
(Shiromani, Overstreet, Levy, Goodrich, Campell & Gillin, 1988) and increased immobility in the 
forced-swim test (which may or may not resemble behavioural despair) (as reviewed by Willner & 
Mitchell, 2002).  Similarly to the cLH rat strain, FSL rats do not display deficits in reward sensitivity 
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under basal conditions, as shown by normal preference for sweet solutions (Pucilowski, Overstreet, 
Rezvani & Janowsky, 1993) and similar response rates to the rewarding effects of ICSS (Matthews, 
Baldo, Markou, Lown, Overstreet & Koob, 1996).  However, after being subjected to a CMS 
procedure, FSL rats displayed lower intake of sweet solutions in one-bottle and two-bottle preference 
tests compared to their controls (Pucilowski et al., 1993).  Whilst the face validity of this model is 
generally good, FSL rats display reduced anxiety behaviours on the elevated plus maze (although 
anxiogenic behaviour has been demonstrated in social interaction tasks, see Abildgaard, Solskov, 
Volke, Harvey, Lund & Wegener, 2011; Braw, Malkesman, Dagan et al., 2006 and Overstreet, 
Keeney & Hogg, 2014), and exhibit a reduced, as opposed to elevated, HPA axis activity with lower 
basal ACTH levels (as reviewed by Czéh et al., 2015). 
 The Wistar-Kyoto (WKY) rat line was originally developed as the normotensive control strain 
for the spontaneously hypertensive rat derived from a Wistar outbred stock (Okamoto & Aoki, 1963).  
However, in the late 1980s and early 1990s, it was discovered that WKY rats display behaviours 
which are perhaps relevant to depression symptomatology.  For example, WKY rats, compared to an 
outbred Wistar control strain, display an increased susceptibility to develop stress-induced ulcers 
(Paré, 1989a; Paré, 1989b; Paré & Redei, 1993), increased immobility on the forced swim test (Paré, 
1989a; Paré, 1989b; Paré & Redei, 1993) and deficient behaviour after being exposed to 
uncontrollable stressors which is consistent with learned helplessness (Paré, 1989a; Paré & Redei, 
1993).  WKY rats also demonstrate abnormal behaviour in the defensive burying task, with higher 
levels of freezing behaviour and less defensive burying (perhaps linked to passive coping) (Paré, 
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1992; Paré & Redei, 1993).  Also consistent with depression (Nutt, Wilson & Paterson, 2008), WKY 
rats demonstrate weight abnormalities (e.g. Nam, Clinton, Jackson & Kerman, 2014) and sleep 
disturbances with increased REM sleep and sleep fragmentation (Dugovic, Solberg, Redei, Van 
Reeth & Turek, 2000). 
 WKY rats exhibit neurochemical and neuroendocrine abnormalities reminiscent of those 
observed in depressed patients.  For example, WKY rats display altered serotonergic, noradrenergic 
and dopaminergic systems (as reviewed by Jiao, Beck, Pang & Servatius, 2011), abnormalities of the 
thyroid stimulating hormone system (Solberg, Olson, Turek & Redei, 2001) and hyperactivity of the 
HPA axis (Pare & Redei, 1993; Redei, Pare, Aird & Klucynski, 1994).  Compared to Sprague-Dawley 
rats, WKY animals exhibit lower tissue content of 5-HT (Scholl, Renner, Forster & Tejani-Butt, 2010), 
decreased expression of tryptophan hydroxylase 2 mRNA (encoding an enzyme involved in 5-HT 
synthesis) (Lemos, Zhang, Walsh et al., 2011), and decreased neuronal excitability of 5-HT neurons 
in the dorsal raphe nucleus (DRN) (a serotonergic nucleus) of the brain stem (Lemos et al., 2011).  As 
reviewed by Jiao, Beck, Pang and Servatius (2011), WKY rats also exhibit abnormalities of their 
dopaminergic function in multiple brain regions.  Briefly, reports have shown that dopamine turnover is 
higher in the NAc shell compared to Wistar control animals.  WKY animals also exhibit altered levels 
of dopamine transporters (DAT) and altered dopamine D1 and D2 receptor densities across multiple 
brain regions, compared to controls.  Noradrenergic transmission is also altered in the WKY rat with 
attenuated noradrenaline activity in response to acute stress (Pardon et al., 2002), lower 
noradrenaline concentrations in the locus coreleus and reduced noradrenaline reuptake in cortical 
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areas (as reviewed by Bruzos-Cidón, Llamosas, Ugedo & Torrecilla, 2015).  By contrast, chronic 
stress is thought to lead to greater sensitisation of the noradrenergic system in WKY rats compared to 
Sprague-Dawleys controls (see Morilak, Barrera, Echevarria, Garcia, Hernandez & Petre, 2005).  
Hypercortisolism has also been observed in this rat strain: At baseline, WKY rats exhibit higher levels 
of ACTH and corticosterone during the light phase compared to their Wistar counterparts (Solberg, 
Loose Olson, Turek & Redei, 2001).  Furthermore, in response to both acute and chronic stressors, 
the increase in plasma ACTH levels is exaggerated in WKY rats (Pare & Redei, 1993; Redei, Pare, 
Aird & Kluczynski, 1994).  For a summary of neurochemical and neuroendocrine abnormalities seen 
in WKY animals and how these might relate to human depression, please refer to Table 2. 
 As anhedonia is one of the cardinal symptoms of depression it is of paramount importance 
that rodent models of the disorder incorporate a reduced hedonic capacity.  However, results in the 
WKY rat strain have been somewhat equivocal.  For example, Mileva and Bielajew (2015) 
investigated the WKY rats’ response in a two-bottle (water vs. 1% sucrose) preference test and found 
no strain differences in sucrose preference between female WKY and Wistar rats.  Similarly, male 
WKY rats were shown to have increased preference for 1% sucrose over water, comparable to the 
Wistar control strain (but greater than a Sprague-Dawley control strain).  Moreover, WKY rats in this 
experiment were shown to consume more sucrose solution overall than the other strains relative to 
their body weight (Nam et al., 2014).  A study by Malkesman and colleagues investigated reward-
related behaviour in pre-pubertal WKY rats.  Whilst signs of hedonic impairment were seen in a 
saccharin preference test, WKY animals showed normal acquisition of a conditioned place preference 
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induced by social interaction with a con-specific (Malkesman, Braw, Zagoory-Sharon et al., 2005).  In 
contrast, WKY male rats were shown to display reduced investigatory behaviour of a novel female 
stimulus compared to Wistar animals, consistent with the female interaction being less rewarding 
(Paré, 2000).  In an instrumental learning paradigm, WKY animals were also found to display less 
lever-press behaviour for sucrose pellet rewards when they were delivered on both a fixed-ratio (FR-
1) and progressive ratio (e.g. 3, 6, 10, 16, 23, 32, 44 etc.) schedule of reinforcement (De La Garza, 
2005).  This may be consistent with reduced hedonic capacity of the WKY rat, but equally plausible 
explanations would be motivational incompetency or psychomotor retardation displayed by these 
animals.   
 Whilst the discrepancies across the literature may result from paradigm, age or gender 
differences, it is interesting to note that testing conditions and prior experience of the animals may 
also have a role.  Where reductions in hedonic capacity have been found, animals were often pre-
exposed to a physical stressor.  For example, reduced saccharin preference in WKY animals 
occurred after they had been exposed to a five minute forced-swim test (Malkesman et al., 2005).  In 
contrast, where normal sucrose preference was exhibited by the WKY strain, testing was performed in 
the animals home-cage environment and no prior stress manipulation was performed (Mileva & 
Bielajew, 2015; Nam et al., 2014).  Furthermore, reduced investigatory behaviour of a novel female 
was amplified for WKY rats after being exposed to either a tail-shock or water-restraint stressor - a 
trend not seen in the control strains (Paré, 2000).  Clearly, further investigations regarding the 
hedonic capacity of WKY rats are warranted.  Combining stress with the genetic vulnerability model 
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may result in a more comprehensive depression-like phenotype, and could offer a more valid way to 
model the disease since depression in the clinic often involves an innate predisposition to depression, 
which is precipitated by stressful life events. 
Table 2 Morphological, neurochemical and behavioural abnormalities in the WKY inbred rat strain.  WIS and SD refer to 
Wistar and Sprague-Dawley controls, respectively. 
Human depression Ref Wistar Kyoto rat strain Ref
↓ in hippocampal volume 1 ↓ hippocampal volume in female 
WKY rats compared to WIS control; 
↓ in hippocampal volume in male 
WKY rats compared to SD control
2, 3
↓ in BDNF in the hippocampus 4 ↓ in BDNF in the CA3 of the 
hippocampus compared to WIS rats 
(pre-pubertal rats)
5 
HPA axis hyperactivity e.g. 6 ↑ in ATCH and corticosterone after 
the diurnal peak
↑in ACTH after acute and chronic 
stressors 
7,8,9
↑ basal levels of CRH 10 ↓ in CRH binding/ CRH Receptor 
mRNA expression
11
Abnormalities of the monoamine 
system
e.g. 6 Abnormal levels of monoamines in 
the limbic system
e.g. 12
Abnormalities in sleep architecture e.g. 13 ↑REM Sleep
↑Sleep Fragmentation
14
↑ Prevalence in females 15 Some evidence for greater 
depression-like behaviours in female 
WKY rats
16
1) Czéh & Lucassen (2007), 2) Tizabi, Hauser, Tyler et al. (2010), 3) Cominski, Jiao, Catuzzi, Stewart & Pang (2014), 4)
Shimizu, Hashimoto et al. (2003), 5) Malkesman & Weller (2009), 6) Saveanu & Nemeroff (2012), 7) Solberg et al. (2001), 8)
Pare & Redei (1993), 9) Redei et al. (1994), 10) Nemeroff et al. (1984), 11) Hauger, Shelat & Redei  (2002), 12) Jiao et al. 
(2011), 13) Nutt et al. (2008), 14) Dugovic et al. (2000), 15) Kessler (2003), 16) Pare & Redei (1993b). 
 Comorbidity of psychiatric conditions is common.  In one study, 67% of those with depression 
had a current comorbid anxiety disorder, while 75% had a lifetime comorbid anxiety disorder (Lamers, 
van Oppen, Comijs et al., 2011).  Moreover, anxiety and depression may exert potentiating effects as 
70 
individuals suffering from both experience longer duration of symptoms and higher symptom severity 
(Lamers et al., 2011).  Anxiety-like behaviours have been investigated in the WKY strain.  WKY rats 
display hypoactivity in response to novel environments (Malkesman et al., 2005), the open-field test 
(Malkesman et al., 2005; Paré, 1989a; Paré & Redei, 1993) and the elevated plus maze (Paré, 1992) 
- each of which may be consistent with anxiety related behaviours in this rat strain (although see Nam 
et al., 2014, where WKY animals spent more time in the centre square of the elevated plus maze 
which is perhaps more consistent with reduced activity or ambivalent behaviour of the strain).  WKY 
rats also rapidly acquire a passive avoidance response, perhaps indicative of increased anxiety or 
reduced locomotor behaviour (Paré, 1993; Paré & Redei, 1993).  Furthermore, WKY rats display 
impaired gastric tone, most likely due to their exaggerated stress response (Gunter, Shepard, 
Foreman, Myers, & Greenwood-Van Meerveld, 2000; Nielsen, Bayati, & Mattsson, 2006).  This is a 
primary characteristic of irritable bowel syndrome, a condition that has long been associated with both 
depression and anxiety (O'Mahony, Bulmer, Coelho et al., 2010; O'Malley, Julio-Pieper, Gibney, 
Dinan, & Cryan, 2010; Spiller, 2004).  Combined, this evidence suggests that WKY rats perhaps best 
constitute a model of comorbid depression and anxiety disorders. 
 As mentioned previously, predictive validity constitutes another important criterion against 
which a putative model is assessed.  Several studies have shown that the increased immobility in the 
forced swim test displayed by WKY rats is attenuated by chronic (but not acute) administration of 
antidepressants, consistent with chronic antidepressant efficacy in the clinic (Lahmame, del Arco, 
Pazos, Yritia & Armario, 1997).  However, antidepressant effects only occur with certain drug types: 
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desipramine (an NA reuptake blocker tricyclic antidepressant) was found to increase swimming time 
in the forced swim test whereas fluoxetine (a 5-HT reuptake inhibitor, SSRI) had limited effect (López-
Rubalcava & Lucki, 2000; Tejani-Butt, Kluczynski & Paré, 2003; Will, Aird & Redei, 2003).  
Desipramine has also been shown to have an effect in the open field test.  While ACTH responses to 
the open field test were increased by prior restraint stress in both WKY and Wistar strains, 
desipramine attenuated this effect in WKY rats only (Durand, Aguerre, Fernandez et al., 2000).  That 
said, desipramine has been found to have no effect on the amount of REM sleep observed in WKY 
rats (Ivarson, Paterson & Hutson, 2005).  Kappa opioid receptor antagonists have also been found to 
reduce forced swim test immobility in the WKY strain (Carr, Bangasser, Bethea, Young, Valentino & 
Lucki, 2010).  This is interesting in light of recent evidence suggesting the antidepressant properties 
of kappa opioid receptor antagonists in the clinic (Berton & Nestler, 2006).  Considered together, 
these results suggest that WKY rats might constitute a model of SSRI-resistant depression.  Whilst 
effective antidepressants are only efficacious against some of the depressive-like behaviours 
observed in the WKY rat model, it suggests that the model has predictive validity (Will et al., 2003). 
 In summary, while there are many possible approaches to modelling depression in rodents, in 
the work reported in this thesis I have focused on the WKY rat as it potentially captures aspects of the 
comorbidity between anxiety and depression and may model the SSRI-resistance seen in some 
patients. 
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1.5 Measuring Reward Processing in Animal Models 
 Alongside choosing valid animal models, it is essential that appropriate and reliable 
measuring techniques are employed to assess disorder-like characteristics of the model.  The 
importance of adopting suitable behavioural measures becomes most apparent when we consider the 
reward-processing deficits which feature in both schizophrenia and depression.  Whilst certain reward 
processes (such as reward 'wanting' and reward 'liking') were once thought to be inextricably linked, it 
is now known that they are served by dissociable neural mechanisms and as such should be 
considered as distinct, but related, entities.  The final section of the general introduction will introduce 
the behavioural paradigms which I adopted to investigate the potential reward processing deficits of 
the neurodevelopmental MAM model of schizophrenia and the inbred WKY model of depression.  The 
techniques were chosen for their ability to tease apart precise aspects of reward-related behaviours, 
in terms of both hedonic and cognitive processing of rewarding events. 
1.5.1 Consumption Measures and Orofacial Reactivity 
 As briefly mentioned in section 1.2, one approach to investigate 'liking' or palatability 
responses, unconfounded by other aspects of reward, is to study the affective orofacial reactions 
elicited by the hedonic impact of sweet tastes.  Such facial 'liking' reactions were initially described in 
newborn babies - with each displaying characteristic lip licking and tongue protrusions to the sweet 
taste of sucrose (Steiner, 1973).  Since then, the technique has been extended to rodents (Pfaffmann 
et al., 1977; Grill & Norgen, 1978a, b): rodents also elicit positive facial reactions to sweet tastes (e.g. 
73 
tongue protrusion) whereas bitter tastes elicit disliking facial reactions (e.g. gaping).  With taste 
reactivity profiles being highly conserved across species, studies in rodents can provide us with useful 
information regarding human pleasure and how this might be affected in disease states.  Furthermore, 
studies using taste reactivity in rodents have demonstrated the importance of not using consumption 
measures in isolation (e.g. sucrose consumption/preference tests) as the early studies using this 
technique demonstrated that consumption and hedonic reactions can dissociate (e.g. Pelchat, Grill, 
Rozin, & Jacobs, 1983). 
Whilst the benefits of using taste reactivity are clear, the technique has several limitations that 
prevent it from being effective for examining the presence of reduced hedonic capacity in rodent 
models of disease.  The most crucial of these is that taste reactivity tests typically provide categorical 
information as to whether something is palatable or aversive to an animal.  In short, gaping reactions 
are only elicited by nausea and never by sweet tastes.  That said, it can be argued that taste reactivity 
responses lie on a continuum from appetitive to aversive and so do, in fact, allow some quantitative 
distinctions to be made (e.g. Beslin, Grill & Spector, 1992).  Indeed, this approach of considering taste 
reactivity responses as a continuum, from appetitive to aversive, is central to the work reviewed in 
section 1.2.  Regardless of this issue, taste reactivity is a subjective (although inter-rater reliability is 
very high) and highly time-consuming method, which does not lend itself to the high-throughput 
environment of the drug discovery process.   
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1.5.2 Microstructural Analysis of Licking 
 Another method by which the value of a reward can be measured in animals, which is both 
more objective and less labour intensive, is to examine the licking microstructure of rats as they 
voluntarily consume a solution.  First utilised by Davis and his co-workers in the 1970s, 
microstructural analysis of licking is grounded on the observation that rats ingest fluids in sustained 
runs of rapidly occurring rhythmic licks (herein referred to as clusters) separated by pauses of varying 
length (Davis, 1973).  Critically, the number of licks in each licking cluster (lick cluster size) is lawfully 
related to the nature or concentration of the solution being consumed.  That is, it bears a positive 
monotonic relationship with the concentration of sweet pleasant tasting solutions, such as sucrose 
and saccharin (Davis & Smith, 1992; Spector, Klumpp, & Kaplan, 1998).  Conversely, it bears a 
negative monotonic relationship with the concentration of bitter, unpleasant solutions such as quinine 
(Hsiao & Fan, 1993; Spector & St John, 1998). 
 Of critical importance in understanding the emotional competence of an animal, certain 
manipulations can induce lick cluster size (LCS) changes when the solution itself is physically 
unaltered.  For example, pairing saccharin with lithium chloride (LiCl)-induced nausea has been 
shown to reduce the size of licking clusters when an animal is given subsequent access to that 
solution in extinction (Dwyer, Boakes, & Hayward, 2008).  That is, the lick cluster sizes elicited by the 
rat become similar to those that would be elicited if the rats were drinking quinine.  With the solution 
being physically unchanged, the change in LCS licenses the inference that the change must lie with 
the animal and more specifically, with the primary driving force behind LCS being the nature of the 
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solution, inferences can be made that the change lies with the perception or evaluation of the solution 
made by the animal (See Dwyer, 2012, for a review).  Importantly, the use of LCS as a measure of 
hedonic evaluation is supported by the fact that a variety of manipulations influence LCS in ways 
analogous to their effects on taste reactivity.  Taking the above example, pairing saccharin with LiCl 
causes rats to display a taste reactivity profile (consisting of behaviours such as mouth gapes) similar 
to one typically elicited by bitter solutions (e.g. Baird, St John, & Nguyen, 2005).   
 Also of importance to the use of LCS as a measure of hedonic value is the fact that LCS is 
not a proxy measure of consumption, the latter often reflecting factors such as motivation that are 
unrelated to pure hedonic processing.  Whilst pairing saccharin with LiCl results in both reduced LCS 
and reduced consumption, evidence of a dissociation between the two parameters can be seen when 
pairing saccharin with amphetamine, as here only consumption measures and not LCS measures are 
reduced (Dwyer et al., 2008).  Furthermore, consumption displays an inverted U-shaped function with 
the concentration of palatable solutions (e.g. Richter & Campbell, 1940) which means that at higher 
solution concentrations (at the peak and descending limb of the function) increases in LCS should be 
met with unchanged or decreasing consumption levels – which is exactly the relationship observed in 
the foundational studies of licking microstructure (e.g. Davis &Smith, 1992; Spector, Klumpp, & 
Kaplan, 1998).  Moreover, studies of conditioned flavour preference demonstrate that LCS can be 
raised through learning in testing situations that prevent conditioned changes in the amount 
consumed (Dwyer, 2008). 
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 Given the fact that taste reactivity and microstructural analysis of licking both show 
comparable responses to different manipulations, but microstructural analysis is a less labour-
intensive technique, and perhaps more sensitive to small changes in hedonic value, this method was 
used in the current series of experiments.  An additional benefit of this technique is that it allows the 
experimenter to determine the length of time between one lick made by the rat and the next.  This 
parameter of interlick interval (ILI) usually shows very little variability across animals, except in cases 
where motoric disturbances are present (e.g. altered posture).  The importance of measuring this 
parameter is high, not only when we consider that motor abnormalities could confound lick cluster 
measurements, but also when we consider the psychomotor retardation that is thought to be present 
in depression and its WKY rat model.  An observation of reduced LCS without corresponding changes 
in ILI would provide strong evidence for reduced hedonic capacity in animal models of psychiatric and 
mood disorders.   
1.6 Measuring Reward Processing Deficits, Beyond Anhedonia, in Animal Models 
 Alongside pure hedonic reactions, be it in-the-moment or expected in the future, appropriate 
processing of rewards also depends on intact cognitive and motivational competencies.  Within the 
reward processing construct are subdomains such as incentive salience, motivation, cost-benefit 
decision making, and the formation of cognitive representations of reward value and their integration 
with ongoing actions (Der-Avakian & Markou, 2012).  Of the reward-related deficits associated with 
both schizophrenia and depression, beyond impaired hedonic processing, patients may be unable to 
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form, maintain or update value representations and use this information to motivate behaviour and 
inform decision making.  Indeed, as has been discussed earlier, a recent experiment revealed that 
patients suffering from schizophrenia were unable to adjust their behaviour to take into account 
reduced reward value when the representation of the reward had to be relied upon (Morris et al., 
2015).  Whilst no direct experiments testing reward valuation have been performed in a depressed 
sample, stress-reactivity in these patients may also render their behaviours as inflexible and 
independent of reward (Schwabe & Wolf, 2011).  Regardless of stress reactivity, at the intuitive level, 
it is plausible that people suffering from depression would no longer perform actions based on the 
consequences those actions engender if they were not pleasurable upon their receipt (Griffiths et al., 
2014). 
1.6.1 Procedures that Assess the Use of Reward Representations 
 To determine whether MAM-exposed or WKY inbred rats are able to form flexible 
representations of reward value, two behavioural paradigms were adopted: the first an outcome 
devaluation procedure (investigating whether ongoing behaviour is sensitive to current reward value) 
and the second a differential outcomes procedure (investigating whether reward identity can guide 
and direct behaviour).  As results for the outcome devaluation procedure have been reported across 
various species, (including monkeys, West et al., 2011, and humans, Klossek et al., 2008; Valentin et 
al., 2007), it suggests that this paradigm has translational relevance for assessing the capacity to 
update the value of future rewards (as reviewed by Markou, Salamone, Bussey et al., 2013). 
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1.6.1a Action and Habits: Behaviour 
 Instrumental performance, such as pressing a lever for a food reward, is thought to be 
mediated by two dissociable processes: a goal-directed process in which action selection is governed 
by an association between the response and the outcome engendered by that response (action-
outcome, or A-O, associations), and a stimulus-driven habitual process in which action selection is 
governed by a direct association between the stimulus and response (stimulus-response, or S-R, 
associations) without any link to outcome value (e.g. Balleine & O'Doherty, 2010).  Crucially, because 
the associations which underlie habitual behaviours do not include outcome representation, 
responding by an individual is independent of any explicit motivation to obtain a reward.  By contrast, 
responding controlled by goal-directed processes depends explicitly on the anticipated outcome and 
its motivational value (Adams & Dickinson, 1981; Adams, 1982; Balleine & Dickinson, 1998; 
Dickinson, 1985).  That is, the assessment of the degree to which instrumental behaviour is goal- 
directed or habitual is a direct test of the nature of reward processing in a given circumstance.  Given 
this, the most common probe of the difference between actions and habits has been to examine the 
effects of devaluing the reward between training and test (Balleine & O'Doherty, 2010).  This can be 
achieved either by specific satiety (during which the rat is allowed free access to the instrumental 
outcome) (e.g. Balleine & Dickinson, 1998) or by pairing the outcome with LiCl-induced nausea (i.e. 
taste aversion conditioning) (e.g. Adams & Dickinson, 1981; Adams, 1982).  If the animals’ 
performance is goal-directed (i.e. sensitive to changes in the current value of a reward) then it should 
be reflected by a lowered willingness to perform the response that produces the devalued outcome –
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even when the test is conducted in the absence of any reward delivery (Balleine & O'Doherty, 2010).  
It is also possible to assess goal-directed behaviour by pre-test degradation of the response-outcome 
contingency, although this method has been less utilised in practice (Balleine & Dickinson, 1998). 
In behavioural terms, the balance between goal-directed and habitual performance has been 
shown to reflect several aspect of the training situation.  One of the first mediators of this difference to 
be identified was the length of training.  During initial instrumental learning in rats, actions are largely 
goal-directed and performed on the basis of their consequences (i.e. sensitive to outcome devaluation 
or contingency degradation).  However, as training continues, action-outcome associations are 
inhibited and reflexive habit behaviour predominates (e.g. Adams, 1982; Dickinson, Balleine, Watt, 
Gonzalez, & Boakes, 1995).  Similarly, if human subjects are trained to key press for different food 
types, they will decrease their responding for a devalued food after moderate training, but not after 
overtraining (Tricomi, Balleine & O'Doherty, 2009).  
1.6.1b Action and Habits: Neuroanatomy 
 The neuroanatomy of goal-directed and habitual control of instrumental action has been well 
characterised - with the main focus on cortico-striatal circuits (reviewed by Balleine & O'Doherty, 
2010).  In brief, for rodents areas implicated in flexible goal directed behaviour include the prelimbic 
PFC and the connecting dorsomedial striatum.  Lesions of either of these two regions prevents goal-
directed behaviour, rendering performance insensitive to both outcome devaluation and contingency 
degradation, even after only minimal levels of training (i.e. behaviour is stimulus bound and habitual) 
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(Balleine & Dickinson, 1998; Corbit & Balleine, 2003; Yin, Knowlton & Balleine, 2005).  While the 
examination of temporary inactivation and lesion timing suggests that the dorsomedial striatum is 
necessary for both the acquisition and expression of goal-directed behaviours, the prelimbic PFC 
appears to be crucial for acquisition only (Ostlund & Balleine, 2005; Yin et al., 2005). 
 The formation of stimulus-response habits appears to be driven by separate (but interacting) 
frontal and striatal systems.  Lesions of either the dorsolateral striatum (Yin, Knowlton & Balleine, 
2004), or the infralimbic PFC (Killcross & Coutureau, 2003), maintain goal directed responding in 
rodents (i.e. maintain performance sensitivity to changes in reward value) even after extended 
training.  Intriguingly, even once habitual behaviour has become established with overtraining of an 
instrumental response, disruption of the infralimbic cortex will reinstate goal-directed responding 
(Coutureau & Killcross, 2003).  Importantly, this finding suggests that the transition from goal-directed 
to habitual responding is not an absolute process: A-O associations are not forgotten or removed over 
the course of training.  Together with results described above, showing that disrupting goal-directed 
control results in reflexive responding, these studies suggest that S-R and A-O associations develop 
in parallel, with factors such as training length (as well as reinforcement schedule, drug exposure and, 
as we have seen earlier, stress) determining the relative influence that these two processes have over 
instrumental behaviour (Dickinson et al., 1995).  Indeed, in terms of the infralimbic cortex, some argue 
that this structure is not involved in the formation of S-R associations per se, but instead inhibits goal-
directed processes, therefore allowing habitual behaviour to predominate (Killcross & Coutureau, 
2003). 
81 
 These cortico-striatal circuits first identified in rodents also appear to underpin goal-directed 
and habitual behaviour in humans (see Balleine & O'Doherty, 2010, for a full review).  For example, 
fMRI analysis reveals that activity of the (medial and lateral) OFC was significantly correlated with 
goal-directed behaviour (i.e. the decreased performance of an action related to a devalued outcome 
relative to an action related to a  valued outcome) (Valentin, Dickinson & O'Doherty, 2007). In 
addition, activity of the vmPFC (including the mOFC and mPFC) was elevated during the performance 
of high contingency schedules compared to low contingency schedules.  Furthermore, the activity of 
the anterior caudate nucleus (a target area of these structures and analogous to the rat dorsomedial 
striatum) was also found to be modulated as a function of A-O contingency (Tanaka, Balleine & 
O'Doherty, 2008: for converging evidence from an overtraining procedure see Tricomi et al., 2009).  
Finally, these functional studies are supported by more recent diffusion tensor imaging research (de 
Wit, Watson, Harsay, Cohen, van de Vijver & Ridderinkhof, 2012), which revealed that the integrity of 
white matter tracts connecting the posterior putamen (analagous to the dorsolateral striatum in rats) 
with pre-motor cortical regions was predictive of habitual behaviour, autonomous of outcome value, in 
healthy humans.  Conversely, the integrity of white matter tracts between the vmPFC and the caudate 
was shown to be positively correlated with goal-directed control of choice behaviours. 
1.6.1c Action and Habits: Neurochemistry 
 Much of the analysis of the neurochemistry of goal-directed and habitual behaviour has 
focused on the actions of psychostimulant drugs such as amphetamine and cocaine, which sensitise 
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dopamine systems in the brain (as reviewed by LeBlanc, Maidment & Ostlund, 2013).  Chronic 
exposure to either amphetamine (Nelson & Killcross, 2006), or cocaine (Schoenbaum & Setlow 2005; 
LeBlanc, Maidment & Ostlund, 2013), reduced or completely blocked the sensitivity of animals to pre-
test reward devaluation. The actions of these treatments may be mediated by long-term neural 
adaptations in the regions that are implicated in the transition from goal-directed to habitual 
responding, including the striatum (dorsal and ventral) and mPFC (Wickens, Horvitz, Costa & 
Killcross, 2007). 
 The involvement of dopaminergic mechanisms is suggested by infusion studies.  For 
example, infusion of dopamine directly into the mPFC of over-trained rats, produced a bidirectional 
effect with rats demonstrating decreased responding for a devalued outcome, but increased 
responding for a non-devalued outcome (Hitchcott, Quinn & Taylor, 2007).  This is further supported 
by 6-hydroxy dopamine (6-OHDA) lesions of the dorsomedial striatum and prelimbic cortex which 
impaired goal-directed responses (Naneix, Marchand, Di Scala, Pape & Coutureau, 2009; Lex & 
Hauber, 2010), whereas 6-OHDA lesions to the nigrostriatal pathway blocked habitual behaviour 
(Faure, Haberland, Conde & Massioui, 2005). 
 In summary, there is good cross-species consistency regarding the brain structures which 
subserve goal-directed and habitual instrumental responding. Given reports of hypofrontality in 
schizophrenia, together with the observation that both patients suffering from schizophrenia and 
depression are impaired in their performance on pre-frontal dependent tasks, this might suggest that 
psychiatric and mood disorders are associated with greater habitual control of behaviour (as 
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discussed in earlier sections, this has been explored in schizophrenic but not depressed subjects).  
Dopamine dysregulation in both of these disorders may also be involved in the shift between goal-
directed and habitual systems, although this as yet has not been directly assessed.  But to the extent 
that altered dopamine signalling is important in both schizophrenia and depression pathophysiology 
(and their animal model counterparts), an impaired balance between goal-directed and habitual 
systems may feature in both of these disorders.  Thus, the outcome devaluation procedure will form a 
valuable assessment of reward processing deficits in the context of models of these disorders. 
1.6.2 Differential Outcomes Procedure (DOE) 
 The outcome devaluation procedure provides useful information regarding the transition of 
association from outcome expectancy to S-R mechanisms.  Whilst an accelerated transition to 
habitual systems is clearly maladaptive for behaviour, the devaluation procedure only speaks to 
whether animals are sensitive to changes in outcome value, and not whether reward identity can 
guide and direct the acquisition of a set of responses.  Therefore, in order to further examine the 
precise nature of reward representations in the MAM-exposed and WKY inbred rat strains, the 
differential outcomes procedure will be utilised.  This is a unique paradigm that was originally 
developed by Trapold (1970) to assess whether specific anticipatory reward information can be used 
by an organism to guide instrumental choice behaviour (as reviewed by Savage & Ramos, 2009). 
 Trapold posited that animals encode many properties of a reward, including sensory and 
magnitude properties, each of which can enter into association with both the environmental stimuli 
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and the response requirement.  This procedure uses a conditional discrimination, where an animal is 
trained to choose from two available responses (e.g. left and right lever press) in the presence of 
different discriminative stimuli (e.g. tone and clicker).  In one group of animals (the experimental or 
differential outcomes group), outcomes are stimulus correlated.  That is, a correct response (e.g. left 
lever press) in the presence of stimulus one (e.g. a tone) is always reinforced by outcome one (e.g. a 
food pellet), whereas a correct response (e.g. right lever press) in the presence of stimulus two (e.g. a 
clicker) is always rewarded by outcome two (e.g. sucrose solution).  In contrast, for the control group 
(the non-differential outcome group), the reward identity is not contingent on the correct stimulus-
response pairing.  That is, subjects are exposed to either a single common reinforcer or multiple 
reinforcers that are uncorrelated with the stimuli or response (e.g. left lever press response in the 
presence of a tone leads to both pellet and sucrose rewards at equal probability).  In both groups, 
incorrect responses made in the presence of each discriminative stimulus are without consequence 
(i.e. non-reinforced).  Trapold found that rats trained with stimulus-correlated outcomes (i.e. in the 
differential group) master the discrimination more rapidly and reach a higher asymptote than rats 
trained with uncorrelated outcomes.  Termed the Differential Outcomes Effect (DOE), this finding has 
since been observed across different tasks, parameters and, importantly, species - giving it good 
translational validity (e.g. Carlson & Wielkiewicz, 1976; Miller, Waugh & Chambers, 2002; Urcuioli & 
Zentall, 1992). 
 There have been numerous explanations as to why faster acquisition occurs when differential 
as opposed to non-differential outcomes are used, including improved cue salience and acquired 
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distinctiveness of the discriminative cues (see Urcuioli, 2005, for a review).  When the differential 
outcomes effect was first discovered, Trapold and Overmier (1972) posited that the animals are 
forming associations between the stimuli and the specific sensory properties of the rewards (through 
Pavlovian S-O conditioning), with the resultant specific reward expectations evoked by each stimulus 
also acting as a cue to guide instrumental behaviour (above and beyond the reward expectations 
general motivational properties).  In other words, better task performance in a differential outcomes 
procedure is thought to be due to stimulus-outcome, outcome-response (S-O, O-R) chaining 
(reviewed by Delamater, Kranjec & Fein, 2010).  Rats under the differential condition learn differential 
associations between each stimulus and the distinct sensory properties of its outcome (S1-O1 vs S2-
O2).  Since an appropriate response made by the animal is reinforced during the presence of an 
outcome representation or expectancy (brought about by the stimulus presentation), differential 
associations also form between the outcome representation and the response (O1-R1 vs. O2-R2) 
(Blundell, Hall, & Killcross, 2001; Urcuioli, 2005).  As a result, alongside instrumental S-R 
associations, each stimulus and the expectation/representation of the reward evoked by the 
presentation of the stimulus signal the appropriate response.  By contrast, rats trained with non-
differential outcomes can only rely on stimulus-response associations to direct their responding.  
Expectation of uncertain outcomes does not provide any additional discriminative cue to the animals 
as the same expectation would be elicited in the presence of both discriminative stimuli (Urcuioli, 
2005). 
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 As a correlation between each choice alternative and a particular reward is also embedded in 
the differential outcomes procedure, differential R-O associations can also mediate the enhanced 
performance observed as part of the differential outcomes effect.  For example, in one study, the 
differential outcomes paradigm was set up in such a way that the differential outcomes group were 
able to form differential R-O associations uncorrelated with the stimuli.  Despite eliminating differential 
S-O associations, the differential outcomes group more rapidly acquired the task, compared to their 
non-differential controls (e.g. DeMarse & Urcuioli, 1993).  
 Regardless of the relative contribution of differential S-O and R-O associations in controlling 
performance, both associations require that the outcome is part of what is learned in discrimination 
learning.  That is, better performance in the differential outcomes group cannot be explained by the 
outcome merely acting as a catalyst (i.e. not explicitly encoded) to enhance S-R relations.  
Furthermore, the reinforcer expectancies that develop in the differential outcome task are unique to 
each of the two rewarding outcomes - non-specific (motivational) effects of S-O/R-O relations would 
not aid choosing between two response alternatives (see Urcuioli, 2005). 
 In summary, the differential outcomes effect requires that the reinforcer becomes part of the 
learning matrix.  In contrast to the outcome devaluation procedure, it is the specific association 
between the stimuli and the unique sensory properties of the outcomes that are required to confer any 
advantage on the task.  With a higher cognitive load than in a typical outcome devaluation procedure, 
the organism must also be capable of monitoring and using multiple unique S-R-O associations 
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(Savage & Ramos, 2009).  Thus, impairments that do not emerge in an outcome devaluation 
procedure may emerge in a differential outcomes task.   
Whilst relatively little research has been performed to determine the precise neuroanatomical 
underpinnings of the differential outcomes effect, lesion studies have sugested a role for the BLA and 
interconnected OFC (Ramirez & Savage, 2007 - see also Ghashghaei & Barbas, 2002).  Lesioning of 
the BLA prior to training abolishes the differential outcomes effect, as well as preventing specific 
pavlovian-to-instrumental transfer and making an animals’ performance insensitive to post-
conditioning changes in outcome value (see Blundell et al., 2001).  Pre-training lesions of the OFC 
also prevents differential outcome expectancies from guiding instrumental choice behaviour across 
training (McDannald, Saddoris, Gallagher & Holland, 2005): although this effect may only emerge 
later in training (Ramirez & Savage, 2007).
How these neurobiological underpinnings relate to schizophrenia and depression is uncertain 
with no studies explicitly investigating the differential outcomes effect in either of these patient 
populations.  As has been previously described, both disorders may involve aberrant activity of the 
OFC.  In terms of the amygdala, however, results in the literature have been somewhat equivocal.  
Some meta-analyses of structural imaging data have revealed volume reductions of the amygdala in 
both schizophrenic (e.g. Honea, Crow, Passingham & Mackay, 2005) and depressed patient (e.g. 
Sacher, Neumann, Fünfstück et al., 2012) populations.  However, other, more recent analyses have 
not supported these findings (e.g. Vita, De Peri, Silenzi & Dieci, 2006) in the context of schizophenia.  
Furthermore, there is some suggestion of greater amygdala activation in schizophrenia patients 
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compared to their healthy counterparts during the processing of fearful and neutral stimuli (Holt, 
Kunkel, Weiss et al., 2006).  Similarly, some studies have revealed that patients with depression 
exhibit increased cerebral blood flow and metabolism in the amygdala (as reviewed by Gold & 
Chrousos, 2002).  Consistently, stress and stress hormones have also been revealed to increase the 
amygdala activity (reviewed by Schwabe & Wolf, 2009).  In recognising that outcome value 
insensitivity is at odds with increased BLA activity in response to stress, Schwabe and Wolf (2009) 
suggest that the amygdala may be exerting it's effects through modulating other brain systems.  
However, it has been shown that depressed patients exhibit decreased resting-state functional 
connectivity between of the amygdala and other brain regions, including the ventrolateral PFC and 
caudate region of the striatum (Ramasubbu, Konduru, Cortese, Bray, Gaxiola-Valdez & Goodyear, 
2014, see also Friedel et al., 2009, section 1.3.6).  Resting state functional connectivity has also been 
shown to be reduced between the amygdala and ventral PFC in schizophrenia patients (Hoptman, 
D'Angelo, Catalano et al., 2010)
 In summary, the DOE procedure offers a sensitive test of whether animals are able to use 
specific information regarding the identity of rewards to acquire and direct their behaviour.  Although 
the presence of a disrupted DOE has not been explicitly identified in either schizophrenia or 
depression, the procedure itself will help characterise the nature of any reward processing deficit in 
models of these disorders.  
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1.7 Summary and Guide to Thesis 
 Historically, anhedonia, defined as a loss of interest or pleasure, was proposed to be a core 
symptom of both schizophrenia and depression.  Today, however, it is becoming clear that a whole 
host of dissociable reward-related deficits are being inappropriately labelled under the anhedonia 
umbrella.  When we start to parse out the precise aspects of reward, we can see how subtle 
differences can exist across the different disorders.  Indeed, consummatory hedonic processing 
appears to be unimpaired in schizophrenia, with anticipatory anhedonia perhaps better reflecting the 
disorder.   
 There is still a long way to go in the human literature but as advances are constantly being 
made it is essential that the animal models of the disorders keep pace.  Furthermore, we must 
develop reliable measuring techniques which precisely assess the intended reward-related construct, 
without being confounded by other aspects of reward processing.  Comprehensive, robust animal 
models together with reliable measuring techniques will provide a platform from which to better 
understand the biological underpinnings of reward-related behaviours and will inform future 
investigations in the clinic. 
 Many animal models of both schizophrenia (e.g. the MAM neurodevelopment model) and 
depression (i.e. the WKY inbred rat strain) have been developed matching the necessary face, 
construct and predictive validities - however, rigorous behavioural characterisation of these models, 
particularly in terms of the hedonic and cognitive processing of reward are lacking.   
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 The experiments reported in this thesis aimed to address two general and related issues with 
respect to the processing of rewarding stimuli and its relationship with modelling schizophrenia and 
depression in animals:  examining first, the hedonic responses to rewarding stimuli and second, the 
ability of rewarding stimuli to motivate and control ongoing behaviour.
 With respect to the first of these issues, Chapter two (EXP 1) develops a method of assessing 
anticipatory hedonics in rodents - a within-subject negative anticipatory contrast procedure.  Chapter 
three assesses the consummatory (EXP 2) and anticipatory (EXP 3) hedonic responses of rats 
prenatally exposed to MAM through the detailed analysis of their licking behaviour during ingestion of 
non-contrasted and contrasted sweet solutions.  Regarding the second issue, Chapter four utilises the 
outcome devaluation procedure (EXP 4 and 6) and the differential outcomes procedure (EXP 5) to 
determine whether MAM-exposed rats can learn that their actions are reliably connected to the 
delivery of pleasurable rewards, and use this information to guide responding in instrumental tasks.   
 The experiments reported in Chapters five and six address the hedonic and cognitive aspects 
of reward-processing in the WKY model of depression.  EXP 7 and EXP 8 specifically address 
affective responses of WKY rats, looking at consummatory and anticipatory aspects of hedonic 
processing in turn.  EXP 9 and 10 employed behavioural assessments (outcome devaluation and the 
differential outcomes procedure) to address the more cognitive aspects of reward-processing in this 
model.   
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Chapter Two 
2. Methods Development 
2.1 Introduction 2.1.1 The Assessment of Anticipatory Anhedonia 
 Dating back to Klein's original definition of anhedonia in the context of depression, a 
distinction has been made between the temporal components of pleasure.  That is, not only can an 
organism experience pleasure in-the-moment when engaged in an enjoyable activity, but pleasure 
can also be anticipated from future events.  The importance of making this distinction has been 
realised in the schizophrenia literature.  Using methods such as the Temporal Experience of Pleasure 
Scale, reports suggest that schizophrenia patients cannot anticipate pleasure, particularly from future 
goal-directed activities, whereas their consummatory pleasure may be relatively intact (Gard et al., 
2007).  Some attempts have been made to assess reward anticipation and expectancy in rodent 
models of disease.  Briefly, these have included successive contrast effects, where the animals 
behaviour is evaluated after an unexpected downshift in the value of reward (i.e. successive negative 
contrast), and anticipatory locomotor responses in the context of sexual behaviour or a preferred food 
type (see Barnes, Der-Avakain & Markou, 2014; Foussias et al., 2015 for a review).  However, whilst 
these methods assess the ability of an animal to anticipate or predict future rewards, they do not 
necessarily look at the animals hedonic responses in light of those predictions, with potential 
confounds such as motor abnormalities and motivational incompetency also obscuring the results.  
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This chapter focuses on the use of Negative Anticipatory Contrast as a means of directly assessing 
hedonic responses in anticipation of a future event. 
2.1.2 Negative Anticipatory Contrast 
 Negative anticipatory contrast specifically looks at the adjustment of an animal's behaviour 
toward currently available stimuli (food) in light of a future rewarding event.  For example, a rat given 
brief daily sequential access to two solutions will learn to expect the second upcoming solution and 
will adjust its consumption of the currently available solution accordingly. If the second solution is 
preferred over the first, intake of the first solution will be suppressed (e.g., Flaherty, Coppotelli, 
Grigson, Mitchell, & Flaherty, 1995). The suppression of the first solutions intake has been ascribed to 
a contrast effect based on the comparison between the levels of reward available at the time and the 
level of reward expected in the near future. This suppression appears to be genuinely anticipatory 
because, in within-subjects designs, intake from the first bottle available in a day is low when the 
upcoming solution is valuable, while the value of the solution consumed the previous day has little 
effect (Flaherty et al., 1995; Flaherty & Rowan, 1985). More generally, the existence of within-subjects 
anticipatory contrast demonstrates that the effect cannot simply be due to a comparison between the 
currently available solution and the animal’s previous overall experience.  Furthermore, increasing the 
interval between solutions within a day reduces contrast, which would not be the case if the reduction 
in consumption was based simply on comparison with previous experience in that context (e.g., 
Flaherty & Checke, 1982; Lucas, Gawley, & Timberlake, 1988).  
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2.1.3 Mechanisms underpinning Negative Anticipatory Contrast 
 While the behavioural phenomenon of anticipatory contrast is well established, few 
mechanisms have been put forward to explain how current behaviour can be suppressed by the 
expectation of a more rewarding event.  Flaherty and Rowan (1985) proposed that exposure to the 
first solution, together with the context of its presentation, allows a comparison between the different 
solution values by invoking an internal representation of the impending preferred solution.  Flaherty 
(1996) considered three general mechanisms by which this might lead to a reduction in consumption 
of the first solution: a relative devaluation of the first solution; spatial competition from goal tracking 
(i.e. the animal repeatedly approaches the location of the not-yet accessible second solution); or 
response inhibition, where the animal learns to inhibit intake of the first solution because the second 
solution is more rewarding (see also Flaherty et al., 1995; Onishi & Xavier, 2011). Of these, the 
devaluation account is perhaps the most plausible.  This account dictates that as an animal learns to 
expect a valuable stimulus in the near future, there is a functional devaluation of the currently 
available reinforcer of lesser value - hence, a lower consummatory response. 
 While intuitively plausible, the devaluation account appears to be inconsistent with some 
previous results.  Indeed, Weatherly, Nurnberger, and Sturdevant (2006) found that a 1% sucrose 
solution subject to anticipatory contrast did not suffer a reduction in its ability to act as a reinforcer for 
operant behaviour, as compared with a non-contrasted 1% solution of sucrose.  Furthermore, when 
different spout cues were paired with contrasted and non-contrasted solutions, Flaherty et al. (1995) 
found that cues paired with the contrasted substance were not avoided in preference tests, as 
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compared with cues paired with the control (non-contrasted) substance.  The fact that solutions 
subject to anticipatory contrast do not suffer a reduction in their ability to act as reinforcers in either 
instrumental (Weatherly et al., 2006) or Pavlovian (Flaherty et al., 1995) situations would seem to 
suggest that their rewarding value has not been diminished by being reliably presented in advance of 
a preferred solution. That said, neither Weatherly et al. (2006) nor Flaherty et al. (1995) actually 
assessed the value of the solution subject to contrast, so they do not directly demonstrate that the 
value of the contrasted solution is maintained.  More importantly, the nature of the anticipatory 
contrast procedure means that the contrasted substance is set up as a perfectly reliable cue for a 
highly rewarding event.  It has long been known that otherwise neutral cues paired with rewarding 
events can themselves support instrumental or Pavlovian conditioning as secondary reinforcers (see 
Mackintosh, 1974). Thus, a solution subject to contrast might have supported subsequent responses 
as a secondary, rather than a primary, reinforcer even if anticipatory contrast had reduced the intrinsic 
value of the initial solution itself.  Direct measurement of the hedonic response to the solution subject 
to contrast would address these issues. 
2.1.4 Combining the Negative Anticipatory Contrast procedure with Lick Analysis 
 The negative anticipatory contrast paradigm can be used in combination with microstructural 
analysis of licking.  The benefits from this are two-fold.  Primarily, it allows the assessment of a 
rodent's hedonic reactions as they learn to anticipate a more rewarding solution being made available 
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in the future.  This has important implications as it allows the first analysis of anticipatory hedonics in 
non-verbal rodents. 
 The second benefit is that it allows for a more direct assessment of the devaluation 
hypothesis of negative anticipatory contrast effects.  There has been one study to my knowledge that 
combined lick microstructure measures with an anticipatory contrast paradigm: Arthurs, Lin, Amodeo, 
and Reilly (2012) found a difference in lick cluster size for a saccharin solution as a factor of whether 
it was followed by higher valued sucrose or more of the same solution.  Such suppressed lick cluster 
sizes appear to be wholly consistent with a reduction in the first solution's rewarding value, relative to 
appropriate controls.  However, the analysis of the results offered by Arthurs et al. led them to 
conclude that this difference was not, in fact, a product of devaluation (I will address these differences 
of interpretation more fully in the Discussion section of this chapter). 
 Regardless of the interpretation of the results, it should be noted that the Arthurs et al. used a 
between-subjects design in their study, which meant that animals in the contrast and control 
conditions differed in their exposure to concentrated sucrose.  Repeated exposure to concentrated 
sucrose in the contrast group could have resulted in a shift in their general adaptation levels to sweet 
and, thus, lowered their sensitivity to the relatively weak sweet taste of dilute saccharin (Albertella, 
Harris, & Boakes, 2008; Boakes, Albertella, & Harris, 2007). Although general differences in 
experience with different concentrations of sucrose cannot explain all previously observed anticipatory 
contrast effects (see the comments above regarding within subjects and intersolution time effects), it 
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remains the case that the suppressed lick cluster sizes observed by Arthurs et al. may reflect 
differences in overall experience, rather than being the product of anticipatory contrast. 
2.1.5 Design of the Current Paradigm 
 The present study used a within-subjects design to address the reliability and source of lick 
cluster size changes in anticipatory contrast.  Importantly, in this design, all animals received 
exposure to all test solutions, eliminating any differences in the level or type of solution exposure.  
This has further importance when the paradigm is used to assess animal models of disease, as 
adaptation level effects may be more prevalent in experimental animals compared to their controls.  
Different contextual cues (chosen on the basis of the work of Flaherty et al., 1995) were used to 
signal which of the two solution pairings (either a low-reward solution followed by more of the same 
solution or a low-reward solution followed by a high-reward solution) was in operation each day. We 
reasoned that if the reduction in consumption (i.e. negative anticipatory contrast) of the initial solution 
when it precedes a preferred solution occurs because the first solution is devalued, it will be mirrored 
by a similar reduction in lick cluster size. 
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2.2 Experiment 1 - Materials and Methods 
2.2.1 Subjects 
 Male Lister-hooded rats (n=8, Harlan, UK), weighing 300-340g on ad libitum food 
(approximately 12 weeks of age), were used in the experiment.  They were paired-housed, under a 12 
hour light/dark cycle.  Experimental sessions were performed during the light phase, beginning 
approximately 3 hours after ‘lights-on’, and were conducted 6 to 7 days per week.  Prior to the start of 
the experiment, all animals were placed on a food-restricted diet, which maintained them between 85 
to 95% of their free feeding weights.  Their food ration was given in their home cage 30 min after the 
end of each daily session.  The experiment (together with the other experiments reported in this 
thesis) was conducted in accordance with the United Kingdom Animals Scientific Procedures Act, 
1986, and was subject to Home Office approval (Project License PPL 30/2703).  In the interest of 
meeting the three 'R's (Reduce, Refine and Replace), the guiding principles underpinning the humane 
use of animals in scientific research, power analyses were performed to determine the sample size 
appropriate for each experiment.
2.2.2 Apparatus 
Testing was conducted in six automated drinking chambers2 (Med Associates Inc., St Albans, 
VT, USA) arranged in a 3 × 2 array.  Each chamber, measuring 30 × 24 × 29 cm, was comprised of 
2This experiment was conducted alongside a secondary experiment not reported in this thesis.  Only 4 of the 6 available 
chambers were used in the current experiment.
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two aluminium side walls, a clear Perspex back wall and a clear Perspex ceiling.  The front wall was 
also made of clear Perspex and served as the door to the chamber.  The chamber floor consisted of 
19 steel rods, 4.8 mm in diameter, spaced 16 mm apart.  Approximately 5 cm above the grid floor, two 
holes, each 1 cm in diameter, were positioned on each side of the right wall to allow the rat access to 
the solutions.  Solutions were delivered through the left (referring to the back of the chamber) and 
right (referring to the front of the chamber) access holes by 50 ml cylinders with ball-bearing metal 
drinking-spouts.  These were mounted to the cage via motorized holders that held the spout flush with 
the outside of the chamber and retracted it as required.  This allowed sequential access to the two 
solutions.  During access to the solution, contact sensitive lickometers registered the timing of each 
lick made by the animal to the nearest 0.01 s, and a computer running MED-PC software controlled 
the equipment and recorded the data.  The solutions used were 4% and 32% (w/w) sucrose 
formulated daily using commercial-grade cane sugar and deionised water.  
 Distinct lighting conditions were created in the room that housed the chambers.  Room 
lighting provided a bright light condition for the animals, while an angle-poise lamp (positioned 
underneath the chambers) provided a dim light condition with the room lighting switched off.  A 
stainless steel mesh insert could be slotted over the top of the grid floor of the chamber to provide an 
alternative tactile floor cue.  White-noise could also be provided by a de-tuned radio that was on 
constantly throughout the session. 
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2.2.3 Procedure 
 On the first day of the experiment, the animals (which had been water restricted for 22 hours) 
were habituated by leaving them in the drinking chambers with 10 min access to water from both 
bottles.  During this initial training, drinking spouts were positioned inside the chamber to allow for 
easy detection by the rats.  After pre-training the animals were returned to an ad libitum water supply 
for the remainder of the experiment.  On each of the following training days, rats were given access to 
solution pairings that were manipulated within-subject.  Rats were presented with either a 4% sucrose 
solution followed by more 4% sucrose (the 4-4 condition or control condition) or a 4% sucrose solution 
followed by a 32% sucrose solution (the 4-32 condition or contrast condition).  These daily solution 
pairings were presented in double alternation (e.g. ABBAABBA) and different contextual cues were 
used to signal which of the two solution pairings was in operation each day.  For half the animals, the 
4-4 condition was presented in context 1 (consisting of bright light, white noise and normal grid floor), 
and the 4-32 condition was presented in context 2 (consisting of dim light, no background noise and 
wire mesh floor insert).  The remaining subjects had the opposite assignment.  The first solution in the 
pair was made available for 3 min on the right-hand side of the chamber.  Following a 4 sec inter-
solution interval, the second solution was then made available for 6 min on the left-hand side of the 
chamber.  Across training, the position of the spout started inside the chamber and was progressively 
moved back, until it was flush with the outside of the chamber (taking around 3 days).  Training 
continued across 32 days until a contrast effect had developed. 
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2.2.4 Data analysis 
Consumption was assessed by weighing the bottle before and after each experimental 
session.  Lick cluster size (defined as the mean number of licks per cluster) was extracted from the 
MED-PC data.  As in previous experiments using these general methods and equipment in Cardiff 
(e.g. Dwyer, Lydall, & Hayward, 2011; Lydall, Gilmour, & Dwyer, 2010), a cluster was defined as a 
series of licks, with each lick separated by no more than a 0.5 s interval.  The same criterion had been 
adopted by Davis and his colleagues (Davis, 1989; Davis & Perez, 1993; Davis & Smith, 1992).  
Although other criteria have been used (e.g. 1 s by Spector, Klumpp, & Kaplan,1998), there is little 
practical difference between them as most pauses greater than 0.5 s are also greater than 1 s (Davis 
& Smith, 1992).  Mean interlick-interval (ILI: the timing between one lick and the next) was also 
extracted from the MED-PC data.  Measuring ILI is essential in determining whether or not other 
licking parameters (namely LCS) are confounded by motoric/ motivational abnormalities displayed by 
the animal.  ILI is usually a very constant measure; with variability (particularly long ILIs) potentially 
reflecting motor impairments, posture changes, or other abnormal drinking patterns.  Across the 
thesis, this parameter will only be reported when inclusion of ILI might reflect important differences 
across strains, groups or conditions.   
 In the current experiment, drinking data were collated into two-session blocks.  Data were 
analysed using repeated-measures ANOVA with factors of block (1-8) and contrast condition (4-4 or 
control condition vs. 4-32 or contrast condition).  All statistical tests reported in this thesis were 
performed using SPSS 20.0 (SPSS Inc., Chicago).  Where the assumption of Sphericity was not met, 
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Greenhouse-Geisser corrections have been reported, as is the case across the thesis.  An alpha level 
of .05 was adopted as the level of significance throughout. 
2.3 Results 
 Figure 1 depicts the consumption (Panel A) and lick cluster size measures (Panel B), across 
the eight 2-session blocks, of the initial 4% solution as a factor of whether it was followed by 4% 
sucrose (the 4-4 condition) or 32% sucrose (the 4-32 condition).  Inspection of Figure 1A suggests 
that intake of the initial 4% solution increased across blocks to a greater extent for the 4-4 condition 
than the 4-32 condition, representing an anticipatory contrast effect.  A repeated measured ANOVA 
with factors of block (1 to 8) and contrast condition (4-4 vs. 4-32) revealed a non-significant main 
effect of contrast condition (F (1, 7) = 2.785, p = .139, MSE = 1.125), a significant main effect of block 
(F (7, 49) = 17.876, p <.001, MSE = 6.271) and a significant contrast condition by block interaction (F 
(7, 49) = 2.310, p = .041, MSE = 0.279).  Simple-effects analysis of the interaction suggest no 
difference between the 4-4 and 4-32 conditions for blocks 1, 2, 3, and 5 (largest F (1, 7) = 1.175, p = 
.314, MSE = 0.051, for block 2), while there were significant differences for blocks 4, 6, 7 and 8 
(smallest F (1, 7) = 5.755, p = .048, MSE = 0.014, for block 7). 
 Inspection of Figure 1B indicates that the anticipatory contrast effect on consumption was 
associated with lower lick cluster sizes in the contrasted (4-32) than non-contrasted (4-4) condition 
during intake of the initial solution.  ANOVA revealed a significant main effect of contrast condition (F
(1, 7) = 24.568, p = .002, MSE = 1203.074), a significant main effect of block (F (1.947, 13.626) = 
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7.112, p = .008, MSE = 2750.778) and a significant contrast condition by block interaction (F (7, 49) = 
3.367, p = .003, MSE = 189.502).  Follow-up analysis revealed no significant differences between 
contrast conditions during blocks 1, 2, 3, 4 and 7 (largest F (1, 7) = 5.448, p = .052, MSE = 11.102, for 
block 4), and that there were significant differences on blocks 5, 6 and 8 (smallest F (1, 7) = 7.218, p
= .031, MSE = 15.272, for block 6).  This result indicates that following 4% sucrose with 32% sucrose 
(in the 4-32 condition) suppresses the increase in lick cluster size for 4% sucrose across sessions 
that would have otherwise occurred if it had been followed by more of the same solution (the 4-4 
condition). 
Figure 1, panels C and D, shows the consumption and lick cluster size measures for the 
second sucrose solution in conditions 4-4 and 4-32 over the eight 2-day blocks of the experiment.  As 
can be seen in Panel C, the consumption of the second solution (4% sucrose) remained consistently 
low across blocks for the 4-4 condition.  In contrast, the consumption of the second solution (32% 
sucrose) in the 4-32 condition increased over the blocks.  ANOVA revealed significant main effects of 
contrast condition (F (1, 7) = 39.169, p < .001, MSE = 198.254), of block (F (2.155, 15.082) = 38.367, 
p < .001, MSE = 96.863), and an interaction between them (F (2.667, 18.666) = 6.457, p = .004, MSE
= 11.374).  Post-hoc tests showed that there was no significant difference between conditions at block 
1 (F < 1), while there were significant differences at blocks 2 - 8 (smallest F (1, 7) = 12.738, p = .009, 
MSE = 0.701, for block 8).  Inspection of Panel D reveals a similar pattern of results for lick cluster 
size in that the lick clusters were consistently higher, at least numerically so, for the 4-32 than the 4-4 
condition across blocks.  ANOVA revealed significant main effects of contrast condition (F (1, 7) = 
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31.393, p = .001, MSE = 4664.573) and block (F (7, 49) = 14.961, p < .001, MSE = 813.666) plus a 
significant contrast condition by block interaction (F (2.288, 16.018) = 6.735, p = .006, MSE = 
1439.224).  Simple-effects analysis revealed no significant difference between conditions at block 1 (F
(1, 7) = 4.177, p = .080, MSE = 20.142), significant differences on blocks 2 to 7 (smallest F (1, 7) = 
6.545, p = .038, MSE = 9.229, for block 7), but no difference in block 8 (F (1, 7) = 2.345, p = .170, 
MSE = 15.085).  This pattern of effects appears to be largely driven by the gradual reduction in lick 
cluster sizes during consumption of 32% sucrose from blocks 4 to 8.  The reason for this downward 
trend is not clear, however, I have also observed similar reductions across exposure sessions when 
animals were repeatedly presented with sucrose in the absence of an anticipatory contrast procedure.  
It is possible that it might reflect within-session adaptation to the concentrated sucrose (Dwyer, 2012) 
that is exacerbated as consumption levels increase3.   
3 It is also possible that the reduced lick cluster size seen for the 32% solution across training is due to sucrose-induced insulin 
resistance.  High sucrose diets have previously been shown to impair insulin action in rats (e.g. Storlien, Kraegen, Jenkins, and 
Chisholm, 1988).  Furthermore, Ribeiro, Lautt, Legare, and Macedo (2005) gave Sprague-Dawley rats free access to a 35% 
sucrose solution (along with food and water ad libitum) and found that insulin resistance was expressed as early as 2 weeks in 
this strain.  Since exposure to concentrated sucrose is restricted to 6 min a day in our paradigm, this possibility may be unlikely 
but cannot be ruled out on the basis of the current data alone. 
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Figure 1 Panel A shows the mean (± SEM) consumption data from the first bottle available (containing 4% sucrose) each day during negative anticipatory contrast for the 4-4 (control) and 4-
32 (contrast) conditions.  Panel B shows the mean lick cluster size (± SEM) for the first bottle available each day as a factor of contrast condition.  The first bottle was available for 3 min.  Panel 
C shows the mean (± SEM) consumption data from the second bottle available each day during negative anticipatory contrast for the 4-4 (control) and 4-32 (contrast) conditions.  Panel D 
shows the mean lick cluster size (± SEM) for the second bottle available each day as a factor of contrast condition (4-4 vs. 4-32).  The second bottle was available for 6 min (beginning 4 sec 
after the first bottle had been retracted).  The data is averaged over two trial blocks.
First Bottle
Second Bottle
A B
C D
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2.4 Discussion 
 In one context, rats received access to 4% sucrose from one bottle followed by access to 4% 
sucrose from a second bottle, while in a different context, they received access to 4% sucrose from 
one bottle followed by access to 32% sucrose from a second bottle. The rats’ consumption of 4%
sucrose was lower on days when 4% sucrose preceded access to 32% sucrose than when it 
preceded access to more 4% sucrose. This reflects a within-subjects anticipatory contrast effect on 
consumption.  Moreover, an analysis of licking microstructure revealed that this contrast effect was 
also reflected in the size of licking clusters.  That is, the same 4% sucrose elicited lower lick cluster 
sizes on days when it was followed by 32% sucrose than on days when it was followed by 4% 
sucrose.  Since lick cluster size is directly related to the perceived value or concentration of sucrose 
and the first solution was physically unchanged, this effect is consistent with anticipatory contrast 
producing a devaluation of 4% sucrose relative to an appropriate control.  That is to say, the 
differences in the mean number of licks per cluster between the 4-4 and 4-32 conditions result from a 
change in the perceived value of the initial solution by the anticipation of future rewards. Moreover, 
because a within-subjects procedure was used, the effects observed here cannot be attributed to a 
general reduction in the sensitivity to sweet tastes as a result of adapting to high sucrose 
concentrations.  Contrary to the majority of previous analyses, this suggests that negative anticipatory 
contrast does indeed include a devaluation of the initial solution. 
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 While the use of a within-subjects design means that the suppressed lick cluster sizes 
observed cannot be attributed to a general reduction in the rat's sensitivity to sweetness as a result of 
shifts in their overall adaptation level (Boakes etal., 2007), there is evidence for context-specific 
adaptation level effects (Albertella et al., 2008). In this light, it is thus possible that the reduced lick 
cluster sizes are due to a comparison between the concentration of sucrose previously experienced in 
a particular context and the currently available solution, rather than being the product of an 
anticipatory comparison process. That said, it should be remembered that the interval between two 
solutions within a day influences consumption effects in anticipatory contrast (e.g., Flaherty & Checke, 
1982; Lucas et al., 1988). This timing effect would not be expected if anticipatory contrast were 
actually due to a comparison between the currently available solution and the stored value of previous 
solutions experienced in the same context. Since inter-solution intervals have not been manipulated 
here, the possibility that context-dependent adaptation effects are contributing to the lick 
microstructure results cannot be ruled out.  Thus, the suppression seen in both lick-microstructure 
and consumption might reflect different causal mechanisms. That said, it might be suggested that it is 
more parsimonious to assume that contrast effects on consumption and on lick cluster size share a 
common cause. This is especially so given that the effects of contrast on consumption and lick cluster 
size emerged at roughly the same point in the experiment.   
 The idea that the lower lick cluster sizes for 4% sucrose in the 4-32 than in the 4-4 condition 
reflects devaluation in the former condition might seem to be a relatively direct corollary of the 
generally observed relationship between lick cluster size and solution concentration or value.  
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However, Arthurs et al. (2012) previously reported similar results from a between-subjects design, 
while concluding that devaluation was not involved. This conclusion was based on the fact that, in 
animals for which saccharin preceded sucrose, the cluster size for saccharin remained relatively 
consistent across training, while in animals for which saccharin preceded further saccharin access, 
the cluster size for saccharin increased across sessions.  That is, there was no evidence from the lick 
cluster size measure that the value of saccharin reduced from its initial level as a result of anticipatory 
contrast (essentially the same pattern of results was observed here with 4% sucrose).  However, it 
should be remembered that rodents typically show a neophobic response to novel tastes that 
dissipates with experience.  Indeed, Lin, Amodeo, Arthurs, and Reilly (2012) reported that lick cluster 
sizes increase over exposure for a variety of solutions and similar results were seen by Dwyer (2009).  
Lin et al. neatly summarised that the clear implication of these results is that “the pleasure of drinking 
increases as the novel, potentially dangerous tastant becomes accepted as safe” (p. 515).  In this 
light, the failure to see an increase in the lick cluster size for saccharin (by Arthurs et al., 2012) or 4% 
sucrose (here) as a result of anticipatory contrast does represent a devaluation, relative to the state 
that would have occurred had the solution simply been exposed on its own.  To be sure, pairing 
saccharin or sucrose with illness can produce devaluations relative to the initial state (e.g. Arthurs et 
al., 2012; Dwyer, 2009), but the mere fact that other treatments produce larger effects does not mean 
that contrast is not producing a devaluation at all. 
 A devaluation account of anticipatory contrast seems intuitively plausible: The decrease in 
responding for a low valued solution when a high-valued solution will be available in the near future 
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occurs because the initial solution has become one of functionally lower hedonic value.  However,this 
devaluation interpretation has generally been rejected; largely because solutions that have been 
subject to anticipatory contrast appear to operate as positive rewards in both instrumental (e.g., 
Weatherly et al., 2006) and Pavlovian (e.g., Flaherty et al., 1995) situations.  But, as was noted in 
section 2.1.3, these are not direct tests of the functional value of the solution subject to contrast, and 
more critically, the reinforcing value of the contrasted solutions could be attributed to a process of 
secondary reinforcement.  Since the present study directly addressed the value of the contrasted 
solution via the analysis of licking microstructure and did see a functional devaluation, it would appear 
that previous theorists might have been premature in rejecting the devaluation account. 
 What should be stressed at this point in time, however, is that an equally plausible 
explanation is that, rather than the devaluation of the first solution driving the contrast effect in 
consumption, the changes in solution value and amount consumed could be independent aspects of 
experiencing contrast.  This issue will be returned to later on in the thesis (see section 5.9). 
 To summarise, the present study is the first to combine microstructural lick analysis with a 
within-subjects negative anticipatory contrast procedure and, thus, avoids the problems either of using 
indirect assessments of reward value or of confounds relating to differences in adaptation level to 
sweet tastes between groups.  The results obtained suggest, contrary to prevailing assumptions, that 
anticipatory contrast does produce a functional devaluation of the solution subject to contrast, but 
whether this is the mechanism behind the reduced consumption remains unclear.  Regardless of the 
mechanism, combining negative anticipatory contrast with lick analysis provides us with a unique 
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opportunity to assess how an animal responds when a predictable rewarding event will be made 
available in the near future.  Specifically, measuring contrast effects in consumption allows us to 
determine whether the animal is able to anticipate or predict the future event, whereas measuring 
contrast effects in lick cluster size allows us to determine how this anticipation impacts upon their 
hedonic systems.  An animal that fails to expect the second solution in the pairing, or cannot 
adequately predict or 'care' about that solutions value, would show a much diminished or even absent 
contrast effect.  This technique will be returned to in the coming chapters to assess the presence of 
anticipatory anhedonia in the MAM-exposed and WKY rodent models. 
Chapter Three 
3. Hedonic Deficits in the MAM Model 
3.1 Introduction 
 Early definitions of schizophrenia routinely included anhedonia as a core symptom of the 
disease (e.g. Kraeplin, 1919; Bleuer, 1911), falling within the negative symptom cluster (e.g. 
Andreasen, 1995).  As has been discussed in the general introduction (section 1.3.2), the empirical 
evidence for anhedonia was largely driven by interview based assessments and self-report 
questionnaires (Horan et al., 2006).  These findings of reduced hedonic capacity have not been 
supported by laboratory-based assessments, which evaluate an individuals in-the-moment pleasure 
when exposed to a range of emotion-eliciting stimuli (e.g. pictures, film-clips and flavoured drinks) 
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(Cohen & Minor, 2010; Kring & Moran, 2008; Llerena et al., 2012).  In an attempt to reconcile this 
apparent 'emotion paradox' it has been suggested that anticipatory anhedonia may better reflect the 
hedonic deficits reported in this patient group (e.g. Gard et al., 2007). 
 This chapter investigates the hedonic capacity of the MAM-exposed neurodevelopmental 
model of schizophrenia.  As injection of MAM on GD17 has been shown to be optimal in producing 
neuroanatomical and behavioural alterations of relevance to schizophrenia, this time-point was used 
for all experiments reported in the upcoming chapters (Chapters three and four).  Whilst this model 
shows promise, its behavioural phenotype has not been subjected to robust characterisation, 
particularly with regard to the negative symptoms of the disease.  For example, the hedonic impact of 
sweet tastes has not been investigated in this model, nor has there been an assessment of 
behaviours analogous to anticipatory anhedonia.  Microstructural analysis of licking of non-contrasted 
and contrasted solutions (as part of the negative anticipatory contrast procedure developed in  
Chapter two) provides a unique opportunity to assess consummatory and anticipatory anhedonia in 
this model, whilst factoring in potential motor confounds (by the inclusion of the ILI parameters - see 
sections 1.5.2 and 2.2.4) that have been seen to potentially influence other putative schizophrenia 
modelling approaches (e.g. Lydall et al., 2011).  Experiment two investigates the consummatory 
hedonic capacity of MAM-exposed rats while Experiment three uses the negative anticipatory contrast 
procedure to investigate anticipatory hedonics in the model.  In light of the clinical literature, animal 
models that exhibit reduced palatability responses to sucrose solutions may not necessarily be 
comparable to the hedonic deficits, or lack thereof, in schizophrenia.  Investigating consummatory 
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hedonics in this model might be seen as a negative control.  Based on current understanding, the 
presence of anticipatory hedonic deficits in the absence of consummatory hedonic deficits, would 
suggest that the MAM neurodevelopmental model has good translational validity to the clinic.   
3.2 Experiment 2 - Materials and Methods 
3.2.1 Subjects 
Chapters three and four pertain to a series of studies done on several cohorts of MAM treated 
rats and their controls, with multiple experiments performed on each cohort of animals (please refer to 
Appendix A for experimental order).  The data from two separate cohorts of rats were combined for 
Experiment two.  Both cohorts were comprised of male Sprague-Dawley rats supplied by Charles 
River UK.  For cohort one, twenty-four rats were prenatally exposed to Methylazoxymethanol acetate 
(MAM: Midwest Research Institute, Kansas City, Missouri) and eighteen acted as control animals 
having been prenatally exposed to saline.  For cohort two, twenty-four rats were MAM exposed and 
twenty-four were saline exposed, again at the embryonic stage.  All animals were bred and given 
MAM/ saline treatment at Charles River as previously described by Moore et al. (2006).  Briefly, a 
single dose of MAM (diluted in 0.9% saline) was delivered at a 28 mg/kg dose (expressed as salt 
weight) by intraperitoneal (i.p) injection in a volume of 1ml/kg to pregnant dams on gestational day 17.  
MAM is a light sensitive compound and was maintained in light-restricting bottles.  Control females 
received injections of 0.9% saline (1ml/kg, i.p.) at the equivalent time point.  MAM- and saline-treated 
rats from multiple litters were delivered to Cardiff at 9 weeks of age (both cohorts).  Rats were housed 
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in groups of two or three for cohort one and pair housed for cohort two in a climate-controlled 
vivarium.  Animals were tested approximately 1 hour after ‘lights-on’, as was the case for all 
subsequent experiments reported in this thesis.  At the start of the experiment, rats were 
approximately 11 weeks old (both cohorts).  Characteristics of both cohorts and can be found in Table 
3.  For dates of when the experiments were conducted, please refer to Appendix A.
Table 3 Cohort characteristics for first and second cohort used in Experiment two.  Data is taken prior to food deprivation. 
Cohort 1 Cohort 2
MAM-Exposed
(n = 24)
Saline-Exposed
(n = 18)
MAM-Exposed
(n = 24)
Saline-Exposed
(n = 24)
Age ~ 11 weeks ~ 11 weeks
Weight range (g) 329 - 397 335 – 483 306 - 389 288 - 392
Mean ad-lib weight (g) 357 403 336 351
MAM-Sham comparison
(Independent (2-tailed) 
T-test)
MAM rats significantly lighter than 
Shams (t (20.663)= - 3.664, p = 
.001)*
MAM rats significantly lighter than 
Shams (t (46) = -2.161, p = .036)**
* Equal variances not assumed 
** No assumptions violated 
 Rats were placed on a food restricted diet to reduce them to ~ 85% of their free feeding 
weights.  Moderate weight gain was allowed over the course of the experiment to match expected 
increases of free-feeding animals, as determined by growth charts.  Rat weights were carefully 
monitored throughout to ensure that weights, as percentages of free-feeding weight, did not differ 
significantly between MAM- and saline-treated control rats.  Food rations were given in the rats’ home 
cage one hour after the end of each daily session. 
113 
3.2.2 Apparatus 
 Cohort One:  Testing was conducted in a room containing 16 drinking chambers.  Chambers 
were white plastic boxes measuring 32 × 15 × 12 cm arranged in an 8 × 2 array.  Both the floor and lid 
of the chamber consisted of metal grids.  Solutions were given in 50 ml cylinders with stainless-steel 
ball-bearing drinking spouts.  These were positioned on the left hand side of the chamber at the start 
of each experimental session and removed by hand at the end of the session.  As described in 
Experiment one, a contact sensitive lickometer recorded the timing of each lick made by the animal to 
the nearest 0.01s.  This was recorded by a computer with MED-PC software.  The solutions used for 
this experiment were 4%, 8% and 16% sucrose formulated daily (w/w) with commercial-grade sugar 
and deionised water.  For pre-training, rats were given 8% maltodextrin, formulated in the same 
manner as the sucrose solution.  Maltodextrin was used as rats seem to process this hydrolysed 
starch as entirely separate from sucrose, even though both types of solution appear to be ‘liked’ (see 
Sclafani, 1987; 2004 for a review).
 Cohort Two:  Testing for cohort two was conducted in the same six automated drinking 
chambers described in Experiment one (Section 2.2.2).  Solutions were delivered through the left 
access hole by 50 ml cylinders with ball-bearing metal drinking spouts.  The spouts were brought 
flush with the outside of the chamber at the start of the session and were retracted automatically at 
the end of the session.  Solutions were again 4%, 8% and 16% sucrose made daily (w/w) with 
deionised water.   
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3.2.3 Procedure 
 Pre-training.  Pre-training was conducted differently across the two cohorts: Cohort one were 
water restricted for 22 h prior to pre-training day one only.  Eight pre-training days were given in total, 
each comprised of 20 min exposure to an 8% maltodextrin solution; for cohort two, animals were 
water restricted for 22 h prior to each of the three daily pre-training sessions.  During each 20 min 
session, water was made available in the operant chamber.  Rats were given free access to water in 
their home cages 1 h after the session for 1 h duration.  Rats were then returned to ad lib water for 
the remainder of the experiment.   
 Test.  All rats (cohorts one and two) were given access to one of three (4%, 8% and 16%) 
sucrose concentrations in the drinking chambers for 20 min each day for five days (Monday-Friday, 
where possible).  The order of sucrose presentations was counterbalanced with half of the rats 
receiving the sucrose in order of increasing concentration (4-8-16) and the other half receiving them in 
order of decreasing concentration (16-8-4).  Two-days rest was given before the next concentration in 
the sequence was presented. 
3.2.4 Data analysis 
 Consumption was assessed by weighing the bottle before and after each experimental 
session.  Lick cluster size (LCS) was extracted from the MED-PC data.  The same parameters were 
used as previously described (section 2.2.4).  Inter-lick interval (ILI) was also extracted from the data.  
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As this normally shows very little variability, any differences in ILI between exposure conditions (MAM 
vs. saline) may be indicative of motor abnormalities in the experimental rats.   
 To overcome potential neophobic effects, consumption, LCS and ILI data were analysed for 
the last three days of test only for each of the three different concentrations of sucrose (i.e. after two 
days of solution exposure).  Data were analysed by a repeated-measures ANOVA with a within-
subject factor of solution concentration (4, 8 and 16% sucrose) and between-subject factors of 
replication (cohort one vs. cohort two), treatment (MAM vs. Sham) and sequence order (4-8-16 or 
ascending vs. 16-8-4 or descending).  All graphs show the data collapsed across the two cohorts with 
an n of 42 for saline-treated animals and 48 for MAM-treated animals. 
3.3 Results 
 The mean amount of sucrose consumed in grams, the mean number of licks per cluster 
(LCS) and the mean inter-lick interval (ILI) at each sucrose concentration are represented in panels A, 
B and C, respectively, of Figure 2.  Inspection of Figure 2A indicates that increasing sucrose 
concentration did not produce an overall increase in the amount consumed, with the moderate (8%) 
concentration instead eliciting the highest intake.  Whether the rats had been prenatally exposed to 
MAM or saline did not appear to influence the amount consumed at any of the three concentrations.   
 A mixed ANOVA revealed a significant main effect of concentration (F (1.565, 128.361) = 
55.099, p < .001, MSE = 564.992).  There was also a main effect of sequence order with rats 
generally consuming more under the descending sequence order condition (16-8-4: 23.13 g) 
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compared to the ascending condition (4-8-16: 21.67 g; F (1, 82) = 4.476, p = .037, MSE = 47.384).  
The ANOVA also revealed a concentration × sequence order interaction (F (2, 164) = 76.681, p < 
.001, MSE = 615.347) with consumption of the 4% and 16% solutions differing significantly across the 
two conditions (4%: F (1, 82) = 51.260, p < .001, MSE = 1098.796; 8%: F < 1; 16%: F (1, 82) = 
24.878, p < .001, MSE = 260.729).  This likely occurred due to lower consumption levels being 
exhibited by rats for the first solution experienced in the sequence, regardless of that solution’s 
intrinsic value.  According to the description of the data, prenatal MAM treatment had no effect on the 
amount consumed by the rats (F < 1).  There was also no interaction between drug treatment and 
sucrose concentration (F (2, 164) = 1.610, p = .203, MSE = 12.924), nor was there a treatment ×
sequence order interaction (F (1, 82) = 1.383, p = .243, MSE = 14.646). 
 In terms of replication, rats in cohort two generally consumed more sucrose (25.75 g) than 
rats in cohort one (19.05 g; F (1, 82) = 93.813, p < .001, MSE = 993.181).  The ANOVA also revealed 
a replication × treatment interaction (F (1, 82) = 5.314, p = .024, MSE = 56.255) and a replication ×
sequence order interaction (F (1, 82) = 9.775, p = .002, MSE = 103.488).  Further analysis of these 
interactions revealed that MAM treated rats consumed non-significantly more sucrose than their 
saline counterparts during the initial replication (F (1, 82) = 3.701, p = .058, MSE = 39.176) whereas 
saline-treated rats consumed non-significantly more than MAM animals during the second replication 
(F (1, 82) = 1.730, p = .192, MSE = 18.315).  Inspection also revealed that higher consumption for 
descending than ascending conditions occurred for replication one only (Replication one: F (1, 82) = 
12.759, p = .001, MSE = 135.072; Replication two: F < 1).  A concentration × replication × sequence 
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order interaction was also revealed by the analysis (F (2, 164) = 7.593, p = .001, MSE = 60.928) with 
significantly different consumption levels between ascending and descending sequence orders for 4% 
(ascending < descending: F (1, 82) = 25.540, p < .001, MSE = 547.472) and 8% (ascending < 
descending: F (1, 82) = 9.115, p = .003, MSE = 144.872) concentrations for replication one and for 
4% (ascending < descending: F (1, 82) =  25.806, p < .001, MSE = 553.181) and 16% (ascending > 
descending: F (1, 82) =  51.154, p < .001, MSE = 536.115) for replication two (16% Replication one: F 
< 1; 8% Replication two: ascending > descending, F (1, 82) = 3.661, p = .059, MSE = 58.190).  There 
was no concentration × replication interaction (F < 1), no three-way interaction between replication, 
treatment and concentration (F (2, 164) = 2.770, p = .066, MSE = 22.229), nor between replication, 
treatment and sequence order (F < 1).  Finally there was no four-way interaction between replication, 
treatment, concentration and sequence order (F < 1).  Whilst it is important to recognise the 
replication differences, it should be stressed that the differences do not detract from the general 
interpretation of the results – MAM rats do not exhibit any changes in consumption indicative of an 
affective impairment when compared with the saline-treated control animals. 
 Inspection of Figure 2B suggest that the number of licks per cluster increased with increasing 
concentration of sucrose for both MAM-treated and saline-treated rats.  ANOVA performed with the 
same factors revealed a significant main effect of concentration (F (2, 164) = 28.225, p < .001, MSE = 
23754.707), no main effect of sequence order (F < 1) and no interaction between these two factors (F
(2, 164) = 2.151, p = .120, MSE = 1799.575).  There was no main effect of prenatal treatment (F (1, 
82) = 1.641, p = .204, MSE = 2594.872) and no concentration × treatment interaction (F (2, 164) = 
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1.729, p = .181, MSE = 1445.972).  Further, there was no treatment × sequence order interaction (F < 
1) and no treatment × concentration × sequence order interaction (F (2, 164) = 1.955, p = .145, MSE
= 1635.454).   
 Briefly, in terms of replication, there was a significant main effect with higher LCSs exhibited 
by rats in cohort two (mean of 86.05 licks per cluster) than cohort one (mean of 61.99 licks per 
cluster) (F (1, 82) = 8.111, p = .006, MSE = 12824.598).  There was no replication × concentration 
interaction (F (2, 164) = 2.452, p = .089, MSE = 2051.179) no replication × treatment interaction (F < 
1) and no replication × sequence order interaction (F < 1).  Furthermore, no three-way interaction was 
revealed between replication, treatment and sequence order (F < 1) or between replication, 
concentration and sequence order (F (2, 164) = 2.279, p = .106, MSE = 1906.045), nor was a four 
way interaction revealed between these factors (F < 1).  There was, however, a replication × 
treatment × concentration interaction (F (2, 164) = 6.407, p = .002, MSE = 5358.710).  Further 
inspection of pairwise comparisons revealed no significant differences in LCS between MAM and 
saline-treated rats for any solution concentration across either replication (largest F (1, 82) = 3.224, p
= .076, MSE = 9033.679 - Replication one (16% sucrose) with MAM rats exhibiting higher licks/cluster 
than saline-treated animals).  Again, replication effects do not question the original interpretation of 
the results.  That is, MAM rats did not display licking patterns suggestive of an affective deficit when 
compared against the saline-treated control strain.   
 With respect to ILI, inspection of Figure 2C suggests that this measure was stable across 
MAM and saline-treated animals and across the three different concentrations of sucrose.  ANOVA 
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analysis revealed no significant main effect of concentration, treatment or sequence order (All Fs < 1).  
There was also no treatment × concentration interaction (F (2, 164) – 2.613, p = .076, MSE = 36.530), 
treatment × sequence order interaction (F < 1) or treatment ×concentration × sequence order 
interaction (F (2, 164) = 1.083, p = .341, MSE = 15.137).  There was, however, a concentration × 
sequence order interaction (F (2, 164) = 3.319, p = .039, MSE = 46.386), further analysis of which 
revealed that rats experiencing the solutions in ascending order of concentration displayed higher ILIs 
when consuming 16% sucrose compared to 8% sucrose (F (1, 82) = 6.591, p = .012, MSE = .446).  
No other significant differences were seen across any other solution concentration within each 
sequence order condition, nor were significant differences seen in ILI for any of the three 
concentrations of sucrose between sequence order conditions (all Fs < 1).   
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A
B
C
Figure 2 Data from the consumption of three sucrose concentrations following prenatal treatment
with either MAM or Saline. A – C: mean amount of sucrose, mean number of licks per cluster and
mean inter-lick interval, respectively (each displayed with ± SEM). Saline-treated animals n = 42;
MAM-treated animals n = 48. Data has been collapsed across two cohorts.
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 ANOVA analysis of ILI revealed a significant main effect of replication (F (1, 82) = 105.577, p 
< .001, MSE = 8158.522) with rats in cohort two exhibiting higher ILIs when consuming the sucrose 
solutions.  There was also a replication × concentration interaction (F (2, 164) = 4.699, p = .010, MSE
= 65.678) as well as a replication × concentration × sequence order interaction (F (2, 164) = 4.460, p
= .013, MSE = 62.345).  Critically, ILI did not vary significantly across MAM and saline-treated rats (all 
Fs < 1; with the exception of the replication × treatment × concentration interaction where F (2, 164) = 
1.157, p = .317, MSE = 16.175).  As such, the pattern of licks/cluster previously reported was not 
confounded by motoric differences induced by prenatal drug treatment. 
3.4 Summary 
 Using microstructural analysis of licking together with consumption measures, Experiment two 
investigated the hedonic capacity of MAM-treated rats.  Rats prenatally exposed to MAM on GD17 
demonstrated consumption and palatability responses to sweet solutions which were comparable to 
their saline-treated controls.  Given that normal consummatory hedonic capacity is a relatively 
consistent finding in the schizophrenia clinical literature, the results of Experiment two may further 
indicate the validity of prenatal MAM-exposure as a schizophrenia model.  Experiment three 
investigates whether or not MAM-exposed rats are impaired in their ability to anticipate the value 
associated with future rewards, a deficit perhaps more relevant to schizophrenia symptomatology.  To 
investigate anticipatory anhedonia in this model the negative anticipatory contrast procedure 
described in Chapter two was utilised.  A failure of MAM exposed animals to anticipate the second 
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solution in the pairing, or accurately predict its value, would lead to the loss or attenuation of the 
negative anticipatory contrast effect, with an increase in the consummatory and palatability responses 
towards the first solution across training regardless of second solutions intrinsic value.
3.5 Experiment 3 - Materials and Methods 
3.5.1 Subjects 
A third cohort was used in Experiment three (see Table 4 for cohort characteristics).  This 
cohort was comprised of forty-eight male Sprague-Dawley rats supplied by Charles River UK.  Of 
these, sixteen rats had been prenatally exposed to MAM, sixteen had been prenatally exposed to 
saline and sixteen had not been exposed to any solution (non-exposed control group).  For full details 
of the MAM treatment please refer to Experiment two (Section 3.2.1).  Pups were delivered to Cardiff 
at 8 weeks of age and pair housed.  All aspects of animal husbandry were as previously described.  
At the start of the experiment, rats were approximately 10 weeks old.  One week prior to the start of 
the experiment, all rats were placed on a food restricted diet to reduce them to ~85% of their free 
feeding weights.  Weight gain was allowed over the course of the experiment and particular attention 
was given to ensure that weights did not differ significantly across the three treatment groups (in 
terms of percentage free-feeding weight). 
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Table 4 Characteristics of cohort three: data is from the day of food deprivation (ad lib weights) prior to the experiment 
start. 
MAM-Exposed
(n= 16)
Saline-Exposed
(n = 16)
Non-Exposed
(n = 16)
Age ~ 10 weeks
Weight range (g) 222 - 355 292 - 369 258 - 389
Mean ad-lib weight
(g)
312 329 334
Weight comparison
(Independent 2-tailed
T-test)
MAM vs. Saline t (30) = 1.625, p = .115
MAM vs. Non-Exposed t (30) = 1.783, p = .085
Saline vs. Non-Exposed t (30) = -.512, p = .613
3.5.2 Apparatus 
Testing was conducted in the same six automated drinking chambers as described in 
Experiment one (Section 2.2.2).  The solutions used in the experiment were 4% and 32% sucrose 
made daily w/w with deionised water.  Distinct light conditions were created by room lighting (bright 
light condition) and an angle-poise lamp fitted with a red bulb (dim light condition). A metal grid floor 
insert could also be inserted into the bottom of the drinking chamber to create a distinct tactile cue.  
Unlike for Experiment one, white noise was not included to create the contexts.  This was to allow 
consistency between MAM and WKY experiments.  For subsequent experiments with WKY rats, 
strain differences in reactions to white-noise needed to be considered due to the stress sensitivity of 
this strain. 
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3.5.3 Procedure 
 Pre-training.  Pre-training was conducted as described for Experiment one (Section 2.2).  
Rats were water restricted (22 h max) during this initial training and drinking spouts were positioned 
inside the chamber to allow them to be easily detected.  After pre-training, rats were returned to ad 
libitum water and remained so for the duration of the experiment.  
 Acquisition Training.  Acquisition training of anticipatory contrast was conducted as described 
in Experiment one.  It consisted of daily drinking sessions 9 min in duration.  During sessions, rats 
received 3 min access to an initial 4% sucrose solution made available from right-hand side of the 
chamber, followed by access to a second solution for 6 min made available from the left-hand side of 
the chamber.  There was a 4 s inter-solution interval.  The identity of the second solution in the pairing 
- more of the same 4% sucrose solution (the 4-4 or control condition) or a more palatable 32% 
sucrose solution (the 4-32 or contrast condition) - was signalled by the context in which the rats were 
placed.  Accordingly, the second solution identity was manipulated within subject with all rats 
experiencing both 4-4 and 4-32 conditions during training.  In this experiment, context one consisted 
of bright light and the mesh floor insert put in the base of the chamber while context two consisted of 
dim light and the normal grid floor of the chamber.  The position of the chamber, whether it was one of 
the top or bottom chambers of the 3 × 2 array, was also factored in to the context assignment.  
Solution pairing and context assignments were fully counterbalanced across rat strains.  That is, for 
half the animals in each group (MAM-treated, saline-treated and non-exposed rats), context one was 
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paired with the 4-4 condition and context two was paired with 4-32 condition, while for the other half 
the opposite assignment was given.  Acquisition training lasted twenty-four days and was carried out 
on consecutive days where possible.  Initially spouts for both the left and right bottles were positioned 
within the chamber, but were gradually moved back across sessions (taking approximately three days 
but done on a rat by rat basis) until they were flush with the outside of the chamber. 
3.5.4 Data analysis 
 Data collection was performed as described for Experiment one (Section 2.2.4).  Drinking 
data were collated into two-session blocks and analysed using a repeated measures ANOVA with 
between-subject factor of prenatal treatment (saline-treated, non-exposed and MAM-treated) and 
within-subject factors of block (1-6) and contrast condition (4-4 or control condition vs. 4-32 or 
contrast condition).   
3.6 Results 
 Figure 3 shows the consumption data for the anticipatory contrast drinking sessions, across 
six 2-Trial blocks.  Panel A summarises the data for saline-treated control rats, panel B the data for 
non-exposed control rats and Panel C the data for MAM-treated experimental rats.  For all panels, the 
data represents consumption of the first 4% sucrose solution, presented for the first 3 min of each 
drinking session, as a factor of whether the second solution was 4% sucrose (the control condition) or 
32% sucrose (the contrast condition).  An anticipatory contrast effect emerged across training with 
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suppressed consumption of the initial 4% sucrose solution on days in which animals received 32% 
sucrose in the second bottle (the 4-32/contrast condition) relative to days in which more 4% sucrose 
was received (the 4-4/control condition).  Whilst prenatal treatment appeared to have impacted on the 
total amount consumed, there was no suggestion that treatment affected the development of 
anticipatory contrast.  ANOVA results were consistent with these impressions: there were significant 
effects of test block (F (3.172, 142.719) = 49.274, p < .001, MSE = 36.760), and contrast condition (F
(1, 45) = 49.304, p < .001, MSE = 42.058), as well as a significant interaction between them (F (2.896, 
130.326 = 22.212, p < .001, MSE = 10.746).  There was a significant main effect of treatment (F (2, 
45) = 8.038, p = .001, MSE = 59.029) but no block × treatment interaction (F (10, 225) = 1.683, p = 
.086, MSE = .796) and, critically, no contrast condition × treatment interaction (F (2, 45) = 2.035, p = 
.143, MSE = 1.736) or block × contrast condition × treatment interaction (F (10, 225) = 1.681, p = 
.086, MSE = .471).  Simple effect analyses revealed that the difference in consumption between 4-4 
and 4-32 conditions was significant on trial blocks 2-6 (smallest F (1, 45) = 5.273, p = .026, MSE = 
.009 - block 2) but not on trial 1 (F (1, 45) = 3.810, p = .057, MSE = .031).
 Figure 4 shows the lick cluster size data for the initial bottle across six 2-trial blocks as a 
factor of whether the second solution in the pairing was 4% or 32% sucrose.  Panels A – C depict the 
data for saline-treated, non-exposed and MAM-treated rats, respectively.  Inspection of this figure 
indicates that the anticipatory contrast effect on consumption was accompanied by lower lick cluster 
sizes for the initial 4% sucrose solution in the 4-32 than the 4-4 conditions, and that this was 
consistent across treatment groups.  ANOVA revealed a significant effect of block (F (2.665, 119.928) 
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= 35.668, p < .001, MSE = 35785.341), a significant effect of contrast condition (F (1, 45) = 32.368, p 
< .001, MSE = 14445.455) and a significant block × contrast condition interaction (F (2.333, 105.003) 
= 9.284, p < .001, MSE = 6264.475).  Further analysis of the interaction revealed significantly higher 
LCSs for the contrast compared to control condition for trial block 1 (F (1, 45) = 4.419, p = .041, MSE
= 3.508), no significant difference for trial block 2 (F < 1), and significantly smaller LCSs for the 
contrast compared to control condition for trials 3 - 6 (smallest F (1, 45) = 12.706, p < .001, MSE = 
48.025 - block 6).  There was a main effect of treatment (F (2, 45) = 5.267, p = .009, MSE = 
16666.788) with saline-treated rats performing significantly more licks per cluster than MAM-treated 
rats (F (1, 46) = 10.523, p = .002, MSE = 32.959) and non-significantly more than non-exposed rats (F
(1, 46) = 2.952, p = .093, MSE = 32.959).  There was no significant difference between the number of 
licks per cluster exhibited by MAM-treated and non-exposed rats (F (1, 46) = 32.959, p = .134, MSE = 
32.959).  There was also a block × treatment interaction (F (10, 225) = 2.277, p = .015, MSE = 
1217.468), further analysis of which revealed higher LCSs for saline-treated rats relative to MAM-
treated rats for blocks 3 - 6 (smallest F (1, 46) = 6.814, p = .012, MSE = 157.578 for block 6).  
Critically, there was no contrast condition × treatment interaction (F (2, 45) = 1.430, p = .250, MSE = 
638.403) or block × contrast condition × treatment interaction (F < 1), indicating that the contrast 
effect in LCS developed equally across all treatment groups.        
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Figure 3 Mean (± SEM) consumption data from the first bottle available each day as a factor of contrast condition (4-4 vs 4-32 - numbers refer 
to the concentration of sucrose presented first and second in each daily drinking session) for saline-treated control (Panel A), non-exposed 
control (Panel B) and MAM-treated experimental rats (Panel C). The data is presented averaged over two-trial blocks. N = 16 in each condition. 
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Figure 4 Mean (± SEM) Lick Cluster Size data from the first bottle available each day as a factor of contrast condition (4-4 vs 4-32 - numbers 
refer to the concentration of sucrose presented first and second in each daily drinking session) for saline-treated control (Panel A), non-
exposed control (Panel B) and MAM-treated experimental rats (Panel C). The data is presented averaged over two-trial blocks.  N = 16 for all 
groups.
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 ILIs were extracted from the record of licks and are summarised in Figure 5.  Data are 
displayed in one figure panel as similar ILIs were displayed by all treatment groups.  ANOVA analysis 
with factors of block, contrast condition and treatment revealed a main effect of block (F (2.188, 
98.447) = 49.682, p < .001, MSE = 8104.750) and a main effect of contrast condition (F (1, 45) = 
10.817, p = .002, MSE = 1256.218).  The main effect of block is likely driven by the lower ILIs found at 
block one, which results from the bottle spout being positioned within the chamber.  The spout was 
progressively moved backwards with normal spout position achieved by block two.  There was no 
block × contrast condition interaction (F (1.553,69.879) = 2.968, p = .071, MSE = 657.985),  no main 
effect of treatment (F (2, 45) = 2.303, p = .112, MSE = 1299.285) and no interaction between 
treatment and any other factor: block × treatment (F < 1); contrast condition × treatment (F (2, 45) = 
2.123, p = .131, MSE = 246.556; block × contrast condition × treatment (F (10, 225) = 1.028, p = .421, 
MSE = 70.759). 
 Figure 6 (Panels A - C) depicts the mean consumption levels for the second solution (4% or 
32% sucrose) which was presented in the final six min of each daily drinking session.  Again, data are 
collated into 2-trial blocks.  As expected, consumption of 32% sucrose was higher than that of 4% 
sucrose.  Whilst this pattern of consumption was consistent across the three treatment groups, saline-
treated rats appeared to consume more overall.  ANOVA was consistent with these impressions 
revealing a significant main effect of block (F (2.680, 120.582) = 156.400, p < .001, MSE = 301.000), 
a main effect of solution concentration (F (1, 45) = 206.771, p < .001, MSE = 1499.787) and a main 
effect of treatment (F (2, 45) = 5.715, p = .006, MSE = 104.249) with saline-treated rats consuming 
131 
significantly more than MAM rats (F (1, 46) = 11.414, p = .002, MSE = .190) and non-significantly 
more than non-exposed rats (F (1, 46) = 3.192, p = .081, MSE = .190).  Consumption levels did not 
differ significantly between MAM-treated and non-exposed animals (F (1, 46) = 2.534, p = .118, MSE
= .190).  There was no block × solution concentration interaction (F (2.951, 132.812) = 1.987, p = 
.120, MSE = 3.086), no block × treatment interaction (F < 1), no solution concentration × treatment 
interaction (F (2, 45) = 1.822, p = .173, MSE = 13.215) and no block × solution concentration × 
treatment interaction (F (10, 225) = 1.486, p = .145, MSE = 1.363).   
Figure 5 Mean inter-lick intervals from the first bottle available each day as a factor of contrast condition (4-4 vs 4-32 
(numbers refer to the concentration of sucrose presented first and second in each daily drinking session) and treatment.  
Filled symbols represent the inter-lick interval to 4% sucrose in the 4-4 condition; open symbols represent the inter-lick 
interval to 4% sucrose in the 4-32 condition. Squares represent the responses of saline-treated rats, Triangles represent the 
responses of non-exposed rats and Circles represent the responses of MAM-treated experimental rats.  Data is collated 
into 2-trial blocks. N = 16 for all groups.
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Figure 6 Mean consumption (± SEM) for the second bottle made available each day for saline treated (Panel A), non-
exposed (Panel B) and MAM-treated (Panel C) rats.  Solutions in the second bottle were made available for 6 min.  In all 
cases, open symbols represent the rat’s intake of the 4% sucrose solution, whereas the filled symbols represent the rat’s
intake of the 32% sucrose solution made available.  Data is collated into 2-trial blocks.  N = 16 for all groups. 
A
B
C
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 Inspection of Figure 7 (Panel A - C) suggests that 32% sucrose was associated with higher 
lick cluster sizes.  Again, it appears that LCS was generally higher for saline-treated rats compared to 
the other treatment groups.  ANOVA results showed a significant main effect of block (F (2.163, 
97.328) = 28.714, p < .001, MSE = 74856.913), solution concentration (F (1, 45) = 32.919, p < .001, 
MSE = 155385.671) and a significant interaction between these two factors (F (2.198, 98.904) = 
10.822, p < .001, MSE = 24903.632).  There was also a main effect of treatment (F (2, 45) = 3.439, p
= .041, MSE = 25922.827) with saline-treated rats displaying significantly more licks per cluster than 
both non-exposed (F (1, 46) = 5.476, p = .024, MSE = 78.517) and MAM rats (F (1, 46) = 4.818, p = 
.033, MSE = 78.517).  No significant difference was seen for mean licks per cluster between MAM-
treated and non-exposed animals (F < 1). 
 Inter-lick intervals were extracted from the record of licks (Figure 8).  ANOVA revealed a main 
effect of block (F (1.600, 72.022) = 108.213, p < .001, MSE = 16919.254), a main effect of solution 
concentration (F (1, 45) = 66.026, p < .001, MSE = 6277.663) and a block × solution concentration 
interaction (F (1.698, 76.405) = 4.750, p = .015, MSE = 480.213).  There was no significant main 
effect of treatment (F (2, 45) = 1.508, p = .232, MSE = 837.055) and no solution concentration × 
treatment interaction (F < 1).  There was, however, a significant block × treatment interaction (F (10, 
225) = 2.922, p = .002, MSE = 146.243), further analysis of which revealed that ILI was higher for 
non-exposed rats than MAM rats for block 1 only (F (1, 46) = 5.764, p = .021, MSE = 12.048).
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Figure 7 Mean Lick Cluster Size (± SEM) for the second solution available (4% vs. 32%) for saline-treated (Panel A), non-
exposed (Panel B) and MAM-treated rats (Panel C).  The second solution was made available for 6 min each day.  In all 
cases, open symbols represent the rat’s response to the 4% sucrose solution made available in the second bottle, whereas 
the filled symbols represent the rat’s response to the 32% sucrose solution made available in the second bottle.  Data is 
collated into 2-trial blocks.  N = 16 for all groups. 
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Figure 8 Mean Inter-lick Intervals (±SEM) as a factor of treatment and solution concentration (4% vs. 32%) for the second 
solution made available each day.  Filled symbols represent the inter-lick interval to 4% sucrose; open symbols represent 
the inter-lick interval to 32% sucrose. Squares represent the responses of saline-treated rats, Triangles represent the 
responses of non-exposed rats and Circles represent the responses of MAM-treated experimental rats.  Data is collated 
into 2-trial blocks. N = 16 for all groups. 
3.6.1 Additional analysis 
 While the analysis of anticipatory contrast did not suggest any detrimental effect of MAM 
treatment, the overall trend of higher lick cluster sizes in the saline control compared to the MAM 
group suggests a potential inconsistency with the results of Experiment two.  However, the difference 
in lick cluster size between the saline and non-exposed controls makes this result hard to interpret.  
Therefore, this cohort of animals was re-tested in the absence of contrast.  The experiment was 
conducted as described for cohort two (Experiment two, Section 3.2.3), with three exceptions: Firstly, 
the solution concentrations used were 2, 6 and 18% sucrose (because rats had already been 
exposed to 4% sucrose during negative anticipatory contrast); secondly, drinking sessions were 10 
min in duration (as very high consumption levels had been previously seen) and thirdly, each 
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concentration was run for three consecutive days only (deemed appropriate due to the rats previous 
drinking experience with sucrose).  The animals were approximately 28 weeks old at the start of the 
experiment and remained on a food-restricted diet as previously described (see Table 5 for cohort 
characteristics at this age).  A single pre-training session was given prior to the experiment start to re-
familiarise the rats with the drinking equipment.  This was deemed necessary due to the intervening 
period between the contrast and non-contrast drinking experiments (see Appendix A for details).  
During pre-training, water restricted rats (22 h/day maximum) were exposed to water for 10 min in the 
drinking chambers.  Rats were then returned to an ad lib water supply for the remainder of the 
experiment.
Table 5 Characteristics of cohort 3.  Data is taken from the first day of the experiment (after pre-training).  Rats are on a 
food restricted diet to maintain them at 85% of their free feeding weights. 
MAM-Exposed Saline-Exposed Non-Exposed
Age ~ 28 weeks
Weight range (g) 391 - 528 403 - 540 411 - 582
Mean ad-lib weight
(g)
468 466 488
Weight comparison
(Independent (2-
tailed) T-test)
MAM vs. Saline t (30) = -.096, p = .924
MAM vs. Non Exposed t (30) = 1.313, p = .199
Saline vs. Non-Exposed t (30) = -1.451, p = .157
Similarly to Experiment two (Section 3.2.4) data were analysed by a repeated measures 
ANOVA with a within subject factor of concentration (2, 6, 18%) and between subject factors of 
treatment (saline, non-exposed and MAM) and sequence order (2-6-18 or ascending vs. 18-6-2 or 
descending).  To overcome potential neophobic effects, data were analysed averaged across the 
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second and third days of exposure for each solution concentration.  Three animals (rats 9, 13 and 28 
(two saline-treated and one non-exposed rat)) were excluded from all data analysis due to their LCSs 
being outside of 3 standard deviations of the mean.  Rats 9 and 13 also displayed low ILIs relative to 
the group mean.  Further inspection of the anomalous data points revealed very low numbers of bouts 
for these animals.  The reason behind such infrequent but long bouts is unknown and has not been 
seen in previous or subsequent experiments. 
3.6.2 Results 
Figure 9A displays the mean consumption levels for saline-treated, non-exposed and MAM-
treated rats in cohort three at each of the three different concentrations of sucrose: 2%, 6% and 18%.  
An ANOVA with factors of treatment, solution concentration and sequence-order revealed a main 
effect of concentration (F (1.578, 61.539) = 155.711, p < .001, MSE = 895.305).  There was no main 
effect of sequence-order (F < 1) but a sequence order × concentration interaction (F (2, 78) = 6.187, p
= .003, MSE = 28.066).  There was also a main effect of treatment (F (2, 39) = 4.244, p = .021, MSE = 
85.508) with saline-treated rats consuming significantly more solution than MAM rats (F (1, 39) = 
8.400, p = .006, MSE = .910) and non-significantly more than non-exposed rats (F (1, 39) = 3.176, p = 
.083, MSE = .939).  No significant difference in intake was seen between MAM and non-exposed rats 
(F (1, 39) = 1.240, p = .273, MSE = .869).  There was no treatment × concentration interaction (F < 1), 
no treatment × sequence-order interaction (F < 1) and no treatment × concentration × sequence order 
interaction (F < 1).  Further analysis of the concentration × sequence order interaction revealed 
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varying patterns of consumption depending on sequence order.  That is, rats given the solutions in 
ascending order of concentration demonstrated an inverted U-shaped pattern of consumption with 
marginally higher consumption at the intermediate concentration of sucrose (2% < 6%, F (1, 39) = 
190.868, p < .001, MSE = .368; 18% < 6%, F < 1; 2% < 18%, F (1, 39) = 111.696, p < .001, MSE = 
.585).  In contrast, rats given the sucrose in descending order of concentration demonstrated 
increased consumption with increasing solution concentration (2% < 6%, F (1, 39) = 72.590, p < .001, 
MSE = .391; 6 < 18%, F < 1; 2% < 18%, F (1, 39) = 54.456 p < .001, MSE = .621).  At no 
concentration were there any significant differences between intake levels due to sequence order 
effects (largest F (1, 39) = 2.691, p = .109, MSE = 31.786). 
Figure 9B depicts the LCSs elicited by the three treatment groups in cohort three (saline, non-
exposed and MAM) when consuming each of the three sucrose concentrations.  Regardless of 
treatment, rats increased the size of their licking clusters as the solution consumed increased in 
concentration.  An ANOVA with factors of treatment, concentration and sequence-order revealed a 
significant main effect of concentration (F (1.697, 66.201) = 54.263, p < .001, MSE = 57411.452), no 
main effect of treatment (F < 1) and no treatment × concentration interaction (F (4, 78) = 1.156, p = 
.337, MSE = 1037.740).  There was also no main effect of sequence order (F (1, 39) = 2.908, p = 
.096, MSE = 11832.124), no treatment × sequence order interaction (F < 1), no concentration × 
sequence order interaction (F (2, 78) = 1.449, p = .241, MSE = 1301.607) and no three-way 
interaction between treatment, concentration and sequence order (F (4, 78) = 1.081, p = .372, MSE = 
970.789).   
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Figure 9 Mean Consumption (Panel A), mean Lick Cluster Size (Panel B) and mean Inter-lick intervals (Panel C) for three 
different concentrations of sucrose solution (2, 6 and 18%) for saline-treated (light grey bars), non-exposed (striped bars) 
and MAM-treated (dark grey bars) animals.  Error bars represent ± SEM.  N: saline = 14, non-exposed = 15 and MAM = 16. 
A
B
C
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Figure 9C displays the mean inter-lick intervals extracted from the record of licks.  An ANOVA 
on this data revealed a significant main effect of concentration (F (2, 78) = 19.280, p < .001, MSE = 
270.057), no significant main effect of treatment (F < 1) and no main effect of sequence order (F (1, 
39) = 3.503, p = .069, MSE = 841.295).  There was also no treatment × concentration interaction (F < 
1).  There was, however, a significant concentration × sequence order interaction (F (2, 78) = 16.435, 
p < .001, MSE = 230.210) and a treatment × concentration × sequence order interaction that 
approached significance (F (4, 78) = 2.478, p = .051, MSE = 34.709).  Further analysis of the 
concentration × sequence order interaction revealed that ILI was lower for both 6 and 18% sucrose 
solutions for rats experiencing the solutions in order of decreasing concentration (18-6-2 sequence 
order) compared to increasing concentration (2-6-18 sequence order): 6% F (1, 39) = 7.275, p = .010, 
MSE = 671.867; 18% = F (1, 39) = 6.250, p = .017, MSE = 629.259; 2% F < 1.  There were no 
significant differences in ILI between the three solution concentrations in the descending order group 
(largest F (1, 39) = 1.490, p = .230, MSE = .949).  In contrast, significant differences in ILI were seen 
between solutions of different concentrations for animals in the ascending order group, with ILI for 2% 
being significantly lower than for 6% and 18% (6%: F (1, 39) = 45.207, p < .001, MSE = 1.290; 18%: F
(1, 39) = 49.658, p < .001, MSE = 1.481).  No significant differences were seen between 6% and 18% 
concentrations (F < 1).   
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3.7 Summary 
 Experiment three investigated whether evidence of anticipatory anhedonia could be found in 
rodents prenatally exposed to MAM on GD17.  Based on our current understanding of the hedonic 
deficits in schizophrenia, it is thought that people suffering from the disorder may be unable to 
anticipate or predict that future events will be pleasurable and adjust their ongoing behaviour in light 
of these predictions.  The results of Experiment three provide further evidence that anticipatory 
contrast effects develop for both consumption and palatability measures.  Lower consumption and lick 
cluster sizes were exhibited by the rats during the presentation of the initial 4% sucrose solution when 
it was followed by a more palatable 32% sucrose solution.  Critically, the development of this contrast 
effect was not affected by prenatal MAM treatment.  Thus, despite the biological and supposed 
phenotypic validity of the MAM model, there is no evidence that this model includes behaviours 
analogous to anticipatory anhedonia.   
 Unlike for Experiment two, MAM-exposed rats in the current experiment demonstrated 
reduced overall consumption and palatability responses for the (contrasted) solutions, but only when 
compared to saline-treated controls and not the non-exposed control.  However, further analysis of 
the cohort in non-contrasted consumption tests did not reveal any differences between the MAM-
treated rats and either of the control groups.  This provides further evidence that the MAM model of 
schizophrenia does not produce consummatory hedonic deficits. 
 The general implications of these findings, combined with those from the analysis of other 
reward-processing studies, will be discussed at the end of Chapter four.  It should be recognised that 
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the evaluation of anticipatory hedonic deficits in schizophrenia patients has produced some 
inconsistent findings (see Strauss et al., 2011).  Therefore, the presence of an anticipatory deficit 
needs to be clarified in the clinical literature.  A lack of anticipatory anhedonia after prenatal MAM 
treatment may highlight a short-coming of the model in recapitulating negative symptoms, or could 
reflect an absence of anticipatory anhedonia as a primary symptom of the disease.  The critical deficit 
may lie in using reward values to guide action selection (see section 1.3.3 of the general introduction).  
Therefore, the possibility of aberrant encoding of rewards by MAM-exposed rats will be investigated in 
Chapter four. 
Chapter Four 
4. Value Representations in the MAM Model 
4.1 Introduction 
 As was seen in Chapter three, MAM-treated rats showed no evidence of impaired hedonic 
reactions, consistent with the absence of consummatory and anticipatory anhedonia.  Therefore, 
Chapter four examines the possible reward processing deficits beyond anhedonia in the MAM GD17 
neurodevelopmental model.   
 As has been discussed in section 1.6.1 of the general introduction, both manipulations of the 
frontal cortex (section 1.6.1b) and repeated exposure to psychostimulants (section 1.6.1c) influence 
the transition from goal-directed to habitual behaviour.  This suggests that this transition is under the 
143 
control of the type of 'frontal' and neurochemical mechanisms thought to be disrupted in 
schizophrenia patients.  Furthermore, direct assessment of an outcome devaluation test in people 
with schizophrenia has demonstrated that integration of reward values with action selection may be 
impaired in these patients (Morris et al., 2015).  Impaired performance in this task was accompanied 
by regional activity differences in the caudate between schizophrenia patients and healthy controls.  
Taken together, these impairments suggest that schizophrenia patients may over rely on habitual 
strategies, perhaps due to impaired cotico-striatal circuitry. 
 Experiment four used an outcome devaluation procedure (described in section 1.6.1a) to 
determine whether rats prenatally exposed to MAM are able to form and update value representations 
and use these representations to motivate behaviour.  MAM-exposed animals and their saline-treated 
counterparts were trained on a random interval schedule of reinforcement before their sensitivity to 
outcome devaluation was tested in extinction.  Outcome devaluation was achieved by LiCl-induced 
gastric malaise as this manipulation has been demonstrated to produce a larger and more robust 
devaluation effect compared to satiety manipulations (see Nelson & Killcross, 2006).  If the animal's 
performance is goal-directed (i.e. sensitive to changes in the current value of the reward), then it 
should be reflected in a lowered willingness to perform the response associated with the devalued 
outcome.  Sensitivity to the outcome devaluation manipulation in the absence of consummatory 
feedback provides evidence that the outcome is encoded as part of the associative framework driving 
behaviour and that this representation has been updated to reflect the change in reward value.  
Alternatively, if the animal's performance is habit-driven (i.e. insensitive to the change in value of the 
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reward) then the subject will perform the devalued action at an equivalent rate to animals for which 
the action has not been devalued.  Under these circumstances, the outcome is not included as part of 
the associative framework controlling behaviour, with the animals performance instead being 
controlled by antecedent stimuli (Balleine & O'Doherty, 2010).   
 Whilst interval schedules are usually used to promote habitual responding, limited training can 
maintain goal-directed behaviour (as indexed by sensitivity to outcome devaluation e.g. Dickinson et 
al., 1995).  Importantly, the use of three days training for a total of 120 rewards (adopted in the current 
experiment) has been shown to maintain sensitivity to outcome value in normal, untreated animals 
whereas amphetamine-treated animals display habitual behaviours (Nelson & Killcross, 2006).  The 
use of a 30 s random interval schedule (RI30s) was employed in the current experiment as this 
reinforcement schedule maintains a high level of lever pressing during extinction (Nelson & Killcross, 
2006), thus allowing good sensitivity to outcome devaluation manipulations in goal-directed animals.   
 Given the likelihood that MAM disrupted prefrontal cortex function and cortical-striatal 
dopamine systems (Flagstad et al., 2004; Lavin, Moore, & Grace, 2005) it might be expected that 
MAM-treated animals would undergo a faster transition to habitual behaviour, exhibiting insensitivity 
to the outcome devaluation manipulation after three days of training. 
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4.2 Experiment 4 - Materials and Methods 
4.2.1 Subjects 
 The two cohorts combined in Experiment two were also using in the current experiment (see 
Appendix A for experiment order for each cohort).  At the start of the experiment rats in cohort one (n: 
Sham, 18; MAM, 24) were approximately 17 weeks old with saline-treated animals weighing between 
393 – 543 g and MAM-treated animals weighing between 376 – 455 g (ad libitum weights).  Rats in 
cohort two were approximately 16 weeks old at the start of the experiment.  Saline-treated animals 
weighed between 326 – 486 g and MAM-treated animals weighed between 374 – 470 g (ad libitum 
weights).  For all aspects of animal husbandry, please refer to Experiment two.  All animals were food 
restricted to ~85% of their free-feeding weights prior to the experiment start.  Moderate weight gain 
was allowed over the course of the experiment. 
4.2.2 Apparatus 
 The training apparatus comprised eight chambers (Med Associates Inc., St Albans, VT), each 
measuring 30 × 24 × 21 cm, arranged in a 2 × 4 array.  The door, back wall and ceiling were made of 
clear Perspex while the left and right-hand walls were made of aluminium.  Chocolate flavoured sugar 
pellets (45 mg; Test Diet, Richmond, IN) were delivered into a recessed magazine located at the 
centre of the right-hand wall.  Access to the magazine could be determined by the means of infrared 
detectors mounted across the mouth of the recess. Flat-panel retractable levers could be made 
146 
available to both the left and right of the magazine, although only the left lever was used in this 
experiment.  Each chamber was housed within a sound-attenuating cabinet ventilated by low-noise 
fans.  A computer equipped with MED-PC (Med Associates) software controlled the equipment and 
recorded the data.
4.2.3 Procedure 
 Training consisted of two stages: magazine training and lever-press training. This was 
followed by an extinction test after devaluation of the instrumental reward by LiCl-induced nausea.  
Each rat was assigned to one of the eight experimental chambers, and thereafter always trained in 
the same chamber (see Figure 10). 
Figure 10 Schematic depicting the experimental protocol for the Outcome Devaluation Task with limited levels of training. 
Magazine training.  All rats were trained to collect food rewards during a single magazine 
training session.  Chocolate flavoured sugar pellets were delivered on a random time (RT) 60s 
schedule whereby a single pellet was delivered, on average, every 60 s.  The session ended once 20 
pellets had been delivered.  Rats that did not collect the food were given a repeat of the session later 
the same day. 
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Lever-press training.  Two initial sessions of lever press training were given during which 
chocolate flavoured sugar pellets were delivered on a continuous (CRF) schedule of reinforcement 
(i.e. each lever press led to reward delivery).  The lever was inserted into the chamber at the start of 
the session and retracted at the end of the session.  The session ended once the rat had earned 20 
reinforcers.  In the subsequent three sessions of training, chocolate pellets were now delivered 
according to a random interval (RI) 30 s schedule whereby the reward was made available, on 
average, every 30 s and delivered on the next lever press.  During this RI30s training the session 
ended once rats had earned 40 reinforcers.   
Devaluation by LiCl.  Animals received two days of devaluation with LiCl. On each day, the 
rats were placed in individual cages measuring 32 × 15 × 12 cm in a separate test room and given 
free access to the chocolate pellets for 30 min.  Once 30 minutes had past, the devalued group 
(Cohort one: 12 MAM-treated, 9 Saline-treated; Cohort two: 12 MAM-treated, 12 saline-treated) 
received intraperitoneal injections of 0.15 M, 15ml/kg LiCl solution (dissolved in deionised water, LiCl 
from Sigma-Aldrich).  The non-devalued group (Cohort one: 12 MAM-treated, 9 saline-treated; Cohort 
one: 12 MAM-treated, 12 saline-treated) were given intraperitoneal injections of the equivalent volume 
of 0.9% saline.  Animals were matched according to lever press levels during the final day of 
acquisition to determine their devaluation group.  Twenty-four hours after the second taste aversion 
session, the animals’ sensitivity to outcome devaluation was assessed via a 10 min extinction test.  
Rats were given the opportunity to lever press during this session but no rewards were available. 
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Consumption test.  Immediately after the extinction session, all rats underwent a consumption 
test to ensure that the devalued group had acquired an aversion to the instrumental outcome.  During 
this, animals were placed in test cages and given 30 min free access to the reward. 
Reacquisition test.  Twenty-four hours after the extinction and consumption tests, rats were 
given a further session in the instrumental chambers.  Sessions lasted 25 min and rats were allowed 
to lever press on a RI30s schedule of reinforcement with chocolate flavoured pellets delivered. 
4.2.4 Data analysis 
Statistical analysis was performed using ANOVA with between-subject factors of replication 
(cohort one vs. cohort two), treatment (saline treated vs. MAM treated), and devaluation condition 
(devalued vs. valued).  Lever presses per minute and magazine approaches per minute during the 
extinction test were calculated as a proportion of baseline.  Baseline was taken as the data from the 
final day (day three) of acquisition.   
4.3 Results 
Instrumental training.  Across the three days training, MAM-treated and saline-treated rats 
acquired the lever press response at the same overall rate.  Importantly, there were no differences in 
baseline lever press responses (day three) as a function of devaluation condition (see Table 6).  
Consistent with this impression, ANOVA analysis on lever press responses (day three only) revealed 
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no effect of prenatal treatment (F < 1) or of devaluation condition (F < 1) and no interaction between 
these two factors (F < 1).  There was no significant main effect of replication (F (1, 82) = 2.582, p = 
.112, MSE = 101.283) and no interactions between replication and any other factor (All Fs < 1, except 
for the replication × condition interaction where F (1, 82) = 2.528, p = .116, MSE = 99.178).  
Table 6 Lever press responses per minute for day three of acquisition (used as ‘baseline’).
Prenatal Treatment Devaluation Condition Mean Lever press/min (±SEM)
Saline Valued 20.069 (±1.500)
Devalued 18.562 (± 1.147)
MAM Valued 19.004 (± 1.418)
Devalued 18.939 (± 1.232)
In terms of magazine approach behaviour (see Table 7), analysis suggested no effect of 
prenatal treatment.  Importantly, there also appeared to be no differences in baseline magazine 
entries between the valued and to-be-devalued conditions.  In line with this impression, ANOVA 
revealed no main effect of treatment (F < 1), devaluation condition (F < 1), and no interaction between 
these two factors, F (1, 82) = 1.883, p = .174, MSE = 39.814.  There was a main effect of replication 
(F (1, 82) = 6.608, p = .012, MSE = 139.692) with higher magazine entries elicited by rats in cohort 
two (Mean of 16.220 entries per min) compared to cohort one (Mean of 13.708 entries per min).  
Replication did not interact with any factor or combination of factors (All Fs < 1).
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Table 7 Magazine approach behaviour as responses per minute for day three of acquisition (used as ‘baseline’).
Prenatal Treatment Devaluation Condition Mean Magazine Entries/min (±SEM)
Saline Valued 15.132 (± 1.033)
Devalued 14.472 (±0.913)
MAM Valued 14.324 (±0.737)
Devalued 16.284 (± 1.188)
Extinction – Lever press performance.  The mean lever press response rates as a proportion 
of baseline for the 10 min extinction test are displayed in Figure 11A.  Both MAM- and saline treated 
animals’ performance was sensitive to post-conditioning changes in the value of the instrumental 
outcome.  That is, regardless of prenatal treatment, animals performed fewer lever presses as a 
proportion of baseline when the outcome was previously paired with LiCl-induced nausea (devalued 
condition – grey bars) compared with those animals where the outcome was not previously paired 
with LiCl-induced nausea (valued condition – white bars).   
 The description of the data was confirmed by statistical analysis.  Between-subjects ANOVA 
with factors of replication (cohort 1 vs. cohort 2), treatment (saline-treated vs. MAM-treated) and 
devaluation condition (valued vs. devalued) yielded a main effect of devaluation condition (F (1, 82) = 
7.417, p = .008, MSE = 2.503), no main effect of treatment (F (1, 82) = 1.375, p = .244, MSE = .464) 
and no devaluation × treatment interaction (F (1, 82) = 1.653, p = .202, MSE = .558).  The ANOVA 
also yielded no main effect of replication (F (1, 82) = 2.538, p = .115, MSE = .856) and replication did 
not interact with any other factor: briefly, replication × treatment (F (1, 82) = 2.042, p = .157, MSE = 
.689); replication × condition (F < 1); replication × treatment × condition (F (1, 82) = .707, p =.403, 
MSE = .239).   
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Figure 11 Effect of prenatal treatment on sensitivity of lever pressing (Panel A) and magazine entries (Panel B) to reward 
devaluation by LiCl-induced nausea.  Mean lever presses/ magazine entries per minute as a proportion of baseline (±SEM) 
in the extinction test are shown, where grey bars represent responses in the devalued condition and white bars represent 
responses in the valued condition. N = 21, saline-treated rats and 24, MAM-treated rats. 
Extinction – Magazine approach performance.  Figure 11B shows magazine approach 
behaviour as a proportion of baseline during the 10 min extinction test.  As indicated in the figure, 
animals with an aversion to the reinforcer (devalued condition – grey bars), regardless of prenatal 
treatment, performed fewer magazine entries compared to animals not averted to the reinforcer 
A
B
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(valued group – white bars).  ANOVA was consistent with this impression: whilst there was a main 
effect of devaluation condition (F (1, 82) = 4.795, p = .031, MSE = .711), there was no main effect of 
prenatal treatment (F (1, 82) = 1.511, p = .222, MSE = .224) and no interaction between these two 
factors (F < 1).  The ANOVA also yielded a main effect of replication (F (1, 82) = 7.785, p = .007, MSE
= 1.154) with rats in the cohort two undergoing more magazine entries as a proportion of baseline 
compared to rats in cohort one (.337 and .235, respectively).  The factor of replication did not interact 
with any other factor (F < 1). 
Outcome devaluation.  The data from the devaluation phase are presented in Figure 12.  
Taste aversion learning was not affected by prenatal MAM treatment as LiCl injection produced a 
strong aversion to the instrumental outcome in both treatment groups.  In contrast, all animals in the 
valued group (where the outcome had been paired with a saline injection) continued to consume the 
outcome across sessions.  An ANOVA with factors of session (day one, day two and test), replication 
(cohort one vs. cohort two) prenatal treatment (MAM-treated vs. saline treated) and devaluation 
condition (valued vs. devalued) was performed.  This revealed a significant main effect of devaluation 
(F (1, 82) = 160.618, p < .001, MSE = 1147.445), session (F (1.621, 132.884) = 152.280, p < .001, 
MSE = 776.115) and a significant interaction between these two factors (F (2, 164) = 54.115, p < 
.001, MSE = 223.475), reflecting the development of the aversion across sessions.  There was no 
main effect of prenatal treatment (F < 1) and no significant interaction between treatment and any 
other factor (F < 1).  The ANOVA did yield a main effect of replication (F (1, 82) = 64.331, p < .001, 
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MSE = 459.578) with rats generally consuming more across the sessions in cohort two (mean of 
6.335 g) compared to cohort one (mean of 3.706 g).  Importantly, there was no replication × treatment 
interaction (F < 1).  Significant interactions (e.g. the replication × condition interaction (F (1, 82) = 
9.704, p = .003, MSE = 69.322)), were all driven by lower overall consumption for cohort one.  
Importantly, inspection of the replication × condition interaction revealed that rats in the devalued 
condition consumed significantly less than their non-devalued counterparts in both cohort one (F (1, 
82) = 42.419, p < .001, MSE = 101.013) and cohort two (F (1, 82) = 125.026, p < .001, MSE = 
321.540).
Figure 12 Mean chocolate pellet consumption (± SEM) over 2 days of taste aversion training and 1 post-extinction 
consumption test for MAM- and saline-treated rats.  Rats received LiCl injections (Devalued) or saline injections (Valued) 
after 30 min free access to the instrumental outcome.  The test phase also took place in a 30 min period immediately after 
the 10-min extinction test.
Reacquisition Test – Lever Press Performance.  The mean lever press responses per minute 
for the 25 min rewarded reacquisition test are shown in Figure 13.  Inspection of the figure shows that 
rats in the devalued group, regardless of prenatal treatment, performed fewer responses compared to 
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rats in the valued group.  Statistical analysis by a between-subject ANOVA with factors of replication, 
prenatal treatment and devaluation condition yielded a significant main effect of devaluation condition 
(F (1, 82) = 86.413, p < .001, MSE = 1411.552).  The effect of aversion conditioning on lever press 
performance during this test was comparable across prenatal treatment groups as there was no main 
effect of treatment (F < 1) and no treatment × devaluation condition interaction (F < 1).  The ANOVA 
also revealed that cohorts one and two responded similarly on the lever during the reacquisition test, 
as there was no main effect of replication and no interaction between replication (F < 1) and any other 
factor (Fs < 1, except for the replication × condition interaction where F (1, 82) = 1.062, p = .306, MSE
= 17.351).
Figure 13 Effect of prenatal treatment (saline vs. MAM) on lever press reacquisition after reward devaluation by LiCl-
induced nausea.  Mean lever presses per minute (+ SEM) in the rewarded reacquisition test after devaluation with LiCl 
(grey bars) or no devaluation (white bars) are shown.  The reacquisition test was given 24 hours after the extinction and 
consumption tests and lasted for 25 min.
Reacquisition Test – Magazine Approach Behaviour.  The mean number of magazine entries 
per minute (± SEM) for saline-treated and MAM-treated rats was as follows: Saline-treated Valued = 
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10.844 (± .934); Saline-treated Devalued = 5.037 (± .562); MAM-treated Valued = 9.370 (± .446); 
MAM-treated Devalued 6.121 (± .682).  Rats in both devalued groups showed a marked suppression 
in their magazine approach behaviour compared with rats in the equivalent valued group.  In support 
of this, ANOVA yielded a main effect of devaluation condition (F (1, 82) = 43.190, p < .001, MSE = 
451.417), no main effect of treatment (F < 1) and no treatment × condition interaction (F (1, 82) = 
3.394, p = .069, MSE = 35.474).  There was also no main effect of replication (F < 1) and replication 
did not interact with any other factor (All Fs < 1).
4.4 Summary 
 Experiment four assessed the control of instrumental actions in MAM-treated rats after limited 
levels of training.  The rats' sensitivity to reward value was assessed by a post-training devaluation 
procedure before testing in extinction.  Both MAM-treated rats and saline-treated controls in the 
devalued group displayed a reduction in their lever press behaviour compared to rats in the non-
devalued group, suggesting that their behaviour was still contingent on outcome value (i.e. goal-
directed).  If anything, the difference in response rates between valued and devalued groups was 
more pronounced for rats prenatally exposed to MAM.  Contrary to the original prediction, rats 
prenatally exposed to MAM on GD17 are unimpaired in their ability to use and update internal 
representations of reward value to modify ongoing behaviour.   
 As intended (see section 1.6.2 of the general introduction), this result was followed with a 
differential outcomes procedure in Experiment five.  As this procedure affords a reversal of the 
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conditional discrimination, and reversal deficits have previously been reported for MAM-treated 
animals (e.g. Featherstone et al., 2007; Flagstad, Glenthøj & Didriksen, 2005; Gastambide, et al., 
2012; Moore et al., 2006), Experiment five also incorporated a reversal phase.   
4.5 Experiment 5 - Materials and Methods 
4.5.1 Subjects 
Cohort three (16 saline-treated, 16 non-exposed and 16 MAM-treated rats) was used for 
Experiment six (please refer to Appendix A to see the timing of this experiment).  At the start of the 
experiment, rats were approximately 19 weeks old.  Saline treated animals weighed between 351 –
430 g, non-exposed animals weighed between 345 – 475 g and MAM-treated animals weighed 
between 300 – 430g.  Animals remained on food deprivation from the previous experiment (reported 
as Experiment three in this thesis).  Moderate weight gain was allowed throughout to match the 
expected increase of free-feeding animals.  For all aspects of animal husbandry, please see 
Experiment two.
4.5.2 Apparatus 
 The same eight experimental chambers used in Experiment Four were also used in the 
current experiment.  Now, however, the chambers were illuminated by a 3-W light bulb positioned at 
the top centre of the left wall.  Two flat-panel retractable levers could be inserted to the left and right 
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of the central magazine positioned on the right wall.  Distinct rewards, a single plain food pellet (45 
mg) and a 20% (w/w) sucrose solution (made daily) could be delivered into the same magazine.  The 
sucrose solution was delivered at a volume of 0.05 ml by a motorized dipper.  Auditory stimuli 
consisted of a 3 kHz tone (delivered at 80 dB) and a 10 Hz train of clicks delivered from speakers 
located at the top left and right of the left-hand wall, respectively. 
4.5.3 Procedure 
 Each rat was assigned to one of the eight experimental chambers, and thereafter always 
trained in the same chamber.  Training consisted of three stages: magazine training, lever press 
training and acquisition training on a continuous performance conditional discrimination task (see 
Figure 14).  Rats then underwent a test session performed in extinction and a reinforcer-only test.  
The two test sessions were separated by one day of reacquisition training.  Following a further day of 
reacquisition training, all rats entered the reversal phase of the experiment.   
Magazine training.  Rats were trained to collect the two different food rewards across 
consecutive days.  Half of the rats (equal numbers of MAM-exposed, saline-exposed and non-
Figure 14 Schematic depicting the experimental protocol for the differential outcomes procedure.
Reacq. 
Training 
1
Pre-Training
1 day
Reversal Training
12 days 12 days2 days 12 days 1 day
TestAcquisition 
Training
Magazine 
Training
CRF
Training
RI30 s 
Training
1 day 1 day
Extinction 
Test
Reinforcer 
Only Test
Reacq. 
Training 
2
Reversal 
Phase 1
Reversal 
Phase 2
158 
exposed rats) were trained to collect the food pellet reward on day one and the sucrose solution 
reward on day two, while the other half were trained in the reverse order.  Rewards were delivered on 
a random time (RT) 60s schedule and sessions finished once 20 rewards had been delivered.   
Lever-press training.  Rats were initially trained to lever press on a continuous reinforcement 
(CRF) schedule, where each lever press led to reward delivery.  Half the rats were trained on the left 
lever on day one and the right lever on day two.  The other half was trained on the right lever on day 
one and the left lever on day two.  For each day, the appropriate lever was inserted into the chamber 
at the start of the session, and retracted at the end of the session.  Lever presses were reinforced 
with pellet and sucrose rewards at equal probability.  The session ended once the rats had received 
40 rewards.  
Across the next two days, lever presses were reinforced on a RI30 s schedule.  Rats were 
trained in the same order as CRF training.  That is, rats trained on the left first and right lever second 
on the CRF schedule also received training on the left lever first and right lever second during the 
RI30s stage.  Again, food pellets and sucrose solution were rewarded with equal probability and 
sessions finished once 40 rewards had been earned.  Additional training, where necessary, was given 
to overcome any lever biases displayed by the rats.   
Discrimination Training.  Instrumental training of the conditional discrimination occurred 
across twelve days; until the rats performed the task with discrimination ratios consistently above .70 
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(see section 4.4.4 for the calculation of discrimination ratios).  Each daily session lasted 48 min and 
consisted of sixteen 3 min presentations of the auditory stimuli.  Therefore, rats experienced eight 
presentations of the 3 kHz tone and eight presentations of the 10 Hz train of clicks during each 
session.  The identity of the first stimulus was randomly allocated, and stimulus identity was then 
strictly alternated thereafter.  Illumination of the house light signaled the active session.  Throughout 
the session, both levers were inserted into the instrumental chamber but only one lever was 
reinforced during the presentation of each stimulus.  That is, during the presentation of the tone, 
pressing the left lever may have been reinforced while the right lever would be non-reinforced.  
Similarly, during the presentation of the train of clicks, pressing the right lever may have been 
reinforced while the left lever would be non-reinforced.  Appropriate lever press responses were 
reinforced on a RI30s schedule.  Before acquisition training, rats were divided into two groups, 
differential vs. non-differential, with equal numbers of MAM-exposed, saline-exposed and non-
exposed rats in each.  Training was identical across the two groups except the stimulus-outcome 
contingencies (See Table 8).  For rats trained under the differential condition, an appropriate lever 
press was reliably followed by a reward of specific identity.  For example, an appropriate lever press 
(e.g. left) in the presence of the tone stimulus would be consistently followed by the pellet reward, 
whereas an appropriate lever press (e.g. right) in the presence of the click stimulus would be 
consistently followed by the liquid sucrose reward.  In contrast, rats trained under the non-differential 
conditions would receive each reward identity (pellet and sucrose rewards) at equal probability after 
each appropriate lever press.  The conditions were fully counterbalanced: For example, during the 
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presentation of the tone half of the rats would need to press the left lever and half the right lever as 
the appropriate response; similarly, for the differential group, an appropriate response during the tone 
stimulus was reinforced by a food pellet for half of the rats and by the delivery of sucrose solution for 
the other half.
Table 8 Stimulus-outcome contingencies for the Differential and Non-differential groups across acquisition training of the 
continuous performance conditional discrimination. 
Group Stimulus 1 Stimulus 2
Differential R1 → O1 R1 →ØR2 →Ø R2 → O2
Non-Differential R1 → O1/O2 R1 →ØR2 →Ø R2 → O1/O2
Stimulus 1 and 2 represent the tone and click stimuli; ‘R’ represents lever press responses (left vs. right); ‘O’ represents 
rewards (pellet vs. sucrose); Ø represents ‘no reward’.
Extinction test.  The extinction test was performed twenty-four hours after the last day of 
training.  Rats underwent a 48 min session similar to a training day, except that reinforcers were 
omitted for duration of the session.  The purpose of this test was to ensure that the rats had learnt to 
solve the discrimination based on the auditory stimuli and were not relying on the presentation of the 
rewards alone to direct their responding.  If discriminative performance was based on the auditory 
cues, differential responding should be maintained in this extinction test.
Reinforcer only test.  The reinforcer only test was carried out twenty-four hours after 
reacquisition training (which occurred the day after the extinction test).  Parameters were again the 
same as during the training phase, with the exception that the auditory stimuli were omitted for the 
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duration of the session.  The purpose of this test was to determine whether the animals could use the 
rewards themselves as discriminative stimuli. Indeed, it is possible that rats trained under differential 
conditions, but not under non-differential conditions, could use reward identity to indicate which lever 
press response to make through the formation of back-associations (O-R).  If animals were using this 
cue to solve the original discrimination, performance would be maintained in this reinforcer-only test 
but decline to chance levels in the extinction test.
Reversal Training.  During reversal training the opposite stimulus-response contingencies 
were given to all rats.  For example, rats which had received a sucrose reward after pressing the left
lever in the presence of a tone and a pellet reward after pressing the right lever in the presence of a 
clicker would now receive a sucrose reward after pressing the right lever in the presence of a tone 
and a pellet reward after pressing the left lever in the presence of a clicker.  After twelve days of 
reversal training (first reversal), stimulus-response pairings were reversed back to the original 
contingencies (second reversal).  Training then continued for an additional twelve days. 
4.5.4 Data analysis 
For all analysis, correct and incorrect lever press responses were converted into 
discrimination ratios, calculated as mean number of correct responses in a session/ mean number of 
correct plus mean number of incorrect responses.  Discrimination ratios were used to counteract the 
higher overall response rates displayed by MAM-treated animals compared to the other treatment 
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groups.  Data were analysed via a three-way ANOVA with factors of session (days 1 – 12), treatment 
(saline-treated, non-exposed and MAM-treated) and group (differential vs. non-differential).   
4.6 Results 
Acquisition of the conditional discrimination.  Discrimination ratios for saline-treated, non-
exposed and MAM-treated rats during acquisition of the conditional discrimination are displayed in 
Figure 15, panels A, B and C, respectively.  Generally, the discrimination ratio was higher for the 
differential than non-differential groups across all treatment conditions, indicative of a differential 
outcomes effect.  A three-way ANOVA with factors of session, treatment and group revealed a main 
effect of session (F (4.978, 209.056) = 171.740, p < .001, MSE = .461) a main effect of group (F (1, 
42) = 5.982, p = .019, MSE = .078) but no session × group interaction (F < 1).  There was no main 
effect of treatment (F < 1), no treatment × group interaction (F < 1) and no session × treatment ×
group interaction (F (22, 462) = 1.201, p = .241, MSE = .001).  A main effect of group without 
interactions with treatment indicates that a differential outcomes effect was established for saline-
treated, non-exposed and, importantly, MAM-treated animals.
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Figure 15 Discrimination ratios (Mean number of correct responses/Total number of responses) across acquisition training 
of the conditional discrimination: saline-treated rats (Panel A), non-exposed (Panel B) and MAM-treated rats (Panel C).  
Open symbols indicate the Non-Differential group; filled symbols indicate the Differential group.  Error bars represent ± 
SEM. 
A
B
C
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 Extinction test.  Figure 16 shows the mean discrimination ratios for the 48 min extinction test.  
All groups maintained the discrimination: 95% CI, Sham Non-differential (.63 - .72); Sham Differential 
(.63 - .72); Non-Exposed Non-differential (.65 - .74); Non-Exposed Differential (.67 - .76); MAM Non-
differential (.59 - .68); MAM Differential (.67 - .76).  This suggests that the rats had learnt the 
discrimination based on environmental cues (tones and clicks) and not merely by the cues supplied 
on the delivery of the rewards.  A between-subject ANOVA of the data summarised in Figure 16 with 
factors of treatment and group revealed no main effect of treatment (F (2, 42) = 1.392, p = .260, MSE
= .006), no main effect of group (F (1, 42) 3.505, p = .068, MSE = .014) and no significant interaction 
between these two factors (F (2, 42) = 1.898, p = .163, MSE = .008).  
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Figure 16 Discrimination ratios during the extinction test for saline-treated, non-exposed and MAM-treated rats.  White 
bars represent the Non-Differential group; Grey bars represent the Differential group.  Error bars represent ± SEM.
Reinforcer Only Test.  Figure 17 shows the discrimination ratios for the 48 min reinforcer only 
test.  All rats showed discrimination ratios above 0.50 (95% CI, Sham Non-differential (.58 - .63); 
Sham Differential (.57 - .61); Non-Exposed Non-differential (.55 - .60); Non-Exposed Differential (.60 - 
.65); MAM Non-differential (.56 - .60); MAM Differential (.61 - .66)).  This suggests that presentation of 
the reinforcer alone could serve as a cue to control performance, presumably with the rats adopting a 
win-stay strategy whereby they would continue to respond on the same lever once they had received 
a reward, combined with a contribution of O-R associations in the differential conditions.  An ANOVA 
performed on the data summarised in Figure 17 revealed a main effect of group (F (1, 42) = 9.546, p
= .004, MSE .011), no main effect of treatment (F < 1) and a treatment × group interaction (F (2, 42) = 
4.663, p = .015, MSE = .005).  Further analysis of this interaction revealed significantly better 
performance for rats in the differential compared to non-differential group for both non-exposed (F (1, 
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42) = 8.338, p = .006, MSE = .010) and MAM-treated animals (F (1, 42) = 9.989, p = .003, MSE = 
.012).  No difference in performance was seen for differential and non-differential groups for the 
saline-treated control animals (F < 1). 
Figure 17 Discrimination ratios for the reinforcer-only test for saline-treated, non-exposed and MAM-treated rats.  White 
bars represent the Non-Differential group; Grey bars represent the Differential group.  Error bars represent + SEM.
Reversal Phase.  After extinction and reinforcer only tests, all rats underwent additional 
training (one day of reacquisition training with inclusion of both auditory stimuli and reinforcers). 
Subsequently the response outcome contingencies were reversed for each rat.  Figure 18 shows the 
discrimination ratios during the acquisition of the first reversal phase of the experiment.  Early in 
training, rats demonstrated more responding on the previously correct/now incorrect lever.  Higher 
discrimination ratios for rats in the differential compared to non-differential group is suggestive of a 
differential outcomes effect.  ANOVA analysis with factors of session, treatment and group was 
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consistent with this impression revealing a significant main effect of session (F (3.426, 143.874) = 
212.835, p <.001, MSE = .901), and a main effect of group (F (1, 42) = 11.111, p = .002, MSE = .144).  
There was also a session × group interaction (F (11, 462) = 12.956, p < .001, MSE = .017), further 
analysis of which revealed that rats in the non-differential group outperformed rats in the differential 
group for session one (F (1, 42) = 12.088, p = .001, MSE = .025) with the reverse pattern seen (with 
rats in the differential group outperforming rats in the non-differential group) for sessions 5 through to 
12 (smallest F (1, 42) = 6.774, p = .013, MSE = .024 – session 12).  The ANOVA also revealed a main 
effect of treatment (F (2, 42) = 6.183, p = .004, MSE = .080) with MAM-treated rats displaying 
significantly higher discrimination ratios than their saline-treated (F (1, 42) = 7.610, p = .008, MSE = 
.000) and non-exposed counterparts (F (1, 42) = 10.731, p = .002, MSE = .000).  There was no 
treatment × group interaction (F (2, 42) = 2.012, p = .146, MSE = .026), treatment × session 
interaction (F (22, 462) = 1.371, p = .122, MSE = .002), nor session × treatment × group interaction (F
(22, 462) = 1.426, p = .096, MSE = .002).  Higher overall discrimination ratios for MAM-treated rats, 
together with the presence of a differential outcomes effect during the reversal phase, provides no 
evidence of impairment in these animals.  
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Figure 18 Discrimination ratios for saline-treated (Panel A), non-exposed (Panel B) and MAM-treated (Panel C) rats for the 
first reversal phase.  Open symbols indicate the Non-Differential group; filled symbols indicate the Differential group.  Error 
bars represent ± SEM. 
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Figure 19 shows the discrimination ratios for saline-treated, non-exposed and MAM-treated 
rats for the second reversal phase of the experiment, where response-reward contingencies were the 
same as original acquisition.  An ANOVA was performed with variables of session, treatment and 
group.  This revealed a main effect of session (F (4.372, 183.603) = 138.534, p < .001, MSE = .434), 
a main effect of treatment (F (2, 42) = 4.293, p = .020, MSE = .095) but no session × treatment 
interaction (F < 1).  Simple effects analysis revealed that MAM-treated animals had significantly 
higher discrimination ratios compared to their non-exposed controls (F (1, 42) = 8.218, p = .007, MSE
= .0002), but non-significantly higher ratios compared to their saline-treated controls (F (1, 42) = 
4.000, p = .056, MSE = .0002).  No significant difference in performance was seen between the two 
control groups (F < 1). The ANOVA analysis also revealed a main effect of group (F (1, 42) = 26.303, 
p < .001, MSE = .580), with rats in the differential group outperforming those in the non-differential 
group, as well as a session × group interaction (F (11, 462) = 16.656, p < .001; MSE = .021).  No 
treatment × group interaction (F < 1) nor session × treatment × group interaction (F < 1) was yeilded 
by the analysis.   
Further analysis of the session × group interaction revealed higher discrimination ratios for 
non-differential compared to differential groups for session one (F (1, 42) = 14.184, p = .001; MSE = 
.025).  This pattern quickly reversed and stayed reversed (with the differential group outperforming 
the non-differential group) from session 3 onwards (smallest F (1, 42) = 9.415, p = .004, MSE = .022 –
session 3).  
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Figure 19 Discrimination Ratios for saline-treated, non-exposed and MAM-treated rats during reversal phase two.  Open 
symbols indicate the Non-Differential group; filled symbols indicate the Differential group.  Error bars represent ± SEM.
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4.7 Summary 
 Rats trained on a conditional discrimination showed better performance when given stimulus-
correlated outcomes (the differential outcomes group) compared to rats for which the outcomes were 
not correlated with the stimuli (the non-differential outcomes group), regardless of prenatal treatment.  
This differential outcomes effect, which could not be explained purely on the basis of backward 
associations formed between the outcome and the response (O-R), demonstrates that rats prenatally 
exposed to MAM are able to use specific anticipatory reward information to guide their instrumental 
choice behaviour.  No deficits were seen during either reversal phase of the task.  Consistent with 
results from Experiment four, this demonstrates that these animals are sensitive to changes in action-
outcome (A-O) contingency.  
 Based on the observations that MAM rats are marginally more sensitive to outcome 
devaluation (Experiment four) and demonstrate higher discrimination ratios during the reversal of a 
conditional discrimination, Experiment six aimed to determine whether or not the behaviour of these 
animals is less sensitive to the effects of overtraining.  Whilst this would be inconsistent with the 
schizophrenia phenotype, lack of specificity of prenatal MAM treatment could mean that the structural 
abnormalities present may actually block habit formation - as is the case for rats with lesions of the 
infralimbic PFC (Killcross & Coutureau, 2003) and dorsolateral striatum (Yin et al., 2004).  Previous 
studies have shown that typically nine to ten sessions (with 360-400 reinforced responses) promotes 
habitual performance in untreated animals, indexed by a lack of sensitivity of the instrumental 
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response to reward devaluation (e.g. Powell, 2013; Wickens et al., 2007).  Nine days training was 
used in the current experiment. 
4.8 Experiment 6 - Materials and Methods 
4.8.1 Subjects and Apparatus 
 Cohort three (16 Saline-treated, 16 non-exposed and 16 MAM-treated rats) was used for 
Experiment five (please refer to Appendix A for the timing of this experiment).  Rats were 
approximately 16 weeks old at the start of the experiment.  Ad libitum weights were as follows: saline 
treated, 345 – 437 g; non-exposed, 329 – 483 g; MAM-treated, 289 – 430 g.  Rats were placed on a 
food restricted diet prior to the start of the experiment to reduce them to 85% of their free-feeding 
weights.  Moderate weight gain was allowed over the course of the experiment.  For all aspects of 
animal husbandry, please see Experiment two (section 3.2.1).The training apparatus was as 
described in Experiment four (section 4.1.2). 
4.8.2 Procedure 
 As in Experiment four, training consisted of two stages: magazine training and lever-press 
training. This was followed by an extinction test after devaluation of the instrumental reward by 
lithium-chloride (LiCl)-induced nausea (see Figure 20).  Each rat was assigned to one of the eight 
experimental chambers, and thereafter always trained in the same chamber. 
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Magazine training.  All rats were trained to collect food rewards during a single magazine 
training session.  45 mg sucrose pellets (Test Diet, Richmond, IN) were delivered on a RT60s 
schedule.  The session ended once 20 pellets had been delivered.  Rats that did not collect the food 
were given a repeat of the session later the same day.
Lever-press training.  The next day, a single session of lever press training was given during 
which sucrose pellets were delivered on a CRF schedule of reinforcement.  The left lever was 
inserted into the chamber at the start of the session and retracted at the end of the session.  The 
session ended once the rat had earned 20 reinforcers.  Subsequently, animals underwent nine days 
training on a RI30s schedule of reinforcement.  Sessions ended once rats had earned 40 reinforcers.   
Devaluation by LiCl.  After the last day of training, all rats were given free access to sucrose 
pellets for 30 min in individual test cages (as described for Experiment four).  Once 30 minutes had 
past, the devalued group (8 MAM-Exposed, 8 Sham and 8 Non-exposed) received intraperitoneal 
injections of 0.15 M, 15ml/kg LiCl solution (Sigma-Aldrich).  The non-devalued group (8 MAM-
Figure 20 Schematic depicting the Outcome Devaluation Task with extended training. EXT = Extinction test;
CT = Consumption Test and RT = Reacquisition Test.
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Exposed, 8 Sham and 8 Non-exposed) were given intraperitoneal injections of the equivalent volume 
of 0.9% saline.  Animals were matched according to lever press levels during the final day (day nine) 
of acquisition to determine their devaluation group.  Outcome-LiCl/Saline pairings were repeated 
across two conditioning days.  Twenty-four hours after the second conditioning day, the animals’ 
sensitivity to outcome devaluation was assessed by a 10 min extinction test.  Here, rats were given 
the opportunity to lever press but no rewards were available. 
Consumption test and Reacquisition test.  Immediately after the extinction session, all rats 
underwent a consumption test to ensure that the devalued group had acquired an aversion to the 
instrumental outcome.  This was followed twenty-four hours later by a reacquisition test.  Both tests 
were conducted as previously described in Experiment four.
4.8.3 Data analysis 
 Statistical analysis was performed with a repeated measures ANOVA with within-subject 
factor of time bin (five 2 min bins) and between-subject factors of treatment (saline-treated, non-
exposed and MAM treated) and devaluation condition (devalued vs. valued).  Lever presses and 
magazine entries per minute were calculated as a proportion of baseline.  Baseline was taken as the 
data from the final day (day nine) of acquisition.  Using the data averaged across the final three days 
of acquisition (days seven – nine) did not affect the statistical outcome.  It should be noted that bin 
was included in the analysis here, unlike for previous and subsequent outcome devaluation 
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experiments, due to the suggestion of a devaluation effect, seemingly during the middle of the 
extinction test.  To not include ‘bin’ in the analysis may have excluded potential significant results.  It 
should be highlighted that the factor of bin did not interact with any other factor for the other outcome 
devaluation experiments reported in this thesis. 
4.9 Results 
 Instrumental training.  At the end of training, rats prenatally exposed to MAM performed more 
lever press responses than both saline-treated and non-exposed control animals (See Table 9).  
Importantly, there appeared to be no difference in baseline lever press responses as a function of 
devaluation condition for any treatment group.  
Consistent with the overall impression, ANOVA revealed a main effect of treatment (F (2, 42) 
= 3.763, p = .031, MSE = 978.897).  Importantly, valued and to-be-devalued groups responded at a 
similar level as there was no main effect of devaluation condition (F < 1) and no treatment ×
devaluation condition interaction (F < 1).
Table 9 Lever press response per minute for day 9 of acquisition training (used as ‘baseline’). 
Treatment Devaluation Condition
Mean lever press/min (± 
SEM)
Saline-treated Valued 30.516(± 3.268)
Devalued 30.920(± 3.633)
Non-exposed Valued 37.123(± 3.733)
Devalued 33.923(± 4.276)
MAM-treated Valued 48.566(± 4.706)
Devalued 43.461(± 3.991)
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Magazine approach behaviour appeared to be similar across all treatment groups and 
devaluation conditions at the end acquisition training (See Table 10).  ANOVA showed no main effect 
of treatment (F < 1), no main effect of devaluation condition (F (1, 42) = 1.083, p = .304, MSE = 
48.758) and no treatment × devaluation condition interaction (F (2, 42) = 1.332, p = .275, MSE = 
266.524).
Table 10 Magazine approach performance per minute for day 9 of acquisition training (used as ‘baseline’).
Treatment Devaluation Condition
Mean lever press/min (± 
SEM)
Saline-treated Valued 14.693(±2.536)
Devalued 17.803(± 2.773)
Non-exposed Valued 17.816(± 2.581)
Devalued 16.092(± 2.822)
MAM-treated Valued 12.097(± 2.343)
Devalued 16.759(± 2.372)
Extinction – Lever Press Performance.  The mean lever press response rates as a proportion 
of baseline across five 2 min bins for the extinction test are displayed in Figure 21 panels A – C.  
Inspection of this figure shows that performance of saline-treated rats (Panel A) and MAM-treated rats 
(Panel C) appeared, to some extent, to be sensitive to the current value of the goal.  That is, saline-
treated and MAM-treated animals performed fewer lever presses as a proportion of their baseline 
rates after the outcome had been paired with LiCl-induced nausea  (devalued – closed symbols) 
compared to those animals that had not received this pairing (valued – open symbols).  In contrast, 
non-exposed animals (Panel B) responded on the lever at equivalent rates regardless of whether the 
outcome had been devalued.   
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Statistical analysis was performed by repeated-measures ANOVA with a within-subject factor 
of bin (1-5) and between-subject factors of prenatal treatment (saline-treated, non-exposed and MAM-
treated) and devaluation condition (valued vs. devalued).  This yielded a main effect of bin (F (2.932, 
123.148) = 14.633, p < .001, MSE = .838), no main effect of devaluation condition (F < 1) but a bin × 
devaluation condition interaction (F (4, 168) = 4.900, p = .001, MSE = .206).  There was no main 
effect of prenatal treatment (F < 1) and no significant interactions between treatment and any other 
factor: critically, bin × treatment, F (8, 168) = 1.392, p = .203, MSE = .058; treatment × devaluation 
condition, F < 1; bin × treatment × devaluation condition, F < 1.  
Pairwise comparisons of the bin × devaluation condition interaction revealed significantly 
higher lever press response rates for rats in the valued group compared to rats in the devalued group 
for bins 3 and 4 (smallest F (1, 42) = 5.568, p = .023, MSE = .363).  After this level of training, it would 
be expected that rats would be insensitive to post-conditioning changes in outcome value.  That is, 
their behaviour would be habitual and lever press responses would be equivalent across valued and 
devalued groups.  The suppressed responding after devaluation treatment is instead indicative of 
goal-directed behaviour.   
Although there was no significant interaction between prenatal treatment and the effect of 
devaluation (nor between the factors of bin, treatment and devaluation), inspection of Figure 21 hints 
that goal-directed behaviour was not necessarily present in all treatment groups.  In fact, when 
examined separately, neither the main effect of devaluation, nor the bin × devaluation condition 
interaction was significant in any individual group: Saline-treated animals, condition, F < 1, bin ×
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condition, F (4, 56) = 2.373, p = .063, MSE = .145; Non-exposed animals, condition, F < 1, bin ×
condition, F (4, 56) = 1.064, p = .383, MSE = .028; MAM-treated animals, condition, F (1, 14) = 1.233, 
p = .286, MSE = .525, bin × condition, F (4, 56) = 1.793, p = .143, MSE = .070.  Thus, although there 
was a hint of goal-directed behaviour in some time-bins when the data was collapsed across all 
treatment groups, there was no support for this being selective to any individual group (or indeed, no 
support for it being present in any individual group). 
Extinction – Magazine Approach Behaviour.  Magazine approach behaviour for the extinction 
test is displayed in Figure 22.  As ANOVA revealed no main effect of bin (F (1.855, 77.906) = 1.713, p
= .189, MSE = .567) or interaction between bin and any other factor (All Fs < 1), the data in Figure 22 
is summarised as mean responses per minute (as a proportion of baseline responding) collapsed 
across the 10 min session.  ANOVA results revealed no main effect of treatment (F < 1), a significant 
main effect of devaluation condition (F (1, 42) = 5.150, p = .028, MSE = 1.358), with rats nose-poking 
more in the valued than devalued group, and no treatment × devaluation condition interaction (F (2, 
42) = 2.704, p = .079, MSE = .713).  
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Figure 21 Mean Lever Press responses as a proportion of baseline responding across the 10 min extinction test, separated 
into 2 min bins, for saline-treated control (Panel A), non-exposed control (Panel B) and MAM-treated experimental rats 
(Panel C).  Open symbols represent responding for the valued group, filled symbols represent responding for the devalued 
group, which had received taste-aversion conditioning.  Error bars represent ± SEM.   
A
B
C
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Figure 22 Magazine approach behaviour as a proportion of baseline responding across the 10 min extinction test for saline-
treated, non-exposed and MAM-treated rats.  Error bars represent ± SEM.
Outcome Devaluation.  Figure 23 shows the consumption of the instrumental outcome across 
the taste-aversion conditioning sessions and test (which immediately followed the extinction test).  
Inspection of the figure suggests that effective taste aversion was acquired by all three treatment 
groups.  Rats in the devalued group exhibited a strong aversion to the instrumental outcome while 
rats in the valued group (where the outcome had been paired with saline) continued to consume the 
outcome across sessions.  An ANOVA was performed with factors of session (conditioning day one, 
two and test), treatment and devaluation condition (valued vs. devalued).  The ANOVA revealed a 
significant main effect of session (F (2, 84) = 186.429, p <.001, MSE = 710.167), a significant effect of 
devaluation condition (F (1, 42) = 84.864, p < .001, MSE = 637.142) and a significant session × 
condition interaction (F (2, 84) = 50.919, p < .001, MSE = 193.968).  There was no main effect of 
treatment (F < 1), nor was there an interaction between treatment and any other factor: treatment × 
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
Saline- NON- MAM-
M
ag
az
in
e 
Ap
pr
oa
ch
es
 a
s a
 
pr
op
or
tio
n 
of
 b
as
el
in
e
Valued
Devalued
181 
devaluation condition, F < 1; session × treatment, F (4, 84) = 1.913, p = .116, MSE = 7.287; session × 
treatment × devaluation condition (F (4, 84) = 1.84, p = .134, MSE = 6.909).
Figure 23 Mean sucrose pellet consumption (± SEM) over two days of taste aversion training and one post-extinction 
consumption test for saline-treated, non-exposed and MAM-treated rats.  Rats received LiCl injections (devalued – open 
symbols) or saline injections (valued – filled symbols) after 30 min free access to the instrumental outcome.  The test phase 
also took place in a 30 min period immediately after the 10 min extinction test.   
Reacquisition test – Lever Press Performance.  The reacquisition test was performed twenty-
four hours after the extinction test.  The data for lever press performance and magazine entries are 
displayed as responses per min in Figure 24 panels A and B, respectively.  An ANOVA was 
performed on the data summarised in Figure 24A and included factors of treatment and devaluation 
condition.  This revealed a significant main effect of prenatal treatment (F (2, 42) = 5.443, p = .008, 
MSE = 665.712) with MAM-treated rats performing significantly more lever presses than both saline 
treated (F (1, 42) = 9.631, p = .003, MSE = 15.288) and non-exposed rats (F (1, 42) = 6.360, p = .016, 
MSE = 15.288).  There was also a main effect of devaluation condition (F (1, 42) = 30.938, p < .001, 
MSE = 3783.640) but no treatment × condition interaction (F (2, 42) = 1.100, p = .342, MSE = 
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134.584).  ANOVA analysis on magazine approach behaviour did not reveal a significant main effect 
of treatment (F < 1).  There was a main effect of devaluation condition (F (1, 42) = 10.540, p = .002, 
MSE = 193.181) but no treatment × condition interaction (F (2, 42) = 2.703, p = .079, MSE = 49.541).  
Figure 24 Effect of prenatal treatment on lever press performance (Panel A) and magazine approach behaviour (Panel B) 
during reacquisition after reward devaluation by LiCl-induced nausea.  Mean lever presses and magazine entries per 
minute (± SEM) in the rewarded reacquisition test after devaluation with LiCl (grey bars) or no devaluation (white bars) are 
shown.  The reacquisition test was given 24 hrs after the extinction and consumption tests.
A
B
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4.10 Summary 
 After extended training of an instrumental response, the control of behaviour usually becomes 
dominated by reflexive stimulus-response associations, as indexed by performance insensitivity to 
manipulations of outcome value.  The current results are somewhat equivocal with some hint that 
MAM-exposed rats may maintain goal sensitivity after extended training, but with the interpretation 
obscured by a similar finding in saline-treated rats.  The results of the current experiment would need 
to be repeated before any firm conclusions can be drawn regarding the reward encoding deficit, or 
lack thereof, in the MAM neurodevelopmental model of schizophrenia.  All that can be said at this 
stage is that MAM rats are capable to forming mental representations of outcome value and using 
these representations to both motivate and direct behaviour.  Whether a deficit lies with the transition 
to habitual behaviour remains unclear.  That said, cognitive, as opposed to reflexive, behavioural 
control in this model may go some way towards explaining the superior performance of MAM-treated 
rats during reversal learning. 
4.11 Validation of Cohorts one, two and three 
 The three cohorts presented across Chapters three and four underwent additional analyses to 
validate the effectiveness of MAM treatment on GD17.  Cohort one was challenged with the 
psychostimulant MK-801 (an NMDA-R antagonist) and the subsequent enhancement of 
hyperlocomotion caused by prenatal MAM treatment was recorded.  Hypersensitivity to the locomotor 
enhancing effects of this drug has been found to be a robust finding  for the MAM model (e.g. Le Pen 
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et al., 2006; 2011).  The full details of the apparatus, experimental protocol and results can be found 
in Appendix B of this thesis.  MK-801 produced higher locomotor activity in MAM-treated rats 
compared to their saline-treated controls. 
 For each of the three cohorts, brains were extracted and their wet weights recorded.  
Evidence suggests that rats prenatally treated with MAM display an approximate 11% decrease in 
total brain weight (Flagstad et al., 2004).  Reductions of 12.39%, 11.66% and 12.21% were found for 
absolute brain weights for cohorts one, two and three, respectively.  Please refer to Appendix B 
further details. 
4.12 Discussion of Chapters 3 and 4 
 Disruption of neurogenesis by MAM on gestational day 17 has been suggested to be a 
comprehensive rodent model of schizophrenia, producing a schizophrenia-like pattern of 
pathophysiological abnormalities and a range of behavioural alterations reminiscent of the positive, 
cognitive and negative symptoms of the disease (e.g. Jones et al., 2011).  However, despite these 
claims, the MAM GD17 model has not undergone robust behavioural characterisation, particularly 
with regard to the negative symptom cluster.  This is a neglect that the current thesis aimed to 
address.   
 Chapter three investigated the presence of hedonic deficits in the MAM GD17 model.  When 
exposed to three different concentrations of sucrose solution, prenatal MAM treatment did not affect 
reward value, as evidence by similar consumption and palatability responses by MAM and saline-
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treated animals.  This demonstrates that during reward consumption, MAM-exposed rats do not 
display a hedonic deficit.  This result is consistent with the normal hedonic capacity to emotional 
stimuli that is often reported in the schizophrenia literature.  Of direct relevance to the current results, 
Berlin et al (1998) found equivalent hedonic responses to a sucrose solution between schizophrenia 
patients and healthy volunteers, as assessed by a sweetness rating scale.  Similar results to sweet 
solutions have also been demonstrated by Berenbaum and Oltmanns (1992), despite schizophrenia 
patients displaying affective flattening to positively-valenced stimuli, while Horan et al (2006b) found 
in-the-moment pleasure for pleasant foods to be intact in schizophrenia. 
 If the actual consummatory pleasure experienced from a reward is intact, then a critical deficit 
may lie with anticipating hedonic consequences from future rewarding events.  Therefore, Experiment 
three investigated the occurrence of anticipatory anhedonia in the MAM model by examining the 
development of negative anticipatory contrast.  Regardless of prenatal treatment, all animals acquired 
a strong contrast effect across training.  This was indicated by the lower consumption and lick cluster 
size measures associated with the initial 4% sucrose solution when it was consistently followed by a 
more palatable 32% sucrose solution.  Whilst these results are consistent with Experiment one (i.e. 
the first solutions' perceived palatability is reduced when it is followed by a solution of higher hedonic 
value), no evidence was provided for an anticipatory hedonic deficit in the MAM model of 
schizophrenia.  Whilst some studies have found increased anticipatory anhedonia in schizophrenia 
patients (Gard et al., 2007), others have found normal (or even increased) anticipatory hedonic 
behaviour (e.g. Gard, Sanchez, Cooper, FIsher, Garrett, Coleman & Vinogradov, 2014; Strauss et al., 
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2011).  As such, the results reported here may highlight either a shortcoming of prenatal MAM 
treatment as a model of negative symptomatology, or an absence of anhedonia as a primary feature 
of schizophrenia.  
 Chapter four investigated whether the MAM-exposed rats can use reward values to guide 
action selection.  In Experiment four, rats were trained to lever press for a reward for three days on a 
random interval schedule of reinforcement.  This level of training was selected because it maintains 
goal-directed behaviour in healthy, untreated animals but is sufficient to push instrumental responding 
towards habitual systems in amphetamine-treated rats (Nelson & Killcross, 2006).  Similarly, rats with 
prefrontal lesions have shown habitual responding after minimal levels of training (e.g. Killcross & 
Couturea, 2003).  However, in the current experiment it was found that rats prenatally exposed to 
MAM in the devalued group (i.e. where the outcome had been paired with LiCl-induced nausea) 
reduced their lever press behaviour relative to rats in the valued group (i.e. where the rats had not 
been averted to the outcome), consistent with goal-directed responding.  This demonstrates that 
MAM-treated rats can alter their behaviour based on changes in outcome value even when that 
outcome is not present at the time of responding.  Moreover, there was even a suggestion that MAM-
treated animals showed a trend towards greater sensitivity to outcome devaluation than the control 
group. 
 Experiment five further investigated reward value representations for the MAM-model using 
the differential outcomes procedure.  MAM rats demonstrated superior performance when trained on 
stimulus-correlated outcomes (e.g. the differential group), compared to uncorrelated outcomes (e.g. 
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the non-differential group), consistent with the differential outcomes effect.  This demonstrates that 
MAM-treated animals can include a representation of the outcome as part of the learning matrix, but 
more precisely that they can use the specific sensory information regarding the identity of different 
rewards to direct their choice behaviour.  The results of Experiments four and five combined highlight 
that the MAM model may not incorporate the problems seen with value representation in 
schizophrenia patients.  The inability of this prenatal MAM treatment to comprehensively model the 
negative symptoms of schizophrenia will be considered in the general discussion. 
 Many studies have shown that when contingencies are reversed, people suffering from 
schizophrenia show significant impairments (Murray, Cheng, Clark et al., 2008; Waltz & Gold, 2007).  
Similar results have also been seen for MAM-treated animals (Featherstone et al., 2007; Flagstad, 
Glenthøj & Didriksen, 2005; Gastambide, et al., 2012; Moore et al., 2006).  However, when the 
instrumental contingencies were reversed in Experiment five, MAM rats outperformed control animals 
with higher overall discrimination ratios.  This result, together with the findings from Experiment four, 
raises the possibility that the MAM rats in the current investigation may rely more on A-O associations 
than their controls.   
 Investigating this possibility in Experiment six did not provide conclusive evidence for 
impaired habit transition in MAM treated animals.  Indeed, whilst there was a hint towards continued 
goal-directed behaviour after extended training in MAM-treated rats, a similar pattern of results was 
seen for saline-treated rats.  This may suggest that saline-treated animals are perhaps not the most 
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appropriate control for the MAM model and highlights the importance of including an additional non-
exposed group in future experiments.   
 In summary, the experiments reported in Chapters three and four provide no evidence for 
behavioural impairments in MAM-treated rats reminiscent of either the negative or cognitive 
symptoms of the disease.  Importantly, it is highly unlikely that the lack of behavioural impairments 
reported can be attributed to ineffective MAM treatment.  Not only were multiple litters included in 
each cohort, but multiple cohorts were often run through the same experiment.  As reported in the 
results sections of Chapters three and four, there were no cases where 'cohort' significantly altered 
the results to question their interpretation.  The lack of behavioural impairments reported in my 
experiments also occurred despite reduced brain weights for each MAM-cohort compared to their 
control animals (Please refer to Appendix B).  Furthermore, I found a lack of deficits for cohort one 
(included in Experiments two and four of this thesis), despite the same animals showing enhancement 
of MK-801 induced hyperlocomotion.  
 While the current results certainly suggest that MAM-treated animals do not show either 
hedonic or reward-processing deficits, such a conclusion relies on the adequacy of the behavioural 
methods.  While the outcome devaluation and DOE methods are relatively well characterised and 
validated in terms of neurobiological manipulations, it is certainly possible that the microstructural 
analysis of licking assay is simply insensitive to changes in hedonic state.  Thus, it would be useful to 
assess the methods against other models of disease characterised by reward-processing 
impairments.  Reward processing deficits feature in depression, and deficits in hedonic capacity in 
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particular are less controversial in this patient group (e.g. it comprises one of two main symptoms 
required for a depression diagnosis).  As Chapters five and six will detail the investigation of the WKY 
inbred depression model, I will postpone further consideration of how the behaviour of MAM-treated 
animals in the hedonic tests used here relates to the clinical presentation of schizophrenia to the 
general discussion.
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Chapter Five 
5. Hedonic Deficits in WKY Rats 
5.1 Introduction 
 Unlike for schizophrenia, where anhedonia is not directly part of the diagnostic criteria, the 
DSM-V criteria for major depression includes a reduction or loss of interest or pleasure in usually 
enjoyable activities in relation to hedonic deficits (American Psychiatric Association, 2013).  As has 
been seen in section 1.2 of this thesis, these criteria present problems in that it assumes equivalence 
between hedonic and motivational capacity, despite these reward processes between subserved by 
distinct neural mechanisms.  Regardless of this issue, the importance of reduced hedonic capacity 
per se in this patient population has been highlighted by both increased self-reports of anhedonia 
(e.g. Berlin et al., 1998; Franken et al., 2007) and a reduction in the pleasure and arousal ratings 
elicited by positive stimuli (e.g. Dunn et al., 2004; Rottenberg et al., 2002; 2004; Sloan et al., 1997). 
 The WKY inbred rat strain is a putative model of depression and comorbid anxiety replicating 
important pathophysiological and behavioural deficits associated with these disorders (e.g. 
Overstreet, 2012).  Some attempts have been made to characterise hedonic deficits in this model, but 
the results have been somewhat ambiguous (see section 1.4.2 of the general introduction).  There is 
some suggestion that, in line with depression in the clinic, the application of an external stressor may 
be necessary for the symptom-like behaviours to manifest.  Therefore, the experiments reported in 
Chapters five and six use a factorial design (i.e. with both stressed and non-stressed conditions for 
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the WKY rats and their controls) to determine stress effects in WKY rats on reward-related 
behaviours.  It should be noted that because WKY rats were originally derived from a Wistar outbred 
strain, Wistar rats are used as the comparison strain for the battery of tests reported here. 
 A subset of stressors used by Willner and colleagues (e.g. Willner, Muscat & Papp, 1992; 
Willner, Towell, Sampson, Sophokleous & Muscat, 1987) were used in the experiments reported here, 
chosen primarily based on their ability to be applied in a semi-random fashion within the constraints of 
the Cardiff University animal unit.  Unlike Willner's work, a forced swim test was also used in the 
current experiments to act both as a stressor and to allow me to assess whether previous reports of 
forced swim test behavioural deficits in the WKY strain are replicable.  Furthermore, unlike for 
Willner's protocol, where stressors are applied daily, a maximum of three stressors were applied per 
week.  In light of this, the current stress protocol may be viewed as marginally less stressful overall 
compared to Willner's design. 
 The first question addressed in relation to the WKY model was whether microstructural 
analysis of licking can detect hedonic impairments (whether inherent or stress-induced) during the 
consumption of palatable solutions.  Referring back to the MAM results in Chapter three, it is possible 
that lick cluster size is somehow insensitive to anhedonia.  In this light, the presence of a hedonic 
deficit in WKY rats would serve as a useful positive control for the MAM results. 
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5. 2 General Methods and Materials 
5.2.1 Subjects 
 Twenty-four male Wistar rats and twenty-four male Wistar Kyoto (WKY) rats were used in the 
experiments reported in Chapters five and six.  Both experimental and control strains were from 
Charles River (UK) breeding stocks and were delivered to Cardiff University at approximately 11 
weeks of age.  On arrival both the Wistars and WKY rats were split in to two weight-matched groups 
of twelve.  Rats in one group were assigned to the ‘No-stress’ condition while rats in the second group 
were assigned to the ‘Stress’ condition (Mean Weights (± SEM): Wistar No-Stress 177.8 g (± 3.9); 
Wistar Stress 182 g (± 6.8); WKY No-stress 182.3 g (± 4.2); WKY Stress 178.4 g (± 7.9)).  No-stress 
rats were housed in pairs and their home cages included standard environmental enrichment (tubes 
and gnawing sticks).  Stress rats were singly housed in a separate room and no environmental 
enrichment was provided.  All other aspects of animal husbandry were kept the same across the two 
groups and were as previously described in Experiment one.  Rats were placed on a food-restricted 
diet to reduce them to 85% of their free feeding weights prior to testing.  Careful monitoring was 
employed throughout to ensure that rat weights, as a percentage of free-feeding weights, did not differ 
significantly between the two strain and stress conditions.
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5.2.2 Stress manipulation 
 Rats in the Stress condition underwent a series of mild social and environmental stressors 
which commenced a week prior to testing.  This continued throughout the course of these 
experiments.  Each week, rats in the stress group were exposed to three of five possible stressors: 
wet bedding, overnight illumination, cage swap with an unfamiliar rat, pair-up with an unfamiliar rat 
and the forced-swim test.  Details of the stress procedures, including their duration, are shown in 
Table 11.  The identity of the stressor was randomly allocated, as was the day on which it was given.  
When stress manipulations were to occur on the same day as an experimental session, the stressor 
was applied after the training or test session had been carried out.  Rats in the No-stress condition 
were gently handled on a daily basis. 
Forced Swim Test. During the forced swim tests, the rats' behaviour was recorded via a 
camcorder mounted above the water cylinders.  Data was scored using a time sampling technique, 
whereby the rats’ predominant behaviour was noted every 2 s across the 120 s test, giving a total of 
60 scores.  Recording commenced as soon as the rats had entered the water.  Their behaviour was 
scored as either ‘Active’, ‘Escape’ or ‘Immobile’.  Active behaviour was recorded when the rat was 
swimming, climbing or diving.  Thus, rats would be considered ‘active’ if they made upward-directed 
movements of the forepaws, horizontal movements across the cylinder (including rapid changes in the 
rat’s direction) or dived to the bottom of the cylinder before resurfacing.  Immobile behaviour was 
recorded if rats were floating in the water without any signs of struggling.  Tiny movements of the back 
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limbs were permitted in this category if they served only to keep the animals head out of the water.  
Escape behaviour was recorded if the rat was able to leave the cylinder.  This would be considered as 
one escape.  For every subsequent 2 s period where the rat was out of the water, an ‘X’ would be 
recorded so that it was not included in subsequent analysis.  Percentage time spent active, immobile 
or escaping was then calculated for each animal.   
 As it was impossible for the primary observer to be blind to the rat strain being scored, a 
single session (n = 24), chosen at random, was re-scored by a secondary observer (who was blind to 
the strain) using the criterion outlined above.  Inter-rater reliability was then assessed for this single 
session via a correlation.  Analysis revealed a strong positive correlation between the two observers 
immobility scores, r (22) = .975, p < .001.  Thus, analysis of the forced swim test could commence 
with the confidence that the observer was not biasing the results.  Immobility data (the main 
parameter of interest) was analysed with a repeated-measures ANOVA with factors of session (1 – 7) 
and strain (Wistar vs. WKY). 
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Table 11 Social and environmental stressors for the stress condition.  Three of the five stressors were randomly applied 
each week in addition to social isolation and unenriched home cages.  Stressor identity and the day that the stressor was 
given were randomly allocated to minimise habituation to the stress procedure over time. 
Stressor Duration Description
Wet Bedding < 4 Hours
Rats were transferred to a different cage where the
sawdust had been dampened with approximately 300 ml
of cold water.
Overnight Illumination Light-dark cycle was temporarily reversed. Thismanipulation was never done on consecutive days.
Cage Swap
The cages of two rats were randomly swapped including
water bottles. Rats remained in the cage of the
unfamiliar rat until their cages were next cleaned
(maximum of 7 days).
Pair-Up < 12 Hours
Rats were paired at random, within their strain, and left
housed together overnight. All pair-ups included a
defending male and an intruder male, as one rat was
placed into the home cage of another instead of into
clean ‘neutral’ home cage. Which rat was to be the
intruder/defending male was randomly allocated. During
food restriction, both of the rat’s food rations were
placed both in the food hopper and inside the cage. *
Forced-Swim Test < 2 Minutes
Rats were carefully lowered into a black container of
water, measuring 33.5 cm by 23 cm (H × D). The
temperature of the water was maintained at 20-22 º C.
To minimize escape, the water surface was kept at 16-
17 cm from the lip of the container. Any rat which
escaped was placed back in the water for a maximum of
four times after which the trial was terminated. As two
rats (1 Wistar and 1 WKY) were run simultaneously in
separate containers, trials were terminated for both rats.
Upon trial termination or once 2-min had elapsed, rats
were removed from the water and carefully dried off
before being replaced in their home cage. Water was
replaced after four rats had been tested.
*Rats were carefully monitored for signs of fighting.  One rat received bite marks after being paired up and so no 
longer underwent this manipulation.
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5.3 Experiment 7 - Materials and Methods 
5.3.1 Apparatus 
 The apparatus used in the consumption experiment was as described for Experiment one, 
Section 2.2.2.  The solutions used were 2%, 8% and 24% sucrose made daily (w/w) with deoinised 
water. 
5.3.2 Procedure 
Pre-training.  The order of the experiments presented here is not the order in which they were 
conducted (please refer to Appendix A for the order of each experiment).  Since rats had already 
undergone anticipatory contrast training involving multiple drinking sessions (reported as Experiment 
eight, Section 5.7), no pre-training or habituation was deemed necessary for these rats for the non-
contrast consumption tests. 
Test.  Rats were given access to one of the three sucrose concentrations which were always 
made available from the left hand side of the drinking chamber.  Each concentration was given for 
three consecutive days and the order of sucrose presentations was counterbalanced so that half of 
the rats received the sucrose in order of increasing concentration (2-8-24) and the other half received 
them in order of decreasing (24-8-2) concentration.  A two-day rest was given before the next 
concentration in the sequence was presented.  All solutions were made available for 10 min each day. 
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5.3.3 Data analysis 
 Data analysis was conducted using the same parameters described for Experiment one 
(Section 2.2.4).  To overcome potential neophobic effects, consumption, LCS and ILI data were 
analysed across the last two days of exposure only for each solution concentration.  One animal (#39, 
a WKY No-stress rat) was excluded from all descriptive and inferential statistics reported.  This was 
due to abnormally high LCSs displayed by this animal, more than 3 standard deviations of the group 
mean.  All other parameters, however, (i.e. ILI and volume/1000 licks) appeared to be within the 
normal range. 
5.4 General Results 
5.4.1 Body Weight and Food Intake 
 Body weight and food rations (i.e. the amount given to rats to maintain them around 85% of 
their free feeding weights) are displayed in Figure 25 panels A and B, respectively.  Body weight was 
recorded at regular intervals (every 2 - 3 days) across the experimental timescale (Experiments seven 
to ten).  The data here represents the averages for the cohort across the four experiments.  Average 
body weight was lower for WKY rats compared to their Wistar counterparts (strain: F (1, 44) = 
11904.686, p < .001, MSE = 4301725.490).  As the food rations were adjusted to maintain a steady 
bodyweight, the application of a chronic mild stress regime did not affect the rats body weight for 
either strain (stress: F (1, 44) = 2.233, p = .142, MSE = 807.014; stress × strain: F < 1).  To maintain 
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these consistent weights across stress conditions, larger food rations were given to rats in the stress 
group (stress: F (1, 44) = 88.386, p < .001, MSE = 62.431).  This was true regardless of strain (stress 
× strain: F < 1).  Overall, however, larger rations were required to maintain Wistar rats at 85% of their 
free-feeding weights compared to WKY rats (strain: F (1, 44) = 65.333, p < .001, MSE = 46.147).
Figure 25 Body weight (Panel A) and food rations (Panel B) for Wistar and WKY rats averaged across Experiments 7-10. 
Food rations were calculated to maintain rats at 85% of their free feeding weights.  Moderate weight gain was allowed 
over the course of each experiment.  Error bars represent ± SEM.
A
B
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5.4.2 Forced Swim Test 
 The percentage time spent immobile for Wistar and WKY strains is displayed in Figure 26.  
As can be observed from this figure, WKY rats spent more time immobile compared to their Wistar 
counterparts across all seven sessions (to see when each forced swim test was performed in relation 
to other experiments, please refer to Appendix C).  Time spent immobile also generally increased 
across sessions, unlike for the Wistar strain.  The ANOVA analysis yielded a main effect of session (F
(3.764, 82.811) = 7.809, p < .001, MSE = 1531.553) and a main effect of strain (F (1, 22) = 161.090, p 
< .001, MSE = 96439.796).  There was also a session × strain interaction (F (6, 132) = 14.532, p < 
.001, MSE = 1788.013), further inspection of which revealed that percentage time spent immobile 
increased across sessions for WKY rats only (F (6, 17) = 21.144, p < .001; Wistar: F < 1).  Inspection 
of this interaction also revealed that immobility increased significantly for session two compared to 
session one for WKY rats (p < .001).  
 The finding of increased immobility for WKY rats during the forced swim test is consistent with 
previous results (e.g. López-Rubalcava & Lucki, 2000; Paré, 1989a; Paré & Redei, 1993; 
Rittenhouse, Lopez-Rubalcava, Stanwood & Lucki, 2002; Tejani-Butt et al., 2003;). The finding of 
increased immobility on day one of test has also been previously reported, as has the increased 
immobility between test days one and two (Nam et al., 2014).  As most forced swim test paradigms 
reported in the literature involve a 15 min pre-test and a 5 min test period, the current results are 
novel in showing significant differences between Wistar and WKY rats despite a significantly reduced 
swim time.  Whilst Nam et al. (2014) suggest that increased immobility on day one of test may reflect 
200 
psychomotor retardation in the WKY strain, the subsequent experiments reported in Chapters five and 
six demonstrate that this alone cannot explain the WKY rats' behavioural phenotype. 
Figure 26 Percentage Time Spent Immobile for Wistar (Dark grey bars) and WKY rats (Light grey bars) during the 2 min 
Forced Swim Test.  Data is displayed per session.  Error bars represent ± SEM. 
5.5 Experiment 7 Results 
 Figure 27 (Panels A and B) depicts the mean consumption at each of the three sucrose 
concentrations (2, 8 and 24%) for Wistar and WKY rats, separated into Stress and No-stress groups.  
Inspection of this figure suggests that increasing sucrose concentration did not produce an overall 
increase in the amount consumed for either strain or stress group, with the moderate (8%) solution 
instead eliciting the highest intake.  Regardless of solution concentration, WKY rats appeared to 
consume less than their Wistar counterparts.  Rats in the Stress groups, regardless of strain, also 
appeared to reduce their intake of the solution at each concentration.  The data summarised in Figure 
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27 was analysed with a mixed ANOVA with factors of sucrose concentration (2, 8 and 24%), 
sequence order (2-8-24 vs. 24-8-2), strain (WKY vs. Wistar) and stress (Stress vs. No-stress).  This 
was subsequently collapsed across sequence order due to a lack of over-arching effects for this 
factor: There was no main effect of sequence order (F (1, 40) = 1.925, p = .173, MSE = 12.990) and 
no interactions between sequence order and any other factor (All Fs < 1, except sequence order ×
strain (F (1, 40) = 1.786, p = .189, MSE = 12.047) and sequence order × stress (F (1, 40) = 1.777, p = 
.190, MSE = 11.989).
 Consistent with the description of the data, ANOVA analysis revealed a main effect of 
concentration (F (1.573, 67.628) = 194.244, p <.001. MSE = 346.670), a main effect of strain (F (1, 
43) = 15.219, p < .001, MSE = 108.595) and a main effect of stress (F (1, 43) = 7.093, p = .011, MSE
= 50.613).  There was no significant strain × stress interaction (F < 1), indicating that stress did not 
differentially affect intake levels across the Wistar and WKY strains.  There was also no strain ×
concentration interaction (F < 1), nor strain × stress × concentration interaction (F < 1).
 Pairwise comparisons for the concentration effect revealed that rats consumed significantly 
more 8% sucrose than both 2% (F (1, 43) = 367.747, p < .001, MSE = .054) and 24% (F (1, 43) = 
10.614, p = .002, MSE = .036) sucrose solutions.  Consumption of 24% sucrose was also significantly 
higher than of 2% sucrose (F (1, 43) = 164.080, p < .001, MSE = .089).  Importantly, further 
investigation of the strain effect revealed that WKY rats consumed less sucrose than their Wistar 
counterparts at all three solution concentrations: 2% (F (1, 43) = 9.081, p = .004, MSE = 46.924), 8% 
(F (1, 43) = 7.288, p = .010, MSE = 22.086) and 24% (F (1, 43) = 24.214, p < .001, MSE = 42.248).  
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Likewise, the ANOVA revealed that rats in the Stress conditions consumed less sucrose at each of 
the three concentrations, with non-significantly lower intake of 2% sucrose (F (1, 43) = 1.335, p = 
.254, MSE = 6.900) and significantly lower intake of 8% (F (1, 43) = 7.712, p = .008, MSE = 23.372) 
and 24% sucrose (F (1, 43) = 13.544, p = .001, MSE = 23.630). 
 Figure 28 (Panels A and B) depicts the mean LCS elicited by Wistar and WKY rats, separated 
into the two stress conditions, when consuming each of the three sucrose concentrations.  Wistar rats 
in both the Stress and No-stress groups increased the size of their licking clusters as the solution 
consumed increased in concentration.  LCS also appeared to increase slightly with concentration for 
both WKY Stress and No-stress rats.  However, their overall affective response to each solution 
appeared to be extremely blunted.   
 An ANOVA was performed with factors of concentration, sequence order, strain and stress.  
As sequence order did not impact on the interpretation of the results, the results presented here are 
collapsed across this factor (sequence order: F < 1; all interactions F < 1 except sequence order ×
strain × stress (F (1, 40) = 2.130, p = .152, MSE = 4074.382); sequence order × concentration × strain 
(F (2, 80) = 1.022, p = .365, MSE = 1379.732); and sequence × concentration × strain × stress (F (2, 
80) = 1.306, p = .277, MSE = 1762.672).  The ANOVA revealed a main effect of solution 
concentration (F (1.497, 64.378) = 49.942, p < .001, MSE = 17458.341), a main effect of strain (F (1, 
43) = 30.713, p < .001, MSE = 26117.736) and a strain × solution concentration interaction (F (2, 86) 
= 17.943, p < .001, MSE = 4695.319).  In contrast to the consumption data, ANOVA revealed no main 
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effect of stress (F < 1).  There was also no strain × stress interaction (F < 1) or concentration × strain 
× stress interaction (F < 1)4.  
Figure 27 Mean consumption of three different concentrations of sucrose (2, 8 and 24%) for Wistar rats (Panel A) and WKY 
rats (Panel B).  Light grey bars represent the No-Stress condition; dark grey bars represent the Stress condition. N = 12, 
except for the WKY No-stress group where N = 11. Error bars represent ± SEM.  
4 Depression is associated with a two - three times higher prevalence of diabetes (Adriaanse & Bosmans, 2010; 
Golden, 2007).  Similarly, chronically activated glucocorticoids, as a result of stress, also leads to insulin 
resistance (Sominsky & Spencer, 2014).  With studies demonstrating a link between insulin resistance and 
opioid dysfunction (Berent-Spillson, Love, Pop-Busui et al., 2011), it is at least plausible that dysregulated 
insulin activity may account for the current results in WKY rats.  
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Figure 28 Mean Lick Cluster Size for each of the three concentrations of sucrose for Wistar (Panel A) and WKY (Panel B) 
rats.  N = 12, except for the WKY No-stress group where N = 11.  Error bars represent ± SEM.
 Pairwise comparisons of the strain × solution concentration interaction revealed that LCS was 
significantly higher for Wistar rats consuming the 8% solution compared with the 2% solution (F (1, 
43) = 108.334, p < .001, MSE = 17.065) and during consumption of the 24% solution compared with 
the 2% solution (F (1, 43) = 69.595, p < .001, MSE = 34.328).  There was no significant difference in 
LCS between 24% sucrose and 8% sucrose (F (1, 43) = 2.465, p = .124, MSE = 14.033).  For WKY 
A
B
205 
rats LCS was higher during the consumption of 8% sucrose than 2% sucrose (F (1, 43) = 7.227, p = 
.010, MSE = 17.834).  There was also a trend toward higher LCSs for 24% sucrose compared with 
2% sucrose but this did not reach significance (F (1, 43) = 3.916, p = .054, MSE = 35.880).  There 
was no difference in the LCSs exhibited when the rats were consuming 8% and 24% sucrose 
solutions (F < 1).  Comparing across the two strains revealed significantly lower LCSs exhibited by 
WKY rats for 8% sucrose (F (1, 43) = 30.374, p < .001, MSE = 15200.990) and 24% sucrose (F (1, 
43) = 25.005, p < .001, MSE = 20085.333).  WKY rats also exhibited lower LCSs when consuming the 
2% sucrose solution, but non-significantly so (F (1, 43) = 3.172, p = .082, MSE = 222.052).   
 Figure 29 displays the mean inter-lick intervals (ILI) extracted from the record of licks.  There 
was a tendency for marginally higher ILIs for WKY rats compared to the Wistar strain, primarily at the 
highest sucrose concentration.  ANOVA revealed a main effect of solution concentration (F (1.739, 
74.763) = 15.006, p < .001, MSE = 221.666) with the lowest ILIs occurring during consumption of the 
2% sucrose solution.  It also revealed a strain × concentration interaction (F (2, 86) = 8.191, p < .001, 
MSE = 105.181) but, critically, no main effect of strain (F (1, 43) = 3.102, p = .085, MSE = 316.681).  
There was also no main effect of stress (F < 1) and no interaction between stress and any other factor 
(All Fs < 1, except concentration × stress (F (2, 86) = 1.136, p = .326, MSE = 14.587).
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Figure 29 Mean Interlick interval for Wistar and WKY strains when consuming each of the three concentrations of 
sucrose (2, 8, and 24%), separated into Stress (dark grey bars) and No-stress (light grey bars) groups.  N = 12, except for 
the WKY No-stress group where N = 11.   Error bars represent ± SEM.
 It is important to recognise that the longer the ILI the greater the chance that the next lick 
performed by the rat will be grouped into the subsequent cluster, leading to generally lower LCSs.  
The lack of a strain effect here implies that ILI differences cannot fully explain the lower LCSs 
experienced by WKY rats.  The absence of a reciprocal relationship between ILI and LCS is further 
highlighted by analysing the strain × concentration interaction.  ILI was significantly longer for WKY 
A
B
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rats compared to Wistar rats for the 24% solution only (F (1, 43) = 13.366, p = .001, MSE = 
484.869).  However, LCS was significantly smaller for WKY rats compared to Wistar rats for not 
only the 24% solution but also for the 8% solution.  Clearly the shorter LCS at the moderate 
solution of sucrose cannot be explained by strain differences in ILI.   
5.5.1 Additional analysis 
 Although the test consumption of sucrose represents only a fraction of the rats overall 
energy intake, the caloric requirements of animals generally scale such that they relate to weight ^ 
0.75 (Kleiber, 1947).  If this scaling is applied to the consumption tests described above, the main 
effect of rat strain is removed (F < 1), but the remaining features of the analysis are unaffected. 
Therefore, differences in bodyweight may have contributed to the lower overall consumption 
exhibited by WKY rats – this, together with the discrepancy between stress effects on consumption 
and LCS measures, emphasises that consumption measures alone can be ambiguous indicators of 
hedonic responses. 
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5.6 Summary 
 The aim of Experiment seven was to determine whether WKY rats display behaviours 
analogous to consummatory anhedonia compared to an outbred Wistar control strain.  Reduced 
reward value was observed for WKY rats as indexed by reduced palatability and consumption 
across the sucrose concentrations.  Importantly, whilst ILI was generally higher for WKY rats, strain 
differences were not statistically significant.  The lack of a reciprocal relationship between ILI and 
LCS for WKY animals further suggests that increased ILI cannot fully account for the decreased 
LCSs seen. Based on the current measures, WKY rats appear to demonstrate a reduced hedonic 
tone that is not dependent on the application of external stressors.  Furthermore, as LCS is 
modulated by solution concentration in the WKY strain, these results suggest that their hedonic 
responses to rewards are blunted but not entirely absent. 
 The results from this experiment demonstrate that microstructural analysis of licking is a 
sensitive measure of hedonic capacity in rodent models of disease, more so than consumption 
measures.  The results both suggest a hedonic deficit in the WKY strain, and provide an important 
contrast to the lack of such an effect in MAM-treated animals.  These issues will be considered in 
greater depth in the general discussion.  To determine whether the WKY rats also include deficits 
in the anticipatory aspects of hedonic processing, Experiment eight adopted the negative 
anticipatory contrast procedure that relies on the accurate prediction of future appetitive rewards. 
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5.7 Experiment 8 - Materials and Methods 
5.7.1 Apparatus 
Testing was conducted in the same six automated drinking chambers as described in 
Experiment one (section 2.2.2).  The solutions used in the experiment were 4% and 32% sucrose 
made daily w/w with deionised water.  Distinct light conditions (room lighting vs. angle-poise lamp 
fitted with a red bulb) and a metal grid floor insert were used to create distinct contexts.  As in 
Experiment three (Section 3.5.2), white noise was not included to create the contexts.  This was to 
avoid potential strain × stress interactions as the anxiety phenotype of WKY rats means that they 
are potentially hypersensitive to external stressors. Previous findings in our lab have found that 
particular noises can be aversive to different rat strains (unpublished observation).
5.7.2 Procedure 
Pretraining.  All rats were habituated to the drinking boxes for 10 minutes each day for 
three days prior to the pre-training phase of the experiment.  This was to overcome stress effects 
caused by a novel environment which may have differentially affected the stress-sensitive WKY 
rats.  No solutions were made available during this habituation.  During pre-training, rats were 
water restricted for 22 hours and then given access to water for 10 min from both the left and right 
hand side of the drinking chamber.  During this initial training, drinking spouts were positioned 
inside the chamber to allow for easy detection by the rats.  Only one pre-training day was given, 
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after which rats were returned to ad libitum water and remained so for the duration of the 
experiment.  
Acquisition Training.  Acquisition training of anticipatory contrast consisted of daily drinking 
sessions, 9 min in duration, as described in Experiment one and three (section 2.2 and section 
3.5).  Briefly, rats received 3 min access to an initial 4% sucrose solution that was followed by 
access to a second solution for 6 min, the identity of which was either more 4% sucrose or 
preferred 32% sucrose depending on the context.  Solution to context assignments, as described in 
Experiment three, were fully counterbalanced across strain and stress conditions: For half the 
animals in each strain and stress group, context one was paired with the 4-4 condition and context 
two was paired with 4-32 condition; while for the other half the opposite assignment was given.  
Acquisition training lasted thirty-two days and was carried out on consecutive days where possible.  
Initially spouts for both the left and right bottles were positioned within the chamber, but were 
gradually moved back across sessions (taking approximately three days but done on a rat by rat 
basis) until they were flush with the outside of the chamber. 
5.7.3 Data analysis 
 Data analysis was performed as described in Experiment one (Section 2.2.4).  Data were 
analysed with a repeated measures ANOVA with factors of block (1-8), contrast condition (4-4 or 
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control condition vs. 4-32 or contrast condition), strain (Wistar vs. WKY) and stress (Stress vs. No 
stress). 
5.8 Results 
 Figure 30 (Panels A – D) depicts consumption of the 4% sucrose solution presented first 
each day across eight two-session blocks.  Data in the top two panels depicts the data for the 
Wistar control strain, separated into No-stress (Panel A) and Stress conditions (Panel B).  Data in 
the bottom two panels depicts the data for the WKY experimental strain, again separated into the 
two stress conditions, No-stress (Panel C) and Stress (Panel D).  Across training an anticipatory 
contrast effect emerged such that consumption levels of the initial 4% sucrose solution depended 
upon the identity of the subsequent solution in the pairing.  That is, consumption of the initial 4% 
solution was higher when it preceded more of the same solution compared to when it preceded the 
more palatable 32% solution.  Critically, an anticipatory contrast effect in consumption appeared to 
develop for both Wistar and WKY strains and did not seem to be overly influenced by exposure to 
an unpredictable chronic mild stress procedure.  ANOVA results were consistent with this 
impression:  There was a main effect of block (F (4.552, 198.981) = 59.884, p < .001, MSE = 
30.420), and contrast condition (4-4 vs. 4-32) (F (1, 44) = 28.357, p < .001, MSE = 10.961) as well 
as a significant interaction between these two factors (F (3.996, 175.843) = 3.968, p = .004, MSE = 
1.868).  The ANOVA yielded a main effect of strain (F (1, 44) = 13.770, p = .001, MSE = 41.557), 
with WKY rats generally consuming less than their Wistar counterparts.  There was also a main 
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effect of stress (F (1, 44) = 6.074, p = .018, MSE = 18.330), with lower consumption levels for 
Stress compared to No-stress rats.  There was no interaction between contrast condition and strain 
(F < 1), or between contrast condition and stress (F < 1).  There was also no three-way interaction 
between either of these pairs of factors and block (block × contrast condition × strain (F < 1); block 
× contrast condition × stress (F < 1)) and no four-way interaction between these factors (F (7, 308) 
= 1.996, p = .055, MSE = .537).  
 Figure 31 (Panels A - D) depicts the average size of licking clusters elicited by the rats 
when consuming the first 4% sucrose solution presented each session across the eight 2-session 
blocks.  Contrast dependent changes in lick cluster size were evident in the Wistar No-stress 
(Panel A) and Stress groups (Panel B).  That is, as training progressed, lick cluster sizes were 
suppressed when the second solution in the pairing was the more palatable 32% solution 
compared to when the second solution was of equal palatability.  In contrast to this, the anticipatory 
contrast effect was severely attenuated for WKY No-stress (Panel C) and Stress rats (Panel D), 
such that lick cluster size of the initial solution was comparable across the two contrast conditions.   
 ANOVA analysis revealed a main effect of block (F (3.556, 156.449) = 7.455, p < .001, 
MSE = 4751.408), a main effect of contrast condition (F (1, 44) = 9.392, p = .004, MSE = 6191.711) 
and a significant interaction between these factors (F (3.996, 175.822) = 2.987, p = .020, MSE = 
727.600).  Overall, WKY rats exerted fewer licks per cluster compared with Wistar animals as the 
ANOVA also yielded a main effect of strain (F (1, 44) = 17.221, p < .001, MSE = 47578.086).  
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Regardless of strain, LCS was not influenced by the application of an external stressor with no 
main effect of stress (F < 1) or stress × strain interaction (F < 1) yielded by the analysis. 
 ANOVA analysis revealed a significant contrast condition × strain interaction (F (1, 44) = 
4.442, p = .041, MSE = 2928.399) but no contrast condition × strain × stress interaction (F < 1).  
There was no three–way interaction between block, contrast condition and strain (F < 1); block, 
contrast condition and stress (F < 1); and no four-way interaction between block, contrast condition, 
strain and stress (F (7, 308) = 1.427, p = .194, MSE = 198.370).  Further analysis of the contrast 
condition × strain interaction revealed significantly higher LCSs for the control (4-4) than contrast 
(4-32) conditions for Wistar rats (F (1, 44) = 13.376, p = .001, MSE = 6.870).  No difference in LCS 
for the initial solution was seen between contrast and control conditions across the two stress 
groups for WKY rats (F < 1).  That is, only Wistar animals showed a negative anticipatory contrast 
effect in their affective responses to the initial solution.
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Figure 30 Mean Consumption (± 
SEM) of the initial 4% solution 
made available each day as a 
factor of strain (Wistar: Panels A 
and B; WKY: Panels C and D) and 
stress groups (No-Stress: Panels A 
and C; Stress: Panels B and D). 
Open symbols represent the 
consumption from the initial 
bottle in the control condition 
(when 4% sucrose is available in 
the second bottle) and filled 
symbols represent the 
consumption from the initial 
bottle in the contrast condition 
(when the preferred 32% solution 
is available in the second bottle).  
The data presented is averaged 
over two-day blocks.  The first 
bottle was available for 3 min per 
day.  
A B
C D
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Figure 31 Mean number of licks per 
cluster (± SEM) during consumption 
of the initial 4% sucrose solution 
presented each day as a factor of 
strain (Wistar: Panels A and B; WKY: 
Panels C and D) and stress (No-
Stress: Panels A and C; Stress: 
Panels B and D).  Open symbols 
represent the mean LCS for the 
initial solution in the control 
condition (when the second bottle 
in the pairing also contains 4% 
sucrose) and filled symbols 
represent the mean LCS for the 
contrast condition (when the 
second bottle in the pairing 
contains preferred 32% sucrose).  
The data presented is averaged 
across 2-session blocks.  The first 
solution in each condition was 
made available for 3 min.
A B
C D
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 ILI was extracted from the record of licks for the initial 4% solution.  Similarly to Experiment seven, 
WKY rats displayed longer ILIs compared with their Wistar counterparts (F (1, 44) = 9.474, p = .004, MSE = 
3663.765) (see Table 12 for details).  There were no significant differences in ILI between Stress and No-
stress groups (F < 1) and no interaction between strain and stress (F < 1).  Importantly, there was also no 
contrast condition × strain interaction (F < 1) and no block × contrast condition × strain interaction (F (7, 
308) = 1.224, p = .289, MSE = 39.067).
Table 12 Mean Interlick Intervals as a factor or strain, stress and pairing (4-4 = control condition; 4-32 = contrast condition) for the 
first solution presented each day. 
Strain Stress Pairing First bottle Mean ILI (±SEM)
Wistar
No-stress 4-4 166.154 (±1.735)4-32 164.361 (±1.536)
Stress 4-4 166.658 (±2.299)4-32 164.064 (±2.147)
WKY
No-stress 4-4 171.189 (±2.082)4-32 170.286 (±2.348)
Stress 4-4 171.356 (±1.518)4-32 165.878 (±3.165)
Figure 32 (Panels A – D) depicts the average consumption levels for the second solution presented 
to the rats (4 or 32% sucrose) separated into the four strain and stress conditions across the eight 2-
session blocks.  Consumption levels were larger compared to the initial solution due to the different 
durations of bottle access:  The first bottle was only made available for 3 minutes; the second bottle was 
made available for 6 minutes.  Similarly to the first solution data, consumption levels from the second bottle 
were larger for the Wistar strain compared to the WKY strain.  For both strains, there was higher 
consumption of the more palatable 32% sucrose solution compared with the moderately palatable 4% 
sucrose solution.  ANOVA results showed a main effect of block (F (3.308, 145.530) = 91.795, p < .001, 
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MSE = 168.344) and solution concentration (4 vs. 32%)  (F (1, 44) = 23.846, p < .001, MSE = 159.824) as 
well as a main effect of strain (F (1, 44) = 65.228, p < .001, MSE = 539.434).  There was no solution 
concentration (4 vs. 32%) × strain interaction (F (1, 44) = 1.127, p =.294, MSE = 7.551).  There was a main 
effect of stress (F (1, 44) = 8.060, p = .007, MSE = 66.652), with rats consuming generally less from the 
second bottle if they were in the stress group, but no strain × stress interaction (F < 1).  The ANOVA 
yielded a block × stress interaction (F (7, 308) = 2.473, p = .018, MSE = 2.143), further analysis of which 
revealed significant differences in total consumption between stress and no stress conditions for block 2-7 
(smallest F (1, 44) = 5.260, p = .027, MSE = 3.953).  Non-significantly higher consumption was seen for 
stressed rats compared to No-stress rats during block one (F < 1).  Thereafter, consumption was always 
lower for the Stress group.
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Figure 32 Mean consumption
(± SEM) for the second bottle
made available each day. Open
symbols represent the
consumption of 4% sucrose in
the second bottle and filled
symbols represent the
consumption of 32% sucrose in
the second bottle. Data
presented is averaged across 2-
session blocks. Solutions in the
second bottle were made
available for 6 min.
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Figure 33 Mean Lick Cluster Size
(± SEM) for the second solution
available each day (4 % vs. 32
%) for Wistar No-stress (Panel
A), Wistar Stress (Panel B), WKY
No-stress (Panel C) and WKY
Stress (Panel D) rats. In all
cases, open symbols represent
the rat’s response to the 4 %
sucrose solution made available
in the second bottle, whereas
the filled symbols represent the
rat’s response to the 32 %
sucrose solution made available
in the second bottle.
A B
C D
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Figure 33 (Panels A – D) depicts the average size of licking clusters performed by the rat 
when consuming solution from the second bottle (4 vs. 32% sucrose) again collated into eight 2-
session blocks.  In accordance with data from the initial solution in the pairing, WKY rats exerted 
fewer licks per cluster compared to their Wistar counterparts.  For Wistar rats, in both Stress and No-
stress groups, LCSs elicited during consumption of the 32% solution were higher compared with 
when the 4% solution was consumed, reflecting the greater palatability of this solution.  For WKY 
Stress and No-stress rats, LCS was also marginally higher for the 32% sucrose solution than for the 
4% sucrose solution, at least early in training.   
ANOVA revealed a main effect of block (F (3.406, 149.882) = 7.825, p < .001, MSE = 
7581.702) and a main effect of sucrose concentration (4 vs. 32%) (F (1, 44) = 21.043, p < .001, MSE
= 76764.604).  There was also a main effect of strain (F (1, 44) = 18.616, p < .001, MSE = 85267.132) 
but not a main effect of stress (F < 1) and no interaction between these two factors (F < 1).  There 
was, however, a block × strain × stress interaction (F (7, 308) = 2.201, p = .034, MSE = 1037.675), 
further inspection of which revealed that WKY rats exhibited higher LCSs, regardless of stress 
treatment, compared to their Wistar counterparts for block one (smallest F (1, 44) = 10.349, p = .002, 
MSE = 1533.681).  For all subsequent blocks, Wistar rats exerted higher LCSs than WKY animals, 
which trended towards being more pronounced for animals in the Stress group (Stress: smallest F (1, 
44) = 2.588, p = .115, MSE = 1490.426; largest F (1, 44) = 19.842, p < .001, MSE = 7646.762; No-
stress, smallest F (1, 44) = 2.076, p = .157, MSE = 1494.208; largest F (1, 44) = 15.149, p < .001,
MSE = 7153.925).  Importantly, the ANOVA yielded a sucrose concentration × strain (F (1, 44) = 
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5.817, p = .020, MSE = 21222.110) and block × sucrose concentration × strain interaction (F (7, 308) 
= 5.628, p < .001, MSE = 2676.065).  Simple effect analyses revealed that WKY rats exerted lower 
lick cluster sizes compared to Wistar rats for both the 4% sucrose solution (F (1, 44) = 11.390, p = 
.002, MSE = 1338.229) and the 32% sucrose solution (F (1, 44) = 13.142, p = .001, MSE = 
11972.926).  Furthermore, it revealed that LCS was significantly larger for 32% sucrose than 4% for 
Wistar rats (F (1, 44) = 24.494, p < .001, MSE = 37.995).  Whilst there was no overall difference in 
LCS between the two solution concentrations for WKY animals (F (1, 44) = 2.366, p = .131, MSE = 
37.995), further analysis of the block × sucrose concentration × strain interaction revealed that WKY 
rats exerted a significantly higher LCS for 32% sucrose compared to 4% sucrose for blocks one and 
two (smallest F (1, 44) = 5.221, p = .027, MSE = 15.912). 
Separate analysis of the right bottle data for LCSs exhibited by WKY rats was then 
performed.  Critically, this revealed a main effect of solution concentration (F (1, 22) = 4.843, p = .039, 
MSE = 8631.161) and no effect of stress (F < 1).  Further analysis again revealed that, whilst LCS 
was always higher for the 32% solution compared with the 4% solution, significant differences were 
only found early in training (Blocks 1-3: smallest F (1, 22) = 4.920; p = .037, Block 3). 
Mean inter-lick intervals (ILI) were extracted from the record of licks for the second solution 
presented each day and are displayed in Table 13.  WKY rats, regardless of stress treatment, 
appeared to display higher ILIs, particularly during the consumption of 32% sucrose.  This was 
supported by ANOVA analysis: There was a main effect of solution concentration (F (1, 44) = 51.117, 
p < .001, MSE = 5302.505), a main effect of strain (F (1, 44) = 35.781, p < .001, MSE = 11658.048) 
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and a significant interaction between these two factors (F (1, 44) = 61.057, p < .001, MSE = 
6333.633).  Further investigation of the interaction revealed that WKY rats displayed significantly 
higher ILIs compared to the Wistar strain when consuming 32% sucrose (F (1, 44) = 93.218, p < .001, 
MSE = 2.198.592).  No significant difference was found between the two strains for the 4% sucrose 
solution (F = (1, 44) = 3.024, p = .089, MSE = 313.703).  In terms of the stress manipulation, ANOVA 
results yielded no significant main effect (F < 1).  Further, there were no significant interactions 
between strain and stress (F < 1), solution concentration and stress (F (1, 44) = 3.024, p = .089, MSE
= 313.703), or solution concentration, strain and stress (F < 1).  It should be noted that higher ILIs 
demonstrated for the WKY strain for the higher concentration of sucrose may well be contributing to 
the lower LCSs seen for this solution concentration.  That said, previous non-contrast consumption 
tests (Experiment seven, Section 5.5) have demonstrated that WKY rats exhibit reduced affective 
responses to sucrose that are not confounded by differences in ILI.   
Table 13 Mean Interlick Intervals as a factor or strain, stress and solution concentration (4% vs. 32%) for the second 
solution presented each day.
Strain Stress Solution Concentration(%) Mean ILI (±SEM)
Wistar
No-stress 4 166.137 (± 1.662)32 164.174 (± 1.507)
Stress 4 165.273 (± 2.088)32 166.258 (± 1.951)
WKY
No-stress 4 168.381 (± 2.169)32 178.297 (± 1.543)
Stress 4 167.126 (± 2.275)32 179.207 (± 1.696)
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5.9 Summary 
 Experiment eight aimed to determine whether anticipatory hedonic deficits are present in the WKY 
model of depression using a negative anticipatory contrast procedure.  For the outbred Wistar control 
strain, the rats’ consumption of the initial 4% sucrose solution was lower on days when 4% sucrose 
preceded access to 32% sucrose than when it preceded access to more 4% sucrose.  Consistent with the 
findings presented in Experiment one and Experiment three, Wistar rats also exhibited contrast dependent 
changes in their palatability responses, with lower LCSs for the initial solution in the contrast (4-32) 
condition compared to the control (4-4) condition.  For the inbred WKY strain, rats also demonstrated 
contrast dependent changes in their consumption levels as, across training, they consumed less of the 
initial solution in the contrast condition compared to the control condition.  However, unlike for the outbred 
strain, WKY rats failed to show any contrast dependent changes in their palatability responses towards the 
initial solution.  That is, the LCSs exhibited by these animals for the initial solution remained equally low, 
regardless of the second solutions identity.  This dissociation suggests that WKY rats are able to form some 
expectation of the second solution in the pairing, but are not able to modulate their affective responses in 
light of this expectation.  These results are consistent with anticipatory anhedonia in this rat strain but it 
must be acknowledged that hedonic range is extremely blunted in these animals (as will be discussed fully 
in the discussion section after Chapter six).  Similar to Experiment seven, antecedent stressors were not 
necessary for this anticipatory hedonic deficit to manifest.  Chapter six reports the investigation of whether 
the deficits present in the WKY model also include impaired reward processing in instrumental conditioning 
situations. 
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Before moving to the analysis of reward processing, it is worth briefly noting the implications of the 
dissociation seen between the consumption and palatability measures in the WKY rats for the analysis of 
negative anticipatory contrast more generally. Whilst ‘normal’ animals usually show suppressed intake and 
palatability responses towards an initial solution that is reliably followed by a preferred solution, the 
behaviour of the WKY animals suggests that these might be two independent consequences of 
experiencing contrast.  That is, the suppressed intake may not be due to the contrasted solution becoming 
one of functionally lower hedonic value as would be suggested by a devaluation mechanism.  However, 
given the possibility of floor effects on the LCS measure in the WKY rats, the current results do not 
conclusively rule out devaluation as a mechanism for producing negative anticipatory contrast – although 
they do clearly suggest that additional experimental evaluation of this possibility is required.   
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Chapter 6 
6. Value Representations in WKY Rats 
6.1 Introduction 
 Based on the negative anticipatory contrast results presented in the previous chapter, there might 
not be any expectation of seeing problems in using outcome expectancy in WKY animals to motivate their 
behaviour per se.  After all, reward anticipation requires a mental representation of the reward from 
previous experience to be projected into the future and the cognitive expectancies of WKY animals appear 
to be spared based on the consumption results of Experiment eight alone.  However, as detailed in section 
1.3.6, there is at least some suggestion of inflexible habit-based behaviour in response to stress (which in 
turn is linked to depression). Thus, it is not immediately obvious whether a general deficit in reward 
processing would be expected in WKY rats.  Furthermore, it is unclear whether current value 
representations can be integrated with ongoing instrumental behaviour in the WKY rat. 
 Chapter six (Experiments nine and ten) investigates the cognitive processing of rewards in the 
WKY model.  More specifically, it investigates whether or not WKY rats can use reward representations to 
motivate and direct their interactions with their environment.  In a novel or changing environment, it is 
necessary to accurately represent both the relationship between an animal's behaviour and its outcomes, 
and the value of those outcomes.  Such representations allow the production of goal-directed behaviour 
whereby actions are performed to attain currently valuable rewards (or allow unpleasant outcomes to be 
avoided).  Experiment nine utilised an outcome devaluation procedure whereby WKY rats and their Wistar 
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control strain were trained for three days to lever press for a food reward on a RI30s schedule of 
reinforcement (a schedule that promotes goal-directed behaviour in healthy rats).  After this training, the 
food reward was paired with LiCl-induced nausea (devaluing the reward) so that the degree of goal-directed 
responding in these animals could be assessed.   
 Experiment ten utilised a differential outcomes procedure to further investigate whether or not WKY 
rats can form explicit knowledge of the reinforcer.  Similar to Experiment five reported for MAM rats, 
animals were trained to solve a conditional discrimination where correct responding during the presence of 
discriminative stimuli (here distinct light cues) was rewarded.  Whilst the conditional discrimination can be 
solved based on stimulus information alone (with the presence of stimulus-response contingencies), the 
presence of correlated outcomes in the 'differential' group (e.g. flashing light → pellets; steady light →
sucrose solution) enables animals to form and use specific reinforcer representations that provide
additional information to aid learning. As a result, better learning of the conditional discrimination occurs for 
when correlated, as opposed to uncorrelated (i.e. correct responses are rewarded with pellets and sucrose 
at equal probability), outcomes are provided.
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6.2 Experiment 9 - Materials and Methods 
6.2.1 Apparatus and Procedure 
 The experiment was conducted in the same chambers as described for Experiment four (section 
4.1.2).  Training consisted of two stages: magazine training and lever-press training, followed by an 
extinction test after devaluation by LiCl-induced nausea (see Figure 34).  Each rat was assigned to one of 
the eight experimental chambers, and thereafter always trained in the same chamber. 
Figure 34 Schematic depicting the experimental protocol for the Outcome Devaluation Task.
Magazine training.  All rats were trained to collect food rewards during two magazine training 
sessions.  45 mg chocolate flavoured sugar pellets (Test Diet, Richmond, IN) were delivered on a RT60s 
schedule.  The session ended once 10 pellets had been delivered.  Rats that did not collect the food were 
given a repeat of the session later that day.  Extra magazine training, compared to Experiment Four, was 
deemed necessary to habituate the stress-sensitive WKY rats to the new environment. 
Lever-press training.  As described for Experiment four (Section 4.1.3), animals received two days 
of CRF training, earning 20 rewards in each session, followed by three days training on a RI30s schedule, 
earning 40 rewards in each session.   
Magazine 
Training
Lever Press 
Training 
(CRF)
Lever Press 
Training 
(RI30s)
Taste 
Aversion 
Conditioning
with LiCl
Extinction
and 
Consumption
Tests
Reacquisition 
Test
Pre-Training Training Test
2 day 2 days3 days2 days 1 day 1 day
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Devaluation by LiCl.  After the final day of instrumental lever press training, animals received two 
days of taste aversion conditioning with LiCl.  This was conducted in the same manner as described for 
Experiment four, Section 4.1.3.  Valued and devalued groups comprised 12 Wistar control and 12 WKY 
experimental rats divided equally among the Stress and No-stress conditions.  After taste aversion 
conditioning days, the rats’ sensitivity to changes in outcome value was assessed via an extinction test 
(See Experiment four for details on the experimental procedure). 
Consumption and Reacquisition tests.  As described for Experiment four, Section 4.1.3, but the 
reacquisition test was 20 min.
6.2.2 Data analysis 
 Statistical analysis was performed using ANOVA with between-subject factors of devaluation 
(devalued vs. valued), strain (Wistar vs. WKY) and stress (Stress vs. No-Stress).  Lever presses per minute 
and magazine approaches per minute during the extinction test were calculated as a proportion of baseline.  
Baseline was taken as the data from the final day (day three) of acquisition.   
6.3 Results 
Instrumental training.  Across the three days of acquisition training, WKY rats exerted a greater 
number of lever press responses per minute compared with the Wistar strain.  Levels of responding did not 
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appear to be affected by stress.  Importantly, there were no differences in baseline lever press responses 
(taken as day three) as a function of devaluation condition for either strain (see Table 14).   
Table 14 Lever press response per minute for day three of acquisition training (used as ‘baseline’).  
Strain Stress Devaluation Condition Mean lever press/min (± SEM)
Wistar
No-stress Valued 24.517 (± 1.367)Devalued 23.552 (± 3.530)
Stress Valued 19.650 (± 2.308)Devalued 23.086 (± 4.083)
WKY
No-stress Valued 30.651 (± 4.535)Devalued 26.558 (± 3.318)
Stress Valued 27.679 (± 2.139)Devalued 27.296 (± 3.220)
Consistent with this impression, ANOVA revealed a main effect of strain (F (1, 40) = 5.517, p = 
.024, MSE = 342.815), and no main effect of stress (F < 1) and no strain × stress interaction (F < 1).  
Importantly, there was no effect of devaluation condition and no interaction between this and any other 
factor (Fs < 1).   
In terms of magazine approach behavior, analysis also suggested an effect of strain but this time 
with WKY rats exerting fewer nose pokes into the magazine compared to Wistar rats (Table 15).  
Importantly, there were no differences in baseline magazine entries between the valued and to-be-devalued 
conditions.   
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Table 15 Magazine entries per minute for day three of acquisition (used as ‘baseline’). 
Strain Stress Devaluation Condition Mean Mag Entry/min (± SEM)
Wistar
No-stress Valued 18.115(± 1.756)Devalued 15.955(± 1.844)
Stress Valued 16.399(± 2.529)Devalued 14.777(± 2.704)
WKY
No-stress Valued 9.358(± 1.150)Devalued 9.620(± 1.174)
Stress Valued 10.575(± 1.716)Devalued 11.399(± 2.741)
ANOVA revealed a main effect of strain (F (1, 40) =17.698, p < .001, MSE = 442.654).  There was 
no main effect of stress treatment (F < 1) and no interaction between strain and stress (F (1, 40) = 1.040, p
= .314, MSE = 26.018).  Critically, there was no main effect of devaluation condition and no interaction 
between this and any other factor (Fs < 1).   
Extinction – Lever Press Performance.  The mean lever press response rates as a proportion of 
baseline for the 10 min extinction test are displayed in Figure 35 panel A.  The performance of Wistar rats, 
regardless of stress condition, appeared to be sensitive to the current value of the goal.  That is, Wistar No-
stress and Wistar Stress rats performed fewer lever presses as a proportion of their baseline rates after the 
outcome had been paired with LiCl-induced nausea (Devalued – grey bars) compared to those animals 
which had not received this pairing (Valued – white bars).  Conversely, the performance of the WKY rats 
was not goal-directed.  This is demonstrated by their failure to show sensitivity to the reward devaluation 
procedure with rats in the devalued group pressing the lever at a nearly equivalent rate (WKY No-stress) or 
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at a greater rate (WKY Stress) to the valued group.  This suggests that the responding of WKY rats after 
limited training is insensitive to changes in goal value and habitual.
The description of the data was confirmed by statistical analysis.  An ANOVA yielded no main 
effect of strain (F (1, 40) = 1.989, p = .166, MSE = .241), stress (F < 1), nor an interaction between these 
two factors (F (1, 40) = 1.809, p = .186, MSE = .219).  It did, however, reveal a main effect of devaluation 
condition (F (1, 40) = 4.706, p = .036, MSE = .571), and critically a significant strain × devaluation condition 
interaction (F (1, 40) = 4.161, p = .048, MSE = .505).  There was no stress × devaluation condition 
interaction (F (1, 40) = 1.543, p = .221, MSE = .187) and no three-way interaction between strain, stress 
and devaluation condition (F < 1).  Simple effect analysis of the strain × devaluation condition interaction 
revealed that performance of rats in the devalued and valued groups differed in the Wistar rats (F (1, 40) = 
8.858, p = .005, MSE = .215) but not in the WKY animals (F (1, 40) = .008, p = .928, MSE = .000). 
Extinction – Magazine approach behaviour.  Figure 35 Panel B shows magazine approach 
behaviour as a proportion of baseline during the 10 minute extinction test.  Inspection of this figure reveals 
that the animals with an aversion to the reinforcer (Devalued – grey bars), regardless of strain, performed 
fewer magazine entries compared to the non-devalued animals (Valued –white bars).  ANOVA yielded a 
main effect of devaluation condition (F (1, 40) = 5.537, p = .024, MSE = .597).  There was no main effect of 
strain (F (1, 40) = 2.221, p = .144, MSE = .239), or stress (F < 1) and no interaction between these factors 
(F < 1).  The ANOVA also yielded no strain × devaluation (F < 1), stress × devaluation (F (1, 40) = 2.426, p
= .127, MSE = .261) or strain × stress × devaluation interactions (F < 1).  Thus, WKY rats’ instrumental 
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performance was insensitive to the effects of LiCl devaluation whereas LiCl was able to produce a 
devaluation of magazine approach behaviour.5
Outcome Devaluation.  Figure 36 shows the consumption of the instrumental outcome across the 
two conditioning days and the consumption test (which followed the extinction test).  Inspection of this 
figure suggests that taste aversion learning was not affected by strain or stress.  Rats in all four conditions 
exhibited a strong aversion to the instrumental outcome in the devalued group.  In contrast, all rats in the 
valued group (where the outcome had been paired with a saline injection) continued to consume the 
outcome across sessions.  An ANOVA with factors of session (conditioning day one, conditioning day two 
and test), strain, stress and devaluation condition (devalued vs. valued) revealed an effect of devaluation 
condition (F (1, 40) = 311.950, p < .001, MSE = 1425.692), and session (F (1.624, 64.979) = 111.210, p < 
.001, MSE = 999.147), as well as an interaction between these two factors (F (2, 80) = 61.321, p < .001, 
MSE = 447.483).  The ANOVA results also revealed a day × strain interaction (F (2, 80) = 3.622, p = .031, 
MSE = 26.431) with WKY rats consuming significantly more than Wistar animals on conditioning day one 
but not on day two or during the consumption test (Day 1: F (1, 40) = 6.352, p = .016, MSE = 60.077).  
5 Although there was no effect of stress condition in the main ANOVA, inspection of the figure does suggest numerically different 
levels of goal-directed behaviour in the stress and no-stress groups.  In order to examine whether the overarching strain effects had 
obscured the stress effect in the main ANOVA analysis, both strains were analysed in a separate ANOVA.  For Wistar rats an ANOVA 
yielded no main effect of stress treatment (F < 1), no main effect of devaluation condition (F (1, 20) = 2.959, p  = .101, MSE = .362) 
and no interaction between these two factors (F (1, 20) = 1.710, p = .206, MSE = .210).  For WKY rats, again there was no effect of 
stress treatment (F < 1), no effect of condition (F (1, 20) = 2.585, p = .124, MSE = .240) and no interaction (F < 1).
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Figure 35 Effect of strain (WKY vs Wistar) and stress condition (No-Stress vs. Stress) on sensitivity of lever pressing (Panel A) and 
magazine entries (Panel B) to reward devaluation by LiCl-induced nausea.  Mean lever presses per minute as a proportion of 
baseline (+SEM) in the extinction test are shown, where grey bars represent responses after devaluation by LiCl and white bars 
represent responses after no devaluation. 
A
B
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Figure 36 Mean chocolate pellet consumption (± SEM) over 2 days of taste aversion training and 1 post-extinction consumption 
test for WKY (Stress vs. No-stress) and Wistar rats (Stress vs. No-Stress).  Rats received LiCl injections (Devalued) or saline 
injections (Valued) after 30 min free access to the instrumental outcome.  The test phase also took place in a 30 min period 
immediately after the 10-min extinction test.
Reacquisition Test – Lever Press Performance.  The results of the reacquisition test provided 
further confirmation that the LiCl injections had successfully devalued the instrumental outcome under the 
devaluation condition of all groups, and that this taste aversion had effectively transferred to the 
instrumental chamber.  The mean lever presses per minute for the rewarded 20 min reacquisition test are 
presented in Figure 37 Panel A.  This indicates that the devalued group, regardless of strain and stress, 
performed considerably fewer lever presses compared to the valued group.  Statistical analysis by ANOVA 
revealed a significant main effect of devaluation group (F (1, 40) = 26.798, p < .001, MSE = 1275.756).  
The trend towards higher levels of responding for the WKY strain was maintained in the reacquisition test 
(F (1, 40) = 3.075, p = .087, MSE = 146.394) but importantly the level of devaluation was comparable for all 
groups as there was no strain × devaluation, stress × devaluation or strain × stress × devaluation 
interaction (all Fs < 1).  Together with magazine approach behaviour during extinction, these data indicate 
that the devaluation procedure was just as effective in all strain and stress groups.   
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Reacquisition Test – Magazine Approach Behaviour.  The effectiveness of the devaluation 
procedure is further supported by analysis of magazine approach behaviour during the 20 min reacquisition 
test (See Figure 37 Panel B).  All devalued groups showed a marked suppression in their magazine 
approach behaviour compared with their appropriate valued group.  In support of this, ANOVA yielded a 
main effect of devaluation (F (1, 40) = 26.902, p < .001, MSE = 356.709).  The WKY animals again 
displayed lower levels of magazine approach behaviour compared to Wistar rats (F (1, 40) = 22.838, p < 
.001, MSE = 302.824).  ANOVA revealed a significant strain × devaluation condition interaction (F (1, 40) = 
4.536, p = .039, MSE = 60.140).  However, further simple effects analysis revealed a significant difference 
between valued and devalued groups for Wistar rats (F (1, 40) = 26.765, p < .001, MSE = 354.891) and the 
WKY strain (F (1, 40) = 4.673, p = .037, MSE = 61.958).  
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Figure 37 Effect of stain (WKY vs. Wistar) and stress condition (Stress vs. No-stress) on lever press reacquisition (Panel A) and 
magazine entries (Panel B) after reward devaluation by LiCl-induced nausea.  Mean lever presses and mean magazine entries per 
minute (± SEM) in the rewarded reacquisition test after devaluation with LiCl (grey bars) or no devaluation (white bars) are 
shown.  The reacquisition test was given 24 hours after the extinction and consumption tests.
6.4 Summary 
 Based on the results from the negative anticipatory contrast procedure (Experiment eight), it would 
appear that WKY rats under certain circumstances can adjust their current (consummatory) behaviour in 
light of future rewarding events, suggesting that WKY rats can mentally represent or predict future rewards.  
However, in Experiment nine, WKY rats regardless of stress condition, were unable to use changes in 
A
B
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experienced reward value to modify their instrumental behaviour.  Although WKY animals showed a 
reduced intake of pellets after LiCl-induced nausea, demonstrating that they had effectively acquired the 
taste aversion, they failed to modify their lever-press behaviour in response to this changed outcome value.  
That is, WKY rats in the devalued group responded at equivalent levels to those seen in the non-devalued 
group.  This suggests that the control of responding in the WKY rats was not dependent on the expected 
outcome but instead was dominated by reflexive S-R habits, even after only limited levels of training. 
 As planned, Experiment ten used the differential outcomes procedure to further investigate the 
deficit in reward representation as it presents itself in the WKY inbred rat strain.  If WKY animals cannot 
form or cannot use associations between the discriminative stimuli and the different sensory properties of 
the two reinforcers, or indeed if they are entirely stimulus bound, they should be unable to show any benefit 
from having differential outcomes during the acquisition of a conditional discrimination.  Based on the 
apparent dominance of habitual S-R behaviour in Experiment nine, I would expect that the performance of 
the WKY rats will be equivalent across acquisition training of the conditional discrimination, regardless of 
training conditions (differential vs. non-differential outcomes). 
6.5 Experiment 10 - Materials and Methods 
6.5.1 Apparatus 
The same eight experimental chambers used in Experiment five (section 4.4.2) were used.  Two 
panel lights, 2 cm in diameter, were located at the top left and right of the right-hand wall above the two 
levers.  A white LED light located in the top of the magazine could also be illuminated.  The discriminative 
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stimuli consisted of flashing panel lights (stimulus 1) and steady panel lights together with illumination of the 
magazine light (stimulus 2) - this was to prevent contamination with planned experiments using auditory 
stimuli that are not reported in this thesis.  
6.5.2 Procedure 
 Each rat was assigned to one of the eight experimental chambers, and thereafter always trained in 
the same chamber.  Training consisted of three stages: magazine training, lever press training and 
acquisition training on a continuous performance conditional discrimination task (See Figure 38). 
Subsequently, rats underwent two tests, one in extinction and one in which the visual stimuli were not 
presented (reinforcer-only test).  One test session was run on each day, interspersed with an additional 
training session (RT).   
Pre-training.  Full details of the pre-training stages can be found in section 4.4.3 (Experiment five).  
Conditional Discrimination Training.  Instrumental training of the conditional discrimination occurred 
across ten days.  Each daily session lasted 40 min and consisted of eight 5 min presentations of the visual 
Figure 38 Schematic depicting the experimental protocol for the differential outcomes procedure.  RT = Reacquisition Training.
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stimuli.  The identity of the first stimulus (flashing vs. steady light) was randomly allocated, and the stimulus 
identities were then strictly alternated thereafter.  All other aspects of conditional discrimination training 
were as described in Experiment five.  An equal number of rats from each strain and each stress condition 
were assigned to the differential and non-differential groups, for which stimulus-outcome contingencies 
were manipulated.  All contingencies were fully counterbalanced across the cohort. 
Extinction test and reinforcer only test.  The extinction test was carried out after the final day of 
acquisition training.  Parameters were the same as during the training phase, except that rewards were not 
delivered after each appropriate lever press response.  The rats then underwent a single day of 
reacquisition training, followed by a reinforcer-only test in which rewards were available but in the absence 
of the visual stimuli. See Experiment five (section 4.4.3) for further details. 
6.5.3 Data analysis 
For all analysis, correct and incorrect lever press responses were converted into discrimination 
ratios (as previously described in Experiment five).  Data were analysed via a four-way ANOVA with factors 
of session (days 1 – 10), strain (Wistar vs. WKY), stress (stress vs. No-stress) and group (differential vs. 
non-differential).   
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6.6 Results 
Acquisition of conditional discrimination.  Figure 39 displays the mean discrimination ratios for the 
continuous performance conditional discrimination task across ten days of acquisition.  Panel A of Figure 
39 shows the performance of the Wistar animals and Panel B shows the performance of the WKY animals.  
For both panels, the filled symbols represent the rats in the differential group (with stimulus-correlated 
outcomes), whereas open symbols represent the rats in the non-differential group (where a correct 
response was reward with pellets and sucrose at equal probability).
As can be observed from the Panel A, Wistar rats in both differential and non-differential groups 
learnt the discrimination as training proceeded.  However, acquisition was slower in the non-differential 
group, who learnt the discrimination at a reduced rate and reached a lower asymptote by day ten.  Better 
performance for Wistar rats in the differential group is indicative of a differential-outcomes effect.  As can be 
seen in Panel B, WKY rats in both groups learnt the conditional discrimination across training.  There was, 
however, no difference in the performance of rats which experienced differential outcomes and those which 
did not.  This suggests that while WKY rats were unimpaired in acquiring the basic instrumental 
discrimination, they did not exhibit a differential outcomes effect.   
ANOVA analysis revealed a main effect of session (F (4.696, 187.850) = 113.191, p < .001, MSE = 
.213) and group (F (1, 40) = 23.099, p < .001, MSE = .231) with rats under the differential condition 
generally outperforming those in the non-differential condition.  There was also a strain effect (F (1, 40) = 
15.009, p <.001, MSE = .150) with WKY rats demonstrating higher discrimination ratios, collapsed across 
groups, compared to the Wistar strain.  The ANOVA also revealed an interaction between strain and 
session (F (9, 360) = 2.614, p = .006, MSE = .005), with the strain differences present on days 1-5 and day 
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7 (smallest F (1, 40) = 6.247, p = .017, MSE = .018) but not on day 6 or on the last three days of training 
(largest F (1, 40) = 2.563, p = .117, MSE = .007).  No main effect of stress was yielded by the analysis (F
(1, 40) = 1.136, p = .293, MSE = .011) nor was there a strain × stress interaction (F (1, 40) = 1.841, p = 
.182, MSE = .018).  Importantly, the ANOVA did yield a strain × group interaction (F (1, 40) = 4.605, p = 
.038, MSE = .046).  Simple effect analysis subsequently revealed that Wistar rats in the differential group 
had higher discrimination ratios than those in the non-differential group (F (1, 40) = 24.165, p < .001, MSE
= .024).  In contrast, the discrimination ratios for WKY rats in the differential group were not significantly 
higher than WKY rats in the non-differential group (F (1, 40) = 3.538, p = .067, MSE = .004).  Consistent 
with the description of the data, the ANOVA confirmed that WKY animals show less benefit from receiving 
stimulus-contingent outcomes during the training of a conditional discrimination task. 
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Figure 39 Discrimination ratios (correct responses/ total responses) during acquisition of a conditional discrimination task for Wistar rats (Panel A) and WKY rats (Panel B).  WS denotes Wistar 
Stress rats (represented by filled squares for the Differential group and open squares for the Non-Differential group) and WNS denotes Wistar No-stress rats (represented by filled circles for 
the Differential group and open circles for the Non-Differential group).  WKYS denotes WKY Stress rats (represented by filled squares for the Differential group and open squares for the Non-
Differential group) and WKYNS denotes WKY No-stress rats (represented by filled circles for the Differential group and open circles for the Non-Differential group).  Error bars represent ± 
SEM. 
A B
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Extinction Test.  Figure 40 displays the mean discrimination ratios (± SEM) for the Wistar and 
WKY strains across the 40 min extinction test for Stress and No-stress conditions.  Wistar rats appear 
to have maintained the discrimination during the unrewarded extinction test with discrimination ratios 
above .50 (95% CIs: Wistar No-stress Differential, .598 - .732; Wistar No-stress Non-Differential, .579 
- .713; Wistar Stress Differential, .589 - .724; Wistar Stress Non-Differential, .546 - .681).  The 
performance of the WKY animals was generally lower than the Wistar strain, but again discrimination 
ratios were above .50 (95% CIs: WKY No-Stress Non-Differential, .530 - .664; WKY Stress 
Differential, .517 - .651; WKY Stress Non-Differential, .539 - .674) - with the exception of WKY No-
stress animals in the differential outcomes group (95% CI: .445 - .579).  Taken together, it appears 
that the animals’ performance during acquisition, particularly for Wistar rats, was not controlled 
exclusively by cues provided on reward delivery. 
Figure 40 Discrimination ratios during the 40 min extinction test.  Data is shown for Wistar and WKY rats separated into the 
No-stress and Stress conditions.  Data displayed in dark grey represents animals in the Differential condition (where during 
training they had received stimulus contingent outcomes) and data displayed in white represent animals in the Non-
Differential group (where animals behaviour was reinforced by random rewards during training).  Error bars represent ± 
SEM.  
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ANOVA analysis on the data summarised in Figure 40 revealed a main effect of strain (F (1, 
40) = 8.975, p = .005, MSE = .059), no main effect of group (F < 1) and no strain × group interaction 
(F (1, 40) = 3.241, p = .079, MSE = .021).  The ANOVA also yielded no main effect of stress condition 
(F < 1), no strain × stress interaction (F (1, 40) = 1.690, p = .201, MSE = .011) and no interaction
between stress and any other factor (all Fs < 1).
Reinforcer-Only Test.  Figure 41 depicts the mean discrimination ratios (± SEM) for Wistar 
and WKY rats during the 40 min reinforcer-only test, where visual stimuli were not presented, for both 
Stress and No-stress conditions.  All Wistars (95% CIs: No-stress Differential, .650 - .734; No-stress
Non-Differential, .563 - .647; Stress Differential, .622 - .706; Stress Non-Differential, .585 - .669) and 
WKY rats (95% CIs: No-stress Differential, .694 - .778; No-Stress Non-Differential, .618 - .702; Stress 
Differential, .674 - .758; Stress Non-Differental, .610 - .693) displayed discrimination ratios above .50 
suggesting that the presentation of the reinforcer alone could indicate which lever press was the 
appropriate response to make in the absence of additional discriminative cues.  As suggested for 
Experiment five (section 4.5), this was likely achieved via a win-stay strategy, together with O-R 
associations accounting for the persistent differential outcomes effect.  With generally higher 
discrimination ratios for WKY animals, perseverative responding and/or backward associations 
between the outcome and the response appears to be more pronounced for this strain.
ANOVA analysis revealed a main effect of strain (F (1, 40) = 8.948, p = .005, MSE = .023) 
with WKY rats displaying higher discrimination ratios overall.  There was no main effect of stress (F < 
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1) and no strain × stress interaction (F < 1).  Consistent with the description of the data, the ANOVA 
yielded a main effect of group (F (1, 40) = 20.279, p < .001, MSE = .052) which was present for both 
strains and stress conditions (strain × group: F < 1; stress × group, F (1, 40) = 1.101, p = .300, MSE = 
.003).  There was also no strain × stress × group interaction (F < 1).  
Figure 41 Discrimination rations during the 40 min Reinforcer only test.  Data is shown for Wistar and WKY rats separated 
into No-stress and Stress conditions.  Data in dark grey represents the performance of animals in the Differential group 
whereas data in white represents the performance of animals in the Non-Differential group.  During trials, no visual stimuli 
were provided to aid responding.  Error bars represent ± SEM.
6.7 Summary 
 Experiment ten used the differential outcomes effect to examine whether WKY rats could use 
differences in the sensory properties of two reinforcers to better learn a conditional discrimination.  
The outbred Wistar control strain trained on a discrimination in which specific rewards were 
contingent on the stimulus identity (e.g. flashing light → pellet; steady light → sucrose) better learnt the 
discrimination compared to rats for which reward type and stimulus identity were not correlated (i.e. 
where correct responses were rewarded with sucrose and pellets with a 50:50 probability).  WKY rats 
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also learnt the discrimination, performing more on the correct than incorrect lever, but failed to show 
the differential outcomes effect.  That is, WKY rats did not use the distinct sensory properties of the 
reward to aid their learning when the visual discrimination cues were present.  However, the fact that 
the WKY rats did show better performance in the differential as compared to non-differential 
outcomes condition in the reinforcer-only test suggests that they may well be forming sensory specific 
R-O associations to some degree.  The implications of this pattern of results will be considered below 
(section 6.8), and in the general discussion.   
6.8 Discussion of Chapters 5 and 6 
 The set of experiments reported in Chapters five and six investigated potential reward-
processing deficits in the WKY rat, a putative depression model, using the same techniques adopted 
for investigation of MAM-treated animals.  Chapter five specifically investigated hedonic deficits in the 
model, whereas Chapter six investigated reward-related processes beyond anhedonia. 
 Experiment seven detected the presence of consummatory hedonic deficits in the WKY rat 
strain by monitoring their licking patterns during the voluntary consumption of three different sucrose 
concentrations.  This was demonstrated by the lower palatability responses exhibited by WKY 
animals to the sweet solutions compared to an outbred Wistar control strain.  Lower lick cluster sizes 
were also mirrored by generally lower consumption levels by WKY rats compared to Wistar animals, 
but only when consumption was not expressed relative to the rats' body weight.  This suggests that 
lick cluster size is a more sensitive and selective measure of hedonic changes than consumption 
247 
measures alone (as will be further discussed in relation to stress in the general discussion section of 
this thesis, section 7.6).   
 The presence of an anhedonic-like profile in the WKY model is in accordance with previous 
work (e.g. De La Garza, 2005; Malkesman et al., 2005; Paré, 2000); however, the current experiment 
is the first to demonstrate its presence using a measure unaffected by potential motivational changes 
in the strain.  Furthermore, from analysing ILI the possibility that the reduced palatability responses 
are an artefact of motoric or postural problems with the animal can be ruled out from the current 
dataset.  In addition to previous work, the application of a chronic mild stress procedure does not 
appear to be a necessary precursor for hedonic deficits to manifest in this strain (stress effects for 
both strains will be considered fully in the general discussion, section 7.6). 
 To detect the presence of anticipatory hedonic deficits in the WKY strain, Experiment eight 
used lick analysis to assess the hedonic component of the reward in conjunction with a negative 
anticipatory contrast procedure.  It was demonstrated that, as WKY rats learn to expect a more 
palatable solution will be made available, they suppress their consumption but not their palatability 
responses towards the currently available solution.  This dissociation between the consumption and 
LCS parameters suggests that WKY animals are able to form some expectations of future events but 
are unable to adjust their affective responses in light of these expectations.  Whilst potential floor 
effects must be considered, this provides the novel suggestion that WKY rats display behaviours 
analogous to anticipatory anhedonia. 
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 With consideration of potential floor effects, the low LCSs exhibited by the WKY strain in both 
Experiment seven and Experiment eight may give little scope for a functional devaluation of the initial 
solution due to the expectation of a more palatable reward.  This is unlikely to reflect an insensitivity of 
the techniques used overall.  Indeed, conditioned taste aversion studies (e.g. Dwyer, 2009; Dwyer et 
al., 2008) show that LCSs can be considerably lower than those seen for WKY animals in Experiment 
eight.  Furthermore, returning to Experiment seven, the LCSs for WKY animals were modulated by 
solution concentration to some degree.  This demonstrates that this parameter is not completely fixed 
at a low level but can be modulated by external factors in a way that would be expected for healthy 
rats. 
 Chapter six investigated other reward-related deficits, beyond anhedonia, in the WKY model.  
Using an outcome devaluation procedure, Experiment nine demonstrated that WKY rats, given limited 
instrumental training for a food reward, are insensitive to post-conditioning changes in outcome value:  
WKY rats averted to a reinforcer responded just as much as animals not averted to the reinforcer.  
This result, considered in isolation, suggests either that WKY animals are unable to encode outcomes 
or that these animals undergo a faster transition to S-R mechanisms, with three days of training being 
sufficient to produce habit-based behaviour in these animals. 
 Several aspects of the data presented in Experiment nine deserve comment.  Firstly, the lack 
of a stress effect on the balance between goal-directed and habitual systems appears to be at odds 
with previous demonstrations that stress attenuates goal-directed responding (see section 1.3.6).  
The general implications of stress for both WKY and Wistar strains will be discussed fully in the 
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general discussion of this thesis (section 7.6).  For now, one possibility is that the stress manipulation 
used for the current experiments was simply less severe than in previous studies. 
 Secondly, the dissociation observed between the effects of reward devaluation on magazine 
approach and instrumental lever pressing in the WKY strain has been previously demonstrated in the 
literature.  Similarly to the current findings, Nelson and Killcross (2006) found that an amphetamine 
challenge made lever-press behaviour but not magazine approach behaviour insensitive to reward 
devaluation.  This finding is consistent with the idea that magazine approach is under the control of 
different psychological and neural processes to lever-press performance (e.g. Killcross & Coutureau, 
2003).  One line of thought is that responses proximal to the reward, such as magazine entry, may be 
more sensitive to devaluation procedures than responses, such as lever pressing, which are more 
distal to reward delivery (Balleine, Garner, Gonzalez & Dickinson, 1995).  Alternatively, it is possible 
that magazine approach behaviour is under greater control by Pavlovian, as opposed to instrumental, 
contingencies (Balleine et al., 1995; Nelson & Killcross, 2006).  Indeed, unlike for instrumental 
behaviour, reward delivery is independent of magazine approach responses (see Killcross & Blundell, 
2002, for further discussion).  Regardless of the underlying mechanisms, the magazine approach 
behaviour (together with the reacquisition test) in this experiment provides unequivocal evidence that 
the devaluation procedure was equally as effective in the WKY groups. 
 Turning to Experiment ten, the presence of a reward processing deficit was reinforced by the 
fact that WKY rats did not display the typical DOE seen in the control groups.  That is, although the 
WKY rats successfully acquired the general instrumental discrimination, their performance was not 
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influenced by whether or not each action was selectively paired with a unique reward.  Taken 
together, the results of Experiments nine and ten show that the current value of a reward does not 
drive instrumental behaviour in the WKY rat, nor do they use the specific properties of rewards to 
direct the acquisition of an instrumental discrimination.  While these results clearly indicate some 
deficits in reward processing in WKY rats, it should be noted that they are clearly sensitive to at least 
some properties of rewards under some circumstances.  In particular, they show an anticipatory 
contrast effect on intake measures in Experiment eight, their magazine entry behaviour in Experiment 
nine is sensitive to outcome devaluation, and they were sensitive to the type of reward in the 
reinforcer-only test in Experiment ten.  In short, although the WKY rats clearly show deficits in both 
hedonic and instrumental responses to rewards, this does not reflect a complete failure to process or 
encode rewarding stimuli.  I will consider the characterisation of the nature of the WKY strain deficit in 
the general discussion (section 7.7). 
251 
Chapter Seven 
7. General discussion 
7.1 Summary of results 
 The general theme of this thesis has been the analysis of hedonic and instrumental 
responses to rewarding stimuli.  Experiment one developed a within-subject anticipatory contrast 
procedure, affording the examination of hedonic responses through the examination of licking 
microstructure.  This demonstrated that, in a context where access to a dilute sucrose solution was 
followed by a more concentrated solution, both consumption and hedonic responses to dilute sucrose 
were suppressed. 
 Experiment two and three investigated the hedonic responses of animals prenatally treated 
with MAM, a putative schizophrenia model, in both anticipatory contrast and simple consumption 
situations.  MAM treated animals displayed no deficits that were indicative of either consummatory or 
anticipatory anhedonia.  Experiments four and five investigated reward processing, beyond 
anhedonia, in this model and also found no evidence of impaired instrumental behaviour in response 
to either post-training outcome devaluation or the provision of differential outcomes in a discrimination 
task.  Experiment six investigated the suggestion from prior experiments that MAM-treated rats might 
be less prone to habit-based behaviours through over-training the instrumental response.  Whilst 
inconclusive, the results did not rule out an over-reliance on A-O associations in MAM-treated 
animals.  In short, MAM treated animals did not display any hedonic deficits or impairments in 
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instrumental behaviour indicative of the sort of reward processing problems that might be expected of 
a comprehensive animal model of schizophrenia. 
 Experiments seven and eight investigated consummatory and anticipatory hedonic responses 
in the WKY inbred rat strain, a putative depression model.  WKY rats displayed lower consumption 
and lick cluster sizes when exposed to sucrose, consistent with a consummatory hedonic deficit in 
these animals.  Furthermore, in the negative anticipatory contrast procedure, a contrast effect 
developed in their consumption, but not in their hedonic responses, to a dilute sucrose solution that 
was presented in a context where it was to be followed by a more concentrated solution.  The 
absence of suppressed lick cluster sizes in this contrast procedure is possibly indicative of an 
anticipatory hedonic deficit in this strain. 
 Experiments nine and ten further examined the instrumental behaviour of WKY rats in 
response to reward devaluation and the differential outcomes procedure.  Instrumental lever press 
responses after minimal training were insensitive to reward devaluation in the WKY rats.  In addition, 
WKY rats showed no benefit (unlike controls) from the presence of differential outcomes during the 
acquisition of a conditional discrimination task.  However, the performance of WKY rats in the 
differential and non-differential groups mirrored those of controls in both a subsequent extinction test 
(where only visual cues could direct performance), and in a reinforcer-only test (where responding 
could only be directed by the presence or nature of the outcome).  While the application of chronic 
mild stressors influenced some of the behaviours examined in Experiments seven to ten (in particular 
those relating to the amount of consumption), these effects did not differ between the WKY rats and 
253 
their Wistar controls.  Considered together, these results for the WKY inbred rat strain are consistent 
with the reward-related deficits that feature in depression. 
 The results of these experiments speak to a number of issues relating to the nature of 
hedonic and instrumental responses to rewards and the ways in which these are affected (or not) in 
preclinical models of human psychiatric disorders.  These will be considered below. 
7.2 Negative Anticipatory Contrast as a measure of Anticipatory Anhedonia 
 Experiment one combined a negative anticipatory contrast procedure with microstructural 
analysis of licking to serve as a sensitive test of anticipatory hedonic behaviour.  It was found that, in 
'normal' animals, expectation of a more palatable solution in the near future caused a suppression in 
consumption and lick cluster size measures to a currently available solution of lesser value.  This 
result was replicated in Experiments three and eight, showing the robustness of the negative 
anticipatory contrast effect (both in terms of consumption and LCS) across Lister-Hooded, Sprague-
Dawley and Wistar outbred strains.  Critically, in this procedure, the central focus of analysis is the 
response to a currently available solution as a function of what is expected to occur in the future.  As 
such, the use of licking microstructure in the context of an anticipatory contrast procedure is a 
potentially valuable means to assay anticipatory hedonic responses.   
 Taken at face value, the fact that anticipatory contrast influences both consumption and 
hedonic responses is consistent with the idea that the suppression of consumption by contrast is a 
direct product of the devaluation of a currently available reward by the expectation of a preferred 
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reward in the future.  However, WKY rats displayed the typical contrast-produced change in 
consumption, which was not mirrored by a similar change in hedonic reactions.  While the implications 
of this dissociation for the WKY rat as a possible depression model will be considered below, it is 
important to note that the dissociation also questions whether anticipatory contrast is actually a direct 
product of reward devaluation, or whether reward devaluation and consumption suppression are two 
separate products of experiencing contrast.  Other things being equal, such a dissociation would be 
clear evidence against the idea that contrast is produced by reward devaluation.  However, the 
generally low level of hedonic responses displayed through lick cluster sizes in the WKY rats allows 
for the possibility that the apparent dissociation was the result of a restriction in the range of hedonic 
responses displayed by WKY animals.  As a result, the relationship between consumption and 
hedonic responses in the contrast situation remains to be determined.  Regardless, the fact that both 
consumption and hedonic responses depend on an anticipation of future rewards means that this 
procedure still affords a behavioural assay of anticipatory hedonic processes.     
 Unlike for the outcome devaluation and differential outcome techniques used in this thesis, 
the neural circuits that underpin the contrast effect have undergone little investigation.  Barbano and 
Cador (2006) used conditioned locomotor activity prior to expected palatable foods as a measure of 
anticipation and found that the systemic administration of a dopamine receptor antagonist 
(flupenthixol), but not an opioid receptor antagonist (naloxone - an antagonist with high affinity for mu 
opioid receptors), decreased the expression of anticipatory activity in food restricted rats.  Conversely, 
Katsuura and Taha (2014) used an anticipatory contrast paradigm and found that the increased 
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consumption that usually occurs for a non-contrasted solution (i.e. 4% sucrose followed by plain 
water) relative to a contrasted solution (i.e. 4% sucrose followed by 20% sucrose) was prevented by 
the administration of non-specific opioid receptor antagonists (naltrexone) and mu opioid antagonists 
(beta-fundaltrexamine, but not delta opioid receptor antagonist, naltrindole) infused into the NAc shell.   
As beta-fundaltrexamine had no significant effects on the same 4% sucrose in the contrast condition, 
the authors suggest that the anticipation of a preferred solution reduces mu opioid signalling-
dependent consumption of a less preferred solution.  In light of these contradictory findings, and given 
the role of dopamine in reward 'wanting' (thought to be closely linked to reward anticipation), it would 
be informative to investigate both dopaminergic and opioidergic manipulations in relation to my 
negative anticipatory contrast procedure.  Moreover, in light of the dissociation of consumption and 
hedonic responses observed in the WKY rats and the fact that the prior investigations of the 
neurobiology of anticipatory contrast were restricted to consumption measures alone, any future study 
would benefit from utilising the licking microstructure techniques exemplified here.  For the moment, it 
suffices to say that neither the basic behavioural mechanisms, nor the underpinning neurobiology, of 
anticipatory contrast have been conclusively established. 
7.3 Reward Processing in MAM-treated Rats 
 Using microstructural analysis of licking in both simple exposure and contrasted situations, no 
evidence for either consummatory or anticipatory hedonic deficits were found in animals prenatally 
exposed to MAM.  The implications for these observations for MAM treatment as a schizophrenia 
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model will be considered in the next section, but to put it succinctly, MAM treatment appears to have 
no effect on the hedonic processing of rewards.  
 Aside from the potentially contentious hedonic component of schizophrenia, Chapter four of 
this thesis demonstrates that the MAM model is also unable to elicit behavioural deficits related to 
reward processing that might reflect symptoms associated with schizophrenia.  Behavioural and 
neuroimaging studies have suggested that alterations in the schizophrenic brain cause patients to rely 
predominately on reflexive habits (see Griffiths et al., 2014, and section 1.3.3 of the general 
introduction).  However, using an outcome devaluation task together with a differential outcomes 
procedure, it was shown that MAM-treated rats are able to form, maintain and update representations 
of reward value and use these representations to both motivate and direct their behaviours.  
Moreover, the MAM-treated rats’ superior reversal learning, together with the trend towards persistent 
goal-directed performance, despite extended instrumental training, suggests that MAM animals may 
be particularly sensitive to A-O contingencies.  Given that this is essentially the opposite of the 
expected pattern of habit-driven behaviour, it would appear that MAM-treated rats are unimpaired with 
respect to their instrumental responses to rewards, or at least they are not impaired in the way that 
that would be expected from a schizophrenia model. 
 The absence of the predicted behavioural deficits requires further comment.  Firstly, the 
absence of anhedonia in the model may not be surprising when we consider that hedonic reactions 
appear to be controlled by discreet hedonic hotspots in the rodent brain (see section 1.2).  Not only 
are these hotspot regions very small (often 1mm3) but only the caudal hotspot of the ventral pallidum 
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has been shown to be necessary for hedonic responses, with damage to this area actually replacing 
hedonic liking reactions with disgust reactions (e.g. Ho & Berridge, 2014).  Moreover, these hedonic 
hotspots are located in close proximity to ‘coldspots’, the stimulation of which suppresses positive 
hedonic reactions (e.g. Castro & Berridge, 2014a).  Given the diffuse effects of MAM throughout the 
frontal cortex, the overall balance between subregions which enhance and diminish hedonic reactions 
might be relatively unchanged, even if both sets of subregions are individually disrupted to some 
degree by MAM treatment. 
 Secondly, the lack of habitual behaviour in MAM-treated rats appears to be inconsistent with 
reports of prefrontal impairments and a hyperactivity of subcortical dopamine systems in these 
animals (e.g. Moore et al., 2006).  However, in as-yet-unpublished experiments performed during my 
PhD, sub-chronic PCP treatment, a manipulation that also produces 'hypofrontality' and increased 
mesolimbic dopaminergic tone in rats (e.g. Jones et al., 2011; Neill et al., 2014), also failed to bias 
behaviours towards habitual systems.   
 Finally, while the importance of cortico-striatal systems in the control of instrumental 
behaviour is well established (see section 1.6.1b), it is important to remember that the balance 
between S-R and A-O control appears to reflect the interaction of prelimbic PFC and dorsomedial 
striatum (promoting A-O control of behaviour) and infralimbic PFC and dorsolateral striatum 
(promoting S-R control of behaviour).  Again, given the diffuse effects of MAM throughout the frontal 
cortex, it is possible that the balance between these two systems is not grossly impaired despite 
partial disruption of both.  While the suggestion of a potential bias to A-O control of behaviour in 
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MAM-treated animals might appear to be consistent with a disruption of either infralimbic PFC or 
dorsolateral striatum, any such disruption cannot be complete, because lesions of these regions (see 
section 1.6.1b) result in the clear maintenance of goal-directed responding even after extended 
instrumental training (which was not seen with MAM-treated animals in Experiment six).  
 In short, in the experiments reported here, MAM treated animals do not show any evidence 
for impaired hedonic responses or impairment in the control of instrumental behaviour that would 
reflect a deficit in reward processing.   
7.4 MAM Treatment in the Context of Modelling Schizophrenia 
 Given that MAM-treated animals do not appear to show a general deficit in reward 
processing, either in terms of hedonic reaction or the control of instrumental responding, it is 
important to reconsider the validity and utility of MAM treatment in the context of providing an animal 
model of schizophrenia. 
The first relevant issue is that of anhedonia.  The presence of consummatory anhedonia in 
schizophrenia has been a topic of debate in the literature, but an overwhelming majority of the 
laboratory-based assessments suggest that schizophrenia patients do experience in-the-moment 
pleasure which is indistinguishable from healthy controls (section 1.3.2 of the general introduction).  
As such, the absence of a simple lowering of hedonic reactions in the MAM model may be entirely 
consistent with the disorder.  However, to reconcile the apparent paradox between self-report 
measures and laboratory-based assessments, one theory is that schizophrenia patients are unable to 
259 
appropriately experience retrospective or prospective pleasure (Strauss & Gold, 2012).  The literature 
remains conflicted: use of both the experience sampling method and the Temporal Experience of 
Pleasure Scale have highlighted a deficit in patients' ability to predict pleasure from future events (e.g. 
Gard et al., 2007); while Strauss and colleagues (2011) were unable to replicate these findings.  If 
anticipatory anhedonia indeed features in the disorder, an anticipatory hedonic deficit, as revealed by 
a lack or attenuation of the negative anticipatory contrast effect, would be expected in any complete 
model of schizophrenia.  No such attenuation was observed in the work reported here, implying that 
prenatal MAM treatment is not a comprehensive model of schizophrenia in terms of anhedonia –
whether characterised in terms of consummatory or anticipatory processes.  Indeed, others such as 
Foussias and Remington (2010) go so far as to suggest that all negative symptoms of schizophrenia 
should be reconceptualised as secondary to a primary motivational deficit.  However, unpublished 
work performed within the lab of my industrial supervisor at Eli Lilly (Gary Gilmour, personal 
communication, 2015) show that MAM-treated animals lack motivational deficits when given the 
opportunity to lever press for rewards under a progressive-ratio schedule of reinforcement.  That is, 
even if amotivation is more central to schizophrenia symptomatology than anhedonia, the MAM model 
still appears incomplete. 
 The second relevant issue is that of reward processing in the context of instrumental 
behaviours.  As noted above, there was no evidence for excessive reliance on habitual responding in 
MAM-treated rats, and, if anything, there was a suggestion that MAM rats may display some bias 
towards A-O control of behaviour.  This does not reflect the observation in clinical samples of a bias to 
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habitual responses (see Griffiths et al., 2014, and section 1.3.3 of the general introduction).  
Moreover, the fact that the outcome devaluation and DOE tasks depend on the cortico-striatal 
networks that had been thought to be disrupted by MAM treatment also appears to be contradictory to 
other findings.  For example, Moore et al (2006) found a behavioural phenotype in MAM-treated 
animals (i.e. increased NMDA-induced orofacial dyskinesias and impaired reversal learning on a Y-
maze task) that is consistent with a dysfunctional frontal cortex, while impaired performance on the 
attentional-set shifting task (another task that depends on intact frontal systems) is a well replicated 
finding for this model (e.g. Gastambide et al., 2012).  That said, there is some evidence to suggest 
that deficits in MAM-exposed rats are limited to only certain aspects of cortico-striatal function.  
Featherstone et al. (2007) studied the performance of MAM-exposed rats on a 5-choice serial 
reaction time task which is analogous to the continuous performance task in humans.  Here, rats are 
required to attend to a light stimulus which is displayed in one of five locations, thus requiring 
continued and divided attention from the animal.  Despite performance on this task being known to 
depend, at least partially, on the prefrontal cortex (Christakou, Robbins & Everitt, 2001; Chudasama, 
Passetti, Rhodes et al., 2003; Passetti, Chudasama & Robbins, 2002) and dorsal striatum (Rogers, 
Baunez, Everrit & Robbins, 2001), no deficit was found in the performance of MAM-treated rats.  
Featherstone and colleagues suggest that the similarities in cognitive impairments seen between the 
MAM model and schizophrenia may occur at a purely superficial level, without the MAM behavioural 
deficits tapping into the same underlying neurobiological processes that are impaired in the disorder.  
Alternatively, with neurogenesis disrupted at a late stage during gestation, the structural abnormalities 
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seen in the PFC (and the hippocampus) may be sufficient to cause behavioural impairments on only a 
limited range of tasks.  For example, Flagstad et al. (2005) failed to show any evidence of working 
memory impairments in MAM-treated rats using a delayed non-match-to-position paradigm (a task 
which depends on prefrontal cortex integrity).  The authors reason that as these memory systems rely 
on early maturation of the PFC, disturbances of PFC-dependent tasks may only relate to a later 
maturation of this structure (although the experimental parameters used in the task (e.g. first 
overtraining animals on a non-delay version of the task or allowing animals to adopt a movement-
mediated strategy) may also explain their results).  Further, the same authors found that disrupted 
hippocampal neurogenesis produced by prenatal MAM treatment was not gross enough (or did not 
target the critical areas of the structure) to see impairment on a reference memory version of the 
Morris Water-Maze task.   
 Reversal learning deficits, which are also thought to be partly attributable to perturbations in 
cortico-striatal functioning, were not observed in Experiment five.  This also appears to be 
inconsistent with the fact that reversal learning deficits that have previously been reported in relation 
to the MAM model (e.g. Flagstad et al., 2005; Gastambide et al., 2012).  However, in the reversal 
paradigm of the Morris Water-Maze task, MAM-treated rats performed as well as controls on the last 
day of testing, despite showing deficient reversal performance earlier in the task (days two and three 
of testing) (Flagstad et al., 2005).  Discrepancies have also been seen across the three reversals 
typically used in the attentional set-shifting task, with Featherstone et al. (2007) reporting impairments 
during the first and third reversal, but Gastambide et al. (2012) reporting impairments during the first 
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and second reversal.  Moreover, unpublished work performed at Eli Lilly (Gary Gilmour, personal 
communication, 2015) has suggested large discrepancies across different MAM-treated cohorts in the 
behavioural impairments displayed.  For example, of the eight cohorts tested on a digging reversal 
task, only half showed a significant impairment, and of the eleven cohorts run through an instrumental 
reversal task, eight failed to show any significant differences between MAM-treated rats and their 
saline treated controls, despite all cohorts showing the expected alterations in brain weights.  Similar 
levels of variability have also been seen across other tasks.  It is not immediately clear what might be 
causing this heterogeneity in response to MAM treatment, though it is possible that it may relate to the 
difficulty in accurately timing the intervention at a precise gestational period (relying on the use of 
vaginal plugs).  Regardless, whilst this sort of variability across the MAM model perhaps reflects the 
heterogeneous nature of schizophrenia, it is not conducive to drug discovery efforts - thus limiting the 
utility of MAM in this context. 
 In summary, MAM treatment has previously been reported to produce a variety of behavioural 
deficits and it clearly results in significant disruption of brain development.  However these 
behavioural deficits do not appear to extend to the processing of rewards in ways that might mimic the 
negative symptoms of schizophrenia.  Moreover, the deficits that have been reported to follow from 
MAM treatment are somewhat variable (to say the least), and may also relate to disruption of brain 
systems at least partially unrelated to schizophrenia.  Thus, while MAM treatment might remain an 
interesting manipulation through which to examine the long-term effects of a time-focused disruption 
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of neural development, it does not appear to produce a particularly useful or consistent schizophrenia 
model when taken in isolation. 
7.5 Reward Processing in the WKY Inbred Rat Strain 
 Chapter five investigated consummatory and anticipatory hedonic deficits in the WKY inbred 
rat strain, a putative model of comorbid depression and anxiety.  Using the same methods employed 
for investigating the MAM model, WKY animals showed behaviours consistent with both 
consummatory and anticipatory hedonic deficits. 
 Turning first to Experiment seven, the results of consummatory hedonic deficits in the model 
are in accordance with previous research on the WKY strain.  Using a wide variety of behavioural 
paradigms it has been shown that WKY rats demonstrate deficits in two-bottle preference tests 
(Malkesman et al., 2005), show less self-administration of pleasurable substances (De la Garza, 
2005) and find a sexually receptive female less rewarding (Paré, 2000).  The current experiment 
advances previous findings by directly demonstrating reduced hedonic tone in WKY rats using an 
appropriate measure that does not conflate hedonic and motivational impairments. 
 Considering the hedonic hotspots of the rodent brain and the importance of opioid systems in 
amplifying pleasure responses (section 1.2 of the general introduction), a reduction of opioid activity 
may feature in WKY rats at one or more of these hotspot regions.  Indeed, reciprocal relationships 
have been seen between the VP and NAc, in that one cannot enhance 'liking' without the other (as 
reviewed by Berridge & Kringelbach, 2015), so increasing opioid levels in either of these two regions 
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may improve hedonic reactions in this strain.  Alternatively, as has been briefly mentioned earlier, 
WKY rats may have altered kappa-opioid receptor systems in the brain with kappa-opioid antagonists 
reversing some of their depression-like behaviours (e.g. reversing increased immobility in the forced 
swim test as compared to a Sprague-Dawley control; Carr et al., 2010).  Carr et al. (2010) found 
elevated baseline levels of Dynorphin A (an endogenous kappa-opioid receptor ligand) in the NAc of 
WKY rats compared to their Sprague-Dawley controls.  Whilst increased kappa-opioid activity in the 
precise hotspot region of the NAc shell should increase hedonic tone (inconsistent with our findings), 
increased levels in regions outside the hotspot would be expected to suppress 'liking' responses 
(Castro & Berridge, 2014a).  The systemic or regional application of a selective kappa-opioid receptor 
antagonist (e.g. U50488H) would determine whether reduced hedonic tone is due to increased kappa-
opioid activity levels in the WKY rat strain. 
 Experiment eight demonstrated that WKY rats were able to display a contrast effect in terms 
consumption, but not in terms of their palatability responses.  The dissociation seen between 
consumption measures and palatability responses for the WKY strain sheds light on the 
cognitive/affective interactions found in the WKY model.  The contrast-dependent changes in 
consumption may suggest that WKY rats are able to form some sort of expectation of the second 
solution in the pairing: they are adjusting their intake of the initial solution in light of this expectation.  
The lack of contrast-dependent changes in LCS suggests that WKY rats are unable to modulate their 
affective responses to the initial solution based on the expectation of the second solution.  This 
blunted modulation of their affective responses in light of future events may reflect the presence of 
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anticipatory anhedonia in this rat strain.  However, it should be remembered that the general 
reduction in hedonic tone in these animals might have produced a restriction of range in the critical 
LCS measure, obscuring any potential hedonic effects of contrast.  Regardless, the results of 
Experiments seven and eight clearly demonstrate that WKY rats display an analogue of the 
anhedonia associated with depression in humans. 
 Chapter six investigated whether the WKY strain also includes reward-related deficits, beyond 
the narrow concept of anhedonia.  WKY rats were unable to use reward representations to control 
their behaviours even after only minimal levels of training, consistent with habitual control of their 
performance.  Furthermore, WKY rats did not benefit from differential outcomes during the acquisition 
of a conditional discrimination task, also suggesting that reward representations cannot be used by 
this strain to direct their choice behaviours.  Both a reliance on stimulus-response associations and a 
lack of the Differential outcomes effect may be consistent with altered amygdala formation in the WKY 
inbred strain.  For example, lesions (e.g. Balleine et al., 2003) and temporary inactivation (Parkes & 
Balleine, 2013) of the BLA render animals insensitive to the devaluation of particular reinforcing 
events.   Furthermore, Blundell et al. (2001) demonstrated that BLA-lesioned animals could not make 
use of the distinct sensory properties of different reinforcers to aid their discrimination learning.  Whilst 
impaired amygdala function would be entirely consistent with an anxious depressed phenotype (e.g. 
Sandi & Richter-Levin, 2009; Wolfensberger, Veltman, Hoogendijk, Boomsma, & de Geus, 2008), it 
cannot account for all WKY-related behaviours, particularly the reduced palatability responses to 
sweet tastes observed in Experiment seven.  Indeed, Mahler and Berridge (2012) demonstrated that 
266 
DAMGO microinjection into either the BLA or CeA does not enhance the number of positive hedonic 
reactions to sweet tastes, and neuroimaging results suggests that amygdala activation does not 
reflect the subjective pleasantness of food cues (Small, Veldhuizen, Felsted, Mak & McGlone, 2008).  
Whilst WKY rats may suffer from deficits in amygdala-related behaviours, clearly deficits in other brain 
regions (perhaps the connected NAc) must account for their impaired hedonic processing. 
 The associations that can be formed in WKY animals will be discussed in section 7.7.  Further 
work is needed to determine the precise impairment in reward representation in this strain, but based 
on current work, WKY rats appear to be impaired in multiple reward-related processes.  Therefore, 
the results presented here reinforce the idea that the WKY rat is a valuable rodent model for the pre-
clinical investigation of depression. 
7.6 Stress Effects in the WKY Model and their Controls 
 Whilst the application of a chronic mild stress procedure generally exacerbated the 
behavioural deficits seen in the WKY strain, no interactions were seen between stress and strain for 
any of the experiments reported in this thesis.  Taken at face value, this suggests that the explicit 
application of stressors is not a necessary antecedent for reward-processing deficits to manifest in the 
WKY rat. 
 Turning first to the results of Experiment seven, regardless of strain, stress appeared to 
reduce general consumption levels across the three concentrations of sucrose.  This general stress 
effect on consumption confirms that the unpredictable chronic mild stress procedure adopted here 
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was effective.  Moreover, the fact that these stress effects were maintained over both Experiments 
seven and eight suggests there was little or no overall habituation/de-sensitization to the procedure.  
The application of a chronic mild stress procedure, however, did not produce a decrease in the LCS 
measure in either the WKY rats or Wistar controls.  The dissociation between consumption and LCS 
measures in the control strain is important when considering the fact that unpredictable chronic mild 
stress is a widely used depression model.  Indeed, the primary impetus for developing the chronic 
mild stress procedure was to simulate anhedonia in rats (see Wiborg, 2013, for a review), and the 
stress-produced reduction in sucrose consumption has been interpreted to reflect abnormal hedonic 
reactions (e.g. Willner et al., 1987).  Considering the consumption data alone from Experiment seven, 
the reduced intake for stressed Wistar rats across solutions is apparently consistent with this previous 
interpretation that chronic stress reduces in-the-moment pleasure.  However, my results show that, at 
least after the stress procedure used here, a reduction in consumption does not necessarily mean a 
reduction in a rat's hedonic responses.  Given that the licking microstructure measure is a more direct 
measure (and potentially less subject to confounding motivational influences) of hedonic responses 
than simple consumption measures, these results highlight that the reduction in sucrose consumption 
following chronic stress might not actually reflect the presence of anhedonia.  More generally, the 
dissociation of consumption and LCS measures implies that both should be considered in 
investigating the presence of an anhedonic profile. 
 That said, the relationship between the current stress procedures and those used previously 
is somewhat questioned by the lack of a stress effect on the balance between goal-directed and 
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habitual systems.  As discussed in section 1.3.6, it has previously been shown that both chronically 
and acutely stressed rats were insensitive to changes in outcome value, indicating that their 
behaviour was under habitual control (Braun & Hauber, 2013; Dias-Ferreira et al., 2009).  The training 
schedule used in both of these experiments differed from the current study, making it hard to 
determine the equivalence of the training regimens.  That said, both used ratio schedules in which a 
response is followed by a certain probability of a reward.  With a high experienced contingency 
maintained between the action and the outcome, these schedules promote goal directed, as opposed 
to habitual, responding in healthy untreated rats.  The lack of a stress effect for Experiment nine may 
suggest that the stress procedure adopted was not substantial enough to modify behaviour on all 
tasks.   
 Returning to the question of whether the application of external stressors is needed to elicit a 
behavioural profile in WKY rats, the fact that there was either no stress effect in the WKY rats, or that 
any stress effects were also reflected in the Wistar controls, certainly suggests that external stressors 
are not required.  However, any interpretation of the stress effects in WKY animals requires the No-
stress group to actually be non-stressed.  Whilst every attempt was made to reduce stress in the No-
stress WKY animals, this strain may well be hyper-responsive to stress effects.  In light of this 
possibility, it is important to consider the possible effects of the experimental manipulations 
themselves.  For example, food restriction (which was used in all the experiments reported here) has 
been used as part of chronic stress regimes used elsewhere (see Willner, 1997; Xu, Barish, Pan, 
Ogle & O'Donnell, 2012, for reviews), and the use of a shared holding room meant that the animals 
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were exposed to the presence of unfamiliar laboratory personnel and other rats.  Furthermore, since 
taste aversion with LiCl was used to devalue the outcome in Experiment nine, all animals were given 
intraperitoneal injections, which again may have affected the WKY animals.  Finally, going back as far 
as the early postnatal period, reduced parental care from a 'depressed' WKY dam may have induced 
stress effects in the WKY animals (see Ahmadiyeh, Slone-Wilcoxon, Takahashi & Redei, 2004; 
Cierpial, Shasby & McCarty, 1987). 
 Based on the current results alone, it is possible either that the WKY rats have a strong 
genetic diathesis that supersedes any environmental influences, or that only minor stressors are 
required to shape their behavioural profile.  Thus, the current results do not definitively determine 
whether stress is required to elicit the WKY deficits seen across these experiments.  That said, the 
fact that applying explicit external stressors, which were sufficient to influence the behaviour of the 
Wistar controls, did not produce any greater effects in the WKY model certainly implies that future 
consideration of the WKY rats can focus on strain effects alone. 
7.7 Representations of Reward in the WKY Model 
 Experiment nine suggests that three days of training were sufficient to bias the WKY rats’ 
behaviour towards habitual systems, controlled by S-R associations.  Considered alone, this could 
reflect one of four possible alternatives: habitual behaviour in the WKY rat may be due to (1) a failure 
to form A-O associations (and thus the WKY rats might be S-R only); (2) a failure to form sensory 
specific (as opposed to general motivational) outcome representations; (3) a fast transition from A-O 
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to S-R controlled behaviours, or (4) that S-R and A-O associations might both form in the WKYs, but 
that S-R associations have the dominant effect on instrumental responses when both types of 
association are retrieved. 
 While all these possibilities are consistent with the results from Experiment nine, the results of 
the other experiments reported in this thesis suggest which of the four are perhaps more likely.  The 
idea that WKY rats are entirely S-R organisms (possibility 1) is certainly consistent with the lack of a 
differential outcomes effect during task acquisition (Experiment ten).  As lever pressing during this 
conditional discrimination task is reinforced in the presence of distinct visual stimuli, it is possible that 
the conditional discrimination can be solved by forming S-R associations alone.  As the reward would 
not be included as part of an entirely S-R associative framework controlling behaviour, no 
performance benefit would be seen for animals in the differential as opposed to non-differential 
groups – which is exactly the pattern displayed by the WKY rats.  However, the reinforcer only test in 
Experiment ten is not consistent with an S-R only analysis.  The fact that WKY rats show better 
performance in the differential than non-differential conditions, when the visual discrimination stimuli 
are not present, implies that the WKY rats must have encoded at least some aspects of the different 
outcomes, even if these outcome representations did not influence behaviour when the visual 
discrimination stimuli were available. 
 Moreover, the idea of WKY rats being entirely stimulus-bound, unable to encode any part of a 
reward, is difficult to reconcile with the contrast effects in consumption seen in Experiment eight.  This 
interpretation would require that the negative contrast effect in consumption can be explained by S-R 
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mechanisms.  However, negative anticipatory contrast is not usually amenable to an S-R analysis: if a 
licking requirement (i.e. an instrumental contingency) is placed on the initial solution before access is 
given to the second solution, the negative anticipatory contrast effect disappears or reverses, 
demonstrating that it is not an instrumental (i.e. S-R) response (see Flaherty, 1996, for further 
discussion of this topic). 
 Moving on to the second possibility, that WKY rats are only capable of impoverished outcome 
representations, an inability to encode the sensory properties of different rewards could also explain 
the lack of a differential outcomes effect during the acquisition of a conditional discrimination.  When a 
conditioned stimulus (CS: such as a light) is paired with an unconditioned stimulus (US: such as 
food), it is thought that several distinct associations can form (Konorski, 1967).  Upon CS presentation 
an internal representation of the CS is evoked.  US presentation is capable of evoking both sensory 
(USs) and motivational (USm) representations.  In the normal animal, associations can be formed 
between the CS representation and the representations of the USs and USm and/or between the CS 
representations and the responses the USs and USm evoke (see Blundell et al., 2001).  It should be 
noted at this stage that USs refers to the sensory and hedonic properties of the reinforcer that are 
specific to the individual outcome, whereas USm refers to the general arousing aspects of motivation 
for each outcome (Blundell et al., 2001).  Similarly to S-R associations, associations formed between 
the discriminative stimuli and the general motivational aspects of the rewards (USm) would allow the 
WKY rats to solve a conditional discrimination, but would not allow differential outcomes to serve as 
additional stimuli to aid learning.  As both discriminative stimuli (S), and indeed both responses (R), 
272 
would elicit the same outcome representation (O), differential S-O and R-O associations would not be 
formed and essentially the stimuli alone (as is the case in the non-differential group) would direct the 
rats’ choice behaviour. 
 This ‘motivation only’ outcome idea is perhaps consistent with the negative anticipatory 
contrast data in terms of consumption.  Insofar as consumption reflects the motivational aspects of 
the reward (USm), while LCS reflects the palatability or sensory aspects of the reward (USs), an 
ability to form USm representations but not USs representations in the WKY rat may promote contrast 
effects in consumption but not in palatability.  That said, this interpretation does not fit with the 
reinforcer only test of Experiment ten where better performance is seen for WKY rats in the differential 
as opposed to non-differential groups.  For this to be explained by the formation of USm associations, 
the sucrose and pellet reinforcers would need to have different motivational values.  But if the USm 
representations were sufficiently different to control responding in the reinforcer-only test, then they 
should also be sufficiently different to support differential responding in the acquisition stage of this 
task.   
 When the results of Experiments eight, nine and ten are considered together, the data are 
probably not consistent with either possibility 1 or 2.  If the rats do encode something about the 
reward under at least some circumstances then the issue may lie with when this learning is 
expressed. 
 A fast transition from A-O to S-R associations (possibility 3) is consistent with the WKY rats 
generally higher response rates during the acquisition of an instrumental task in Experiment nine (and 
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indeed in Experiment ten, although the raw lever-press data is not presented here).  As mentioned 
previously, one potentially important determinant of the associative structure underlying instrumental 
behaviour is the experienced contingency between the response and its outcome (Dickinson, 1985).  
Dickinson proposed that both overtraining and interval schedules reduce the experienced correlation 
between response rate and reward rate.  As awareness of the instrumental contingency is dependent 
on a variation in behaviour giving rise to a variation in the delivery of rewards, it is possible that WKY 
rats are responding at sufficiently high levels to reduce the effective correlation between response 
and reward rates, causing their responses to be driven by S-R associations.   
 This idea of a fast transition can be also be used to explain the reinforcer-only results of 
Experiment ten if the R-O associations can be expressed when S-R links are not retrieved (given that 
the S is not there in the reinforcer-only test).  However, this also fits well with the idea that WKYs 
might form both A-O and S-R associations and that it is simply a matter of S-R associations 
dominating (possibility 4).  Both these possibilities also fit with the neurobiological data on reward 
devaluation, and the idea that both A-O and S-R associations form, and that different parts of the 
cortico-striatal circuits alter the balance between which is expressed. That is, results showing that 
infralimbic cortex lesions after extended training cause animals to return to A-O dependent 
behaviours suggests that these two associations compete for their influence over instrumental 
responding, such that one can dominate but does not remove the other (Coutureau & Killcross, 2003).  
Finally, both possibilities are consistent with the results from the negative anticipatory contrast 
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procedure.  When S-R associations cannot be formed, WKY rats can and do form associations 
between the stimuli (i.e. the context) and the outcome (i.e. the second solution's identity). 
 In summary, the most appropriate characterisation of the WKY deficit based on the current 
results is not a failure to process/encode the specific nature of rewards, but a dominance of habitual 
behaviours, even though A-O associations are formed.  Whether this reflects a rapid transition to S-R, 
or is a general result of an imbalance to S-R control of behaviour, cannot be determined on the basis 
of the current data.  Section 7.10 will highlight potential future investigations which would afford a 
better understanding of the precise reward processing deficits seen in the WKY model.  But 
regardless of the exact characterisation, the dominance of S-R associations (be it overall or through a 
swift transition) suggests that WKY animals have a deficit in using, but not necessarily encoding, the 
nature and value of rewards.  Thus the WKY inbred rat strain may provide a good model of the 
inflexible behaviour which features in depression. 
7.8 WKY Model and Depression 
 Based on the current results, the WKY rat strain appears to provide a valuable rodent model 
of depression, at least in terms of the affective and reward processing deficits.  However, a few 
factors require consideration.  First, Experiment seven demonstrated that consumption was clearly 
modulated by solution concentration in WKY rats, whereas the modulation of their palatability 
responses was severely attenuated.  Indeed, LCS was only marginally higher for 24% sucrose than 
2% sucrose.  As such, it is at least possible that the reduced LCSs seen could reflect a licking 
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behaviour that is so impaired that changes in affective responses are untraceable.  That said, analysis 
of the WKY rats alone demonstrated that the differences between the high and low concentrations of 
sucrose were statistically significant, suggesting both that the WKY rats licking behaviour is not fixed 
by some motor impairment and that the WKYs affective responses to the solutions were severely 
blunted rather than entirely absent.  Moreover, the analysis of the inter-lick intervals within licking 
clusters did not reveal a general motor impairment which could have produced all of the lick cluster 
size reductions observed in Experiments seven and eight. 
 Second, whilst the majority of laboratory-based studies have indicated that depressed 
individuals, compared to healthy controls, generally rate positive stimuli as less positive and/or 
arousing (e.g. Berenbaum & Oltmanns, 1992; Dunn et al., 2004; Sloan et al., 1997), inconsistencies 
do exist in the literature (see Treadway & Zald, 2011).  Of particular relevance to the current 
investigation, the “sweet-taste test” in depressed individuals (a test that closely mirrors our animal 
measure of hedonic experience) has shown normative in-the-moment pleasure ratings across four 
separate studies (Amsterdam et al., 1987; Berlin et al., 1998; Dichter et al., 2010; Kazes, Danion, 
Grange et al., 1994 - see Treadway & Zald, 2011, for a review).  While the sizeable individual 
differences in taste sensitivity found in human subjects may explain the lack of power to discern a 
depression-related difference in responses to sweet tastes (Duffy & Bartoshuk, 2000), it is also 
possible  that hedonic deficits in depressed patients are stimulus specific.  That is, patients 
experience deficient hedonic processing of some stimuli (i.e. pictures and film-clips) but a relatively 
unimpaired hedonic capacity to experience other stimuli (e.g. food and drink - although see 
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Berenbaum & Oltmanns, 1992).  Perhaps it is simply the case that responses to sweet solutions may 
not be as sensitive to changes in hedonic perceptions in humans as is the case for animals.  One 
important distinction that may also underlie these discrepancies between clinical and preclinical 
studies is that studies in the clinic rely on subjective ratings, whereas studies in rodents rely on 
objective measures.  Regardless of these issues, the current results show that WKY rats model 
consummatory anhedonia, if not perhaps towards the same eliciting stimuli as in clinical depression. 
 Despite Experiment seven showing some concentration effects for LCS in the WKY strain, it 
must be conceded that the greatly blunted range of LCSs seen in these animals may give little scope 
for the typical lowering of hedonic responses that are seen for a contrasted solution (i.e. a 4% solution 
that is reliably followed by a 32% solution).  As discussed in the summary section for Experiment 
eight, a potential floor effect for WKY animals during the negative anticipatory contrast procedure is 
unlikely to be due to a measurement problem, as taste aversion studies strongly indicate that LCSs 
are capable of going far lower than that seen in the current study.  Furthermore, as alluded to earlier, 
the reduced hedonic range in WKY rats does not appear to be the result of gross disturbances in the 
general licking competency of these animals as other parameters such as ILI appear relatively 
normal.  Regardless, it is clear that further work must also be carried out to confirm the presence of 
anticipatory hedonic deficits in the WKY rat strain. 
 The presence of anticipatory anhedonia in depressed patients has not received much 
attention in the literature.  McFarland and Klein (2009) found that individuals suffering from 
depression gave significantly lower ratings of positive emotions during the anticipation of monetary 
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rewards compared to never depressed control subjects.  Similarly, fMRI studies have revealed 
diminished striatal responses to anticipation of reward (Forbes et al., 2009; Smoski et al., 2009).  High 
self-report of anticipatory anhedonia has also been shown for depressed patients (Sherdell et al., 
2012).  Combined, these data provide some evidence for a deficit in experienced emotion during 
reward anticipation in depression.  However, some contradictory findings also exist in the literature.  
Using the Monetary Incentive Delay task (that probes consummatory and anticipatory hedonics) no 
differences were found between depressed individuals and control individuals during reward 
anticipation (Knutson et al., 2008; Pizzagalli et al., 2009).  The interpretation of these experiments is 
made difficult, however, as the period of reward anticipation was not passive, but instead required the 
subject to prepare for a speeded manual response.  Clearly, the measure of anticipatory anhedonia 
may be confounded by the depressed subjects heightened punishment motivation (Treadway & Zald, 
2011).  Further work, specifically using the temporal-experience of pleasure scale and passive 
Pavlovian versions of the MID task (see Dowd & Barch, 2012), needs to be carried out before we can 
be certain as to how the WKY model relates to the hedonic processing deficits found in depression. 
 The demonstration that WKY rats' instrumental behaviour is controlled predominantly by S-R 
associations (Experiment nine and ten) is consistent with the cognitive and motivational deficits 
recognised in depression.  As discussed in section 1.3.6, early descriptions of the disorder placed a 
large emphasis on cognitive inflexibility, while more recently it has been suggested that reward 
processing impairments may be central to these cognitive disturbances.  In relation to depression, 
Griffiths et al. (2014) state that "as experienced rewards are no longer pleasurable, it is easy to 
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envisage how action control could become biased away from goal-directed actions" (p. 8).  The idea 
of an over-reliance on habitual systems is also in line with the impaired decision-making abilities seen 
for depressed individuals together with the high comorbidity seen between depression and other 
habit-based disorders such as substance abuse.  Moreover, structural and functional changes in the 
depressed brain show significant overlap with the core circuitry known to control the balance between 
A-O and S-R systems. 
 As acknowledged in section 7.6, it is currently unclear whether the strain alone or interactions 
between strain and stress was critical in biasing behaviour towards reflexive habits, primarily due to 
the increased stress vulnerability of the WKY rat.  With both stress (Schwabe & Wolf, 2010) and 
pharmacological manipulations implicating cortisol (Schwabe et al., 2010) in increased habitual 
behaviours in human studies, it is possible that the hypercortisolaemia seen in the WKY strain 
induced the shift to habitual behaviours reported here.  Moreover, it likely that any neurochemical 
alterations in the strain are accompanied by structural or functional changes in the cortico-striatal 
circuits underlying goal-directed and habitual behaviours.  The bias to habitual systems in rats after a 
stress procedure has been shown to be accompanied by atrophy of the medial prefrontal cortex and 
dorsomedial striatum (implicated in A-O control) and hypertrophy of the dorsolateral striatum 
(implicated in S-R control) (Dias-Ferreira et al., 2009; Schwabe & Wolf, 2011).  While the stress 
manipulation used here was clearly not substantial enough to induce a similar behavioural profile in 
the control strain, it is possible that similar stress-induced or inherent structural abnormalities are 
present in WKY rats.  Further work in the clinic is required to both confirm a dominance of S-R 
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associations in depressed patients (on a comparable outcome devaluation task) and to determine the 
neural mechanisms involved.   
 While the results here suggest that the WKY rat is a promising model for the pre-clinical 
investigation of depression, as with any modelling approach, there are some potential complicating 
factors that need to be considered in any future work.  Most importantly, the breeding history of the 
WKY rat has resulted in some divergence between the genetic profiles of rats associated with 
different suppliers (e.g. Zhang-James, Middleton & Faraone, 2013).  These genetic differences are 
reflected in phenotypic variability among WKY rats (Kurtz & Morris, 1987; Paré & Kluczynski, 1997) 
suggesting that there are actually a number of substrains of WKY animals.  Genotyping suggests that 
WKY rats supplied by Charles River from UK (used here) or USA breeding stocks are the most 
relevant for studying depression-like behaviours in this rat strain (see Zhang-James et al., 2013). 
 Furthermore, WKY rats, alongside the spontaneously hypertensive rat (SHR) were originally 
developed from an outbred Wistar strain.  As such, a large number of studies have used both Wistars 
(e.g. De La Garza et al., 2005; Malkesman et al., 2005; Malkesman, Braw, Maayam et al., 2006) and 
SHR rats (e.g. Paré, 1989a; Paré & Schimmel, 1986) as the control strain due to their common 
genetic backgrounds (e.g. Nam et al., 2014).  However, in some studies, particularly concerning 
antidepressant effects and neurochemical characterisation, Sprague-Dawley comparison strains have 
been used (e.g. Carr et al., 2010; López-Rubalcava & Lucki, 2000; Rittenhouse et al., 2002; Tejani-
Butt et al., 2003), despite their genetic divergence from the WKY strain (see Nam et al., 2014).  
Additionally, because the WKY rat was not completely inbred prior to initial distribution, this has led 
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some investigators to generate two fully inbred substrains of WKY ("WKY more immobile" and their 
"less immobile" controls) through bidirectional selective breeding, based on forced swim test mobility 
(e.g. Will et al., 2003; Williams, Mehta, Redei, Wang & Procissi, 2014).  Regardless of the potential 
issues around control strains, the pattern of deficits seen here cannot simply be attributed to 
abnormally high levels of performance in the Wistar controls.  For example, hedonic changes in the 
negative anticipatory contrast paradigm were seen in MAM, Lister Hooded, and Sprague-Dawley rats, 
but not WKYs, and the DOE and reward devaluation effects have been observed in multiple strains 
(including the Sprague-Dawleys and Wistars used here).  Moreover, the WKY deficits are not simply a 
quantitative difference to controls, but in many cases reflect a qualitative difference between the 
behaviour observed in the WKY animals and that of controls (e.g. the absence of a DOE and 
devaluation effects, or the consumption/LCS dissociation in the negative anticipatory contrast 
paradigm). 
7.9 Reward Related Processing in Psychiatric Disorders and their Animal Models 
 As supported by the results reported in Chapters five and six of this thesis, Ribot's original 
definition of anhedonia, as an inability to experience pleasure, appears to be outdated as it does not 
reflect the nuances that exist in reward processing nor how these might relate to different psychiatric 
and neurological disorders.  Whilst understanding in this area is growing, many researchers still use 
anhedonia as a blanket term and use measuring techniques that could reflect an array of reward-
related deficits alongside the intended hedonic measure.  The picture in the clinic is further 
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complicated by a lack of clarity with the classification criteria used for the disorders.  Indeed, as has 
been highlighted previously, the DSM-V includes a loss or reduction in interest or pleasure in usually 
enjoyable activities in relation to anhedonia in depression (American Psychiatric Association, 2013; 
Rømer-Thomsen et al., 2015).  Yet, assuming equivalence between hedonic and motivational 
systems is clearly misguided given that these two processes are dissociable at both the behavioural 
and neural levels.   
 Based on the current experiments reported in this thesis it is clear that many different aspects 
of rewards should be considered using a battery of sensitive methods.  Whilst translational 
assessment techniques (such as those reported here) are a critical first step, animal models need to 
reliably include symptom-like behaviours.  In light of the heterogeneity of disorders such as 
schizophrenia and depression, it is unlikely that all behavioural impairments associated with these 
disorders will be replicated in a single model.  Understanding the short-comings of a model (such as 
the MAM neurodevelopmental model) can be just as informative as finding positive results.  
Furthermore, it must be recognised that animal models of disorders are only as good as the 
knowledge in the clinical literature allows.  More precise investigation into the affective and cognitive 
aspects of reward processing in disorders such as depression must be performed to inform the 
preclinical models of which face and construct validities they should encompass. 
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7.10 Future Directions 
 The presence of hedonic and other reward processing deficits in the WKY rat reinforces the 
idea that it might offer a useful pre-clinical depression model.  This possibility would require further 
validation.  One obvious possibility might be through the examination of the effects of established anti-
depressant pharmacology on the sorts of deficits identified here.  Another possibility is suggested by 
epidemiological studies which clearly demonstrate a strong gender bias for depression, with a higher 
likelihood of women developing depression, and indeed comorbid anxiety.  Future work performed on 
the WKY strain should also consider comparing behavioural differences across genders.  But prior to 
such model-validation research, the accurate characterisation of the precise reward-related deficits 
displayed by this model should be completed.   
 To date, I have demonstrated that the behaviour of WKY rats is controlled by S-R 
associations at the expense of A-O associations.  To tease apart whether this is best characterised by 
a fast transition to S-R systems or a general imbalance to S-R control, future studies could adopt an 
outcome devaluation procedure after one day of instrumental training.  By significantly reducing 
training length, an animal which is capable of goal-directed behaviour (but with a rapid transition to 
habitual control) should be sensitive to post-conditioning changes in reward value: reducing its 
responding on a lever paired with a devalued outcome compared to a non-devalued outcome.  
Similarly, instrumental tasks that employ two levers and two outcomes are also designed to promote 
goal-directed behaviours by maintaining a high experienced instrumental contingency (choosing one 
action completely stops reward delivery for the alternative action) regardless of training length.  Using 
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these paradigms, a failure to detect suppression in lever press rates in WKY animals would provide 
cogent evidence that they cannot use reward value to guide their behaviours.   
 Whilst the current data reported here suggests that impoverished value representations (i.e. 
USm but not USs associations) is not the best characterisation of the WKYs behaviour (i.e. this does 
not allow for the differential outcomes effect during the reinforcer-only test of Experiment ten), the use 
of a differential outcomes procedure, with the two rewards varying in terms of their motivational rather 
than sensory properties, would provide the empirical evidence required to support this claim.   
 My work recently performed at Lilly UK has started to investigate these alternatives: In a two-
lever, two-outcome paradigm WKY rats responded less on a lever associated with the devalued 
outcome (fed to satiety immediately before test) compared to the lever associated with the non-
devalued outcome (not fed to satiety); moreover, while a marginal performance benefit was seen 
when WKY rats were trained on a conditional discrimination where stimulus-response contingencies 
were correlated with outcomes of different magnitudes (e.g. Flashing light: Left lever → 1 plain pellet; 
Steady light: Right lever → 5 plain pellets) than when the outcome magnitiude was not consistently 
paired with different responses, this benefit was substantially less than for controls.  Although
preliminary, these results suggest that WKY animals may well form A-O associations relatively 
normally, but that they control instrumental behaviour only under restricted experimental conditions.  
One possible way to further probe these circumstances might be to put S-R and A-O associations into 
conflict – as has been attempted by using rewards as cues in an instrumental discrimination (e.g. 
Dwyer et al., 2010; de Wit, Kosaki, Balleine & Dickinson, 2006; Dickinson & de Wit, 2003) 
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 In one sense, the results in this thesis raise as many questions about the nature of reward 
processing in the WKY rat as they provide answers.  But regardless of the outcome of future attempts 
to characterise the precise reward processing deficits displayed by WKY rats, the fact that they clearly 
display a range of hedonic and cognitive deficits compared to controls suggests that any such future 
work should prove to be particularly valuable given the potential for the WKY rat to contribute to pre-
clinical research.  In contrast, the absence of any consistent reward processing deficits following MAM 
treatment suggests that the prime contribution of my research in this area is to question the utility of 
this treatment as a potential pre-clinical model for schizophrenia. 
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8. Appendices 8.1 Appendix A – MAM and WKY cohorts and testing order 
Strain Cohort Experiment Chapter Start Date
MAM 1
(n = 24
MAM, 18
Sham)
Consumption in MAM rats
(Exp. 2)
3 June ‘12
Outcome devaluation procedure
in MAM rats (Exp. 4)
4 July ‘12
Conditional discrimination and
reversal
Not included in
thesis
Aug ‘12
Hyper-locomotion in MAM rats
after an MK-801 challenge
Included in
appendix only
Sept ‘12
MAM 2
(n = 24
MAM, 24
Sham)
Consumption in MAM rats
(Exp. 2)
3 Feb ‘13
Outcome devaluation procedure
in MAM rats (Exp. 4)
4 March ‘13
WKY 1
(n = 12
KNS, 12
KS, 12
WNS, 12
WS)
Chronic mild stress procedure commenced Oct ‘13
Negative anticipatory contrast in
the WKY rat (Exp. 8)
5 Oct ‘13
Consumption in the WKY rat
(Exp. 7)
5 Dec ‘13
Stress procedure stopped - rats given environmental
enrichment in home cages
23rd Dec
‘13
Stress procedure reinstated Jan ‘14
Outcome devaluation procedure
in the WKY rat (Exp. 9)
6 Jan ‘14
Differential outcomes effect in the
WKY rat (Exp. 10)
6 Feb ‘14
MAM 3
(n =16
MAM, 16
Sham, 16
Non-
exposed)
Negative anticipatory contrast in
MAM rats (Exp. 3)
3 Feb ‘14
Outcome devaluation procedure
with extended training in MAM
rats (Exp. 6)
4 March ‘14
Differential outcomes effect in
MAM rats (Exp. 5)
4 April ‘14
Consumption in MAM rats
(Exp. 3)
2 July ‘14
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8.2 Appendix B – MAM validation tests 
To further validate the MAM model, Cohort one underwent a psychostimulant challenge with MK-801, 
see below.  Brains for each of the three cohorts were also extracted and weighed after the completion of 
behavioural analyses.  Evidence suggests that rats prenatally treated with MAM display an approximate 11% 
decrease in total brain weight (Flagstad et al., 2004).  Animals were culled via a rising concentration of CO2 and 
their brains extracted and weighed without fixation.  The juvenile brain weights reported for cohort one were 
provided by Charles River, UK.  
Juvenile Brain Weights: MAM Cohort 1 
1) Absolute Brain Weights: 
The brains of pups prenatally treated with MAM were significantly lighter than saline-treated controls, t (6) = -
4.568, p = .004 
 2) Relative Brain Weights: 
When relative juvenile brain weights (brain weight/ body weight) were considered, there was no difference 
between MAM-treated and saline-treated animals, t (6) = -.547, p = .604 
Adult Brain Weights: MAM Cohort 1-3 
Table 16 Effect of prenatal MAM and saline treatment at GD17 on adult brain weights (g) for each of the three cohorts.  
Relative brain weights were calculated as Brain Weight/Body Weight. 
Cohort Prenatal
Treatment
n Mean
Brain
Weights
(g)
SEM % Difference Mean Relative
Brain Weights
(g)
SEM % Difference
1 Saline 18 2.242 0.022 12.391 0.357 0.008 0.615MAM 24 1.965 0.011 0.351 0.005
2 Saline 24 2.297 0.023 11.657 0.368 0.007 10.965MAM 23* 2.023 0.097 0.328 0.029
3
Saline 16 2.216 0.021 M v. S 12.211 0.415 0.010 M v. S 13.329
MAM 16 1.946 0.021 M v. N 12.137 0.360 0.008 M v. N 7.729
Non-exposed 16 2.214 0.023 S v. N 0.085 0.390 0.009 S v. N 6.069
*one saline-treated animal died after testing and it's brain was not harvested 
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Independent 2-tailed t-test: 
Cohort 1:  
1) Absolute Brain weights: t (26.037) = - 11.219, p < .001
2) Relative Brain weights: t (36) = -.648, p = .521
Cohort 2:
1) Absolute Brain weights: t (45) = -8.968, p < .001
2) Relative Brain weights: t (45) = -4.445, p < .001
ANOVA analysis:
Cohort 3:
1) Absolute Brain weights: 
 Main effect of treatment (F (2, 45) = 50.780, p < .001, MSE = .388).   
 Simple effect analyses: 
o MAM-brains were significantly lighter than brains from both saline-treated (F (1, 45) = 76.421, p 
< .001, MSE = .001) and non-exposed animals (F (1, 45) = 75.298, p < .001, MSE = .001).  
o No significant difference in brain weights for saline and non-exposed control groups (F < 1).
 2) Relative Brain weights:  
 Main effect of treatment (F (2, 45) = 9.647, p < .001, MSE = .012) 
 Simple effect analyses: 
o MAM-brains were significantly lighter than for saline-treated (F (1, 45) = 17.899, p < .001, MSE
= .0002) and non-exposed controls (F (1, 45) = 5.325, p = .021, MSE = .0002). 
o No significant difference in brain weights between saline and non-exposed control groups (F (1, 
45) = 3.698, p = .052, MSE = .0002). 
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Cohort 1: MK-801 Challenge: 
Hypersensitivity to the locomotor enhancing effects of MK-801 (a NMDA-R antagonist) has previously 
been found to be a robust behavioural feature of prenatal MAM treatment (e.g. Le Pen et al., 2006; 2011). 
Apparatus 
Activity testing took place in eight white plastic boxes, measuring 48 × 31 × 18 cm, with metal grid floors 
and lids. Two infrared beams spanned the boxes.  Interruption of the beam by the movement of the animal 
generated a signal that was recorded by a linked PC. 
Protocol 
Upon completion of behavioural analysis, rats in cohort one received locomotor activity assessments to 
test the effectiveness of the prenatal MAM treatment.  MAM-induced augmented hyperlocomotion following MK-
801 treatment was assessed.  Rats were placed in LMA cages and left for a 30 min habituation period.  Animals 
were then given 0.1 mg/kg MK-801 sub-cutaneously and returned to the cages for a further 60 min.  Across the 
90 min session, the number of interruptions that occurred to infrared beams spanning the cages recorded the 
activity of the animals. 
Measurements 
The apparatus used for locomotor activity testing counted the number of movements made and grouped 
them into ten-minute bins. The data were analysed using mixed ANOVA with ‘bin’ as a within-subject factor, and 
'drug treatment' as a between-subject factor. 
Results 
 Data for the first MAM cohort are shown in Figure 42.  Rats prenatally exposed to MAM were 
hypersensitive to the locomotor effects of MK-801 (given at 30 min). 
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Figure 42 Locomotor activity for saline-treated and MAM-treated rats before and after an MK-801 challenge.  MK-801 was 
given at a 0.1 mg/kg dose at bin 3.  Beam beaks were recorded for 30 min before drug administration and 60 min after.  N = 
MAM, 20; Sham, 14.  8 animals are missing from the data set due to a recording error.  Error bars represent ± SEM. 
ANOVA revealed significant effects of bin (F (3.448, 110.348) = 21.017, p < .001, MSE = 24668.780) 
and an interaction between bin and prenatal MAM treatment (F (8, 256) = 2.028, p = .044, MSE = 1025.920). 
There was also main effect of MAM treatment (F (1, 32) = 7.464, p = .010, MSE = 25366.765).  Simple effect 
analyses of the bin × treatment interaction revealed no significant difference between prenatal treatment for 
blocks 1 – 3 or 5-8 (Largest F (1, 32) = 3.836, p = 0.59. MSE = 3450.038).  A significant difference between 
treatment groups was seen for blocks 4 and 9 (smallest F (1, 32) = 7.706, p = .009, MSE = 7364.194). 
8.3 Appendix C - Stress procedure 
Forced swim tests performed on 07/02/2014 and the 27/02/2014 were not recorded due to equipment problems.
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Day Date Stress /Husbandry Experiment details
Thur 17/10/2013
Arrival - rats weight-matched and separated into Stress and No-Stress
conditions
Fri 18/10/2013
Sat 19/10/2013
Sun 20/10/2013
Mon 21/10/2013
Tue 22/10/2013
Wed 23/10/2013
Thur 24/10/2013 Cage Swap
Fri 25/10/2013 Pair Up
Sat 26/10/2013 Overnight Illumination
Sun 27/10/2013
Mon 28/10/2013 Habituate to test equipment (all)
Tue 29/10/2013 Habituate to test equipment (all)
Wed 30/10/2013 Overnight Illumination Habituate to test equipment (all)
Thur 31/10/2013 Forced Swim test PT_NAC
Fri 01/11/2013 NAC_1
Sat 02/11/2013 NAC_2
Sun 03/11/2013 Pair up NAC_3
Mon 04/11/2013 Overnight Illumination NAC_4
Tue 05/11/2013 NAC_5
Wed 06/11/2013 NAC_6
Thur 07/11/2013 Wet Cage NAC_7
Fri 08/11/2013 Wet Cage NAC_8
Sat 09/11/2013 NAC_9
Sun 10/11/2013 Rest
Mon 11/11/2013 NAC_10
Tue 12/11/2013 Pair up NAC_11
Wed 13/11/2013 NAC_12
Thur 14/11/2013 Cage Swap NAC_13
Fri 15/11/2013 NAC_14
Sat 16/11/2013 Forced Swim Test Rest
Sun 17/11/2013 NAC_15
Mon 18/11/2013 NAC_16
Tue 19/11/2013 Overnight Illumination NAC_17
Wed 20/11/2013 NAC_18
Thur 21/11/2013 Forced Swim test NAC_19
Fri 22/11/2013 Overnight Illumination NAC_20
Sat 23/11/2013 NAC_21
Sun 24/11/2013 Rest
Mon 25/11/2013 NAC_22
Tue 26/11/2013 Cage Swap NAC_23
Wed 27/11/2013 Wet Cage NAC_24
Thur 28/11/2013 Pair up NAC_25
Fri 29/11/2013 NAC_26
Sat 30/11/2013 Rest
Sun 01/12/2013 Rest
Mon 02/12/2013 Overnight Illumination NAC_27
Tue 03/12/2013 NAC_28
Wed 04/12/2013 Cage Swap NAC_29
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Thur 05/12/2013 NAC_30
Fri 06/12/2013 Forced Swim test NAC_31
Sat 07/12/2013 NAC_32
Sun 08/12/2013
Mon 09/12/2013 Pair Up
Tue 10/12/2013
Wed 11/12/2013 Wet cage Cons_T1
Thur 12/12/2013 Wet cage Cons_T2
Fri 13/12/2013 Cons_T3
Sat 14/12/2013
Sun 15/12/2013
Mon 16/12/2013 Pair Up Cons_T4
Tue 17/12/2013 Cage Swap Cons_T5
Wed 18/12/2013 Cons_T6
Thur 19/12/2013
Fri 20/12/2013 Forced swim Test
Sat 21/12/2013 Cons_T7
Sun 22/12/2013 Cons_T8
Mon 23/12/2013 Cons_T9
Mon 06/01/2014
Tue 07/01/2014 Environmental Enrichment removed
Wed 08/01/2014
Thur 09/01/2014 Overnight illumination
Fri 10/01/2014 Cage Swap
Sat 11/01/2014
Sun 12/01/2014
Mon 13/01/2014
Tue 14/01/2014
Wed 15/01/2014 Wet-Cage
Thur 16/01/2014 Pair-Up, Food deprivation Food deprivation
Fri 17/01/2014 Wet-Cage
Sat 18/01/2014
Sun 19/01/2014
Mon 20/01/2014 Forced Swim test
Tues 21/01/2014 Overnight Illumination
Wed 22/01/2014
Thur 23/01/2014 Pair-Up Habit - Magazine train 1
Fri 24/01/2014 Magazine train 2
Sat 25/01/2014
Sun 26/01/2014
Mon 27/01/2014 Lever Press pretrain 1
Tue 28/01/2014 Cage Swap Lever Press pretrain 2
Wed 29/01/2014 Overnight illumination Lever Press Train 1
Thur 30/01/2014 Forced Swim test Lever Press Train 2
Fri 31/01/2014 Lever Press Train 3
Sat 01/02/2014 LiCl Devaluation
Sun 02/02/2014 LiCl Devaluation
Mon 03/02/2014 Overnight illumination Extinction and consumption test
Tue 04/02/2014 Reinforced test
292 
Wed 05/02/2014 Pair Up
Thur 06/02/2014
Fri 07/02/2014 Forced Swim test
Mon 10/02/2014 Cage Swap
DOE - Magazine training for
reward one
Tue 11/02/2014 Magaine training for reward two
Wed 12/02/2014 Wet Cage Lever Press Training - Left Lever
Thur 13/02/2014 Wet Cage Lever Press Training - Right Lever
Fri 14/02/2014
Additional training on lever if 
necessary
Sat 15/02/2014
Sun 16/02/2014
Mon 17/02/2014 RI30
Tues 18/02/2014 RI30
Wed 19/02/2014 Cage swap Discrimination Training1
Thur 20/02/2014 Pair Up Discrimination Training2
Fri 21/02/2014 Wet Cage Discrimination Training3
Sat 22/02/2014 DiscriminationTraining4
Sun 23/02/2014 DiscriminationTraining5
Mon 24/02/2014 DiscriminationTraining6
Tue 25/02/2014 Moved cages to different room DiscriminationTraining7
Wed 26/02/2014 Moved cages back DiscriminationTraining8
Thur 27/02/2014 Forced Swim test DiscriminationTraining9
Fri 28/02/2014 Overnight illumination DiscriminationTraining10
Sat 01/03/2014 Extinction
Sun 02/03/2014 Pair Up Reacquisition
Mon 03/03/2014 Overnight illumination Reinforcer Only Test
Tue 04/03/2014 Cage Swap
Wed 05/03/2014
Thur 06/03/2014 Overnight Illumination
Fri 07/03/2014
Sat 08/03/2014
Sun 09/03/2014
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